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This study explored the association between transport accessibility to healthcare facilities and
health outcomes for patients in England with Arthritis.  The aim was to provide evidence on the
impacts on patient health from changing where patients attend hospital and a method for
evaluating who would be affected under a range of scenarios.  The study had three main stages:
1.  Systematic review to consider the current evidence. This review focused on studies that
had considered the associations between travel time/ distance and health outcomes in
global north countries. Out of 108 identified studies 77% reported evidence that patients
who live further from where their healthcare is provided have poorer health outcomes.
2. Exploring the association.  The study used two datasets to explore the association between
transport accessibility and health outcomes.  These were the linked Hospital Episode
Statistics and Patient Reported Outcomes Measures dataset (using West Yorkshire patient
data) and the English Longitudinal Study of Ageing (using a national sample).  These were
used to assess whether travelling further to the hospital or the GP was associated with
poorer health. The results include some evidence of a decline for those travelling the
furthest, but importantly that the key association with health outcomes was ease of travel.
The burden of travel to healthcare was exacerbated for individuals without access to a car,
living alone and with mobility issues.
3. Assessing the impact of changes to healthcare provision.  Using mapping techniques
(including location-allocation methods), the study has assessed the impact on patient travel
and inequalities within groups for a number of service provision scenarios.  Modelling was
used to predict changes in health outcomes from these changes.
These findings can help inform future planning decisions concerning where patients attend
healthcare services to minimise the impact on patient travel and health inequalities.
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This thesis was designed to investigate the potential impact on health inequalities from policies
such as centralisation of healthcare services or restructuring where treatment takes place.  It
does this by exploring the association between transport accessibility to healthcare and
differences in health for individuals through the current literature (by way of a systematic
review), a case study of patients in West Yorkshire (WY) who have had a total hip replacement
(THR) or total knee replacement (TKR) operation and a case study of individuals in England who
have Osteoarthritis (OA) or Rheumatoid Arthritis (RA).  Based on the results from the case
studies and the systematic review, the thesis simulates a number of scenarios focusing on the
impact of changes to where patients access healthcare and the predicted impact on health
outcomes from this.  This chapter provides the context and background to the research together
with the key aims and objectives and summaries of the subsequent chapters.
1.2 Policy	Background		
Over recent years there has been a move towards the reconfiguration of healthcare services and
specialised healthcare centres both in the UK and more widely (Douw et al., 2015; Hollingworth
and Ness, 2012). This has been driven by a number of factors including increasing costs of
providing healthcare (with budgets that have not risen to meet this), but has also allowed
increased specialisation of teams to treat specific diseases that could not be replicated in every
hospital (in terms of training, staff required and budget) (Luft et al., 1986; Maerki et al., 1986;
Ho and Hamilton, 2000).  There is evidence that having specialist teams in fewer hospitals will
have a positive impact on the health outcomes of those patients treated in these specialised
centres  (Woo  et  al.  (2012),  Forshaw  et  al.  (2006)).   However,  there  are  also  drawbacks  from
increasing the distance patients travel to attend healthcare; specifically a “distance decay”
association, which suggests that those who live closer to healthcare facilities have higher rates of
utilisation after adjustment for need than those who live further away (Haynes, 2003; Goddard
and Smith, 1998). Indeed as long ago as 1850 Jarvis proposed this distance decay effect,  finding
that fewer patients were admitted to a mental hospital in Massachusetts the further they lived
from that hospital (Hunter and Shannon, 1985).  There is also evidence that not only are
utilisation rates lower, but that those attending from further afield have poorer health outcomes
(Baade et al., 2011; Jones et al., 2008b).  At a primary care level there is evidence that increased
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distance to GP practices can have a negative impact on health outcomes (Jones et al., 1998)
and studies such as  Haynes and Bentham (1982) have demonstrated that the number of visits
made by relatives and friends to see inpatients decreased with increasing distance from the
patients’ homes to the hospital.  Whilst there is evidence of this “distance decay” effect both, in
terms of utilisation of healthcare and health outcomes, there is less evidence on how this
impacts on health inequalities.  It is important to consider the impact of changing where patients
attend healthcare facilities on health inequalities and where possible adjust policies to
reduce these inequalities especially where they are deemed unfair.
This  conflict  of  centralisation vs.  locally  provided healthcare is  a  growing point  of  debate.   A
recent study by Morris et al. (2014) found there were clear health benefits (increased survival)
for  patients  from centralising  stroke care in  a  large metropolitan area (London).   It  could  be
argued that the difference in distance between the nearest hospital to the patient and the
centralised hospital attended in London is relatively small compared to other areas of the UK,
especially where hospitals are more sparsely located.   A number of studies have shown that
there are benefits to consolidating resources into fewer hospitals leading to scale benefits from
learning by doing and treating larger volumes of patients with the same illnesses (Luft et al.,
1986;  Maerki  et  al.,  1986;  Ho  and  Hamilton,  2000).   These  studies  conclude  that  this
consolidation increases healthcare quality and has a positive impact on patients’ health and so
is desirable, but also highlight that the disease context may be crucial.  As the trend towards the
potential restructuring of healthcare services gathers pace through initiatives such as the
Sustainable Transformation Partnerships (STPs) in England, there are likely to be differences in
the trade-offs for patients between travelling further and improvements in health.     STPs are
NHS and local authority partnerships that work together to provide a more holistic approach to
patient care (NHS England, 2017).  Each region in England has been required to develop plans to
show how they are going to provide healthcare in the future.   A number of STPS include plans
to shut certain hospitals, downgrade others and restructure how services are provided (NHS
England, 2017).   Following the growing trend of centralisation there is also a growing call  to
reverse this.  Simon Stevens (Chief Executive of the NHS, UK) stated that “patients are being
robbed of dignity and compassion because of a lack of local care” (Guardian, 2014).  Having to
travel further and the impact this has on patients’ health requires further investigation.   This




Health inequalities are “differences, variations, and disparities in the health achievements of
individuals and groups”  ((Kawachi et al., 2002) p647).  Whilst some differences in individuals
health are to be expected in society (e.g. older people are more likely to be in poorer health than
younger people) the key concern is for “the absence of avoidable, unfair or remediable differences
among groups of people whether those groups are defined socially, economically, demographically
or geographically or by other means of stratification.  “Health equity” or “equity in health” implies
that ideally everyone should have a fair opportunity to attain their full health potential and that no
one should be disadvantages from achieving this potential” (WHO, 2019). The NHS was launched
in 1948 and was the first healthcare system in Western society to provide free healthcare to the
whole population, with one of the founding principles to improve health equity.   The NHS was
designed to be “universal, equitable, comprehensive, high quality, free at point of delivery and
centrally funded” Delamothe (2008), p 1216).   If access to healthcare does differ for those in
equal need this does not satisfy the equitable criteria and could lead to health inequalities. The
Acheson report  -  an independent enquiry into health inequalities in the UK, recommended that
“all policies likely to have an direct or indirect impact on health should be evaluated in terms of
their impact on health inequalities, and formulated in such a way that by favouring the less
well-off they will, wherever possible, reduce such inequalities” ((Acheson, 1998) p 75).  If
changes to where patients access healthcare are expected to impact on health in any way then
this provides ample justification for researching this issue.   The Marmot Review of 2010 goes
further and states that “health inequalities that are preventable by reasonable measures are
unfair. Putting them right is a matter of social justice” (Marmot,  2010).   Finding solutions  to
minimise health inequalities is therefore desirable.
Health inequalities can be observed between countries.  For example, residents of Angola in
Africa had a life expectancy at birth of 61.5 compared to the UK of 80.95 and Australia of 82.5
in 2016 (World Bank, 2019).  Heath inequalities can be observed within countries.  For example,
in the UK males living in Kensington and Cheslsea had the highest life expectancy at birth at 83.4
years compared to males living in Glasgow who had the lowest life expectancy at birth of 73.4
years (ONS, 2018c).  Health inequalities can also be observed across cities.  For example,
research from the London health observatory identified that starting from individuals living in
Westminster in London (see Figure 1) and travelling east that each tube stop (from Westminster
tube station) represented nearly one year of life expectancy lost (London Health Observatory,
2014 ).  By the time you got to those individuals living in Canning Town the male life expectancy
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was  on  average  6.1  years  less  than  those  living  in  nearby  Westminster  with  slightly  lower
differences for females of 3.6 years.
Figure 1:  Life expectancy within London a tube map.  source: (London Health Observatory, 2014 )
A wide range of differing and interconnecting factors that can influence an individual’s health
have been identified in the literature.  These factors are commonly characterized into an
individual’s genetics (e.g. age), the economy and environment that they live in (e.g. there local
community) and the choices that they make (e.g. lifestyle – including smoking), as shown by
Figure 2.  This includes where their live, their levels of interactions with other people, where
they work, shop and the physical environment that they have access to.   Transport accessibility
to healthcare (the focus of this thesis) plays a key role in this wheel of health and wellbeing.  But
there are of course many others some of which are now described.
One of the key areas identified in the literature linked with differences in health among the
population are levels of deprivation.  This is commonly represented in the UK using the Index of
Multiple Deprivation (IMD), which is relative deprivation at the lower level super output area
(LSOA) in England (Department for Communities and Local Government, 2011).  It is a composite
index combining data from seven domains: Income Deprivation, Employment Deprivation,
Health Deprivation and Disability, Education, Skills and Training Deprivation, Barriers to Housing
and Services, Crime, Living Environment Deprivation, so recognising that deprivation is a
multifaceted construct.  It does not measure an individual’s deprivation, but the relative
deprivation for the location (LSOA) that they live.  A range of studies have considered the
impacts of area deprivation on population health.  ONS (2018c) reported that boys born in the
23
least deprived areas in 2016 would be expected to live 9.3 years longer than those in the most
deprived areas and the gap for girls was 7.4 years. Studies in the UK have reported that patients
with OA who need a hip or knee replacement in the most deprived groups are less likely than
those in the least deprived groups to have a joint replacement (Judge et al., 2010).
Figure 2: Determinants of health and wellbeing (Source: Barton and Grant (2006))
The social networks- the people and community surrounding an individual (their social capital)
have been found to contribute to the health of individuals.  Putnam (2000) summarized research
from around the world identifying that “people who are socially disconnected are between two
and five times more likely to die from all causes, compared with matched individuals who have
close ties with family, friends, and the community” (p 327).  Other research has shown that living
alone is associated with differences in a range of health outcomes including delays in hospital
admissions, increased length of stay in hospital and patients being less likely to be discharged to
their own home (Agosti et al., 2018; Fleischman et al., 2018), more frequent readmissions and
worse  health  outcomes  (Edwards  et  al.,  2018).   Theiss  et  al.  (2011)  found  that  patients
undergoing joint replacements that had strong social support had “shorter hospital stays, are
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more likely to be discharged home, to meet ambulation and transfer-out-of-bed targets, and to
score hospital quality of care higher, and are more confident and ready to go home on discharge”
(p357).  It might be expected that having greater social networks and not living alone would
improve a patient’s ability to travel to healthcare when needed.
Another key group showing differences in health is gender.   This was shown clearly in Figure 1
where there were differences in the life expectancy between males and females. The factors
that affect health for men and women differ, for example, conditions such as polycystic ovary
syndrome affect only women, others such as OA are more prevalent in women at a younger age
than men and treatments differ.  WHO (2001) identified that there was a need to focus
differently on men and women, due “to their biological differences and their gender roles, have
different needs, obstacles and opportunities” (p2).  A number of studies have reported worse
outcomes for women with Rheumatoid Arthritis (RA) compared to men with RA, in particular
with women having more severe disease than men and lower remission rates (Symmons, 2002;
Forslind et al., 2007).  Similarly there are studies that indicate that women with Osteoarthritis
(OA) report worse knee pain and hip pain and reduced function than men with OA (Tonelli et al.,
2011).  Studies have shown that OA displays differently in men and women, particularly in
certain parts of the joints.  For example, Hanna et al. (2009) found that women have increased
rates of cartilage loss and more cartilage defects than men in their study
It is widely reported that health and physical function declines with age.  Ageing can be described
as the “progressive changes in the tissues or organs of the body, leading to decline in function
and death” (p 836).  It is affected by the full spectrum of factors portrayed in Figure 2.  Grundy
and Holt (2000) identified that adults who had experienced more difficult lives (e.g.  Death of a
child, long periods in unemployment), were more likely to report being in poorer health at an
older age than matched equivalents.  Changes over time lead to increases in problems such as
falls, as people age, but contributing are factors such as life transitions, where changes such as
retiring from work can influence health (Grundy and Holt, 2000).
Research has shown a  high rate of prevalence  of comorbidities (one or more diseases alongside
OA or RA) for patients with OA (Kadam et al., 2004) and RA (Dougados, 2016) .  Kadam et al.
(2004) matched by sex and age 11,375 patients over the age of 50 who had attended a GP in
England and Wales for  OA  with  11,375  without  OA  and  found  that  there  were  statistically
significant associations with having OA and comorbidities including, upper limb sprain, synovial
and tendon disorders, obesity, gastritis, phlebitis, diaphragmatic hernia, ischaemic heart disease
and intestinal diverticula.  A review of studies focusing on comorbidities in patients with RA by
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Dougados (2016) found that studies had identified lung cancer, lymphoma, atherosclerosis-
related cardiovascular diseases, infections, osteoporosis, gastrointestinal disorders and
depression, as comorbidities at higher rates than would be expected in the general population.
A number of studies have focused on whether health differs by ethnic group.  It is documented
in the UK that individuals from non-white groups have poorer health than people from white
groups, with individuals living in the UK originally from Bangladeshi having the poorest health
(Nazroo, 2014; Evandrou et al., 2016).  Nazroo (2014) argues that the key reasons for differences
in health by ethnic group include; genetic differences, migration effects, cultural differences,
poorer access to quality healthcare and socio-economic inequalities including experiences of
racism and discrimination.  Smith et al. (2017)  found that ethnic minorities were less likely to
receive a Total Hip Replacement (THR) or Total Knee Replacement (TKR) than their white
counterparts and also identified that patients with OA having a THR or TKR from ethnic minority
groups were younger and from more deprived areas.
Lifestyle factors such as smoking, physical activity, diet and alcohol use have been identified in
the literature as contributing to differences in individual’s health.  (WHO, 2008) reported that
“Up to 80% of heart disease, stroke, and type 2 diabetes and over a third of cancers could be
prevented by eliminating shared risk factors, mainly tobacco use, unhealthy diet, physical
inactivity and the harmful use of alcohol” (p5). Whilst the numbers of people smoking and
inhaling secondary smoke in recent years has declined (in part due to the UK smoking ban in
2007,  where  it  banned  smoking  in  enclosed  spaces)  there  are  still  an  estimated  7.4  million
people over the age of 18 smoking in the UK (ONS, 2018b).  The UK has seen a steady increase
in the number of admissions attributable to alcohol.  (NHS Digital, 2018a) calculated that there
were 337,000 admissions where the hospital admission could be directly attributable to alcohol
in 2016/17, which was 17% higher than in 2006/07.  In terms of physical activity levels 66% of
men and 58% of women were found in 2016 to have met the expected aerobic activity level,
which is “greater than 150mins of moderate activity or 75 mins of vigorous activity per week or
an equivalent combination of both in bouts of 10 minutes or more”((NHS Digital, 2018d) (p1),
which means that over 34% of men and 42% of women are not achieving this level.  NHS Digital
(2018d) also report that there was an estimated 617,000 admissions to hospital where obesity
was considered a factor in 2016/17 a rise of 18% on the 2105/16 data.  The negative lifestyle
factors that the WHO reported in 2008 are not going away and are in the above cases getting
worse contributing to the health inequalities experienced in society.
The World Health Organisation defines health as “a state of complete physical, mental and social
well-being, and not merely the absence of disease”.  ((WHO, 1946) p1).   A realisation that to
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measure an individual’s health is not limited to being free from disease, but also includes quality
of life and social wellbeing.  The first stumbling block then is how to accurately measure this
definition of health in the population, so going beyond purely the categorisation of having or
not having an International Classification of Diseases (ICD10) diagnosis code for a particular
disease (e.g. M16 = Osteoarthritis of the hip) (WHO, 2016).  Most commonly in the literature the
health of the population is measured using indicators such as morbidity, mortality rate and life
expectancy, which can easily be calculated and mapped overtime using national datasets.  For
example, the life expectancy at birth for men and women living in London in Figure 1.  In order
to operationalise a more holistic measure of the health of the population (not just an estimate
of  how  long  a  person  will  live  or  whether  they  have  a  disease)  in  the  context  of  the  WHO
definition a number of instruments have been developed to measure health in a variety of
contexts.  One of the most commonly used to measure health in the context of health economics
is the EQ-5D, which was developed as a standardized measure of Health Related Quality of L ife
(HRQoL) by The EuroQol Group (1990).  The EQ-5D comprises of five domains; mobility, self-care,
usual activities, pain/discomfort and anxiety/ depression.  For the EQ-5D-3L, each domain has
three possible responses (no problems/ some problems/ severe problems)  and from the
answers an index value of HRQoL can be generated, which could be used to assess someone
level of health, but also changes in HRQoL over time (e.g. before and after operations/
procedures).  Whilst the EQ-5D was designed as a generic health measure (to be applied across
a range of diseases) other measures have been developed that are more context specific.  For
example, the Oxford Hip score (OHS) was developed to assess the level of disability in patients
undergoing THR (Dawson et al., 1996) and the Centre for Epidemiologic Studies Depression scale
(CES_D) developed to assess the levels of depression in the general population (Radloff, 1977).
These measures are discussed in more detail in Chapters 3 and 4.
If access to healthcare does differ for those in equal need this does not satisfy the equitable
criteria.  Whilst there are many potential determinants of health and health inequalities
understanding the impact that the journey to and from healthcare has on patient outcomes is
critical.  For this thesis I am  focused on exploring whether differences in transport accessibility
to healthcare are associated with inequalities in health, answering questions such as – Is unequal
transport accessibility to healthcare associated with differences in health?  Importantly
recognising that in doing this there are multiple possible determinants of health, as discussed
above that need to be considered.
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1.4 Transport	Accessibility	
The role that transport plays in the health of the population was highlighted by Acheson who
stated that a “lack of transport may damage health by denying access to people, goods and
services...”.(Acheson (1998): p55).  Exploring whether transport accessibility to healthcare is
associated with health inequalities in the population addresses one specific and potentially
important linkage in this field.   Accessibility has been conceptualised in a number of ways in
the  literature  over  time.   Hansen  (1959b)  described  accessibility  as  “a measurement of the
spatial distribution of activities about a point, adjusted for the ability and the desire of people or
firms to overcome the spatial separation “(p73).  Critically Hanson identified that accessibility
was not purely a distance calculation and recognised that different individuals have differing
abilities and willingness to travel to get to key goods and services.  More recently this definition
has been simplified into “people’s ability to reach desired goods, services and activities” (Litman,
2011) and in the case of this thesis patients ability to reach healthcare facilities and services.
Unpicking some of the reasons why patients might find accessing healthcare facilities more
difficult or impossible has been considered by a number of authors.  The Social Exclusion Unit
(SEU) (2003) report - Making the Connections defined transport accessibility through the
following statement “Can people get to key services at reasonable cost, in reasonable time and
with reasonable ease?” (p6). Or to put it another way:
· Does transport exist between the people and the service?
· Do people know about the transport, trust its reliability and feel safe using it?
· Are people physically and financially able to access transport? And
· Are the services and activities within a reasonable distance?
There are a number of modes of transport that patients can use to travel to healthcare services
in the UK – including, but not limited to car, taxi public transport, walking/cycling, community
transport and the NHS Patient Transport Services (PTS).  Whilst it is most commonly reported
that people travel to healthcare using a private vehicle, we know that, for example, in the UK
26% of households do not own a car, and that this percentage is higher for older households
and for  those with limiting  long term illnesses  (ONS,  2016a).   For  some local  authorities  the
proportion is as high as 40% (ONS, 2016b).  The SEU (2003) reported that 31% of people without
a car have difficulty travelling to their local hospital, compared to 17% of people with a car.  In
addition 1.4 million individuals had missed/ turned down or chosen not to seek medical help
over a year because of transport problems.   The data illustrates that having a car does not
preclude individuals from having issues with transport accessibility to healthcare, but as
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described by the Health Development Agency (HAD) “inadequate public transport is by far the
most frequently mentioned transport problem identified by people who have difficulty getting
to local services.  Other access issues include the location of NHS sites and car parking facilities,
limited access to specialist transport services for those with social needs and under-resourced
community transport services” HDA (2004) (p2).
The most common method used to measure transport accessibility to healthcare facilities is by
calculating the travel times and distances that patients would have to travel to get to the
healthcare facilities.  Either to the nearest available facility or the actual facility attended.  A
growing number of studies have determined transport accessibility levels to healthcare using
Geographical Information Systems (GIS) techniques, by mapping car and public transport travel
times and distances to healthcare facilities. These can be broadly split into revealed accessibility
and potential accessibility methods, (Khan, 1992). Revealed accessibility refers to methods
that utilise data from actual healthcare trips; for example the drive time or straight-line
distance between a patient’s home address and the hospital they attended (Jackson et al.,
2013; DeNino et al., 2010).  Potential accessibility refers to methods that look at the potential
for accessing healthcare facilities in a particular area, for example,  using  gravity models
(Hansen, 1959a) and specialised gravity models, where 2 step flotation catchments
areas method have been used (Lou and Wang, 2003; McGrail and Humphreys, 2009).
Local authorities in England have typically focused on the percentage of the population that
can get to a specific local hospital by bus within 30 and 60 minutes in their Local transport
plans, with the aim of improving this percentage  (e.g. West Midlands (2006)).  One of the
key issues with this is that the hospital selected might not be the hospital where all patients
are treated, either because it lacks the specialism they require, or because they or their GP
have not chosen it for other reasons.  The National Travel Survey (NTS) reports annually on
the percentage of the population that could access their nearest GP and hospital within a
specified time by bus or walking.  In 2016 92% of individuals could access a GP in <15 minutes
and 11% the nearest hospital by bus or walking in <15 minutes.  Whilst all individuals could
get to their nearest GP in under 60 minutes, 5% would have travel times >60 mins to the
nearest  hospital  (DfT,  2017).   The  key  issues  with  this  measure  is  that  it  assumes  that
individuals attend their nearest healthcare facility, that individuals can walk at a speed of at
least 4.8kmph and can walk a distance up to 800 metres to get to the bus stop.  This may be
very difficult for some groups in society, who are likely to make up a larger proportion of
those attending health services.  Equal access for equal need in the NHS maybe less
achievable if the transport system does not allow equal transport accessibility.
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In order to formalise this multifaceted concept of accessibility to healthcare facilities (multi-
modal and varying in quality and affordability), the thesis turned to a utility based approach
using the concept commonly used in economics of Generalised Cost (GC), which is very widely
used in  transport economics (Small and Verhoef, 2007).  GC is the sum of the monetary and
non-monetary  costs  of  travelling  from  A  to  B.   The  monetary  costs  include  out-of-pocket
expenses such as bus fare, taxi fare, fuel costs and parking costs.  The non-monetary costs of the
journey comprise of the travel times (and the value to the patient of this time), and other aspects
of the journey, such as the level of comfort or pain whilst travelling and feelings of safety and
security, which are included as other sources of disutility.  These key concepts are represented
by equation 1 and map onto the three key areas identified by SEU (2003):
GC = C + VT + D           Equation 1
where:
· GC = generalised cost
· C = Out-of-pocket costs
· vT = value of time, v, multiplied by the journey time T
· D = ‘other sources of disutility’
An individual’s level of transport accessibility A, can be derived from the GC of a journey, and
the relationship is an inverse one, as shown in Figure 3, which is represented as a deterrence
function.  At GC*** a journey to healthcare facilities will be rendered impossible (the GC to the
individual is too high), so there is zero transport accessibility.  Possible reasons for this could be
that there is no viable transport option to get them to the appointment, or the pain whilst
travelling is so high they can’t make the journey, or their value of time is so high for when there
are  available  GP  appointment  (e.g.  they  are  at  work),  that  they  don’t  seek  or  attend  an
appointment.   As the GC reduces the transport accessibility improves, as can be seen moving
from GC*** to GC* results in an increased transport accessibility at A*.  At the point at which
the GC is zero there is no further improvement possible to the individual transport accessibility
to the healthcare facility.  Accessibility to healthcare is not infinite at this point, because even
home visits have scheduling and time costs and telemedicine has time costs, so the curve
intersects the axis at this point.
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Figure 3: Measuring the impact of GC on a patients transport accessibility to healthcare
The focus of this thesis is whether policies changing where patients access healthcare, are
associated with inequalities in health outcomes.  What impact does this have on their GC and so
association with transport accessibility and as a result the association with health outcomes?   It
is likely that within the patient population there are many different responses to changes in the
GC of a journey to healthcare facilities.  As different patients will have different weights for the
components of the GC function and differing values.
To explain, there are a number of possible responses.  One possibility is that for a policy such as
centralisation, as GC increases (e.g. increases in travel time, or cost of travel or other disutility’)
transport accessibility does not change at all or reduces by a smaller proportion than the
increase in GC.  Under this scenario transport accessibility is said to be inelastic.  The second
extreme is as the percentage of GC increases transport accessibility is reduced by a larger
percentage are transport accessibility is said to be elastic.  These second group of patients are
less likely to be able to cope with changes in the GC and as a result their transport accessibility
to healthcare will fall.  In the most extreme cases of an increase in GC this results in them not
being able to make the journey.   There are many different responses to changes in the GC of a
journey to healthcare facilities.
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Whilst the focus of the thesis is on transport accessibility there are other factors that can
influence the level of healthcare offered to the patient.  Similar affects to those identified for
transport accessibility can be identified where services are not available for particular groups in
the population.  It is well documented in the literature and media that there are differences in
provision of health care around the UK.  For example, differing requirements or criteria which
patient must meet for operations or labelling operations as ‘procedures of limited value’
(Harrogate and Rural District CCG, 2014). These are often referred to as the ‘postcode lottery’,
as patients living in different areas have differing levels of access to the same treatment.   In
addition the quality of the services provided to patients might differ.  For example the quality of
the hospital might differ and the costs to different groups of patients may also vary.  Whilst in
the UK NHS healthcare is provided free at point of use, it is possible to select to pay privately
and be treated more quickly for operations such as THR and TKR, so there may be difference in
the cost that individuals pay for the same treatment.
It is important to understand the potential impact to patients of both how they currently access
healthcare services and the impact transport has on this and how this might change under
different reconfiguration scenarios.  Whilst it is not possible to put a healthcare facility in all
areas to minimise all patients’ journeys (make all journeys equal) it is likely that some options
(locations) will provide patients with a better service and minimise the impact on inequalities.
1.5 The	 Patient	 Group:	 Individuals	 with	 Osteoarthritis	 and	
Rheumatoid	Arthritis	
To explore the policy of restructuring healthcare services this thesis has focused on patients
with musculoskeletal (MSK) diseases, specifically of Osteoarthritis (OA) and/or Rheumatoid
Arthritis (RA).  Over 8.5 million of the population are estimated to have OA and around 400,000
RA (NICE, 2014a; NICE, 2015b), the majority are over the age of 50 years old.  It is estimated
that the NHS spent £5.34 billion on MSK diseases in 2012/13, which was the 4th highest area
after mental health disorders, circulation problems and cancers/tumours (Arthritis Care, 2012).
The UK population at pensionable age is expected to increase from 12.4 million in 2016 to 16.3
million in 2041 and therefore treatment for arthritis is likely to form an increasing proportion
of future NHS budgets (ONS, 2017 ).  Research has shown that individuals with RA have worse
health than those with OA and those with OA have worse health than the general population
(Dominick et al. (2004)).   Dominick et al. (2004) reported that compared to individuals
without arthritis “older adults with OA and RA reported poorer general health, physical health,
mental health, and sleep as well as more activity limitations and pain” (p5) and that individuals
with RA reported lower Health Related Quality of Life (HRQoL) scores than those with OA.  OA
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and RA are treated in different ways and are associated with different health outcomes and
demands on the health service.
Osteoarthritis		
OA  is  the  most  common  form  of  chronic  arthritis.   It  is  a  chronic  progressive  MSK  disorder
characterised by joint damage, affecting cartilage and causing the growth of new bone in joints.
It affects mainly the knee, neck, hip, hand, and spine, leading to painful rubbing of bone on
bone in joints. Guidance for the diagnosis and care of OA in England is provided by NICE
(2014a).   The current  care management  pathway for  OA is  shown in  Figure 4.   It  shows a
number of stages including self-management and information about how to lose weight, with
a focus on links to primary care before the patient would need to attend a hospital for further
treatment (e.g. for replacement of a joint).  The guidance states that before referring a person
for joint surgery they must have been offered at least the core non-surgical treatments first.
The emphasis is on the majority of treatment management at a primary care level including
an annual review.
Figure 4: Management of Osteoarthritis (Adapted from (NICE, 2014a))
There are two main approaches used to diagnosis OA, these are a clinical diagnosis based on the
symptoms that the patient presents with and radiographic diagnosis (and also can be used
together).  The first, considers the symptoms that the patient is experiencing.  For example the














Referral for consideration of
joint surgery
Surgical Options
Follow up & Review
33
· “they are over the age of 45, and
· have activity related joint pain and
· have either no morning joint related stiffness or morning stiffness that lasts no longer
than 30 minutes” (NICE (2014a) p1)
The second uses images, more commonly x-rays, but also Magnetic Resonance Imaging (MRI)
scans or ultrasound scans that look directly at the joint to diagnose OA.  These images are used
to evaluate changes in the bone, osteophyte formation (lumpy bone that forms on or next to
the affected joints) and joint space narrowing, as shown in the centre of the diagram in Figure
5, which can result in the bones rubbing together.
Figure 5:  Graphical depiction of a normal joint, a joint with OA and a joint with RA Source:
(iStock, 2019)
Research has shown that evidence gathered from using radiographic images to diagnose OA
does not always align with the evidence of the symptoms reported by the patient.    For example,
Parsons et al. (2015) compared whether the radiographic, clinical and self - reported diagnoses
of knee OA for ~400 men and women correlated and found that 58% of those with a radiographic
OA diagnosis of the knee did not have either a self-reported diagnosis of OA or symptomatic
diagnosis of OA.  Kim et al. (2015) reported a discordance between the two methods of diagnosis
for hip OA with 9.1% of patients with a clinical diagnosis also having evidence of radiographic
hip OA and 23.8% of those with a radiographic diagnosis reporting painful hips. Not all
individuals who have a radiographic diagnosis of OA have the relevant symptoms for the
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symptomatic diagnosis and not all patients who have a symptomatic diagnosis have
radiographic evidence of OA.  In England NICE (2015a) argue against using radiographic images
where the clinical diagnosis criteria, as described above have been satisfied, stating that
“minimal changes [in the joint] can be associated with substantial pain, or modest structural
changes to joints can occur with minimal accompanying symptoms” (p50).  Other studies have
argued that radiographic evidence is not enough on its own as, whilst a patient might exhibit
radiographic evidence, which indicates changes to the structure, the symptoms of OA are
exacerbated by other aspects including comorbidities, muscle strength, mood and obesity (Issa
and Sharma, 2006).
Reviews  focusing  on  the  epidemiology  of  OA  have  identified  a  range  of  risk  factors  where
individuals are more likely to have a diagnosis of OA.  The literature splits the risk factors into
person level and joint level characteristics.  Person level risk factors include Age, gender, obesity,
genetics and diet, whilst joint level risk factors include injury, joint loading and deformity of the
joint (Palazzo et al., 2016; Allen and Golightly, 2015; Glyn-Jones et al., 2015; Issa and Sharma,
2006; Vina and kwoh, 2018).   The loss of function and pain from having OA can have major
impacts on quality of life affecting both the physical and mental health of the individuals.
Research has shown associations between having OA and increased risk of falls (Prieto-Alhambra
et al., 2013; Hoops et al., 2012), reduced ability to perform daily tasks at home (McIntyre et al.,
2014)  and at work (Harris and Coggon, 2015), issues with walking and climbing stairs (Felson et
al., 2000) and evidence of higher rates of suicidal thoughts than the general population
(Tektonidou et al., 2011).
Rheumatoid	Arthritis		
RA is a chronic progressive auto-immune disease, which causes inflammation in the joints,
leading them to become swollen, tender and warm, while stiffness limits joint movement.
Rheumatoid Arthritis is an incurable disease that affects approximately 500,000 individuals in
England (Symmons, 2002).  The RA joint is shown the right hand side of Figure 5 shown with a
swollen inflamed synovial membrane and bone erosion.   Whilst incurable, patients can go into
remission for periods of time.  Patients with RA usually present with symmetrical inflammation
of the small joints, most commonly the metacarpophalangeal, proximal interphalangeal and the
metatarsophalangeal joints.  Key symptoms include joint pain, early morning stiffness and
swelling round joints.  Patients are referred to specialists quickly, as research has shown that
early treatment within 3 months of onset can reduce disability and long term damage (Lard et
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al., 2001).  The current NICE guidelines for diagnosis of RA in England state that patients with
suspected persistent synovitis of undetermined cause should be referred for specialist opinion
if any of the following apply:
· The small joints of the hands or feet are affected
· More than one joint is affected
· There has been a delay of three months or longer between onset of symptoms and
seeking advice.
In order to make a diagnosis of RA there is then a suite of tests added to the criteria above.
Patients can be tested for rheumatoid factor in their blood.  This is an autoantibody found in
around half of patients with RA, but can also be found in patients without RA such as those with
infections (NHS, 2019b).  Studies have found that smoking status and age increases the
prevalence  of  rheumatoid  factor  in  the  general  population  (JÓNsson  et  al.,  1998;  van
Schaardenburg et al., 1993) without them having RA.   Testing for rheumatoid factor is not 100%
accurate in diagnosing RA, as it does not identify all individuals with RA and does identify some
without.  The next test measures a different antibody in the individual’s blood an anti–cyclic
citrullinated peptide (anti-CCP), which is predominantly found in individuals with RA.  This test
has much better specificity (96%), so rules out more of those without RA, but, as the review of
studies by Braschi et al. (2016) reported that it is only present in 25% – 50% of patients before
or at diagnosis, so a negative result does not rule out a positive diagnosis of RA.  The final method
that  is  used  to  enable  a  diagnosis  is  to  carry  out  an  x-ray  (and  or  ultrasound  or  Magnetic
Resonance Imaging (MRI)) on the hands and feet to look for damage to the bones.
The diagnosis and care guidelines for RA in the NHS in England are described in NICE (2015b).
The management pathway for RA patients in England is shown in Figure 6.  Like the
management of OA there is guidance on diets, but the focus lies on hospital attendance for
treatment and diagnosis.  RA can ‘flare up’ at times and the emphasis is on patients having a
named  person  at  the  hospital  to  contact  in  these  times  to  manage  their  care.    The  main
treatment is through drugs called disease-modifying anti-rheumatic drugs (DMARDs),
although surgery is offered to patients to improve joint function, reduce pain and to prevent
deformity.  The guidance states that patients with recent onset of the disease should be
monitored monthly and that all patients with RA should have an annual review and access to
a specialist at the hospital.  A number of studies have reported increased prevalence of
certain comorbidities including cardiovascular disease, infections and malignancy in those
with RA (Dougados et al., 2013 ; Avina-Zubieta et al., 2008; Uresson and Matteson, 2013).
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These comorbidities also increase the likelihood of the need to attend healthcare more
regularly.  Unlike OA, which can be diagnosed by the GP, RA requires referral to a specialist.
Figure 6: Management of Rheumatoid Arthritis (adapted from NICE (2015b))
Studies focusing on the epidemiology of RA have identified a range of risk factors where
individuals are more likely to have a diagnosis of RA (Allen et al., 2018).  Although the mechanism
of developing RA is unclear the literature has investigated a number of genetic, environmental
and personal /lifestyle factors associated with developing RA and its severity (Symmons, 2003;
Alamanos and Drosos, 2005).   Studies have shown that women are more likely to get RA than
men at a ratio of 3: 1, with a higher ratio of women to men diagnosed at an earlier age (Alamanos
and Drosos, 2005).  Research has shown that those patients diagnosed with RA before the age
of 60 tend to be more likely to enter spontaneous remission, whereas older-onset patients have
more  active  disease  and  are  more  disabled  when  help  is  sought  (Symmons,  2003).   Socio
economic factors have shown no evidence for being a predictor of risk of developing RA, but
there is some evidence that socio economic status is associated with different prognosis of the
disease, with those individuals in lower socio economics groups having worse outcomes
following treatment (Symmons, 2003).   Although it is not clear how this currently manifests
itself.  A large number of studies have focused on the association between smoking as a risk
factor for the development of RA (Wilson and Goldsmith, 1999).  Against this there is some
evidence that smoking may have a protective effect in reducing joint inflammation in the early
stages  of  RA and so limiting  bone deterioration (Harrison,  2002).   A  number of  studies  have










Initial Treatment for newly
diagnosed RA  -DMARDS
Introducing new drugs for those
with established RA if DMARDs
are not working.
Reducing doses  for those with
stable RA
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on development of RA.  Sköldstam et al. (2003) reported on the protective effects of having a
Mediterranean diet on development of RA, which resulted in “a reduction in inflammatory
activity, increase in physical function and improved vitability” (p208).  Different ethnic groups in
society have been found to have different prevalence rates of RA with a higher prevalence rate
in North America and North Europe than in other areas of the world (Alamanos and Drosos,
2005).
As with OA the loss of function and pain from having RA can have a major impact on quality of
life affecting both the physical and mental health of the individuals.  Studies have shown that
patients with RA have a higher prevalence of depression and anxiety than the general population
(Margaretten et al., 2011).  There are associations with not being able to work, with the disability
caused by onset of RA in some cases preventing individuals from carrying on working (Young et
al., 2002).  Patients with RA are more likely to report having lower quality of life, with increased
pain, disease and reduced physical function and level of independence (Malm et al., 2017)
Tengstrand et al. (2008) questioned 1000 RA patients in Sweden and found that 80% had current
foot problems and 71% found walking difficult.  A range of potential impacts on quality of life
have therefore been identified.
1.6 Patient	Public	Involvement	Group	(PPI)	
At the start of the study a PPI group was set up that included five patients who had had
experience of RA, OA or both.  This group was recruited through the Leeds Biomedical Research
Centre.  This involved advertising the roles and setting out the expectations of being part of the
group.  The objective of this group was to ensure that the study focused on patient need.  The
group met six times during the study and were a dedicated group who contributed their
experiences of travelling to healthcare for appointments and treatment and was a great benefit
to the study.  One of the original group members also read and commented on my original
proposal.  Key aspects brought out by the PPI group are discussed where relevant in this thesis.
1.7 Aim	and	Objectives	
The aim of the thesis  is:
To investigate the association between transport accessibility to healthcare and health
inequalities for individuals with rheumatoid arthritis and osteoarthritis
In order to achieve this aim the following objectives have been determined:
Objective 1: To undertake a systematic review to provide evidence concerning the association
between transport accessibility to healthcare and health outcomes.
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Objective 2: To explore and document the healthcare and transport accessibility needs of
patients with osteoarthritis and rheumatoid arthritis.
Objective 3: Develop statistical models to examine the associations between transport
accessibility to healthcare and inequalities in health for individuals diagnosed with RA and OA.  For
two case studies:
· Case  Study  1:  West  Yorkshire.   Using  the  linked  Hospital  Episode  Statistics  –  Patient
Reported Outcome Measures (HES-PROMS) dataset
· Case Study 2: England.  Using the English Longitudinal Study on Ageing (ELSA) dataset
Objective 4: To employ the results of the systematic review and statistical models to explore
policy implications of restructuring healthcare services for individuals with RA and OA.
1.8 Structure	
In order to address the aims and objectives the thesis is structured into six interlinked chapters.
A summary of the content of each chapter is provided below:
Chapter 2 explores the associations between travel time/ travel distance and health outcomes
through  a  systematic  review.   It  focuses  on  the  question  - Are differences in travel time or
distance to healthcare for adults in global north countries associated with an impact on health
outcomes?  It describes the methods, reports the results and discusses and summarizes the
findings. The findings feed into the case studies described in Chapters 3 – 4.  This chapter
addresses objective 1.
Chapter 3 describes the first case study used to explore the association between transport
accessibility (measured in this case study using travel times and distance to healthcare) and
differences in health/wellbeing.  The case study uses the HES-PROMS dataset, which includes
hospital appointment data for patients identified as having OA and a subset of these who have
had a THR or TKR.  This targets objective 3
Chapter 4 describes the profiles of those individuals who are part of the ELSA who have OA or
RA.  This includes how they travel and differences between the two MSK disease groups.  The
case study uses individuals health and well-being data and transport accessibility (measured in
this case study using travel time/distance to the nearest healthcare facility and ease of access
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to the GP/hospital) to explore the association. It considers whether there are any key differences
across the regions of England in particular the London / outside London divide.  This chapter
targets objectives 2 and 3.
Chapter 5 brings together the case studies and systematic review results to test a number of
different scenarios for provision of healthcare using a West Yorkshire population including the
scenarios assessment of which hospital would minimise the travel times/ distances to healthcare
and predicted changes in health outcomes.  A method is tested to estimate individuals who are
likely to not have access to a car.  This chapter targets objective 4.
Chapter 6 (the final chapter) of the thesis draws together the findings from the previous
chapters and brings out the key points and discusses the overall findings. Results of previous
chapters will be interpreted collectively to develop overall conclusions. It discusses the strength
and limitations of the thesis.  The implications for public health research and policy will be




The aim of this chapter is to describe the systematic review that was undertaken to answer the
research question - Are differences in travel time or distance to healthcare for adults in global
north countries associated with an impact on health outcomes?  (Study objective 1). The aim of
this chapter is to gain a better understanding on whether travelling further to access healthcare
facilities has a negative association with health outcomes.  This systematic review brings
together studies that have calculated patients travel to healthcare facilities following their
attendance at the healthcare facility (revealed accessibility) and explored whether this is
associated with health outcomes.   The thesis was primarily interested in whether there was an
association between travel time / distance and health outcomes, but also, secondly, an interest
in the data and methods used by the studies.  This would then be used to inform the data
needed and methods of analysis for the two case studies presented in this thesis in Chapter 3
and Chapter 4.  Parts of this chapter were published in Kelly et al. (2016) and Kelly et al. (2014).
2.2 Methodology	
When designing the protocol for the systematic review it was considered whether it would be
suitable to include a meta-analysis to pool results to give an average effect across studies.  This
was ultimately not included in the review protocol, as considerable heterogeneity was
anticipated in the data with differences in populations, outcome measures (e.g. follow up,
mortality), scale of distance to the healthcare facility, study designs (e.g. cohort, cross sectional)
and disease groups (see Table 5) that would reduce the meaningfulness of the results.  As noted
in The Cochrane Collaboration (2011) “if studies are clinically diverse then a meta-analysis may
be meaningless and genuine differences in effect may be obscured” (part 9.1.4).
The study followed the PICOS (Population, Intervention, Comparator, Outcome, Study Type)
search design (Sackett et al., 1997). The population were adults accessing healthcare in Global
North countries (studies were included from the following regions and countries: Northern
America,  Western Europe,  Australia  and New Zealand).   Papers  were restricted to  studies  in
Global North countries to increase the relevance of the results to the UK case and application.
The intervention and comparator were the distance and travel times to healthcare.  The
outcomes were any health outcomes (e.g. survival, mortality, and quality of life) and proxy
measures for health outcomes (e.g. follow up attendance, utilisation of clinic).  No restriction
was made on study type or design.  The following databases were searched: Web of Science,
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MEDLINE, Embase, and Transport database, HMIC, and EBM Reviews for relevant papers in
November 2014 and updated the search on 7th September 2016.  As an example, the search
strategy that was developed for MEDLINE is provided in Appendix 1.
All the titles and abstract were screened by myself and 20% were independently screened by
Professor Claire Hulme (CH) to check for consistency.   The key inclusion criteria were that the
study quantified distance or travel time to healthcare AND identified whether there was an
impact from this on health outcomes AND the assessment of travel time/ distance on the health
outcome was the primary objective of the study.  The study excluded papers:
· Including children (< 18 years old and maternity).
· Reporting only patient opinions and views.
· Reporting  only   one   off   emergency   events   or   travel   by   different   types   of
emergency vehicles including Myocardial Infarction and transfers between
healthcare facilities.
· Reporting studies from Global South countries.
The full papers of studies that met the inclusion criteria were reviewed and data extraction and
quality assessment completed.  Reference lists of included papers were then reviewed to
identify any additional studies.  Any identified papers were subjected to the same review process
described above.  The quality assessment of the studies was undertaken using a modified
version of the cohort studies Critical Appraisal Skills Programme (CASP) tool (CASP, 2015) linked
to the PICOS terms.  One of the critical aspects of the systematic review is that the quality of the
paper needs to be robustly assessed.  As the Centre for Reviews and Dissemination (CRD)  state
“There are many different checklists and scales, readily available…which can be modified to
meet the requirements of the review, or a new detailed checklist, specific to the review maybe
developed” CRD (2009) (p43).  This review included a range of study types (e.g. cohort, cross
sectional), which ruled out a number of existing checklists that have been developed for specific
types of study and some specifically as part of a meta-analysis.  There are positive and negative
issues with most of the checklists.  For example, the Newcastle-Ottawa Scale assesses the quality
of non-randomised case control studies and separately cohort studies, so is not directly relevant
in its current form for the range of papers and study types included in this review and has been
shown to have poor levels of agreement between raters (Hartling et al.,  2013).  Currently no
single approach to assessing study quality is appropriate to all systematic reviews.   This review
adapted the existing CASP checklist to quality assess the papers that were included in the review
to make it specific to the key areas of bias that the study wanted to assess.  This included key
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components of the CASP tool for example: Did the study address a clearly defined question?
Had a representative population been used? Was the exposure (distance or travel time)
accurately measured to minimise bias? And the same for the health outcome; whether
potentially confounding variables had been identified and included in the analysis.  In addition
the review included whether the funding source was external to the organisation and whether
the study was peer reviewed.  This was important as studies completed in-house may have an
inherent tendency to be biased.  CK extracted the data and assessed for quality, according to
the study protocol and 20% were independently extracted and assessed by CH.  No studies were
excluded on the basis of the quality assessment.
The review protocol was developed and published on the PROSPERO database (Kelly et al., 2014).
2.3	Results	
One hundred and eight studies met the inclusion criteria and were included in the review.  The
study flow diagram is provided in Figure 4, which shows that over 19,000 abstracts were initially
identified and after removing duplicates (due to multiple databases being searched) 13,346
abstracts and titles were screened by hand.  Two hundred and thirty were deemed to meet the
study criteria.  Full  texts were accessed for these papers and screened of which 108 met the
study criteria. For three papers the full papers were not accessible.
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Figure 7: Review flow diagram
The studies covered a wide range of diseases groups, interventions and health outcomes.  The
results of the quality assessment are summarised in Table 1.   Which shows that the main area
of concern with regards to quality assessment was the funding source where – 37% of the
studies were funded in-house or it was unclear how they were funded, which may introduce
bias.  The other question over the quality was whether the method used to calculate the
distance/ travel time was reported accurately.  Studies where no information on how the
distances and travel times were calculated are highlighted in the results tables by study.  No
studies were excluded on the basis of this assessment.
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Table 1 Quality Assessment of Studies n (%)
Yes No Unclear/Partial
Did the study address a clearly focused
question?
108 (100%) 0 0
Was the study population recruited in an
acceptable way?
105 (97.2%) 0 3 (2.8%)
Did it include all the population or describe
the population not included?
97 (89.8%) 7 (6.5%) 4 (3.7%)
Was the method used to calculate the




Was the health outcome accurately
measured to minimise bias?
108 (100%) 0 0
Have important confounding factors been




Is the funding source external to the
organisation?
68 (63.0% ) 16
(14.8%)
24 (22.2% )
Was the research peer reviewed? 101 (93.5%) 0 7 (6.5%)
Studies were categorized according to the following 3 groups:
1. Distance Decay Association – Studies that showed evidence of an association between
patients living closer to the healthcare facility and having better health outcomes/
higher access rates to the healthcare services compared to those living further away
(these studies are presented in Table 2).
2. Distance Bias Association – Studies that showed evidence of an association between
patients living further away from the healthcare facility and having better health
outcomes/  higher  access  rates  to  the  healthcare  services  compared  to  those
living closer to the healthcare facilities (these studies are presented in Table 3).
3. No Association – Those studies that found no evidence of an association between
distance from the health facility and health outcome (these studies are
presented in Table 4).
Studies are organised within the results tables by disease type.
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(meeting the criteria of
living < 6 hours to the
treatment centre).
Overall Survival Travel Time.
Calculated using driving distance and
average driving speeds along the road
network
Travel time was treated as a
categorical variable using 3 groups:
≤40, 41 - 159, ≥160 mins and also a
continuous variable.  The range of




The study found that longer drive times
to the transplant centres was associated
with worse overall survival in patients
alive and disease free after 1 year -   This
was only true using travel time as a
continuous variable.  They suggest this
may be in part related to the lower
number of visits in patients living further










had a unilateral or
bilateral mastectomy
with or without









Straight-line distance.  Using the
“Great Circle Distance” in the
database.
Treated as a continuous variable.
Average distance travelled for
mastectomy without reconstruction –
27.1 miles &  34 miles with
reconstruction.
Patients’ Residence (zip





The study found that patents had
travelled further for breast
reconstruction services than for
mastectomy without reconstruction.
Indicating a distance bias.   Patients were
more likely to have immediate breast
reconstruction the further they had
travelled (0-20 miles 13.9%






A set of cross sectional
telephone survey of the
population > 18 years in
the USA.  Taken from






The study calculated 1 mile grid cells
for the state of Utah and for each grid
cell populated with individuals aged
Patients’ Residence
(determined using a 1
mile grid reference for
the addresses)
The study found that residents living >
20 mins from the nearest colonoscopy
provider were significantly less likely to






50 or older they calculated the actual
travel time to the nearest
colonoscopy provider.  This was then
used to calculate a population
weighted median travel time by zip
code.
Travel times was treated as a
categorical variable and   grouped
into 3 categories: <10 minutes, 10 -




screening than those living < 10 mins





Breast Cancer New Mexico Tumour














Distance was treated as a categorical
variable and split into the following
categories:
<10 miles, 10.0-24.9, 25.0-49.9, 50.0-
74.9, 75.0-99.9, ≥100 miles.
Patients’ Residence
(street address (70% of






The study found that by controlling for
age the likelihood of receiving
radiotherapy following breast conserving
surgery decreased significantly with
increasing travel distance to the nearest
facility.  This was significant for












Road Distance and Travel Times.
The distances were treated as a
categorical variable using the
following groups: < 50km, 50 - 99km,
100 - 199, 200 – 399 and ≥400km.
The travel times were treated as a
categorical variable using the






The study found that after adjusting for
age, sex and stage at diagnosis, patients
who lived 100 - 199km, 200-399km and
400km or more from a radiotherapy
facility were 16%, 30% and 25%
respectively more likely to die from
cancer than patients living within 50km
of such a facility.  For every 100km
increase in distance there was on
average a 6% increase in risk of
mortality.  Similar results were found
when travel time was used in the
calculations, where patients living
greater than 6 hours away were 22%
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more likely to die from cancer than














Travel Time and Road distance.
The distances and travel times were
treated as categorical variables using
the following method of grouping -
low - the lowest quartile, Medium -
quartiles 2 and 3, High - records
between the 75th and 95th
percentiles and Highest - the highest
5% of records.
The 2001 census area




The nearest GP and
nearest Cancer Centre
The study found that increased travel
time/ distance was weakly associated













(Does not say what method used)
calculated using ESRI ArcMAP
Distance was treated as a categorical
variable and split into quintiles from <
5km up to > 80km.
Patients’ Residence
TO
The treating hospital and
the closest high volume
hospital.
The study found that living > 80km
(compared to < 9km) from a high volume
hospital was associated with an
increased risk of non-adherence to care
plans (OR = 1.88, Confidence interval,
1.61 - 2.10). The study found that
distance to a high volume hospital and
distance to receive treatment could be
used to predict whether patients would
meet the guidelines for care for















(no info on GIS methods used)
Distance was treated as a categorical
variable using the groups of < 50km
(where it was assumed that patients
could travel on a daily basis from
home) 50 - 200km (where it was
assumed patients would go home for
weekends only) and > 200km (where







The study found that waiting times for
radiation therapy among lung cancer
patients in Queensland was not
associated with distance from home to
the nearest public radiation treatment
facility. The study found that those
living > 200km away had slightly worse
survival than those who lived < 50km.
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need to spend the duration of their


















Distance was treated as a categorical
variable using the groups of 0 - 5km,
6 - 37km, 38 - 57km and ≥58km.








The study identified that increasing
distance from the nearest cancer centre
was associated with a higher chance of
disseminated disease at diagnosis and

















Distance was treated as a categorical
variable using the groups ≤ 5km, 6 -





The nearest cancer centre
The study found that increasing distance
from the nearest cancer centre was
associated with a reduced chance of
diagnosis before death for stomach,
breast and colorectal cancer and poorer



















Distances were treated as categorical
variable using the groups <20 miles,
20 to <40, 40 to < 60, ≥60 miles.  The









The study found that women were less
likely to have breast conserving surgery
with increasing distance from the
nearest facility.
They were also less likely to have
radiation therapy the further away they













Sample = 26,390  Males






Shortest travelling time by road.
Travel time was grouped into 3
categories based on practical
considerations.  < 2hours, 2 - 6 hours
and >6 hours





The study concluded that the proportion
of premature deaths was higher for
those living >2 hours from a treatment
facility for breast cancer.  Colorectal
patients living > 6 hours from a
treatment facility had poorer outcomes
than those in the 2- 6 hour category, but














Calculated using ArcGIS 9.2 using
average car speeds along the shortest
route.
Travel time was treated as a
categorical variable - dividing the
patients into equal quartiles.  Patients
were then put into 1/ 16 groups that
combined 4 quartiles of travel time






The study found that patients living in
the most deprived areas were least likely
to receive histological diagnosis, active
treatment and thoracic surgery.  They
found that travel time “amplified this
effect “– patients in the most distant &











and Saone et Loire) and






Using ArcGIS in England and Mapinfo
in France.  The study used road map
databases using legal speed limits by
road class.
Travel time was treated as a
categorical variable using the 5
groups of 0 - 5 mins, 6 - 20 mins, 21 -
40mins , 41 - 90 mins and ≥ 91mins
for travel times to the nearest cancer
centre & nearest radiotherapy unit
and 0 - 5, 6 - 10, 11-15, 16 - 40 and
Patients’ Residence (at





The study identified (unadjusted
analysis) that travel times were
significantly associated with survival, as
patients living further from healthcare
resources had a worse  chance of
survival than those living closer.  When
including material deprivation in the
model this effect was removed.
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Burgundy - testing the
diagnostic properties of
two types of faecal
occult blood test.






Calculated using Mapinfo 9.1
combined with CHRONOMAP 2.1
based on the MultiNet Map database
(Tele Atlas).
Distances were grouped into
quartiles: 0 - 5.5km, 5.5 - 13.8, 13.8 -
22.1 & 22.1 - 52.3km.
Patients’ Residence






The study found that distance to the
regional capital and distance to the
clinical trial centre were independently
associated with colonoscopy uptake.
Distance to the nearest

























The nearest permanent &
mobile mammography
sites.
The study showed that increasing
distance from a permanent
mammogram facility was significantly
associated with decreased mammogram
rates.  After controlling for age, race and
education this relationship was still


















Distance were included as a
categorical variable using groupings





(HGE), and physician (not
The study found that incidences of
colorectal cancer were not significantly
associated with distance to the GP, HGE,
or the physician.  The study did find a
significant interaction between place of
residence and the distance to the GP and
place of residence and the HGE.  The




clear whether these were
the nearest)







Breast Cancer Romagna Cancer
Registry
Patients were included
if they had a diagnosis














Calculated using Google Maps.
Travel time was split into categories
≤15 mins, 16 – 30 and >30.
The study also considered the




The centre for cancer
prevention
The study found that patients were less
likely to have a yearly check-up (over the
10 years) if they had to travel >30 mins























Travel Distance and Travel Time
Shortest travel time/ distance was
calculated using Google Maps.
Distance and travel times were
treated as categorical variables and
split up into quartiles.
Travel distance <3.2miles, 3.2-5.6,
5.7-9.2 and >9.2miles.   Travel times








were contacted by phone
and the referral obtained)
The study found that patients living
further away from the radiation therapy
centre in the categories of  5.7-9.2miles
and >9.2miles compared to < 3.2 miles
(REF) were significantly more likely to
have a mastectomy than breast
conserving surgery followed by RT.
Patients living > 19mins compared to <9
mins were also more likely to receive a














Calculated using Google Maps
Distance was treated as a categorical
variable.  Using the categories of < 50
Patients’ Residence
TO
The study found that increasing distance
to the facility was a significant predictor
of 90 day mortality (univariate model)
and was still significant after controlling
for nodal status.  For long term survival
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distance was significant for those



















Travel time was treated as a
categorical variable and split into 4
categories (Low, medium, High,
Highest) low - lowest quartile,
medium (quartile 2 and 3) high
records between 75% and 95
percentiles and highest - highest 5%
of records.
Population weighted
centroid of the 2001




The nearest cancer centre
and nearest GP
The study had mixed results.   After
controlling for the extent of the disease,
poor survival was associated with longer
travel times to the GP for prostate
cancer and longer travel times to the
nearest cancer centre for colorectal,
breast and prostate cancers, but not
lung cancer or melanoma. The study
found that the disease tended to be less
advanced in patients who lived further
from the cancer centres and living
further from a GP practice was not





Prostate Cancer Physician workforce












 Distance was treated as a categorical
variable and used 3 groups of: 0 - 10
miles, 11 - 20miles and > 20 miles.
Patients’ Residence ( zip




The study found that increasing distance
to an urologist was significantly
associated with higher risk of prostate











Diagnosis Stage Road Distance.
Distance was treated as a categorical
variable using the groups - <5 miles, 5
- 9, 10 - 14 and ≥15 miles
Patients’ Residence ( 78%
were geocoded based on
street address.  15% using
the centroid of the 5 digit
zip code and 7% using the
5 digit zip code + 2 or + 4
digits)
TO   The nearest
mammogram centre
The study found that patients diagnosed
with advanced stage diagnosis had
longer average travel distances than
early stage diagnosis.   After controlling
for age, race, insurance and education
the odds of advanced diagnosis were
significantly greater for women living






Breast Cancer Hospital Records.
2007
Sample = 260  (women
were excluded if they









Distance was treated as a categorical
variable using the following groupsː <





The study found that the further the
distance the more likely women were to
be diagnosed at a later stage and the
more likely women were to have a
mastectomy.
The study found no association between
travel distance, age at diagnosis, receipt























Calculated using average car travel
speeds by road class on the road
network.  Travel time was treated as
a continuous variable.
The study also determined:  -whether
patients were within 800m of an
hourly bus service for rural patients.
Straight-line distance to the nearest
cancer centre, car journey to the
closest railway station, travel time to
the GP and first referral hospital.
Patients’ Residence
TO
The GP, Hospital of first
referral and closest
cancer centre
The study found that late stage diagnosis
was associated with increasing travel
time to the GP for breast and colorectal
cancer and risk of death was associated
with increased travel time to the GP for
prostate cancer.
The study identified residential






















Road Distance  and Travel time
Calculated using average travel
speeds using the road network.
Straight-line distance and whether
patients lived within 800m walking
distance of an hourly weekday bus
service & whether there was a local
community transport scheme.
Travel time to hospital was modelled








The study found that the highest odds of
being diagnosed at death were for those
living in the least accessible quartile of
travel time for the hospital, but this
association was only statistically
significant for colorectal and ovary
cancer.
The study found that living in the least
accessible travel time quartile to the GP
had the highest odds of being diagnosed
at death, but was not statistically
significance.   Breast and prostate cancer
patients living closer to a frequent bus




















Travel time was modelled as a







The study identified an inverse
relationship between travel time and
treatment take up.  Patients were less
likely to receive radiotherapy the further
they lived from the hospital.
Lung cancer patients were less likely to
receive surgery & Lung and rectal

















Distance was treated as a continuous
variable.  Average distance was 75km






The study found that distance to the
neuro oncological centre had a
significant effect on overall survival.
Patients were less likely to be treated
with chemotherapy following surgery
the further they lived away from the
centre.  The study found that when a
new treatment was introduced that
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could be administered locally this
removed this effect.













Distance was treated as a categorical
variable using the following groups -
≤10 km, > 10 to ≤ 20 km, > 20 to ≤ 30





The study found that those travelling ≥
30km from the treating hospital had
significantly poorer survival, but that
those living 20 - 30 km away appeared to


















Calculated using “GIS” and average
vehicle speeds by road type.
Travel time  was treated as a
categorical variable using 4
categories: 0 - <30 mins, 30 - < 60





The nearest  treatment
centre
The study found that Palliative
radiotherapy use declined with
increasing travel time and community
deprivation.








Patients aged 18 – 80
who had a colectomy
within 3 months of
diagnosis and









Calculated using Google Maps.
Distance was treated as a categorical
variable using the following
categories; 0 – 12.49miles, 12.5-49.9,
50-249, and ≥250miles.  For patients
flying in from outside the USA for
treatment straight-line distance was
used.  Average distance travelled to
the oncologist was 12.5 miles.
Patients’ residence at




had treatment in the
reporting facility.
The study found that patients travelling
in the further two categories 50 –
249miles and ≥250 miles had a lower
likelihood of receiving chemotherapy






Breast Cancer Anonymised data






Distance was treated as a categorical
variable and a continuous variable.
Distances were grouped into 2 km






that they were invited to
attend.
The study found that when analysed as a
continuous variable there was a small
but significant decrease in uptake of
breast cancer screening with increasing
distance - adjusted odds ratio of 0.87
(95% CI -0.79 - 0.95) for a 10km increase
in distance.    The strongest effect on


















Unclear method.  Likely to be
straight-line.
Distance was treated as a categorical
variable. Distances were split into <45
miles and ≥45miles.  Average distance





The study found that access to breast
conserving surgery declined as travel
distance increased.  Patients living




















Distance was treated as a categorical
variable - using the groups of <
5miles, 5 to <10, 10 to < 15, 15 to <
20, 20 to <30, 30 to <40, ≥ 40 miles
for receipt of BCS vs mastectomy and
the groups of 0 to <10, 10 to <20, 20
to <30, 30 to <40 and ≥ 40 miles for





The nearest hospital with
a radiotherapy facility
(centroid of the zip code)
The study found a statistically significant
decline in the likelihood of patients
undergoing breast conserving surgery
living ≥15 miles from a hospital with
radiotherapy facilities when compared
to those living < 5miles.  They also found
a statistically significant result for those
patients living ≥ 40 miles having a













Road Distance and Travel Time.
Calculated using ESRI ArcGIS.
Distances were treated as continuous
& categorical variables
Patients’ Residence
(street address for the
patients (where available)
/centroid of patients zip
code where not)
The study found that women who
missed none of their 5 annual
mammograms lived a median of 15
minutes from the nearest facility, whilst
those who missed 5 /5 lived a median
time of 27 minutes.
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2014
Travel times were split into the
categories of  0 - 5 mins, 5 - 15 mins,





The study found that patients living >30
miles to the closest facility were less






Breast Cancer Hellenic Cooperative
Oncology Group
(clinical trials in 6 Greek
cities)
1997 - 2005
Sample  = 2,789
(women)
Survival Road Distance and Travel Time.
Distance was grouped into < 300km
and ≥ 300km.  Travel time was
grouped into < 4 hours and 4+ hours.
Additional tests using the following
distance categories: <50, 50 - 149,
150 - 249, 250 - 349, 350+km.
Patients’ Residence
(98.7% of the sample
using residential address,
or the city centre of the
city of residence, for the




TO The treating hospital
The study found that travelling a
distance >300km and travel time of 4 +
hours were significantly associated with
worse survival outcomes (HR = 1.37 &
















Distance was treated as a continuous
and categorical variable.  Using
categories of <25, 25-50, 50-75 and
75+ miles.  5 patients living more than
900 miles away were excluded, as
were patients in Hawaii.  The median





The study found that increasing distance
to the nearest radiation treatment
facility was associated with a decreased
likelihood of receiving radiation
treatment therapy.  For each extra 25
miles of travel was associated with
declining odds of receiving radiation.
The effect of distance showed as being
stronger where patients were >75 years

















Distance was modelled as a
categorical  using  10 miles, 10 - 25, >
25 - 50 and > 50 miles (range 0 -
84miles)





The study found a higher rate of
mastectomy the further distance the
patient lived from the nearest radiation
therapy facility (after controlling for













enrolled at time of

















Driving Time and Driving Distance
Calculated using MapQuest
(www.mapquest.com)
Distance and travel time were treated
as categorical variables.
Patients’ residence (9





The study found that later stage
diagnosis for breast cancer was
associated with increased driving time
(but not lung or colorectal cancer).  A
significant result was found for the time
to first treatment for colorectal patients
where after controlling for socio
demographic factors, year of diagnosis,
and cancer stage for every 1 hour
increase in drive time, time to treatment
was delayed by 5.9 days.
The study concluded that there was no
evidence that drive time was a better
















Travel Time and Distance
Calculated using the Google Maps.
Treated as continuous variables.
Distance range 0.3 – 12 miles.  Travel





The study found mixed results - 87% of
the sample completed the therapy.  11
people did not complete and 8 died
before completion.  They found that
those patients living <10 miles or >50
miles were less likely to complete
treatment (13% of the sample).  Those
living further were more likely to die





















Distance was treated as a categorical
variable.   Distances were divided into
teriles.  1 and 2 were combined
(≤30.81km) & group3 (>30.81km).
Group 3 was then defined as living




The hospital they were
treated at.
The study assessed the impact of
distance on the components of the QLQ-
30 and by gender.  The study found that
living a greater distance from the
hospital was associated with – lower
physical functioning and role functioning
(for women and not men).  For men
living remotely (>30.8km) had a
significant negative impact on their self-
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Survey - 1273 sent, 496
returned
















Calculated using the ‘Great Circle
distance calculator’
Distance was treated as a categorical
variable using 3 groups of 0-39km,




public hospital (NASH) &
nearest general hospital.
The study found that patients living
further away from the specialist
hospitals were less likely to attend the
specialist hospital & less likely to have
curative surgery – Resulting in lower
survival rates.
Patients who lived further away & were
admitted to a specialist hospital and
received curative surgery were more
























Calculated using the ‘Great Circle
distance calculator’
Distance was treated as a categorical
variable using 3 groups of 0-39km,




public hospital (NASH) &
closest general hospital.
The study found that 51% of patients
living >100km from a specialist hospitals
didn’t have surgery compared to 38% of
those living <40km.  Patients living
further from the specialist hospitals
were more likely to be treated at a













Distance was treated as a continuous
variable and categorical variable for
which it was grouped into equal
quartiles -  0 - 5km 5.1-9.0km, 9.1-






The study concluded that there was an
increasing trend in the unadjusted
hazard of death model with increase in
distance to the closest public
gynaecological Oncology hospital.  The
study reported that whilst they had used
the closest hospital in their calculations







Breast Cancer Illinois Cancer Registry
1998 - 2000
Sample = 30,511 (9,077




Straight-line Distance and Travel
Time.
Travel times were calculated using
the ArcInfo network analysis module
– using the minimum road distance
when taking account of travel speed.
Patients’ Residence
(Population weight





The study found that travel time to
mammography services had no
statistically significant association with
late stage risk.
The study did find that as travel time to
the nearest GP increased patients were






















Distance was treated as a categorical
variable.  Using the following 6
categories 0-50, 50.1 - 100, 100.1 -
200 and >200km




The study found that when using a base
of <50km, patients living >50km were
less likely to visit a nephrologist, less
likely to have follow up measurements
of A1c and urinary albumin within a
year.  Plus have a higher change of all























Distances were treated as a
categorical variable using the groups :
0-50, 501 - 100, 100.1 - 200
and >200km.
Patients Residence (6
digit home postal code)
TO
The nearest nephrologist.
The study found a statistically
significantly  higher incidence of stroke
and hospitalisations in those travelling a
greater distance, but no association for
the other outcome measures






Calculated using Google Maps.
Patients’ Residence The study found that living ≥100 km
away from the nearest peritoneal
dialysis unit was not significantly
associated with time to first peritonitis










Distance was treated as a categorical





association between living ≥ 100km
away from the nearest unit and






















Average speeds were assigned to
roads and GIS transportation
software Base Trans CAD used to
estimate the minimum travel time.
Travel time was treated as a
continuous and categorical variable
split into 4 groups: < 15mins, 15 -
29mins , 29 – 45, & 45+ mins
Patients’ Residence
(Centroid of the CAS
Ward (average 2670
people in each ward))
TO
The nearest Dialysis Unit
The study found that patients living >45
min travel time from the nearest dialysis
unit were 20% less likely to commence
or receive renal replacement therapy

















Distances were divided into 3 groups
<5km, 5 - 20km and >20km
Patients’ Residence





The study found that increasing distance
was associated with increased use of






Kidney Dialysis Dialysis Outcomes and
Practice Patterns Study
(DOPPS) - questionnaire
1996  - 2001 (DOPPS 1)
2002 - 2004 (DOPPS 2)
Sample = 20,994 (from
7 countries, France,
Germany, Italy, Japan,









The survey asked the question - How
long does it take you to get to your
dialysis unit or centre (1 way)?
Respondents could answer ≤15mins,
16 - 30, 31 - 60 and >60mins.  They
were also asked how they usually





The study found that longer travel times
were associated with a greater adjusted
relative risk of mortality.   Health related
quality of life scores were lower for
those with longer travel times when






Kidney Disease United States Renal
Data System.
Jan 1995 – 2007
Sample = 726,347
(the study excluded
patients with missing or
invalid postcodes)
Mortality Shortest Driving Distance.
Distance was treated as a categorical
variable.
Using 5 categories: 0-10 miles, 11-15,
26-45, 46-100 and >100miles.  The
categories correspond to the 0 – 75th ,
75-95th, 95th -99th, 99th-99.9th
and >99.9th percentiles.
Patients’ Residence ( 5






The study found that distance, but not
living in a rural area was associated with
increased mortality.  The adjusted model
identified a statistically significant hazard
ratio between the reference case (0-
10milles) and the 11-25 miles

















Distance was treated as a categorical
variable.  Using the following
categories: ≤50km, 50.1 - 150km,
150.1 - 300, >300km.




The study found that patients were less
likely to have seen a Nephrologist 90
days prior to starting haemodialysis
therapy, and were more likely to have a
sub optimal levels of phosphate control










Mortality Shortest Road  Distance
Calculated using postal data
converted using Melissa (2019)and
entered into ArcGIS.
 Distance was treated as a categorical
variable using the groups of:  <50km,





The practice location of
the patients’
nephrologist.
The study found that remote dwelling
Canadians with kidney failure were
significantly more likely to start renal
replacement on Peritoneal Dialysis (PD)
and switch to PD if their initial dialytic
option was haemodialysis.  The adjusted
rates of death and the adjusted hazard
ratios were significantly higher in those
living ≥50km from the nephrologist








1990 - 2000 (when  the
sample started dialysis)
Sample = 18,722
(random sample of 75%
Mortality (from
all causes) Then




Calculated using ArcGIS 9.1.
Distance was treated as a categorical
variable using the following groups -
Patients’ Residence
TO
The practice location of
the attending
nephrologist.
The study found that mortality
associated with haemodialysis was
greater for patients living further from
their attending nephrologist.    This was
particularly evident for infectious causes.
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Type 2 diabetes Vermont Diabetes
Information System.
Adults completed
postal surveys and were
interviewed at home.
Years Unknown
Sample = 781 (131






Calculated using ESRI ArcView 3.3 and
a geographic data set of roads from
Tele Atlas.
Distance was treated as a continuous
and categorical variable. Distances





The study found that insulin users had
shorter driving distances to the
healthcare facility than non-users.
Longer driving distances were associated
with poorer glycaemic control.  The OR
for those using insulin, living <10km,
having glycaemic control was 2.29 (CI












postal surveys and were
interviewed at home
(23% of the contacted
population)
July 2003 - March 2005
Sample = 973 (794 non







Shortest Road  Distance
Calculated using a road network in
ArcvIEW 3.3.
Distance was modelled as a
categorical variable.  Patients were
split into 3 equal groups  <3.8km, 3.9
- 13.3km,  ≥13.3km
Patients’ Residence
( home  address)
TO
Primary care facility used.
The study identified that longer driving
distances from the patients’ home to
the site of primary care were

















Driving distance using the network
analyst tool in ArcGIS.
Distance was treated as a continuous
and categorical variable.  Distance
was divided into 2 categories ≤10
miles and >10 miles.   The average






The study found that living > 10 miles
away significantly contributed to lower
levels of glycaemic control for diabetes
patients.  Those who lived ≤ 10 miles
from the diabetes treatment facility
were 2.5 times more likely to have
improved their levels of glycaemic























Distance  was  treated  as  both  a
continuous and categorical variable.
5 distance categories: 0 - 100miles,






The greater the distance from a VATC or
any transplant centre was associated
with a lower likelihood of being put on a
waiting list or receiving a transplant and





Liver Transplant Hospital Data and
HRQOL (Health Related
Quality of Life) survey.
Dates unknown











Distance treated as a continuous
variable.  The distance range was 0 –





The study found that increased distance
to the transplant centre was associated
with a decreased post-transplant
physical HRQOL, but that there was no
















Using ArcGIS Software.  Distance was
treated as a categorical variable using
two different sets of groupings.
The following groups - 0 - 50 miles, 51
- 100 miles, 101 - 150 miles, 151 - 200






The nearest adult lung
transplant centre
The study found that the distance from a
lung transplant centre was inversely
associated with the hazard of being
listed (both before and after the
introduction of the lung allocation
score). Once waitlisted distance from the






Liver Transplant United Network for
Organ Sharing








Distance were calculated using
ww.zip-codes.com
Distance was considered as a
continuous & categorical variable and
divided into the following 3 groups:





centre & nearest 300 bed
hospital.
The study found that increased distance
from a specialised liver transplant centre
was associated with an increased
likelihood of death.  The likelihood of
wait list drop out was significantly higher
for patients living > 30 miles from the


















Calculated using Google Maps.
 Distance was treated as a continuous
variable.  The average distance for






The study identified that compliance
with follow up following LAGB is
associated with better weight loss.
Patients living closer to the treating
hospital were more likely to regularly
attend follow up.  The study reported
longer public transport journey times in
the non-attending group - but did not
















Distances were treated as a
categorical variable using groups:
<50 miles 50 - 100 miles and >100
miles
Patients’ Residence ( zip
code
TO
The Clinic they were
treated/ followed up at.
The study found that travel distance
from the clinic did not significantly affect
compliance at the initial follow-up, 3-
month, and 12-month appointments.
However, distance did affect compliance
at the 6-month appointment and


















Distance. Method not reported.
Distance was treated as a categorical
variable and split into the following
distance groups <10, 10 - 20, 20 - 30
and > 30.  (all miles)






The study found that patients attended
fewer follow up clinics, as distance
increased from the patient’s home
address.  The percentage estimated
weight loss was lowest in the group that
lived furthest from the hospital, but this













Patients who received a
diagnosis of
schizophrenia or bipolar
disorder in the year
Oct 1997 - Sept 2008










Distance was treated as a continuous
variable.  Average distance to the
nearest provider was 11.8 miles.
Patients’ Residence
(population centroid of
the patients zip code)
TO




serving at least 500
unique patients where at
least 20% were mental
health visits.
The study found that patients who had a
12 month gap in VA services utilisation
were more likely to live further away.
Living ≥25 miles from VA care was
associated with a greater likelihood of a
gap in VA health utilisation.   The hazard
ratio associated with each 5 miles
















Distance from Peterborough Ontario.
They do not provide any other




The study concluded that severity of








Regional population  &
actual patient data
from the  Stokmarknes
Clinic in Nordland
1992 - 1996
Sample = 10,996 (total







Calculated from information gathered
from local bus and ferry companies.
The study treated travel time as a
categorical variable using the cut off
of 35 minutes.
All residential addresses
in the local area & actual
patient attendees.
TO
The outpatient clinic at
Stokmarknes.
The study found that a significantly
higher proportion of those living < 35
mins from the clinic had used the clinics











times were < 1 hour.






Calculated using DMTI routing data
and the ArcGIS Network analyst
function.
Travel time was treated as a
continuous variable and categorical
variable.  The mean travel time was
20.8 mins.  The cut point for the





The sleep disorder clinic
The study found that travel time to the
sleep clinic was a predictor of
obstructive sleep apnea severity
(controlling for sex, age, obesity and
education).  Every 10 min increase in
travel time was associated with an
























Distance to the healthcare facility was
based on respondents stating which
hospital, clinic or doctor they would
normally go to for "a really bad
emergency", A less serious




TO    The self-reported
hospital, GP, clinic that
they would normally go
to for a really bad
emergency, a less serious
emergency or for regular
care.
The study found that distance was
significantly associated with the number
of regular check-up care visits and
chronic care visits.  Distance was not
associated with acute care visits.
They identified that those people with a
driving license had an estimated 1.58
times more regular care visits and 2.3













No information in paper on specific
method.
Distance was split into the categories
of <10 miles and ≥ 10 miles.
Patients’  Residence ( zip
code)
TO
The hospital attended (zip
code)
The study found that increased distance
from the patient’s residence to the
hospital that they were treated in was


















Distance was treated as a continuous
variable.
Average distance 14.9 miles.
Patients’ Residence
(Centroid of the patient’s
residential zip code)
TO      The admitting
hospital
The study found that high risk CABG
patients living further from the


















No information on method.
Distances were treated as a
categorical variable and split into
quintiles.    The average distance was
226 miles.





The study found that patients who lived
closer were less likely to have a serious























The University of Virginia
Ryan White HIV clinic
The study found that after adjusting for
severity of illness and respiratory failure,
patients living >40 miles from the clinic
had a fourfold increased risk of in-











Sample = 470,650 acute
episodes, 13,425
psychiatric episodes





Distance was treated as a continuous
variable.  The furthest distance to the
GP was 8km and to the acute
hospitals 41km.
Patients’ Residence




general hospital.   &
nearest GP surgery
The study found that after controlling for
key confounders distance to hospital
was a significant predictor of hospital
episodes, especially psychiatric episodes.
The study found that distance to the GP
was only significantly associated with










May 2003 - April 2011
Sample = 866
Length of Stay Road Distance with the shortest
travel time.
Distance was treated as a continuous
variable.  The mean distance travelled
was 146.9 miles (range 2 - 2984).  The
study transformed distance and





The hospital treated at (5
digit zip code).
The study found that in the adjusted
model increased travel distance from a
patient’s residence to the hospital was














Length of Stay Road Distance (shortest travel time)
Distance was treated as a continuous





The hospital treated at (5
digit zip code)
The study found (in the general model)
that for each additional 100 miles







Asthma Regional Deaths System
for East Anglia.
1985 - 1995
Sample = 768 (of which
asthma was the
underlying cause of
death in 365 of these).
Mortality Travel Times.
Travel times were treated as
categorical & continuous
The groupings used for travel to the
GP were 0 - 4mins >4 - 6 mins, >6 - 9
mins and ≥ 9mins.  The minimum
travel time was 3 minutes and the
maximum 20.8 minutes.   The
categories to the hospital were 0 -
10, > 10 - 20, > 20-30, ≥ 30mins.  The
minimum time to the hospital was 4.4




at the ward level-average
number of households =
2,726)
TO
The nearest GP and the
nearest acute hospital
with over 200 beds.
The study identified an association
between asthma mortality and
increasing travel time to the nearest
acute hospital.  The study found no
relationship between distance to the GP

















Distance was treated as a categorical





The TB treatment facility
The results indicate that attending a TB
centre with low case load or greater
distance was associated with poorer
treatment outcomes.  The study
identified that distance to a TB
treatment centre was insignificant for



















Calculated using the Finish road
network data (Digiroad) using ESRI
ArcGIS 10.
Distance was treated as a categorical
variable using 0-1.9km, 2 – 4.9 km




centre facility (or where
there were more than
one – the closest  was
used)
The study found that the number of
people attending health centres and
mean number of visits declined with
distance for people living in rural areas,
but this was not significant, but the
opposite was the case for the sub group













Calculated using Chrono Map in
MapInfo with the 1997 Michelin light
road network table (which includes
major roads).









The study found that the detection rate
for Hepatitis C decreased in each of the
studies socioeconomic clusters as













Calculated as total miles.  Split into
“miles to “  the nearest highway and
“miles on” the nearest highway.
Distance was treated as a continuous
variable.  The range of distances was





The study found that the number of
“miles to" and "miles on" the highway
significantly affected the probability of
attendance at an alcohol abuse aftercare
appointment.  Distance to the major
highway was more predictive of
















Distance was treated as a categorical
variable using the following
groupings: 0-50km, 50 - 100km, 100 -







The study found that increased distance
from the cardiac surgery centre was
independently associated with a greater
likelihood of experiencing an adverse
event at 30 days.
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Calculated using ESRI ArcMap 10.0.
Distance was treated as a categorical
variable using quintiles.  Categories for
hospital attended: <5km, 5-9, 10-16,
17-31, ≥32km.  Categories for nearest
high volume hospital: <9km, 9-17, 11-
20, 21-49 & ≥80km.   80% of patients
travelled ≤28.3km to the hospital they
were treated at. 80% of patients were




The hospital treated at
and the nearest high
volume hospital.
The study found that travelling 5-9km,
17-31 km and ≥32km to the hospital
compared those travelling <5km
(reference case) was associated with a
reduction in the risk of mortality.  After
controlling for hospital size and
adherence to treatment guidelines 5-
9km and 17-31km compared to the
reference case were still significant.
The opposite case was found for
distance to the nearest high volume
hospital for patients travelling ≥80km
compared to the reference case of
<9km.  This was no longer significant






Cancer 4 phase II chemo
radiotherapy studies





Driving miles (using an "internet based
mapping engine").
Distances were treated as a categorical
variable and split  into two groups ≤ 15







The study found a positive association
between the distance that patients
travelled and survival.  Those living > 15
miles had only 1/3 of the hazard of
death than those living ≤15 miles.  With
every 10 miles that a patient travelled













Distance was treated as a categorical
variable using the following groups - 0 -





The treating centre (zip
code area)
The study found that survival improved



















Calculated using Melissa (2019)
Distance was treated as a continuous
variable and categorical variable split







The study found that increasing distance
from the transplant centre was
associated with improved overall
survival.  The authors identified that this
could be due to a referral bias, but could
also be due to a healthier and more













Distance was treated as a continuous
variable and categorical variable split







The study found that adjusted hazard
ratios were significantly lower for
patients travelling > 50 miles compared
to < 50 miles.  This was true for liver,
oesophageal and pancreatic cancer.
They concluded that those that
travelled > 50 miles to the treatment















Calculated using Google Maps.
Distance was treated as a continuous
variable.  The average distance to the




The hospital treated at.
The study found a weak relationship
between increased travel distance to the
hospital and increased weight loss.
Travel distance was found not to be
significant for attending follow up visits.
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Years & Sample size
Health
Outcome












Driving Time and Road Distance.
Calculated using ESRI ArcGIS and data
from ESRI on street networks, posted
speed limits and driving distance.
Distance and travel time were treated
as categorical variables.
Using the following groupings: < 5
miles, 5 - <10 miles, 10 - < 15.0 miles,
≥15 miles.  For travel time < 5 mins, 5 -
< 10 mins and ≥ 10 mins
Patients’  Residence
(Addresses of patients
were geocoded to an
exact street
address(91%) or to the
zip code centroid if only
a post office box or
rural route address was
available.)
TO   The nearest
mammography facility.
The study identified no significant
association between later stage breast
cancer and travel time to the nearest
mammography facility.  They did identify
that there was good access (patients did
not have to travel a large distance) to
mammography facilities in the area








Sample = Number of
patients in each local
authority district attending
hospital with a diagnosis of






Modelled used to obtain off peak drive
times + use of a commercially available
computer programme
Travel time was treated as a
continuous variable.  Maximum travel
times 1 hour.
Population weighted




centre serving the area.
The study found no significant
relationship between overall


















Shortest road route and average
driving speeds along the routes by road









The study found no effect of travel time
distance on stage of diagnosis or receipt
of treatment.  They also found no













Distance was treated as a categorical
variable.  Using the following groups:








The study found no significant difference
between patients travelling <30 miles
and those travelling >30 miles for
survival.  They found that non













The automobile Association route
planner was used to estimate distance
travelled by road.
Data was treated as a categorical
variable using the groupings of < 30km
and >30km.  The median distance was




The study found no significant
association between distance travelled
and Breslow thickness on presentation.
The study concluded that this could have
been due to the type of patients in the






Breast Cancer US North American
Association of Central
Cancer Registries.





The study calculated 3 accessibility
measures including shortest road
network drive time.  This used the
Road nearest the
population weighted
centroid of each census
tract
TO
The study found that after adjusting for
poverty there was no impact of distance
on late stage diagnosis.  They found that
poverty was independently associated
with late stage diagnosis.
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Sample = 174,609 NAACCR shortest path calculator
(NAACCR, 2019)
Travel times were treated as
categorical variable using the following
groups - ≤ 5 mins, > 5 - 10, > 10 - 20, >
20 - 30, > 30.  93% of the breast cancer
cases lived < 20 mins from the nearest









Breast cancer 10 state population based
cancer registries - covering
30% of the population of







Travel time was modelled as both a
continuous and categorical variable.
There were 7 categories ranging from <
10 mins to ≥ 60 mins.  76% of the
women lived <20 mins from their
diagnosing facility & 93% < 20mins










The study concluded that increased
travel time was not a determinant of late
stage diagnosis.  They found that
insurance status, race and poverty were
associated with risks for a late stage





















Distance was treated as a continuous
and categorical variable.  Categories
≤100km, 100- 500, 500, 1000 and >
1000km from the centre were used.
Categories of <170km and ≥170 km
were used to assess mortality.  Median








The study found no relationship
between increasing distance and non-
relapse mortality, relapse mortality and
survival at 200 days.  The study does
state that patients are required to stay
within 30 minutes of the hospital for the
first 80 to 100 days, which allows them
to be closer (for most patients than their
residential address) for any early  issues.
After this patients were followed up via














Distances were treated as categorical
variable and split into the following
quartiles: 0 - 0.53 miles, 0.54 - 1.07
miles,1.09 - 1.82 miles and 1.83 - 26.5
miles.  The study also calculated the
number of public transit stops within 3
miles of the respondent and split these
into quartiles.
Patients’ Residence
(70% of the sample
were geocoded based
on the nearest street to
their residence, 30% to




The study did not use the distance
calculations in the final model (as they
were not significant)- but instead used
mammography density within 2 miles of
a patient’s residence instead - which was
found to be significant.  The number of
bus stops within 3 miles was not
significant.  This indicated that density of
mammography facilities and not















Distance from the transplant centre
was split into 2 groups of <170km
and >170km.  This represented a cut
off at 75th percentile.
Patients Residence (Zip
code at the time of the
transplant)
TO  The medical centre
where they were
treated.
The study found that distance did not





















Fastest Travel time using the road
network.  Using ArcGIS and the
Meridian digital road network.
Sections of the road were assigned
average car travel times.
Distances were treated as categorical
variables using the categories of ≤30
mins, 30 - 60 mins > 60 mins.  The
study also collected information on








The study found that the choice of
breast conserving surgery or receiving
radiotherapy was not associated with
the estimated travel time.  They did find
that travel time to radiotherapy was only
significant as a predictor of surgery







Breast Cancer Virginia Cancer Registry





Calculated using ArcGIS.  Distance was
treated as a continuous variable.  The
average distance was 5.7 miles and






The study found that distance to the
nearest mammography facility had no
consistent relationship between invasive
tumour size at diagnosis in the adjusted
model.    They found that only advanced







Liver Transplant Medical Centre Transplant
Database.












Calculated using Yahoo! Maps.
Travel time was treated as a categorical
variable using > 3 hour and ≤3 hour.  38
people had travel times > 3.  The range
of travel times was 0 - 7 hours.
Patients’ Residence
(where not available





The study found that those patients
living > 3 hours away from a transplant

















Sample = 15,983.  670 (with





Travel Time (using road distance)
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McNally TripMaker Version 1.1.
Distance was treated as a categorical
variable using the groups 0 - 150miles
151 - 300 miles and >300miles.  207
patients lived in group 1, 69 patients
lived in group 2 and 36 in group 3.





The study concluded that long distance
management of heart transplant
recipients is successful and is not
associated with an increase in adverse
outcomes.  Patients living further away
had similar results to those in the closest
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AAT deficient individuals.
Achieving a 38% response
rate.
2003
Sample = 1,851 (Achieving a
38% response rate)
Diagnostic delay Distance.
Calculated using GIS software
Distance was treated as a categorical
variable using the groups of < 50 miles
and ≥ 50 miles to the CRC.  38% of the
survey respondents lived within 50






The study found that neither urban
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expertise (living within 50 miles) was








Eating Disorder Contact records, clinical
records and appointment
records of patients at a
treatment centre.
Unknown date
Sample = 139  (37







Distance was treated as a continuous
variable.  The average distance for
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The study found that the likelihood of a
transplant was not affected by the
distance to the nearest transplant
centre.
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The studies came from a wide range of countries the majority 56% from the USA, with 17.6%
from the UK and 8.3% from Australia and New Zealand (combined).  Over 50% of the studies
reported on cancer (55% in Table 2, 83% in Table 3 and 53% in Table 4) with the majority being
breast or colorectal studies.   Other diseases and outcomes are summarised in tables 2 – 4 and
table 5.  The studies covered a wide range of contexts and travel requirements for patients.
Studies that identified a distance decay association  ranged from a very localised cohort of
patients - average distances to the healthcare facility of 13.3 miles for treatment for diabetes
(Zgibor  et  al.,  2011),  to  >  6  hours  travel  in  Canada  for  breast  and  colorectal  cancer  survival
(Cramb et al., 2012) , to > 300km for remote kidney dialysis (Tonelli et al., 2007a), and an inter
country study with a range of 1km – 870km for treatment for malignant brain tumour
(Kerschbaumer  et  al.,  2012)  .   These  differences  reflect  both  the  geographical  sizes  of  the
countries in question and the need to travel for specialist treatment.  There was no obvious
difference in the distances and travel times between the three groups (distance decay, distance
bias and no association).
A range of associations were found.  Seventy seven percent of the included studies were
classified as a distance decay association; six studies reported a distance bias association and 19
identified no association.  The studies were diverse in nature with five of the studies (Table 3)
reporting a positive association between increasing travel distance and better survival rates for
cancer (Lamont et al., 2003, Bristow et al., 2015).   Lipe et al. (2012) concluded that survival rates
were higher for those travelling further to the transplant centre potentially due to referral bias,
but also patients living further away being healthier and more motivated.   Other effects
identified by the review include the study by Kim et al. (2000) who highlighted a U shaped all-
cause mortality relationship.  When the data was split into three categories of distance travelled,
those in the middle (20 – 30 km) category had lower all-cause mortality than those living in the
closer or further away categories.  This indicated that there was something different about this
geographical area and the people living in it.  This effect was evidence in other papers, but not
at statistically significant levels.
A wide variety of methods and data (e.g. registry data, patient surveys, hospital data) were used
to explore the association.  There were differences in the patient origins and healthcare
destinations used to determine the patient journeys.  The majority used the patient’s address
(full address/postcode/ zip code) as the origin for the journey, but others used the centroids of
larger geographical areas (Judge et al., 2012b; Haynes et al., 2008; Brewer et al., 2012; Jones et
al., 1999),  or the referring hospital (Goldberg et al., 2014)  or the city of residence (Rodkey et
82
al., 1997) .   It was recognised that for the longitudinal studies there was a potential for patients
to move address, but no studies used differing residential locations where people moved house
to  calculate  the  distances  and  travel  times.   For  example,  Dejardin  et  al.  (2014)  applied  the
residential location at the time of diagnosis and assumed this remained constant during
treatment.   Forty – eight percent of the studies had access to data on the nearest healthcare
facility to the patient, with the remainder using the actual healthcare facility attended.   Bristow
et al. (2014)  and Henry et al. (2011b)  calculated both the nearest and actual facility attended.
All the studies that showed health outcomes improved as distance/ travel time increased used
the actual healthcare facility attended by the patients in their study.
The methods used for calculating travel distance / travel time in the studies ranged from
straight-line distance (Euclidean distance), travel distance using a road network (either shortest
distance or shortest travel time); travel speed using the shortest distance by road network (with
and without adjusted road network speeds) or patients’ self-reported travel time.   As shown in
Table  1  9%  of  the  studies  did  not  clearly  state  how  they  had  calculated  this  variable.    One
hundred percent of the studies in the distance bias association group calculated travel distance,
77% in the distance decay association group and 63% in the group that identified no association.
The results presented by disease group and health outcome measure and decay, bias and no
association categories, as shown in Table 5.  This shows the same patterns of the majority of
studies reporting significant statistical associations between a distance decay effect and
differing outcomes can be observed.  As can be seen clearly the majority of studies focus on
cancer (breast, cervical, ovarian, gynaecologic, lung, stomach, prostate, bladder, gastrointestinal,
colorectal, colon, rectal, brain, nonspecific and nonspecific hematopoietic stem cell
transplantation),  The highest number of studies reviewed have considered whether stage at
diagnosis is associated with differences in distance and travel times to healthcare facilities with
twelve studies identifying a distance decay effect and seven of them not identifying a statistically
significant association (mixed results).  The next highest number of studies have considered
whether survival following cancer is associated with distances or travel times to healthcare
facilities, again there is some mixed results, as whilst the majority present a statistically
significant association with poorer outcomes for those travelling further, 19.1% indicate no
statistically significant association.
83
Table 5  Review results by disease group and outcome measure1`
Disease Measure Decay Bias None











Stage at diagnosis (tumour size, diagnosis at
death and emergency presentation)
12 7
Survival 13 4 4
Mortality 1 1 1
Receipt of Radiotherapy 3 1
Uptake of Radiotherapy 1 1
Receipt of Chemotherapy 2
Receipt of surgical resection (lung) 1
Type of treatment received(e.g. breast
conserving vs mastectomy, surgery)
7 1
Time to first treatment 1 1
Completion of treatment 2
Attending screening / adherence to screening
guidelines
5 1
Quality of life 1
Diabetes Glycaemic Control 3
Foot Ulcers 1
Amputation 1
Obesity Gastric Band: Compliance with follow-up 3
Gastric Band: Weight Loss 2 1
Kidney Failure Mortality 5
Visit a nephrologist 2
First peritonitis episode 1
Complications (e.g. infection) 1
Quality of Life 1
Type of Dialysis (renal replacement therapy) 2
Quality Care indicators 1
All cause hospitalisation 2
Transplant (split into




Being listed 2 1
Receipt / likelihood of a transplant 1
Likelihood of infection 1
Likelihood of  re-transplantation 1
Quality of life 1
General Surgery Length of Stay 2
In hospital mortality 1
Mortality 1
30 day complications 2
Readmission 1
General healthcare Inpatient episodes 1
Primary care attendance/ check ups 2
Mental Health (split
into general and eating
disorder)
Attendance 1 1
Continuity of care 1
Seriousness of diagnosis 1
Completion of treatment 1
Asthma Mortality 1
Alcohol abuse Follow up Attendance 1
Hepatitis C Detection Rate 1
1 The total results by disease differ to the total number of studies (108), as some studies explored more
than one outcome or diseaase.
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HIV with severe sepsis In hospital mortality 1
Tuberculosis Completion of treatment 1




AAT deficiency Delayed diagnosis 1
There is a running theme of patients receiving different treatments based on where they live.
For example, patients being less likely to receive renal replacement therapy for kidney disease
the further they live away (e.g. Judge et al. (2012b)) or less likely to receive breast conserving
treatment and more likely to have a mastectomy the further they live from the hospital (e.g.
Schroen  et  al.  (2005).   A  large  number  of  studies  have  considered  the  impact  of  later  stage
diagnosis of disease (e.g. Wang et al. (2008a)  and increased severity of disease at diagnosis ( e.g.
Joseph and Boeckh (1981)).  Although less in number there are some studies that do not show
statistically significant results for either of these associations.  The split by disease in table 5
shows that more research is needed in both those areas more commonly studied (e.g. cancer
where the evidence is mixed) and the growing range of other diseases, where this association is
being considered.
2.4 Discussion	 	
The results were mixed.  Eighty three studies identified an association between increasing
distance/ travel time and worse health outcomes, nineteen no evidence, and six studies
evidence of an association between increasing distance and improvements in health outcomes.
Thus the majority of studies reported a negative association between distance and travel time
to healthcare facilities and health outcomes.  This was true across a multitude of disease groups,
geographical distances and boundaries.  The wide range of methods, sources of data, disease
areas and outcome measures and ranges of distances travelled add to the complexity of the
comparisons.  The focus of this discussion is on the key differences in the way that the distances
and travel times were calculated and analysed and whether there any themes to link an
association between distance/ travel time and health outcomes.
Travelling	to	healthcare	
The critical elements of calculating an accurate representation of the distances and travel times
that the patients have endured requires a starting location for the journey (e.g. patient home
address), end point (healthcare facility) and method for accounting for the estimated route
taken between these two points.  The included studies differed on all three inputs.   Where the
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patient’s address  was unavailable less specific geographical identifiers were used by the studies,
ranging from patient’s postcode (Lake et al.,  2011) zip code centroid (Engelman et al.,  2002),
centroid of a census district (Judge et al., 2012b) referral hospital (Goldberg et al., 2014), to the
centroid of town of residence   (Rodkey et al., 1997).  A mixture of the methods was used where
data was missing at the less aggregated geographical levels (Celaya et al., 2010).  Using an origin
point that is less accurate than the patient’s home address has the potential to reduce the
accuracy of the results, as it may influence the route taken affecting the distances and travel
times.   Though it should be noted that even this location is a proxy as not all patient journeys
start from the patient’s home address.
The geographical data available for the healthcare facilities attended also differed across studies.
Fifty-two percent of the studies had the address of the healthcare facility attended by the
patient.  The remainder used the address of the nearest facility to the patient, as a proxy.
Knowing how realistic the proxy measure is would be a benefit, as it may dramatically change
the distances/ travel times calculated. For example, Tracey et al. (2014) identified in their study
that only 37% of the patients attended the nearest facility, so using this as the proxy would
underestimate the distances travelled by patients.
Studies such as Dejardin et al. (2014) and Bello et al. (2012) identified that where patients were
followed up over time - patients had the potential to move home address. It was argued by some
studies that grouping distances into large categorical bands allowed patients to move residence,
but not actually move categories during the study.  In the study by Thompson et al. (2013), 27%
of the study’s population changed their residence during the 5 year follow up, but 91% of the
patients had remained in the original distance category.
The majority of studies focused on one destination (e.g. hospital attended), for one type of
treatment (e.g. an operation).  This has the potential to underestimate the impact of distance/
travel  times on health  outcomes –  where patients  are  potentially  making multiple  trips  to  a
range of hospitals over the course of the year for a range of health issues.  In an attempt to be
more  representative  of  the  travel  burden,  Brewer  et  al.  (2012) used the follow up radiation
centre address as the destination for patients rather than the place they had the surgery, as they
argued patients would have to make this journey more frequently.   Studies such as Jones et al.
(2008b) considered the impact of a range of potential healthcare settings (e.g. distance to the
nearest cancer centre, GP, hospital of first referral). They found a significant association
between distance and survival for the GP, but not the other healthcare settings studied. Similarly,
Wang et al. (2008b) found that as travel times to the nearest GP increased, patients were more
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likely to have a later stage breast cancer diagnosis, which was not evident when focusing on the
distance to the nearest mammography service.  These examples imply that focusing on a single
site healthcare location (e.g. hospital where the surgery took place) could miss the location that
most influenced the patient health outcomes. The primary referral place for patients with OA
and RA as described in Chapter 1 is the GP, so would be important to measure the association
to both the GP (as the gate keeper) and hospital.
Measuring	distance	and	travel	time	
Straight-line distance was used to calculate the distance for >25% of the studies.  It is unlikely
that any healthcare trip can be made in a straight-line, but it was argued by some studies that
grouping distances into categories that covered large geographical areas, can reduce the effects
of differences between using road distance and straight-line distance.  The remainder of the
studies calculated travel time or road network based distance (either shortest route or quickest
route).    This was calculated in a variety of ways including making use of specific GIS software
(e.g. ESRI ArcGIS, MAPINFO, ARCinfo), but more recent papers had used online routing websites
such  as  Google.com  (2019),  Melissa  (2019)  or  MapQuest  (2019).   Online  resources  are
straightforward to use and highly accessible to calculate distances and travel times, but there is
an ethical question as to whether patient data (e.g. patients home addresses and the hospital
attended) should be uploaded to such websites and how secure this is, especially in the case of
rarer diseases.  A number of studies did take account of the time of year to control for potential
differences  in  the  weather  and  the  impact  this  might  have  (Celaya  et  al.,  2010),  but  none
included traffic congestion to calculate the travel times, which could significantly have increased
the travel times included.
Distances and travel times were included in the statistical models as continuous or categorical
variables or both separately.    Studies identified that distances / travel times tended to be
positively skewed towards more patients living closer to the healthcare facilities that they were
attending.   In order to better represent this phenomenon Haynes et al. (2008) split the travel
times into categories according to the lowest quartile, medium (quartile 2 and 3), high (75th –
95th percentile) and highest (95th– 100th percentile) categories.  Other studies linearized
distance/ travel time from the natural scale to the log scale, but the majority did not.  For studies
that included distance/ travel times as a categorical variable there was no consensus on what
categories should be used.  Study examples include,  Sauerzapf et al. (2008) who split the travel
distances  into  <  30  miles,  30  –  60  miles  and   >  60  miles,  Panagopoulou  et  al.  (2012)   used
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dichotomous categories < 300km and > 300km, Littenberg et al. (2006) split data into < 10 km
and ≥ 10 km and Allen et al. (2016) calculated the mean distance and used this to split the data
into two groups.  Other studies used quartiles or quintiles.  In many cases no justification was
given for how the categories were determined, which has the potential to hide effects, where
critical thresholds are missed.   What the studies did identify was that the results were sensitive
to  the  cut  offs  used  in  the  model.  Athas  et  al.  (1999)  found  that  after  adjusting  for  age  the
likelihood of receiving radiotherapy following breast conserving surgery decreased significantly
with increasing travel distance to the nearest facility for distances >74.9miles compared to
<10miles, but not for categories in-between.  In this case a dichotomous threshold that
compared < 30 and ≥ 30 might not have picked up this effect.  Undertaking a sensitivity analysis
around the reference distance groups and categories used in models would be advantageous–
as this may greatly influence the results.   Abou-Nassar et al. (2012)  and  Maheswaran et al.
(2006)  presented results from the model that treated distance as a continuous variable, the
results were not statistically significant for the models that they had tested using categories.
This systematic review was designed to reduce some of the heterogeneity in the studies by
focusing on studies completed in global north countries, as they were more likely to have similar
healthcare provision and transport networks to get patients to the healthcare facilities.  Whilst
this has reduced some of the heterogeneity it does not completely remove all of it.  There are
still differences between the studies in how the healthcare is provided and in the distances that
some patients have to travel in some of the studies to access healthcare within these countries
(among other things).   For example, focusing on colorectal cancer survival, Cramb et al. (2012)
grouped patients into the travel time bands of < 2 hours, 2- 6 hours and > 6 hours of travel time,
which is very different to the travels times to the healthcare facility recorded for the study by
Dejardin et al. (2014), using the categories of 0 – 5 mins, 6- 20 mins, 21-40 mins, 41-90mins and
≥91 mins.  All of which would have fitted into the first category (<2 hours) of Cramb et al (2012).
These are the key reasons why the results were not pooled in a meta-analysis.  The results should
be interpreted as answering the research question -  Does it show any association between
travelling further and having worse health outcomes?, but alongside being aware that the
different studies as shown in tables 2 – 5  may have differences in the scales of distances and
travel times to the healthcare facilities in the study.
Mode	of	transport	
It was assumed in the majority of studies that patients would travel by car although there were
exceptions (e.g.  Skarsvag and Wynn. (2004), Arcury et al. (2005), Moist et al., (2008)).  For some
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patients (potentially in the most deprived groups) it will not be possible to access healthcare by
car.  Moist  et  al.  (2008)   reported  that  increased  public  transport  travel  time  for  patients
contributed to missed kidney dialysis sessions.  Jennings et al. (2013) reported that public
transport travel times were longer for patients who did not attend follow up appointments
compared to those that did.  Other studies included public transport access through proxy
measures (e.g. whether patients were within 800m walking distance of an hourly bus service).
Issues with this include that it does not account for whether the bus service identified goes to
the hospital, the travel time once on the bus or the likelihood of the patient being able to walk
800m.   In one study, a travel survey of patients’ trips to the hospital found that 87% were made
by car (Crawford et al.,  2009). To ensure representative travel times/ distance it is critical to
understand the patient population (in this case how they are travelling).
Key	Relationships	
The studies in the review highlight some of key factors that were found to be more sensitive to
the distance decay effect.  For example, Joseph and Boeckh (1981) identified that the distance
decay effect was more pronounced for less serious illnesses and Arcury et al. (2005) that patients
attended more regular check-up care visits the shorter the distance to the facility.  Whilst for
Lara  et  al.  (2005)  distance  was  a  predictive  factor  for  not  attending in-between follow  up
appointments (at 6 and 9 months), whereas it was not predictive for the 12 month or 3 month
follow up appointments following a gastric band being fitted.  These studies all suggest that
when patients feel the health situation is more serious or they live closer they are more likely to
attend.  In their study Abou-Nassar et al. (2012) found that the impact of distance on health
outcomes was only statistically significant 1 year after a transplant suggesting that the point at
which the health outcome and distance is measured could be critical to the results.    Lake et al.
(2011) identified that whilst there was an effect of distance on patients attending treatment for
tuberculosis, when doing sub-group analysis this was only statistically significant for those
patients not native to the country, so potentially identifying an impact of reduced ability to travel
for patients who are less familiar with the healthcare system and transport network.  All of which
could be considered when tailoring healthcare provision and require further research.
One of the key influencing variables identified by the studies was deprivation. Dejardin et al.
(2014) found that when controlling for deprivation the effect of distance on health outcomes
was removed, whilst Crawford et al. (2009) that distance amplified the effect from deprivation.
From one side it might be argued that by controlling for deprivation this is also removing some
of the impact of distance/ time that is experienced by those who do not have access to a car and
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would have to travel by other means.  Those studies in the review not controlling for deprivation
may be overestimating the true impact of distance travelled/ travel time on patients’ health.
Studies such as those in Table 3 indicate that in some cases patients are able to travel longer
distances and have better health outcomes than those living closer.  This indicates that there
are factors other than distance (such as deprivation) that contribute to how easily patients can
travel to access the healthcare facilities.    Differences in distances that patients would be willing
to  travel  (travel  thresholds)  to  primary  care  practice  have  been  explored  in  studies  such  as
McGrail et al. (2015) who asked patients “What is the maximum time (minutes) you are
prepared to travel to see a GP (for something that wasn’t an emergency)?” (p 3).   Communities
where the population was sparsely located were found to be willing to travel a maximum of 22.2
minutes more to visit the primary care practice than those in closely settled communities. Buzza
et al. (2011) found that distance was the most important barrier to accessing healthcare in their
study, but also identified “health status, functional impairment, travel costs and work or family
obligation” as key barriers (p648).  Similarly the Social Exclusion Unit in the UK proposed that a
person’s ability to travel was influenced by key factors including their Travel Horizons (Where
are they willing to travel to? What is the maximum distance they are willing to travel?  And do
they have full awareness of available transport options for the journey), Cost (Can they afford
to travel to the healthcare facility?), Physical Access (their health state may make accessing
transport physically difficult or if accessing public transport there may not be an appropriate
route) and Crime (they may not want to travel unless they felt safe making the journey) (Social
Exclusion Unit, 2003).  All these factors need to be considered when deciding on where to locate
a healthcare facility / improve access for patients to an existing facility and ultimately improve
health outcomes.  For studies such as Bristow et al. (2015)  closer investigation of those patients
living  <5km from the hospital whose health outcomes were worse than those living further away,
or in the case of Kim et al. (2000) what makes those patients living 20 – 30 km away have better
health outcomes – what makes them different? And how can these other groups be better
supported to access healthcare services?  Using the types of studies brought together in this
review allows some of these questions to be explored and inform debate over potential
solutions.
The reason for undertaking this review was to collate and review evidence on the potential
impact of distance and travel time to healthcare on patients’ health outcomes.  This is
particularly pertinent given the move to centralised specialist services which typically means
increased travel distance to access those healthcare facilities.  Studies such as Kerschbaumer et
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al. (2012) have shown that if follow up can be completed successfully at a local level (even if the
surgery is centralised) this can improve health outcomes and reduce travel burden.  The review
has shown that by making use of ex-post healthcare data, providers can identify spatially pockets
of patients who would be disadvantaged through having to travel further to access healthcare
facilities and could use this to examine how these patients match with existing support and
transport networks.  It has also shown that it is not just about identifying patients who have to
travel the furthest with evidence of patients living in close proximity to the healthcare facilities
often fairing the worst.  More research is needed to pick up on these factors and to explore in
more detail the impact that the methods and data sources have on the results.
Strengths	and	Limitations	
This systematic review has for the first time synthesised available evidence on the association
between differences in travel time/distance to healthcare services and patients’ health
outcomes.  It identified a wealth of studies and generated evidence for a wide range of disease
groups and health outcomes, across multiple countries.   There was great variation in study
design, distances and travel times to the healthcare setting, and range of health outcomes; this
precluded pooling of data for meta-analysis.  The study followed a search strategy to maximise
the identification of relevant studies of which 19 did not find an association between distance/
travel time and health outcomes; this is likely to be an underrepresentation if authors have a
tendency to not publish results that showed no effect.   While the review findings are of
undoubted value in broadening our understanding of the wider societal factors that influence
health outcomes, their applicability may be limited to countries with similar healthcare systems.
The studies in this review were limited to Global North countries.
2.5  Conclusions
The majority of studies (77%) showed evidence of an association between worse health
outcomes the further a patient lived from the healthcare facilities they needed to attend.  This
was evident at all levels of geography – local level, interurban and inter-country level.  A distance
decay effect cannot be ruled out and distance/ travel time should be a consideration when
configuring the location of healthcare facilities and treatment options for patients.    None of
the included studies focused on an OA/RA patient group, which is the focus of this thesis, but
did identify valuable key findings.  The key findings taken forward in the remaining chapters of
this thesis are:
· The statistical models used in the studies showed differences when including travel times/
distances, as continuous and categorical variables.   It is important to consider both, as the
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thresholds used in the categories might highlight differences that are not apparent as a
continuous variable.  The studies used a range of methods (e.g. straight - line distance and
road network distance) and it will be important to assess whether there are any
statistically significant differences in these different approaches.
· The studies used a range of more and less specific patient home locations (postcode, wider
geographical area)
· The studies used a range of more or less specific healthcare locations (nearest/ actual
facility attended).  It will be important to assess whether the nearest facility is equal to the
actual facility attended and whether the nearest is a suitable proxy for the hospital
attended.  This will be considered in Chapter 3, as Chapter 4 relies on nearest facilities, as
the destination point.
· A number of the studies that focused on a range of healthcare destinations found that
distance/ travel time to the GP (as the gatekeeper to healthcare treatment) had a
statistically significant association with health outcomes.  It is therefore important not to
focus just on one point of healthcare access.
· Assuming that patients have travelled to healthcare facilities by car may underestimate the
distances and travel times that some patients will have to travel.  It is also important to
take account of key variables including deprivation and comorbidities in the statistical
models, as identified in a number of the included studies.
This chapter has focused on bringing together the evidence on the association between travel
time and distance to healthcare and health outcomes.  None of the included studies in the
systematic review focused on OA or RA as a disease group.  The next chapter describes the first
case study focusing on whether travel times and distances are associated with differences in








Chapter 2 of this thesis reported on the systematic review that assimilated evidence on studies
that had considered the association between health outcomes for patients and living further
(measured using travel times or travel distances) from the healthcare facilities that they needed
to attend.  This Chapter takes this evidence forward and explores the associations between
travel time and distance to healthcare facilities (e.g. GP and hospital) and differences in health
outcomes for total hip replacement (THR) and total knee replacement (TKR) patients in West
Yorkshire (WY), England.   It has been designed to contribute to the following study objectives:
Objective 2: To explore and document the healthcare and transport accessibility needs
of patients with osteoarthritis and rheumatoid arthritis.
Objective 3: Develop statistical models to examine the associations between transport
accessibility to healthcare and inequalities in health for individuals diagnosed with RA and
OA.  For two case studies:
· Case Study 1: West Yorkshire.  Using the linked Hospital Episode Statistics – Patient
Reported Outcome Measures (HES-PROMS) dataset
West Yorkshire is a Metropolitan county with a population of over 2.2 million spread across five
districts; Leeds, Bradford, Calderdale, Kirklees and Wakefield (shown in Map 1).    Data was
accessed  for  2009/10  –  2011/12,  which  falls  into  the  period  of  time  when  healthcare  was
organised into Strategic Health Authorities (SHA) and Primary Care Trusts (PCTs), which were
abolished in March 2013 in favour of Clinical Commissioning Groups (CCGs).  West Yorkshire was
under the NHS Yorkshire and Humberside SHA and five PCTs; NHS Calderdale PCT, NHS Kirklees
PCT, NHS Wakefield District PCT, NHS Bradford and Airedale Teaching PCT and NHS Leeds PCT.
Whilst healthcare delivery was organised geographically into PCTs, following changes to the NHS
constitution in April 2009 patients had the right to choose (from hospitals that treat NHS patients
in England) where to have their THR or TKR operation (Department of Health, 2009).
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Map 1: Location of West Yorkshire in England (source:  ONS: 2011)
The	HES-PROMS	dataset		
The study accessed the linked Hospital Episode Statistics (HES) and Patient Reported Outcome
Measures (PROMS) dataset to explore the research question for this Chapter.  The HES dataset
contains key information for every NHS outpatient, inpatient and Accident and Emergency (A &
E) appointment or visit for patients in England.  Every time a person goes into hospital
information is recorded by the hospital on things including their age, gender, any diseases that
they have (e.g. osteoarthritis) and their home postcode.  Plus information about who their
appointment was with (e.g. type of consultant) and the treatment they received (e.g. total hip
replacement).  The dataset is held by NHS Digital (previously called the Health and Social Care
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which collects data including quality of life data before and after patients undergo operations
for THR or TKR, varicose vein removal or hernia repair.  Patients are given a questionnaire to
complete before the operation and a second questionnaire is sent out to patient’s homes six
months after the operation to be completed and returned.  One of the key advantages of using
this dataset is that it provides linked health outcome and patient data for patients that could
be identified from the records as having either OA or RA.   The data requested from the HSCIC
for the study (summarised in Box 1), includes all outpatient, inpatient and A & E data on the
patients with OA/RA who accessed a WY hospital between April 2009 and March 2012.
Box 1 Population data request for HES-PROMS dataset.
Stage 1:
· Patients who attended at least one West Yorkshire or Harrogate (outpatient or inpatient
hospital appointment) between April 2009 and March 2012  (provider codes - NT225,
NT332, NT348, NT349, NT350, NT447, NT448, NVC20, RAE, RCD, RCF, RGD, RR8, RWY, RXF-
X, TAD) AND
· Had an International Classification of Diseases Version 10 (WHO, 2016) code for
Osteoarthritis (M13, M15, M16, M17, M18, M19, M47) or Rheumatoid Arthritis (M05, M06,
M45) or the treatment speciality code recorded as rheumatology  AND
· Were > 17 year old.
Stage 2:
For those patients identified in Stage 1 the study requested all data (A & E, Outpatient,
Inpatient and PROMS) linked to these patients for the years requested.
In order to correctly identify those patients with OA or RA the International Classification of
diseases version 10 (WHO, 2016) was searched to select those specific codes that are entered
by the hospital into the dataset for each patient’s inpatient episode that identifies them as
having OA or RA. It should be noted that this classification is not always entered against the
patient’s record for the outpatient appointments or A & E attendances, but is required for
inpatient stays, due to associations with entering the data and reimbursement of costs for the
hospitals.  The hospitals cannot claim the costs if the data is not entered.  There are seven codes
specifically for OA:
· M13 = Other arthritis
· M15  = Polyosteoarthritis
· M16 = Osteoarthritis of hip
· M17 = Osteoarthritis of knee
· M18 = Osteoarthritis of first carpometacarpal Joint
· M19 = Other and unspecified osteoarthritis
· M47 = Osteoarthritis in the spine
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There are three code specifically for RA:
· M05 = Rheumatoid arthritis with rheumatoid factor
· M06 = Other rheumatoid arthritis
· M45 = Ankylosing spondylitis (in the spine)
In order to identify only those patients who had attended a hospital in West Yorkshire in the
given timeframe the hospital provider codes were collated.  For example, hospital provider
code NT225 in box 1 refers to the Nuffield Health, Leeds Hospital and RR8 refers to all the
hospitals within Leeds Teaching Hospital NHS Trust.
The key variables requested from the HES-PROMS dataset are summarised in Table 6.   Data
was requested on inpatient stays, outpatient appointments and A & E visits at the patient level.
Only the inpatient stays and outpatient appointments were subsequently used in the analysis.
This was due to the study narrowing the focus onto the THR and TKR operations rather than
the patient’s visits to the A & E.   The data was accessed at the patient level, which means that
for every A & E visit and outpatient appointment there is a record for each patient.  For the
inpatient appointments the data is provided at the episode level.  An episode is the time a
patient spends under the continuous care of one consultant.  If the patient as a result of their
treatment transfers during their time in hospital to more than one consultant then there would
be more than one episode recorded across a multiple episode stay for that patient for their
inpatient stay.  Whilst some of the variables for a patients stay in hospital will remain the same
(e.g. age, gender) others might change including the consultant type and the hospital attended
if a transfer between hospitals had been required.
At the time of this study taking place it was not possible to link primary care data (which is
collected through a separate system) to the HES-PROMS dataset.  This is still not possible (at
the time of this thesis being submitted).  As noted in Chapter 1 access to the GP is one of the
main ways that patients with OA are treated and was also identified as a key access point in
some of the studies included in the review in Chapter 2.  The patients’ registered GP practice
was included in the request to take some account of this in the analysis.
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Table 6: Summary of main variables requested from HES and PROMS




Variables based on where
the patient lives
Home Address (postcode)
Census output area 2001
LSOA (Lower Layer Super Output Area)
Rural/ Urban indicator
Index of Multiple Deprivation
Healthcare facility Attended GP practice







Treatment specialty of consultant
Appointments/ Hospital
stays
Dates of attendance at hospital
Length of stay (for inpatient appointments only)
Missed Appointments
Discharge method
Whether the patient died in hospital.




Oxford Hip Score (OHS)
Oxford Knee Score (OKS)
Living Arrangements
The study applied for home postcode data to allow distance and travel times (home to
healthcare facility) to be calculated.  An added complication of this was that by applying for the
home postcode variable (classed as patient confidential) there was a requirement to get a higher
level of ethical approval than for the standard HES-PROMS applications.  An alternative
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geographical identifier that would not have required approval at this level is the Lower Super
Output Area (LSOA), which can provide a location (using the population weighted centroid for
the LSOA) based on groups of 400 - 1200 households, but is potentially less accurate than the
home postcode, which is representative of between 2 and 80 households.   The study used both
types of geographical locations (home postcode and LSOA) in the calculations to assess whether
there were any statistically significant differences between the results.
3.1.1.1 Ethical Approval for the HES-PROMS data
The study went through multiple ethical approval stages to gain access to the data required.  An
NHS Integrated Research Application System (IRAS) application was populated with information
including the study protocol, the study population, the data security procedures and policies.
This was reviewed by the Faculty of Medicine Ethics within the University of Leeds before being
submitted to  the NHS Health  Research Authority  (HRA)  Research Ethics  Committee (REC)  for
review and approval.  The proposal went before the Leeds East Committee in December 2014
and was granted approval on the 4th of December 2014 (reference 14/YH/1262).  As the study
was requesting access to data at the level of the patients’ home postcode there was a
requirement to submit the forms and additional information to the HRA Confidentiality Advisory
Group (CAG).  Patient home postcode data is classed as patient confidential, which requires
either the permission of the patients whose data has been included or alternatively Section 251
approval, which allows the use of the data without individual patient permission, subject to
meeting eligibility criteria.  The study was granted Section 251 approval in April 2015 from CAG
(ref: 15/cag/0001).  The final stage was to request the data from the then Health and Social Care
Information Centre (HSCIC) (now NHS Digital).   Approval was granted in September 2015 and
the  data  was  received  in  December  2015.   The  HRA  and  HRA  CAG  approval  both  require
submission of an annual report to maintain access to the data (updating the organisations on
how the data is being used). The NHS Digital data sharing agreement required an annual renewal.
The process of obtaining the data was a long and arduous one.  Key issues included that the
HSCIC had imposed a blanket ban on releasing HES data, which was only lifted just before the
study requested the data.  The process for applying had new procedures including new
considerations for the fair processing of data that were still being determined during the
application.   The data was stored on a secure drive accessible only through the computer at the
University.  This met the NHS requirements for holding data securely.
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The	Patients:		THR	and	TKR	
As described in Chapter 1 surgery in the form of joint replacements is one of the options on the
care pathway for patients with OA or RA.   Two of these possible operations that are completed
to ease pain,  improve mobility and improve sleep are the TKR and THR.  The THR involves a total
joint  replacement,  which  is  the  replacement  of  the  femoral  head  with  a  stemmed  femoral
prosthesis and the insertion of an acetabular cup, which can be completed with and without
cement.  The TKR involves replacing both sides of the knee joint. The end of the femur replaced
by a curved piece of metal, and the end of the tibia replaced by a flat metal plate. A plastic spacer
is placed between the pieces of metal to reduce the friction as the joint moves. THR is a common
surgery with over 105,000 taking place across England, Wales and Northern Ireland in 2017
(National Joint Registry, 2017).  There were more TKRs at over 114,000 in the same timeframe
(National Joint Registry, 2017).  The operations are designed to replace joints worn by age or
damaged by conditions such as arthritis.  For THR operations patients undergo either a
cemented hip replacement, which involves a layer of bone cement between the patient’s bone
and prosthesis, or uncemented where the prosthesis has a rough surface or porous coating that
encourages the natural bone to grow onto it.  The review by Abdulkarin et al. (2013) comparing
the two options (cemented and uncemented) concluded that there were “no significant
differences in the revision rate, mortality or the complication rate” (p 1), but that patients
reported improved HRQoL for pain under the cemented THR. For a TKR operation the damaged
cartilage and bone is removed and metal implants are attached to the thigh and calf bones with
a plastic spacer inserted in-between to ease movement.
As part of the process for deciding where patients attend for their operation, information is
provided to the patients through the NHS Choices website (NHS, 2017) on how to make the
choice over where to have the operation.  The information includes distance to the hospital,
waiting times, number of parking spaces, number of hip revisions completed at the hospital, and
HRQoL scores for previous patients.
Having a diagnosis of OA or RA in the hip or knee does not automatically qualify an individual to
have a THR or TKR.  As discussed in Chapter 1 some individuals have radiographic evidence of
OA in their joints, but do not experience the severe pain and others have pain or a symptomatic
diagnosis, but no radiographic evidence.  As shown in Figure 4 and 6 there are other approaches
(e.g. exercise, diet, pain killing injections such as corticosteroids) that are promoted before an
individual is considered for a THR or TKR.  In England the criteria for allowing an individual to
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have a TKR or a THR is set by the individual CCGs, as it is not a routinely funded surgery.    It is a
NHS clinician’s decision to decide whether the individual meets the required threshold for a THR
or TKR.  An example of the key requirement for THR  and TKR for OA from Harrogate and Rural
District CCG (2014) states that it will be commissioned if the :
· “Patient is experiencing moderate-to-severe persistent pain not adequately relieved by
an extended course of non-surgical management. Pain is at a level at which it interferes
with activities of daily living – washing, dressing, lifestyle and sleep;
· Is troubled by clinically significant functional limitation resulting in diminished quality of
life;
· The patient is fit for surgery with a BMI ≤35 and a non-smoker. Patients with a BMI >35
and/or who smoke should be advised and given appropriate support to address lifestyle
factors that would improve their fitness for surgery. … a clinician should confirm that
reasonable attempts have been made to stop if still a smoker.
· The patient has radiological features of disease.
·  A simple x-ray to confirm diagnosis has been carried out within the past 6 months” (p1)
The study focused on TKR and THR as they both form one of the possible treatments on the care
pathway for patients with OA and RA.  In addition, critically linked data was collected at the
individual patient level through the PROMS dataset for patients having these two operations, so
providing linked treatment, location and health outcome data for the patients. Other operations
that are also carried out for patients with OA or RA such as shoulder replacements could be
identified in the HES dataset, but did not have the corresponding patient health outcome data.
An alternative dataset that was considered is the National Joint Registry (NJR), which collects
information on hip, knee, ankle, elbow and shoulder joint replacement surgery and monitors
the performance of joint replacement implants.   At the time of applying for data for this study
it was not possible to get access to elbow, shoulder or ankle data for the timeframe that was
being considered (they have been collected from later dates than hip and knee.).  The NJR
collects more detailed information on the specifics involved in the operations than HES including
the surgeon’s details, operation details (e.g. anaesthetics used) and surgical approach and
collects the patients BMI, but does not collect data on the patient’s ethnicity or registered GP or
record any other hospital appointments other than the TKR or THR.  One of the limitations of
the NJR is that unlike the HES dataset (where hospitals are required to enter the patient data
onto the system) patients have to give permission for their personal details to be held by the
database.   In   2009/10,  one  of  the  years  being  considered  in  this  study  only  87.5%  of  the
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submitted forms to the NJR had consent to be included (so were missing from the NJR dataset)
and some of the NHS hospitals had not submitted any forms , so were not included in the dataset
(which is only mandatory for independent sector hospitals) (NJR, 2010)(p22).    The decision was
made to apply for the HES-PROMS dataset in 2014 as it allowed access to data on all
appointments (inpatient, outpatient and A& E) that were attended by the patients for the THR
and TKR not just those, where the hospitals had submitted the data and the patients had
consented to the data being used by researchers.  Plus is allowed access to code of the patients
registered GP to allow this aspect to be explored.  New rules have since been introduced for the
HES data to ensure that patients who want to opt out of having their data used for research
purposes will not be available in the datasets given out to researcher (an opt out rather than opt
in).  This rule was not applied to the data used for this study, so all data was included and there
were no missing patients.
Health	Outcome	Measures		
Measuring health outcomes is important as whilst studies have shown that THR and TKR
procedures reduce the symptoms in the majority of patients and the operation is associated
with low rates of complications and mortality there are still a proportion of patients reporting
unfavourable  outcomes.   A  systematic  review  by  Beswick  et  al.  (2012)  concluded  that  “The
proportion of people with an unfavourable long-term pain outcome in studies ranged from about
7% to 23% after hip and 10% to 34% after TKR. In the best quality studies, an unfavourable pain
outcome was reported in 9% or more of patients after hip and about 20% of patients after knee
replacement” (p 1).  A review of the literature identified a plethora of measures that had been
developed and used to assess health outcomes following THR and TKR operations.  The most
commonly used measures in the literature are summarized in Appendix 2 including an
assessment of whether they are a generic measure, or disease specific and who makes the
assessment (patient or clinician).  The literature represents a mixture of measures that are
assessed by clinicians, patients self-reported assessments of their health and quality of life and
objective measures (e.g., mortality).  These include generic health measures such as the EQ-5D-
3L and  SF36 , which were designed to measure a patient’s health, but were not disease specific
- to disease and joint specific measures for assessing the hip such as the Oxford Hip Score
(OHS)  ,Harris  Hip  Score(HHS),  Hip  Outcome  Score  (HOS),  Western  Ontario  and  McMaster
Universities Arthritis Index (WOMAC), HiP Disability and Osteoarthritis Score (HOOS) and Lower
Extremity Functional Scale (LEFS) and for the knee including the Knee Society Score (KSS), Knee
disability and Osteoarthritis Outcome Score (KOOS) and Oxford Knee Score (OKS).   Added to this
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are objective measures such as mortality, and joint failures and functional ability assessed by
clinicians using measures such as the six minute walk test (6 mWT) and Timed Up and Go test
(TUG).
A number of these measures are included in the PROMS questions that patients complete before
and six months after their THR or TKR operation in England.  The most commonly used are the
generic EQ-5D-3L and EQ-5D VAS, which form the basis of the health related quality of life scores
(The EuroQol Group, 1990), Self-Reported General health, and disease specific Oxford hip score
(OHS) (Dawson et al., 1996) and Oxford Knee Scores (OKS) (Dawson et al., 1998).   A number of
studies have compared the performance of these measures for THR and TKR patients (e.g.
Benson et al. (2016) and Oppe et al. (2011)).  With Benson et al. (2016) defining the OHS and
OKS as the Gold Standard measure for THR and TKR.
As discussed in Chapter 1 there are a number of potential determinants that can potentially
affect a patient’s health.  A growing number of studies have sought to identify key patient
predictors for patients undergoing THR and TKR operations.  Buirs et al. (2016) systematic review
of predictors of physical functioning after a THR identified 33 relevant studies focusing on
predictors, which used the following health outcome measures; HHS. OHS, SF36, LEFS, TUG and
WOMAC.  They reported that there was strong evidence for an association between BMI, age,
comorbidities, preoperative physical function and mental health with functional outcomes
following the THR, but only weak or inconsistent evidence for education, gender and
socioeconomic status. Gordon et al. (2014) used a large Swedish cohort of THR patients and
showed that there were worse outcomes for older people (they achieved less improvement
following the operation).  Fitzgerald et al. (2004) followed 222 patients for 12 months following
their THR or TKR operation and identified that following the operation lower pain levels were
associated with being over  the age of  75 years,  having greater  social  support  (e.g.  not  living
alone), undergoing a THR rather than TKR and having less pre- operation body pain.  Being male,
having greater social support and higher pre-operative scores were associated with better
quality of life outcomes in terms of physical function (ibid).   McHugh et al. (2013) followed 206
THR patients in England and identified that patients with anxiety and depression prior to the
operation were associated with poorer recovery outcomes following the operation.
Not all the evidence currently points to a strong association between predictive factors and
health outcomes/ proxy measures.  Hofstede et al. (2016) identified 35 studies covering the
health outcomes and proxy measures of SF36, EQ-5D-3L, SF12, WOMAC, OHS, HHS, HOOS, Pain,
Satisfaction, 6 mWT and revisions that had focusing on studies focusing on  the association
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between age, gender, education/SES, comorbidities, BMI, radiology severity, patient
expectations, and pre- operation function, pre-operation pain, pre –operation HRQoL and
mental health and outcomes following a THR.  They concluded that currently “there was not
enough evidence to draw succinct conclusions on pre-operative predictors for postoperative
outcome in THR, as results of studies are conflicting and the methodological quality is low” (p9).
Towheed and Hotchberg (1996) argued that future research in this area should focus on “patient
level predictors and the role of various surgical approaches” (p483).  Judge et al. (2012a) also
focused on identifying pre-operation predictors of health outcomes following knee surgery and
found that patients reported worse outcomes if they had more severe disease prior to the
operation, had OA compared to RA and lived in the most deprived areas.  They concluded that
“other predictive factors need to be identified to improve our ability to recognize patients at risk
of poor outcomes” (p1804). One of these “other predictive factors” could be living further from
the hospital, or GP for this group of patients, as patients need to attend the GP in the first place
to be referred into the system to be considered for a THR or TKR.  There is a need to attend
hospital for the pre-operative appointments (including to have x-rays), operation and then
follow up appointments.  This could lead to an increased travel burden over time given that the
majority of patients have to travel to healthcare facilities to attend appointments and receive
treatment.  The patient level predictive factors that have been investigated in the literature has
focused on the association between age, gender, BMI, education/ SES, comorbidities, alcohol
consumption,, allergies, deprivation, living alone, pre-operation radiology severity, pre-
operation function and pain, pre-operation HRQoL, mental health and post operation health
outcomes and time on the waiting list. None of the studies have focused on the association
between transport accessibility and health outcomes for TKR and THR, which is the focus of this
thesis.
Length of Stay (LoS) in hospital and missed appointments have also been considered in the
literature.   Studies such as Jackson et al.  (2013) found an association between living further
from the hospital and an increased LoS, as a proxy outcome measure for health outcome.  Whilst
Hamilton and Gourlay (2002) in their report on missed appointments argue that “there  is  a
strong link between transport and nonattendance of hospital appointments” (p32).  They also
argue that there is little research in this area, which falls between the responsibility of the
Department of Health and Department of Transport and is not considered a priority by either.
Missing appointments can result in delays in diagnosis and treatment.
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The review in Chapter 2 did not identify any studies that had explored whether travel times or
distances to healthcare facilities were associated with changes in health outcomes either for
patients  with  arthritis  or  after  having  a  THR  or  TKR,  which  will  be  the  focus  of  this  chapter.
Preliminary investigation of the data found that there were only 50 patients with RA that had
had a THR/TKR in the timeframe of the data.  A decision was made at this point due to the small
numbers to focus this Chapter on those patients with a OA diagnosis on their hospital records
who had had a TKR or THR.
3.2 Methods	
Once the study had access to the data and had stored it securely in the University’s encrypted
drive there were a number of stages to the process for analysing the data.   These focus on:
Section 3.2.1:   Dependent Variable: Health Outcomes
Section 3.2.2:  Dealing with missing health outcome data
Section 3.2.3     Independent Variable: Travel time and distances to the healthcare facilities
Section 3.2.4:   Other Explanatory / Predictor Variables
	Dependent	Variable:	Health	Outcomes		
The key aim is to model the association between the travel times and distances to healthcare
facilities and the dependent variable which is the health outcome or proxy health outcome.  The
study makes use of the health outcomes that were included in the PROMS survey completed by
the patients at baseline (pre operation) and 6 months following the operation.  These outcomes
measures were the OHS, OKS, EQ-5D-3L, EQ-5D VAS and General Health.  The OHS, OKS and EQ-
5D-3L have previously be applied in studies that have focused on patients who have had a TKR
or THR (as discussed in section 3.1).  In addition to this the study included the proxy measure of
LoS in hospital (days) following the operation and attendance at outpatient appointments, which
were both accessed just from the HES data for this population of patients.   A summary of the
measures are provided in Table 7 and description in the next section.
104
Table 7: Health and Proxy Health Measures
Dataset Measure Use Range/ scale
PROMS EQ-5D-3L Generic - 0.594 – 1.0
EQ-5D  VAS Generic 0 - 100
General Health Generic Excellent, Very Good, Good, Fair, Poor
Oxford Hip Score THR 0 – 48
Oxford Knee Score TKR 0 – 48
HES Length of Stay Generic Days
DNA Generic Attended/ did not attend an
outpatient appointment
3.2.1.1.1 EQ-5D-3L
The EQ-5D-3L was developed by the EuroQoL group as a generic measure of self-assessed health
to be applied to a range of conditions (The EuroQol Group, 1990).  It consists of 5 dimensions of;
mobility, self-care, usual activities, pain/discomfort and anxiety/depression, as shown in Figure
8.  Patients are asked to state whether they have no problems (scored 1), some problems (scored
2), or extreme problems (scored 3) against each of the 5 dimensions.  This is converted into a
self-assessed health state of 11111 if they have no problems on any of the domains and 33333
if they have extreme problems for each of the 5 domains, with a total possible 243 health states.
Health states are assigned an index score between -0.549 and 1 by applying the UK population
preference weights (tariffs) taken from (Dolan, 1997).  Where 1 is bounded as full health and 0
as death.  Values below 0 are classed as states worse than death.
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By placing a tick in one box in each group below, please indicate which statements best
describe your own health state today.
Mobility
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
Self-Care
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
Usual Activities (e.g. work, study, housework, family or leisure activities)
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
Pain/Discomfort
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
Anxiety/Depression
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
Figure 8: EQ-5D-3L Domains    Source: (The EuroQol Group, 1990)
3.2.1.1.2 EQ-5D VAS
The EQ-5D VAS (visual analogue scale) was designed to be used alongside the EQ-5D-3L (The
EuroQol Group, 1990).  Whereas the EQ-5D-3L splits the health of a patient into a number of
pre-specified domains the EQ-5D VAS allows patients to make an assessment of their overall
health.   Patients indicate on the scale shown in Figure 9 how good or bad their health state is
on the day they completed the survey.  This point on the scale represented as a value between
0 and 100 can be analysed as a quantitative measure.
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Figure 9: EQ-5D VAS  Source: (The EuroQol Group, 1990)
3.2.1.1.3 General Health
The next measure of health is the Self-Assessed General Health.  This is the only measure of
health that is also included in the ELSA dataset used in Chapter 4. It is presumed that when
answering the question “In general would you say your health is? “   that  multiple  facets  of
health are being considered by the individual.   This questionnaire has been applied in numerous
settings and forms one of the questions in the UK 10 yearly census.  For example, in the 2011
census 81.4% of people in England reported their general health as either ‘Very Good’ or ‘Good’
(ONS, 2016a). The general health question in the PROMS dataset is completed before and after
the operation and asks patients:
In general would you say your health is? Excellent, Very Good, Good, Fair, Poor.
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3.2.1.1.4 Oxford Hip Score (OHS) and Oxford Knee Score (OKS)
The three previous measures discussed (EQ-5D-3L, EQ-5D VAS and Self Assessed General Health)
are all generic measures and can be applied to a range of disease groups to assess HRQoL.  The
Oxford Hip Score (OHS) and the Oxford Knee Score (OKS) were developed to provide PROMS for
joint replacements specifically for the knee and hip (Dawson et al., 1996; Dawson et al., 1998).
These two measures are described in Benson et al. (2016) as the gold standard measure for
capturing the results of THR and TKR.  The questionnaire in each case has 12 questions, which
relate to the previous 4 weeks of the patient life, so is not just based on how the patient feels
on the day they complete the questions.  This differs from measures such as the EQ-5D VAS,
which asks about the patients’ health on the day that they complete the questions.  An example
showing the OHS (questions used for the THR patients) is shown in table 8.   Each question is
scored between 0 and 4, with a 4 indicating no problems.  These scores are combined to give a
total score between 0 and 48. Where 0 is the worst possible score and 48 the best.  It covers a
wider range of questions than the previous measures.  For example, instead of asking whether
they have no/ some or extreme problems in mobility, as in the EQ-5D-3L measure there are a
range of questions that are specific to the hip problem (e.g.  “Have you had trouble washing and
drying yourself (all over) because of your hip? “).
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Table 8: Oxford Hip Score questions.  During the past 4 weeks…
Q1 - How would you describe the pain you usually had from your hip?
Score                      None = 4, very mild = 3, Mild = 2, Moderate = 1, Severe = 0
Q2 –Have you had any trouble washing and drying yourself (all over) because of your hip?
Score No  trouble  =4,  Very  little  trouble  =3,  Moderate  trouble  =2,   Extremely  difficult  =1,
Impossible to do =0
Q3 – Have you had any trouble getting in and out of a car or using public transport because
of your hip?
Score No  trouble  =4,  Very  little  trouble  =3,  Moderate  trouble  =2,   Extremely  difficult  =1,
Impossible to do =0
Q4 – Have you been able to put on socks, stockings or tights?
Score Yes easily =4, Little difficulty =3, Moderately difficult =2,  Extremely difficult =1,
Impossible to do=0
Q5 – Could you do the household shopping on your own?
Score Yes easily =4, Little difficulty =3, Moderately difficult =2,  Extremely difficult =1,
Impossible to do=0
Q6 – For how long have you been able to walk (with or without a stick) before pain from your
hip becomes severe?
Score No Pain = 4, 16-30mins =3, 5 – 15mins = 2, Around the house only =1, Pain severe on
walking =0
Q7 - Have you had trouble washing and drying yourself (all over) because of your hip?
Score:  No  trouble  =4,  Very  little  trouble  =3,  Moderate  trouble  =2,   Extremely  difficult  =1,
Impossible to do =0
Q8 – How much has pain from your hip interfered with your usual work (including
housework)?
Score: Not at all = 4, A little bit = 3, Moderately =2 , Greatly = 1, Total= 0
Q9 - Have you been limping when walking, because of your hip?
Score: Rarely/Never =4, Sometimes or just at first=3, Often, not just at first=2, Most of the
time =1, All of the time=0
Q10 - have you been troubled by pain from your hip in bed at night?
Score: No nights =4, only1/2 nights=3, some nights=2, most nights =1, Every night=0
Q11 - Have you had any sudden, severe pain -'shooting', 'stabbing' or 'spasms' -from the
affected hip?
Score: No days =4, only1/2 days=3, some days=2, most days =1, Everyday=0
Q12 - After a meal (sat at a table), how painful has it been for you to stand up from a chair
because of your hip?
Score: Not at all painful =4, Slightly Painful =3, Moderately Painful=2, Very Painful =1,
Unbearable=0
Source: Dawson et al. (1996)
3.2.1.1.5 Length of stay (LoS)
The Los data is collected by the HES through calculating the number of days that a patient is in
hospital from the date at which they were admitted to the date at which they were discharged.
It is therefore possible for each patient included in the study to determine how long (days) they
spent  in  hospital  for  their  THR  or  TKR.   Studies  such  as  Jackson  et  al.  (2013)  identified  that
patients with colorectal cancer stayed in hospital on average longer if they lived further from
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the hospital they were attending.  The thesis is including the number of days that the patients
stayed in the hospital following the THR or TKR as the proxy health outcome measure.
3.2.1.1.6 Missed Appointments (DNA)
Reports such as Hamilton and Gourlay (2002) and SEU (2003) have highlighted the impact of
transport problems on patients missing appointments.   An estimated 1.5 million hospital
appointments per year were missed in the UK due to transport problems (SEU, 2002).  Missed
appointments were estimated to cost the NHS £ 1bn in 2016/17 with an estimated 8 million
missed appointments in total (NHS England, 2018 ).  Critically for the patient, missed
appointments can result in issues such as delayed diagnosis and delays to treatment or worse
health  outcomes due to  incomplete follow up following treatment.   In  the case of  THR/ TKR
patients have to attend outpatient appointments prior to having the operation and then follow
up outpatient appointments so that the surgeon can check that the operation was successful.
Missing these may lead to worse health outcomes if issues are not identified.   As Lara et al.
(2005)  found patients living further from the hospital were more likely to miss some follow up
appointments.
Missed appointment are not recorded in the HES dataset for inpatient stays, but are recorded
for outpatient appointments.  The study used the complete requested HES outpatient dataset
(Box  1)  for  those  patients  with  a  diagnosis  code  of  OA  or  RA.   This  was  all  patients  with  a
diagnosis code of OA or RA and was not restricted to those who had undergone a THR or TKR.
The unattended appointments are recorded in the HES dataset split into a number of reasons
why the appointment might not have been attended.  These are; appointments cancelled by the
hospital, appointments cancelled by the patient, appointments not cancelled by the patient and
not attended, and appointments where patients attended late and were seen and whether they
attended late and were not seen.   The thesis included all outpatient appointments as not
attended if the patient had not attended their appointment and had not cancelled.   The thesis
is interested in whether not attending the appointment is associated with living further away
from the hospital.  With the idea that missed appointments are a proxy for a patient’s health.
Dealing	with	Missing	Health	Outcome	Data		
One of the key observations from the HES-PROMS dataset during cleaning the data was that
whilst it was possible to get a complete dataset for the travel times and distances for each of
the patients, as this required the home postcode and healthcare facility attended, which is
collected through the hospital system, what was missing in a number of cases was the patients’
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responses to either all or some of the health measures.  The PROMS dataset relies on patients
completing the full set of questions both at baseline (prior to undergoing their operation) and
at  follow up and also that  the people  entering the data  are  able  to  read their  answers.   Not
having complete answers where large numbers of patient data is missing is obviously an issue,
as it does not provide the complete picture for the full patient population.   A summary of the
level of missing data is provided in Table 9.   It shows that for the generic self-assessed health
measures there were higher levels of missing data for the THR patients compared to the TKR
patients.  The disease specific questions (OHS and OKS) had much lower levels of missing data
at 16.8% and 21.4% respectively than the generic health measures.
Table 9: Summary of missing data by health measure
Type Total Sample Missing baseline and / or follow up
ED-5D-3L  Index THR 4550 33.7%
TKR 5506 24.9%
EQ-5D VAS THR 4550 36.6%
TKR 5506 27.2%
General Health THR 4,550 34.3%
TKR 5506 34.0%
OHS THR 4550 16.8%
OKS TKR 5506 21.4%
Length of stay THR/THR 0%
DNA THR/THR 0%
In  terms  of  having  missing  data  and  how  critical  it  is,  one  of  the  key  aspects  to  focus  on  is
whether there are any systematic differences between those patients who have missed out
some of the questions and those with complete responses.  This is tested using the t-test and X2
tests at the 95% level.   A number of methods have been developed for dealing with missing
data issues.  These methods mostly deal with data that is assumed to be Missing at Random
(MAR).   Missing at  random is  interpreted as  there “could be systematic differences between
missing and observed values, but these can be explained by the other observed variables”
(Bhaskan and Smeeth, 2014).   Whilst there are missing values these can be imputed using
evidence from all the other potential explanatory variables (e.g. sex, age, deprivation level, non-
missing domains etc.).    One of the key methods proposed for imputing data is to use multiple
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imputation using a chained approach (MICE) (Royston and White, 2011).  This fits with the MARs
assumption that the other explanatory variables can be used in the imputation.
The thesis used the MICE methodology implemented in STATA 10.4, with 30 imputations (it is
recommended to have as many imputations as the % of missing data). For the EQ-5D-3L data,
Simons et al. (2015) found that imputing at the index level was more accurate for smaller sample
sizes  (e.g.  100),  but  imputing  at  the  domain  level  (the  EQ-5D-3L  index  is  calculated  from  5
questions and the OKS/OHS from 12 questions) was more accurate for larger sample sizes, as is
the case for this study.   This intuitively makes sense, as with a large number of patients with
only one domain missing then the imputation is based on imputing one domain rather than
assuming there is no valid information available for the patient.  Stata code was written to
undertake the multiple imputations at the domain level for the EQ-5D-3L values and then the
weights used from Dolan (1997) to convert this data to an index value once the values had been
imputed.
A graphical presentation of imputing data using the individual domains is shown in Figure 10 and
using index values in Figure 11 for the EQ-5D-3L.  It can be observed that when imputing using
the domains the imputed data follows the bimodal distribution of the observed data (Figure 10).
Whilst 31% of the patients had not completed any of the questions, 69% had completed the self-
assessed score for at least one domain in the questionnaire, so imputing by domain allows the
model to use all data available.  Imputation using the EQ-5D-3L index values (-0.549 to 1) gives
a normal (bell shaped) distribution that does not match the observed data, as shown in Figure
11.   The imputations for this study show the same findings as Simons et al. (2015).    Imputation
at the domain level was carried out using an ordered logit model (due to the data being recorded
at 3 levels).
The same process  was used for  the OHS and OKS whereby missing data  was imputed at  the
individual question level (12 questions), so where patients had completed some but not all of
the question in the OHS/OKS this data could still be included and not dropped.  The rule of thumb
is that there should be as many imputations, as percentage of missing data.  Thirty imputations
were run for each model.  In all cases observations were dropped where there was no baseline
data (where none of the questions had been answered at baseline).
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Figure 10: Kernel distribution of the inputted missing EQ-5D-3L data using the individual
domains.
 Figure 11:  Kernel distribution of imputed missing EQ-5D-3L data using index value (imputed
















































The literature reviewed in Chapter 2 identified a number of methods used to calculate the travel
times and travel distances to healthcare facilities.  This section describes the methods used to
calculate the travel times by bus and car, as a proxy measure for transport accessibility
(discussed in section 1.4), as one element of GC in this thesis.
3.2.3.1 Geocoding the origin and destination points
The  key  data  requirements  used  to  calculate  the  travel  times  and  distances  was  the  origin
location (patient’s home address/ geographic location) and destination location (healthcare
facility address, or nearest healthcare facility).   For the HES-PROMS dataset this was of the form:
· Origin – Postcode for the patient’s home address (HES code: homeadd )
· Origin – LSOA of the patient’s home address
· Destination – Patient’s registered GP Practice (HES code: gprach)
· Destination – Nearest GP
· Destination – Hospital where the appointment/ treatment took place (HES code: sitetret
or procode).
· Destination – Nearest (researcher defined nearest facility based on all hospitals that
undertook THR or TKR or GPs)
The centroid of the patient home postcode was geocoded into easting and northing coordinates.
To do this the full set of UK postcodes with corresponding easting and northing coordinates was
downloaded from Doogal (2016).  The merge of the two sets of data – patient postcode and
easting northing coordinates was undertaken using STATA 14 using the _merge code and linked
by postcode.  The same process was completed for the LSOA codes, where the population
weighted centroid for each LSOA (and corresponding easting and northing coordinates)
accessed through ONS (2018a) was merged with LSOA codes in the HES-PROMS dataset.
The locations of the hospitals attended for the patients’ appointments (inpatient and outpatient)
were converted from sitetret (code of the hospital) or if not available procode (provider code of
the hospital) to a postcode by interrogating the care quality commission website (Care Quality
Commission,  2018).   For  example,  RCB00  corresponds  to  York  hospital,  which  is  located  at
postcode YO31 8HE.  This postcode was converted to easting northing coordinates, using the
same method described above.   The GP practice codes from the HES dataset (registered GP)
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were converted to a practice geographical location using the GP location file (EPRACCUR file)
accessed through the NHS Digital website (NHS Digital, 2016b).    This file includes the name and
address details of all the GPs in England alongside their GP practice codes.  These centroids of
these postcodes were also geocoded into easting northing coordinates by merging the file with
the downloaded easting and northing coordinates in STATA 14.   In total patients attended 31
different hospitals for their THR/TKR both within and outside WY.   The patients were registered
at 358 different GP practices both within and outside of the WY region.
3.2.3.2 Calculating the travel times and distances
As discussed in Chapter 1, whilst transport accessibility is a multi-dimensional construct with
different implications for different individuals the most common method that is used in the
literature  as  shown  by  the  review  in  Chapter  2  is  to  use  a  proxy  measure  of  travel  time  or
distance to healthcare facilities.  Drawing from the literature the three key methods that have
been employed to calculate travel times and distances using GIS are:
· Straight-line distance (Euclidean distance)
· Car driving distance (using the road network)
· Car travel time (using the road network)
In addition to these the travel times by public transport were also calculated to provide a
comparison.  The methods used to calculate each of these approaches are now described.
3.2.3.2.1 Straight-line distance
The straight-line distance (or Euclidean distance) is the distance using a straight-line from the
origin location to the destination point.   The study used the Near tool in ESRI ARCMAP 10.2.2 to
calculate the straight-line distance from the geocoded home postcode and LSOA to the actual
and nearest facilities.  This is the most straightforward measure of distance to calculate as it
requires the starting and end points and draws a straight-line between the two.  The main
criticism of this approach is that very few journeys are made in a straight-line, as for example
rivers and one way systems get in the way.  This will mean that the results using this
measure will tend to underestimate the travel distance.  This method was used by over
25% of the studies included in Chapter 2.
3.2.3.2.2 Road distance and road travel times
The next approaches are to calculate the travel distances and travel times using the road
network.  This is an improvement on the straight-line distance as it takes account of the fact that
very few journeys are made in a straight-line and does this by using the road network.  The study
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used the Ordinance Survey (OS) Integrated Transport Network Layer (ITN) as the road network.
This was accessed in September 2016 through (EDINA Digimap Ordnance Survey Service, 2016).
The OS ITN includes the road network and road routing information for the whole of Great
Britain.  This includes ~ 544,000km of roads, which are classified by name and road type.  The
network includes information that might affect how a driver might travel along a route including;
one way streets, pedestrian zones and access restrictions, which will restrict the route and
ultimately road network travel times.  One of the main decisions to be made when applying the
ITN is to determine the travel speeds to be used along the routes.  The default is to use the speed
limits on the roads.  Findings published by the Department for Transport (DfT) showed that in
2015 84% of cars exceed the 20mph speed limit, 52% exceed the 30mph limit, 9% the 60mph
speed limit for single carriageways and 46% the speed limit of 70mph on a motorway in free
flow  conditions  (DfT,  2016).    On  the  basis  of  this  information  together  with  the  lack  of
knowledge about the times of day when the patients were travelling for their appointments and
the mix between urban and rural areas the national speed limits by road type were applied to
the model.   With the assumption that at some points in the day the journey will potentially be
faster than using the speed limits and at other times slower, as it doesn’t account for congestion
levels.   Studies such as Haynes et al. (2006) have explored whether travel times to hospital using
GIS are comparable to the travel times reported by patients for the same journey by car.  They
found that 77% were within 10 minutes of the patient reported journey times and 90% within
15 minutes of the road network estimated travel times and concluded that the GIS estimates
“were more appropriate for modelling purposes because they represented average conditions”
((Haynes et al., 2006)(p7).
The study used the Network Analyst tool in ESRI ARCMAP 10.2.2 to calculate the travel times
and distances using the origin and destination locations and the ITN network.  The process was
automated by programming in Python, which is an object oriented programming language that
allowed the process to be automated and as a result speed up the process of calculating all the
travel  times  and  distances,  as  they  can  run  in  a  loop.   The  process  was  intensive  and  time
consuming, as it needed to be run for each GP practice in the dataset and hospital provider
individually.  Due to the ethical approval process described in section 3.1.1.1 the data had to be
accessed through a password protected computer on the University of Leeds campus and could
only be accessed in the office (not remotely), which lengthened the time needed to run the
programme and determine the travel times and distances.
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3.2.3.2.3 Travel times by public transport
A number of studies in the review in Chapter 2 had considered travel by bus to hospital for
patients.  For example, Jones et al (2010) calculated whether patients had access to a weekday
bus service within 800m of their home and Moist et al (2008) asked patients how long it took
them to get to the dialysis unit and how they got there.  However none of the studies reviewed
had calculated the bus travel times using patient data.  The transport software Visograhy TRACC
produced by Basemap Ltd was used to calculate the travel times by public transport from the
patients home postcode and LSOA to the hospital (nearest and actual attended).  The study did
not calculate the travel times to the GP by bus, as it was not possible to automate the bus travel
times, so was not possible in the timeframe.
The bus travel times were calculated using the Visography TRACC software, the National bus
scheduling data and public transport bus stop data.    The public transport stop data for England
was accessed through the National Public Transport Access Nodes (NAPTAN, 2016).  This
provides the coordinates of all public transport stops (including bus stops) in England.  The public
transport scheduling data was accessed through the Traveline National Dataset ((TNDS, 2016).
This includes the detailed information on all bus routes in England.  Those bus routes relevant
for this study were cut from the National data.  Visography Tracc uses the ITN, bus schedules
and bus stops to calculate the travel times by bus from a given origin to destination point.  The
origins (home postcode and LSOA) and destinations (nearest and attended) need to be uploaded
individually.
One of the key differences with the bus routing data is that generally the bus does not go directly
from outside of an individual’s home and in many cases requires an interconnected bus journey
involving multiple buses.  In order to capture these differences a number of additional
assumptions  are  included  in  the  algorithm  for  calculating  the  travel  times.   Using  the  same
approach as used by DfT (2017) to calculate the travel time by bus and walk to local facilities the
study assumed that patients could walk a maximum of 800m to the bus stop at a walk speed of
4.8Km/h at the start of their journey.  For example, an individual who walked 500m to the bus
stop  and  then  walked  500m  from  getting  off  the  bus  to  get  to  the  hospital  would  add  12.5
minutes to their journey time.  It also means that patients who would have had to walk beyond
800m to get to the first bus stop would be recorded as not having an accessible route.   This
seems a reasonable assumption to make as the patients are likely to have mobility issues limiting
their ability to walk long distances.  Where patients have to change buses (e.g. one bus does not
go all the way) an assumption was included that there should be a maximum 500m
interconnection distance. This would result in an inaccessible route if the patient had to catch
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two buses to get to the hospital and the distance between getting off the first and getting onto
the second was greater than 500m to walk.  This walking distance between buses is included in
the travel time calculations, as is a 5 minute interchange penalty (the time allowed to get off
one bus and onto the next).   The software uses the routing information to calculate the fastest
route to get from the starting to end location including all the sections where patients would
have had to walk.   One of the disadvantages of using bus scheduled data and home to hospital
travel times by car (rather than the actual journey data) is that it is based on a perfectly running
network, so not accounting for changes to the schedule due to road closures, the weather, slow
running schedules, congestion etc…  Data that can account for differences in road speeds is
currently being collected by Basemap and would be available in the future, but without
knowledge about what time the patients have travelled to the hospital for their appointment
additional assumptions would be needed to apply this information to the data.
3.2.3.3 Comparing between the travel times and distances
A number of studies in Chapter 2 had used differing combinations of home location and
destination descriptors (e.g. nearest hospital, actual hospital attended).  T-tests were run to
assess whether there were any statistically significant differences between the distance and
travel time combinations, as  set out in Table 10.   The t –test was used, as it allows an assessment
of whether there is a statistically significant difference between the means in combinations of
pairs.  For example, is there a statistically significant difference in the means between calculating
the road network distance using the home postcode and hospital attended vs. the proxy for the
home address (LSOA) and hospital attended.  The 95% confidence interval (CI) around the mean
is shown to assess whether there is a 95% confidence that the means are different to each other.
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3.2.3.4 Additional Transport Data
The HES-PROMS dataset did not contain specific data on how far away patients lived from the
hospitals they were attending or their registered GP practice, so this data needed to be
calculated as part of this thesis, as discussed above.   The PROMS dataset did have questions
within the OKS and OHS on how easy patients find it to walk and how easy is it  to get into a
vehicle.  The following questions (and potential answers) are reproduced below in the context
of THR patients:
· During the past 4 weeks, for how long have you been able to walk before pain from your
hip becomes severe? (with or without a stick) – Answer not at all, around the house only,
5 – 15 mins, 16 – 30 mins, no pain / more than 30 mins.
· During the past 4 weeks have you had any trouble getting in or out of your car or using
public transport because of your hip? – Answer impossible to do, extremely difficult,
moderate trouble, very little trouble, No trouble at all.
These two questions have been analysed using descriptive statistics in this thesis.  Someone who
finds it extremely difficult to get in/ out of a car may have issues with transport accessibility in
terms of the discomfort it creates or not being able to use public transport.
Other	explanatory	/	predictor	variables		
As discussed in Chapter 1 there are a large number of potential determinants of a patient’s
health, which range from differences in age and ethnicity to whether patients live alone or have
comorbidities.  It is important to ensure (as far as is possible) that what the study is measuring
is the association between travel time or distance and the health outcome and not some other
association.   The  review  of  potentially  predictive  factors  identified  in  section  3.2.2  and  the
introduction on health inequalities in Chapter 1 included: age, gender, BMI, education/ SES,
ethnicity comorbidities, alcohol consumption, vitamin D deficiency, smoking, deprivation, living
alone, pre-operation radiology severity, pre-operation function and pain, pre-operation HRQoL,
mental health and post operation health outcomes, time on the waiting list and length of stay in
hospital, type of hospital. The HES-PROMS dataset includes a subset of these potential
explanatory variables that could be associated with the outcome measure (health outcome) or
in some cases could be argued to be associated with both the travel time measure and the health
outcome measure as a potential confounder.
Gender was identified as being a potential determinant of difference in health outcomes
following THR and TKR replacements (Jüni et al., 2010).  Older patients have been shown to have
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lower gains in health outcomes following a TKR than younger patients (Williams  et al., 2013)
and there have been shown to be differences in access to THR and TKR and health outcomes for
differing ethnic groups (Smith et al., 2017) and by deprivation levels (Edwards et al., 2018) living
arrangements (Edwards et al., 2018) and by number of comorbidities (Podmore et al., 2018)
A summary of the key variables available as potential explanatory variables from the HES-
PROMS dataset is provided in Table 11.  These include variables that were directly available from
the data (e.g. gender, ethnic group, and days in hospital) and variables that needed to be coded
using the data (e.g. Charlson Index that focuses on comorbidities and type of hospital).  As can
be seen it includes a subset of variables that have been considered in the literature.
Whether a patient had comorbidities was one variable, which could affect a patient’s health
outcome.  The study used the Charlson Comorbidity Index calculated using Charlson et al. (1987)
and coded in STATA 14.  This method determines a score for comorbidities based on the ICD 10
diagnosis codes (WHO, 2016) that have been entered against each inpatient appointment within
the HES dataset.  For example, a patient may have no comorbidities, whilst another will have
multiple (including for example cancer or heart failure) and as a result have a higher Charlson
Index score.    The study decided to convert this score (between 0 and 12) into a categorical
variable as shown in Table 11, as there were fewer patients as the number of comorbidities
increased.
The study also wanted to include in the analysis a proxy for the quality of the hospital, as this
may impact on the health outcomes of the patients who were treated there.  The hospital quality
indicator was derived from Care Quality Commission (2018) assessment for each hospital as a
whole (e.g. “needs improvement” “good” or “excellent”).  In addition to the measure of hospital
quality the study included whether the patient was treated at an NHS hospital or an independent
private  sector  provider.    This  was  important  as  patients  treated  in  the  private  sector  have
differing characteristics to those treated by the NHS, where the NHS treats the more high risk
cases.  Chard et al. (2011) reported that patients treated for a TKR or THR in the private hospitals
were fitter for surgery, had fewer comorbidities and higher EQ-5D-3L index scores and OHS/OKS
score before having the operation.
To determine which of the available variables to include, the correlations between potential
explanatory variables (strength of association) were examined.  Including two highly correlated
variables, as independent variables in the regression analysis will cause problems with
collinearity.  This has a disabling effect on the coefficient estimates for the independent variable,
as it causes an increase in the standard errors of the coefficients, which can make some variables
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incorrectly statistically non-significant.  Pearson’s correlation coefficient and Phi Coefficient
were employed to assess the strength of association between the variables (test for collinearity)
(Hinkle  et  al.,  2003).    Pearson’s  correlation  evaluates  the  linear  relationship  between  two
continuous variables, for example, days in hospital and travel time to hospital.  Phi coefficient
evaluates the correlation between two categorical variables (e.g. gender and Age groups). The
coefficient ranges between – 1 (negative relationships) and + 1 (positive relationships). A
summary of how to interpret the coefficients strength of association is provided in Table 13.
Table 11: Potential explanatory variables available / calculated from the database
Dataset Variable Description
HES Sex Coded  0 = male, 1= female
Age Coded: 1 = < 60 2= 60 – 80 3= >80
Ethnicity Coded:  0 = white British ,  1 = other
Comorbidities (Charlson Index) Coded:  0 = none, 1 = 1/2, 2 = 3 - 12
Days on the waiting list Continuous
Days in Hospital Continuous
Index of Multiple Deprivation quintiles
Attended Nearest Hospital Coded:   0 = nearest, 1= not nearest
Hospital Type Coded:   0= NHS, 1 private provider
Travel  time  /  Distance  to  the
hospital/ GP
A range of methods
Season Coded: 0 = not winter 1 = winter
PROMS Living alone Coded:   0 = cohabiting ,  1=alone
CCQ* Quality of the Hospital Coded 0 = Needs  improvement
                   1 = Good/ Outstanding
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Follow up SAH 0.3203* 1
Sex -0.1335* -0.0435* 1
Ethnicity -0.0158 -0.0269* 0.0131 1
Age 0.0634* 0.0661* 0.0849* -0.0285* 1
Deprivation -0.1496* -0.1590* 0.0240* 0.0930* -0.1025* 1
Living Alone -0.0343* -0.0238* 0.2095* -0.0256* 0.2399* 0.0556* 1
Comorbidities -0.0989* -0.1321* -0.0131 -0.0147 0.1256* 0.0782* 0.0440*
Days on the
waiting list
- -0.0677* -0.0088 -0.0050 -0.0574* -0.0094 -0.0094
Days in
Hospital
- -0.1685* 0.0406* -0.0384* 0.2232* 0.0269* 0.1529*
Type of
Hospital
0.0937* 0.0801* -0.0013 0.0774* -0.0005 -0.0815* -0.0097
Hospital
Quality
0.0474* 0.0835* 0.0276* 0.0276* 0.0164 -0.0967* 0.0062
Rural/ Urban
Location
0.0447* 0.0513* -0.0105 -0.0154 0.0083 -0.1573* -0.0224*
Travel time to
hospital





































































-0.0564* -0.1277* -0.1400* 1
Hospital
Quality
-0.0370* -0.2722* -0.1246* 0.4173* 1
Rural/ Urban
Location
-0.0355* 0.0130 -0.0197* 0.0246* -0.0097 1
Travel time to
hospital
-0.0681* -0.0349* 0.0057 -0.068* 0.1482* -0.036* 1
(Legend * p<0.05)
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Table 13: Interpretation of correlation coefficients
Positive Correlation Negative correlation Correlation
0.9 to – 1.00 -0.9 to – 1.00 Very High
0.70 to 0.90 - 0.70 to - 0.90 High
0.50 to 0.70 - 0.50 to - 0.70 Moderate
0.30 to 0.50 -0.30 to - 0.50 Low
0.00 to 0.30 0.00 to – 0.30 Negligible
Adapted from (Hinkle et al., 2003)
The results presented in Table 12 show that travel time to hospital was negatively correlated
with gender, ethnicity, age, deprivation, living alone, comorbidities, days on the waiting list,
types of hospital and rural/urban location.  As can be seen from the table that whilst zero
correlation  was  not  recorded  for  any  pair  of  variables  the  highest  correlations  were  with
deprivation (as deprivation increases patient travel time to hospital declines) and hospital
quality (as hospital quality improves travel time to hospital increases).  On the basis of Table 13
all of these correlations fit into the ‘negligible’ correlation category, so would not be considered
an issue to include in the model.
The study used the entry approach (including all explanatory variables at once) or a priori
knowledge to determine variables to include in the regression models.  All included variables
had been identified in the literature as potential predictors of differences in health outcomes
for this group in the population and had been assessed for collinearity.  All variables that were
included either had evidence of being associated with the dependent variable (health outcome)
or were being tested by this research (e.g. travel times).  The other main approach that could
have been used to determine which variables to include in the models is the stepwise approach
whereby variables are included or removed from the model based on whether they improve or
reduce the predictive ability of the model using a computer algorithm.  There has been a lot of
criticisms of stepwise approaches in the literature including that it has the potential to over fit
the model and include variables that have no associations to the outcome measure (Derksen
and Keselman, 1992; Babyak, 2004). Therefore it was decided on the basis of this to use the
entry approach.
3.2.4.1 Statistical Models
The next stage was to determine which statistical models would best fit the data.   The different
health measures and final statistical models used to model the data are summarized in Table 14.
A description of these methods and why they were selected is provided next.
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PROMS EQ-5D_3L Generic -0.594 – 1.0 OLS
EQ5D - VAS Generic 0 - 100 OLS
General
Health




OHS THR 0 – 48 OLS
OKS TKR 0 – 48 OLS
HES Length of Stay Generic Days OLS
DNA Generic Attended/ DNA Binary Logit Model
Starting with the EQ-5D-3L a number of models were considered to evaluate the values, which
range between -0.549 and 1.  This index has been the subject of much discussion about which
regression methods are most suited to use.   Most recently the adjusted limited dependent
variable model (ALDVMM), specifically designed to analyse this data was proposed.  This method
caps the index values between - 0.549 and 1 (similar to a Tobit model (Tobin, 1958)) and adjusts
to account for the gap in index values between 0.883 and 1 and then employs a mixture model,
so identifying different groups within the data (Hernandez -Alva et al., 2012; Hernandez -Alva
and Wailoo, 2016).  As the study was interested in changes in scores (whether patients health
improved as a results of the THR/TKR) the ALDVMM method was not suitable as it was designed
to take account of the distribution of the EQ-5D-3L index and not the distribution of the change
scores.    The method that was chosen to analyse the data was the ordinary least squares (OLS)
because of a match of assumptions with OLS, as discussed below.
In the simplest form the study focused on whether the change in EQ-5D-3L health measure was
associated with the baseline EQ-5D-3L health measure and travel time OR distance controlling
for baseline health.  It was important to control for the baseline EQ-5D-3L index, as individuals
had differing starting points.  A patient with a higher pre-op index value would have less
potential scope for improvement than those with a lower pre op index value.  By controlling for
the baseline health score this controls for this issue (regression to the mean).  For example, an
individual who started at an index value of 0.67 would be able to achieve a much smaller gain
(even if the follow up score was 1) than an individual whose starting point was -0.549.  This first
model is shown in Equation 2.
Y*i = α+ β1X1i + β2X2i + εi                   Equation 2
εi ~ N(0, σ²)
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Where: I = refers to observation number, Y = health measure (change in score), α = constant
term (y intercept), X1 = health measure Baseline (pre operation), X2 = transport accessibility
measure to hospital (travel time or distance), ε= random error term
Equation 3 expands this to control for other explanatory variables.   The multivariable model
included all the independent variables (travel time plus the other explanatory variables), as
described by Equation 3.
Y = α+ β1X1 + β2X2+… + βMXM + ε                   Equation 3
εi ~ N(0, σ²)
Where: Y = Change in the health measure (post operation – pre operation), α = constant term,
X1 = health measure (pre operation), X2 = transport accessibility measure to hospital (travel
time or distance),  …+BMXM = All other included explanatory  variables. ε= random error term
In order to apply an OLS model to the data the study is making the parametric assumption that
the data comes from a population with a normal distribution.   This assumes that the values from
the population (from which the sample was taken) are normally distributed.  The central limit
theorem states that “given random and independent samples of N observations each, the
distribution of sample means approaches normality as the size of N increases, regardless of the
shape of the population distribution” (Anderson (2010 ),p 1).   It is widely reported that 30 is the
minimum sample size required to satisfy this ‘large’ N (Anderson, 2010 ).  In addition to the study
having a large sample size and a linear relationship between the dependent and explanatory
variables, the following tests were run for each model to see whether it was suitable to apply an
OLS to the data.  These were:
· Are the residuals (error terms) normally distributed?  This was tested by plotting the
residuals as a histogram and including a normal curve for comparison.
· Are the residuals homoscedastic?  This was tested by plotting the residuals against the
predicted values.  For the residuals to be homoscedastic there should be no pattern to the
data.  Where the residuals were found to be heteroscedastic (patterns identified) this was
controlled for using robust errors in the models.
· Is there any multicollinearity? Are the predictor variables highly correlated with each other?
This was tested by calculating the variance inflation factor (VIF).
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The tests were applied to all the models and on the basis of this the OLS was chosen as the best
approach to be used for the EQ-5D VAS, OHS and OKS.  An example of the tests for the OKS
model are shown in Figure 12 to assess whether the residuals were normally distributed.  In
Figure 13 to allow an assessment of whether the residuals are homoscedastic (whether there is
a pattern to the data). The assessment found that the data was heteroscedastic (there was some
pattern to the data) and so robust errors were included in the OLS statistical models. Table 15
presents  the  results  of  the  Variance  Inflation  Factor  (VIF)  to  test  to  see  the  levels  of  multi
collinearity between the variables in the model.  Predictors that are highly collinear (linearly
related) can cause problems in estimating the regression coefficients. .  A value of VIF of 1
indicates no correlation.  For the models the average VIF was 1.39 indicating that there was low
correlation between the variables.  Hair et al. (2014) argue that as a rule of thumb “values of
VIF >10 indicate large amounts of multicollinearity” (p206), so in the case of the models in this
thesis we can say there were not large amounts of multicollinearity.
Figure 12 Kdensity plot of the residuals (OKS
model categorical travel times to hospital)
Figure 13: Scatter plot of residuals vs fitted
values (OKS model categorical travel times
to hospital)
The OLS approach was also used for the LoS in hospital model, which was also a continuous
variable, but required modifications to Equation 1 and 2, as baseline results were irrelevant.  The
OLS approach was also used to assess whether travel time or distance to the GP was associated
with pre operation health scores.  Again in this case there was no baseline data to control for in
the model.
In developing the model the study did consider whether to include interactions in the model
particularly between the categories of deprivation and travel times,  as this had been considered
in some of the studies in the systematic review (e.g.  Crawford et al.  (2009).  The interaction
effects would in this case represent the combined association of deprivation and travel time on
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an interaction effect (a statistically significant interaction effect (p<0.05)), so dropped them from
the models presented in the thesis.
Table 15: Testing for Multi collinearity (OKS model categorical travel times to hospital)
Variable VIF
Baseline Health Baseline OKS score 1.17
Travel time
(Baseline 0 – 10)
10 – 20 1.39
20 – 30 1.51
> 30 1.05
Gender Female 1.11
Age groups (baseline < 60) 60 – 80 1.57
> 80 1.65
Deprivation Quintiles





Length of stay in hospital Days 1.15















Measures of fit can be used to assess how well the models fit the data.  In terms of evaluating
the fit of the results of the OLS, the study has used the R2 and RMSE.  The R2, is a measure of
how close the real data points are to the fitted regression line.  An R2 of 1 indicates that the OLS
model explains all the variability.    It is often used in the health economics literature due to its
intuitive interpretation on a scale between 0 and 1.  For example an R2 = 0.18 can be interpreted
as 18% of the variation in the dependent health variable can be explained by the independent
variables in the model.  The Root Mean Square Error (RMSE), which is the square root of the
variance of the residuals.  It can be interpreted as the standard deviation of the unexplained
variance and is  a  good measure of  how accurately  the model  predicts  the outcome.   Lower
values of RMSE indicate a better fit.  Other approaches that are commonly used to assess the fit
of OLS regression models include the adjusted R2,, which adjusts the R2for the number of
predictors in the model.   Adding more predictors to the model can inflate the R2 value.  The
adjusted R2 for the models were reviewed, but are not included in the results tables.
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The study included travel times as both a continuous variable and as a categorical variable in the
models. The models with the better fit in the case of the OLS models with higher R2 and lower
RMSE  tended  to  be  the  ones  with  travel  time  included  as  a  categorical  variable,  which  are
presented.  Other approaches would have been to include travel times as a polynomial (e.g.
quadratic and cubic), but there was no indication that the association between the independent
variable and dependent variable were nonlinear, so these were not employed.
In terms of the coefficients the study is assessing whether the p-values are <0.1, < 0.05 and <
0.001.  This means that the null hypothesis (H0 : β1 = 0)  can be rejected (H1 : β1 ≠ 0) if the p
values are less than the thresholds.  For example, if the p value for the coefficient for an
independent variable was 0.04 then the null hypothesis could be rejected at the 10% and 5%
significance level, but not at the 0.1% significance level.  Having a result that is statistically
significant at the 5% versus 10% level the less likely the model will conclude an association
between the dependent variable and the independent variable, when there is no association.
The literature has focused predominantly on statistically significance levels of below 0.05
(p<0.05), which indicates a 5% risk of making this type of error widely attributed to Fisher (1950).
A number of authors have commented that the p<0.05 is somewhat an arbitrary threshold, that
serves a general purpose (Stigler, 2008).  One of the criticism of this threshold is that using just
p<0.05 means that those results with a p value p<0.049 are deemed statistically significant whilst
those at p<0.051 are not.  It is common practice in the field of health economics to present a
range of p values (e.g. p<0.1, 0.05 and 0.01) to show the range at which different variables are
statistically significant.
OLS models are not suitable for data that is binary (e.g. missed / attended the appointment), as
it would violate the assumption that there is a linear association, a better fit are binary logistic
regression models.   In logistic regression the outcome Y (independent variable), which is a
binary  0  or  1  outcome  is  transformed  using  a  logit  transformation  (see  equation  4)  so  the
dependent variable becomes ln  rather  than  Y,  as  used  in  the  OLS  equation  shown  in
Equation 2.
= 	 + 	 + 	 + ⋯+ 	 + 																	Equation 4
Where:
· ln = the natural log of the odds that Y equals one of the binary categories (0 /1)
·   = the odds ratio (whereby p = the probability of an event occurring e.g.  person
having access to a car when needed or probability  Y = 1))
· = the constant
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· 		 	→ 		  = the independent variable coefficients for the n independent variable
x 	to	x
The results are interpreted in a similar way to the OLS model.  It is not possible to use the R2 to
measure model fit, but a pseudo R2 can be determined, which allows comparisons between the
model with and without covariates (unadjusted and adjusted)..  The  interpretation  of  the  p
values are the same.   P value  ≤ 0.1, 0.05, 0.001 allows you to reject the null hypothesis that the
independent variable coefficient equals zero (H1 : β1 ≠0 ) at the 10%, 5% and 0.1% levels and
conclude that there is a statistically significant association between the independent variable
and the dependent variable at that level.
Binary logit regression models are a good fit for data with binary outcomes, but the self-reported
general health is ordinal data that has more than two categories (Excellent, Very Good, Good,
Fair,  Poor).   The method commonly  used to  model  these type of  data  is  the ordered logistic
regression model.  It  caters for ordinal dependent variables (such as the 5 point Likert scales
used to measure ease of access and self-reported general health), where the data is ordered.
The formula is shown in Equation 5, where the unobserved (latent) variable y* is a function of
the constant and independent variables, as for the OLS, but that the error term is assumed to
have a logistic distribution.
∗ = 	 + 	 + +⋯+ 	 + 	 ,																			 ~ (0, )              Equation 5
The continuous unobserved (latent) variable y* is divided into observed, ordinal categories (in
this study 4 categories) using the thresholds of 0 to	 .
= 				 	 ≪ ∗ < 		 	j = 1 to 4
Where 0 =  - ∞ and  = 	∞ .  For the self-reported general health the observed categories






1 = 	, 	 																					 	 = −	∞	 ≤ ∗ < 	
2 = 																																																																							 	 ≤ ∗ < 	
3 = 																																																																						 		 ≤ ∗ <
4 = 																																																										 	 ≤ ∗ < = 	∞
One of the main assumptions of the ordered logit regression model is that there is no difference
in the coefficients produced when comparing between the different outcome categories i.e. the
proportional odds are the same of going from very easy to quite easy and quite difficult to very
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difficult for example.  The Brant Test (Brant, 1990) assesses whether this assumption holds –
whether any deviations from the model (differences when comparing between categories) are
bigger than would be expected by chance.   If the assumptions do not hold then the option
available that is a better fit for the data would be to use a generalized ordered logit model, which
updates the model to allow for different coefficients (betas) between differing categories
(Williams (2006)).   As for the binary logistic regression a pseudo R2 can be calculated to assess
the fit of the models and used to compare between models, but it cannot be used (unlike the
R2 for OLS) to say how much of the variance is explained by the model.
For each of the methods the statistical model was run firstly unadjusted (the dependent health
/ wellbeing variable and independent transport variable plus) and then adjusted for the
identified other potential explanatory variables.
3.2.4.2 Interpreting the results from the models
The study uses the health outcomes in the HES PROMS data in two ways.  Firstly to see whether
transport accessibility (as measured using travel time from the patient’s postcode to the
hospital/ GP) is associated with differences in self-reported health (at baseline), LoS (number of
days) and outpatient appointments either attended or not attended.  Secondly, to explore
whether transport accessibility is associated with differences in the change in health outcome
(6 months post operation minus pre –operation)  The justification for using the change in score
is on the basis that “the main purpose of medical treatment is to enhance the patients’ health”
(Blome and Augustin (2015) p110). The measurement that we have of this enhancement in the
case of THR and TKR is how much HRQoL improves (or changes) from before the operation to
after from the perspective of the patient.  This is the main justification for collecting the PROMS
data from patients both before their operation and 6 months after, in order to enable an answer
to the question - Has the operation enhance the patients’ health?
The results are being tested in both cases by seeing whether the differences in the results are
statistically significant ( p<0.05).  For the calculations including change in score the results are
also being assessed using the minimal clinically important difference (MCID) (e.g. would patients
notice any difference in their health – so does the change really matter).  The implication is that
the study might be able to detect a statistically detectable change, but it might be clinically
meaningless to the patient.  For this second method a body of literature has been developed
using the PROMS questions to define a MCID.  MCID is  defined as “the smallest difference in
score in the domain of interest which patients perceive as beneficial and which would mandate
in the absence of troublesome side effects and excessive cost a change in the patient’s
management” (Jaeschke et al., 1989) (p408).
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To operationalise this definition two key methods have been used in the literature to calculate
what this MCID should be.  These are the anchor based and distribution based methods.  The
anchor based methods investigate how the change in score in the health measure compares
with change in the “anchor” reference question, which seeks to determine whether the patient
is better following the operation.  For example, Beard et al. (2015) calculated the MCID for the
OHS and OKS following a THR and TKR and used the global transition item anchor question:
“Overall, how are you <hip/knee> problems now, compared to before your operation? With five
response categories: much better…a little better…about the same…a little worse…and much
worse” (p74)
Following this either a statistical test (e.g. average change) or a receiver operating characteristic
(ROC) curve is used to identify the MCID,  as the threshold best separating the anchor question
thresholds.  For example, what is the average change in score between “about the same” and
“a little better”.  One criticism of this method is that it is not suitable for conditions where the
majority of patients do improve, so there is less ability to discriminate, which as noted earlier is
the case for THR and to a lesser extent TKR.  The alternative method is the distribution based
methods which rely on calculating variations on the standard deviation of the data, the standard
error  of  measurement  and  the  effect  size.    Using  this  method  has  similar  issues  to  the
statistically  significant calculations, as they may not be relevant to what is clinically important
(Maltenfort and Diaz-Ledezma, 2017).  Research has shown that the MCID differs across diseases
and health outcomes, so requires different values.   It is also important to note that there are
variations  in  the  timeline  where  these  calculations  are  made  –  some  include  follow  up  of  6
months, others 1 year, which are likely to lead to some differences.
NICE (2014b) state that the following MCIDs should be used in assessments for THR and TKR (in
clinical trials) on the conclusive or non-conclusiveness of effects; for OHS/ OKS this in the range
of 5 to 7.  Beard et al. (2015) reported that using the anchor method and ROC analysis resulted
in minimal important changes of 5 points for the OHS and 4 for the OKS following hip and knee
joint surgery respectively.   Whereas Murray et al. (2007) suggests the thresholds could be lower
than 3.  There is therefore some dispute in the literature as to what the MCID for OHS and OKS
should be.  For the EQ-5D-3L NICE (2014b) suggest basing the MCID threshold at an average of





The results are presented in this chapter by first describing the characteristics of the participants.
This is followed by the results from the data on travel times and distances to the healthcare
facilities and then an exploration of the health outcomes for this group of patients and
presentation of the results of the statistical models
Who	are	the	THR	and	TKR	patients?		
In total there were 4,550 THR patients and 5,506 TKR patients included in the sample that also
had an OA diagnosis summarized in Table 16.     In summary for those who had a THR 40.7% of
the population were male, 88.93% were White British, 29% of them lived on their own, 34.78
had comorbidities, 83.43% were treated in an NHS hospital, 43% of them attended a hospital
that had a good or excellent CQC rating.  They travelled on average 14.80 mins to the hospital
that they attended.  In summary for those who had a TKR 46.2% of the population were male,
85.5% were White British, 25.5% lived on their own, 40,62% of them had comorbidities , 85.85%
were treated in  an NHS hospital,  39% of  them had attended a  hospital  with  a  CQC rating of
excellent or good.  They travelled on average 14.5mins to the hospital that they attended.  They
attended 31 different hospitals, as shown in Map 2.
A comparison between the two subgroups (THR and TKR) is provided in Table 16 to assess
whether there are any differences in patients using t- test and X2.   It can be seen that the patient
groups differ in a number of ways.  There are proportionally more males in the TKR subgroup.
Patients in the TKR group are on average older than those in the THR group.  TKR patients live
on average in a more deprived area, measured using the index of multiple deprivation (IMD
score).   There is a higher percentage of White British patients in the THR group.  THR patients
are more likely than TKR patients to be living alone.   TKR patients on average spend longer on
the waiting list than THR patients and spend longer in hospital following the operation.  Whilst
THR patients were statistically significantly more likely to have attended a hospital that was
classed as excellent/ very good.   There were no statistically significant differences between THR
and TKR patients in terms of the distances and travel times to hospital at the 95% CI level, but
there was a significance difference at the 90% level for travel times to hospital using the t-test
(p=0.08).  There was no statistically significant differences in terms of the type of hospital
attended (NHS vs. privately provided), or where the patient lived (urban vs. rural).
The results showed that there are some key differences between the two patient groups.  There
are also differences between the health measures results for the two groups.  It should be noted
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that it is not possible to compare the OHS and the OKS directly as they include slightly differing
questions.  As is summarized in Table 16 there were statistically significant differences in the
health status at both baseline and follow up for the EQ-5D-3L and EQ-5D VAS.   With TKR having
higher baseline scores and index values, but lower follow up scores.   Based on this discussion
and the differences between the explanatory variables and health measures a decision was
made to analyse the two groups (THR and TKR) separately in the statistical models.
Table 16: Do THR and TKR patients differ?
Characteristics








Total 4,550 5,506 - -







Ethnicity (% White British) 88.92% 85.5% χ 2 p < 0.001***






t-test p < 0.001 ***
Living alone (%) 29.01% 25.50% χ 2 p < 0.001 ***







t-test p = 0.0219 **
Comorbidities 34.77% 40.62% χ 2 p < 0.001 ***
Type of Hospital (% NHS
provider)




43.08% 39.14% χ 2 p < 0.001 ***
Rural / Urban Location (%
urban)
93.19% 93.69% χ 2 p = 0.393
Travel to the hospital




t-test p = 0.08































p < 0.001 ***







p < 0.001 ***
(Legend * p<0.1, **p<0.05, ***P<0.001)
133





























Author: C Kelly, Date: 09_01_2019
Source: ONS, 2011 Census: Digitised Boundary Data
Projection: Transverse Mercator
Projection Coordinate System: British National Grid
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Travel	time	and	distances	to	healthcare	facilities		
The travel times and distances calculated using the HES data for the THR and TKR patients
(combined) are summarized in Table 17 with combinations of:
· LSOA vs home postcode data
· Actual Hospital vs nearest
· Different measures of transport accessibility: straight-line distance (miles), road
network distance (miles) , road network travel time (mins) and bus travel time (mins)
It is worth noting that 91 patients in table 17 could not have got to a 10 am appointment by bus
using the current bus schedules even if they left by 7am in the morning.  These are based on the
total sample of 10,056 patients.
 Table 17 : A summary of the results allowing comparisons between the different methods of











































95% CI 2.88 – 2.91 4.31 – 4.40 9.66 – 9.83 26.64 – 27.11
LSOA vs
Postcode


























95% CI 5.26 – 5.41 7.15 – 7.34 14.75 – 14.98 43.76 – 44.70
LSOA vs
Postcode










Postcode t-test p < 0.001*** p < 0.001*** p < 0.001*** p < 0.001***
LSOA t-test p < 0.001*** p < 0.001*** p < 0.001*** p < 0.001***
Attended &
Postcode  vs
Nearest &  LSOA
t -test p < 0.001*** p < 0.001*** p < 0.001*** p < 0.001***
(Legend * p<0.1, ** p<0.05, ***p<0.001)
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Starting with the results focused on distance shown in Table 17.  As expected, the straight-line
distance calculations are statistically significantly lower than the distances calculated using the
road network.   On average 2.91 miles  compared to  4.44 miles  (1.5  miles  less)  for  the home
postcode to the nearest hospital and 5.33 miles compared to 7.25 miles for the home postcode
to the actual hospital attended (1.92 miles).  The 95% CI do not overlap, indicating that there is
a statistically significant difference.  The results of the t- tests show that there are no statistically
significant differences comparing using home postcode or LSOA, to the hospital attended using
straight-line distance (p<0.388).  Under this comparison the results would not differ if only LSOA
(population weighted centroid) was available and not home postcode.  Statistically significant
differences are observed between using straight-line distance to the nearest available hospital
compared to the actual hospital attended (p< 0.001) and when comparing the most accurate
origin and destination (home postcode and hospital attended) and least accurate (LSOA and
nearest hospital) (p < 0.001).  The key aspect that influences the result for the straight-line
calculations is in knowing the hospital attended (compared to using the nearest facility).
For distances calculated using the road network there was a statistically significant difference
comparing LSOA and home postcode to the nearest facility, but not the actual hospital attended.
The results showed a statistically significant difference comparing the nearest vs actual hospital
attended and most accurate vs least accurate starting and finishing points (where there was a
3.06 mile difference in the averages).    For example, using LSOA and the nearest hospital had
an average distance of 4.19 miles compared to home postcode and actual hospital attended
with an average distance of 7.25 miles.  Again, whilst the starting point (home postcode or LSOA)
had a small impact on the results the key influence was the hospital attended and the method
using the road network compared to Straight-Line distance.
Calculating travel times using the road network resulted in a similar pattern emerging as with
the distance calculations.  There was a statistically significant difference between the means
comparing the LSOA and home postcode starting points travelling to the nearest hospital and
actual hospital attended.  There was a statistically significant difference between calculating the
LSOA to the nearest facility and home postcode to the actual facility (p<0.001), with a difference
in the average travel time of 5.32 mins.   The key differences occurred in using the travel times
calculated using the bus network and schedules.  We know that over 25% of households
nationally do not have a car (ONS, 2016a) and that if the only driver in the household is having
an operation they would have to find an alternative method to travel, as they would not be able
to drive back following the operation.   The alternatives for travelling to hospital are by private
taxi or getting a lift from a family member or friend which would have the same travel times as
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the road network travel time, using public transport (e.g. getting a bus) or in the case of hospital
treatment the PTS, which could involve picking up multiple passengers.  Calculating bus travel
times  provides  a  better  proxy  for  the  latter  two  options.   Section  5.6  provides  an  example
comparing the different modes of travel to Chapel Allerton Hospital in Leeds.
The results indicate that there are no statistically significant differences in the means when
comparing  use  of  LSOA  with  home  postcode  to  the  nearest  facility,  but  that  there  is  a
considerable inequality  in travel time between travelling using the road network (e.g. by car)
and travelling by bus, which takes 2.8 times longer on average.  This is even more extreme when
comparing the nearest facility to the actual facility attended.  On average the travel time would
be 44.13 min, with one person travelling just under 3 hours by bus to get to the hospital and
ninety-one patients are not be able to get to the hospital by a 10 am appointment if they left at
7 in the morning and used public transport.
The conclusion is that not knowing the actual hospital attended (rather than using the nearest)
has the biggest effect on the results. One of the patients who travelled the furthest from their
home postcode to  the actual  hospital  where they received their  THR,  had one of  the fastest
travel times when it was assumed that they attended the nearest facility.  Whilst in some cases
using LSOA vs home postcode has a small effect on the results it did not have the same effect of
reordering the patients in terms of who lives the furthest away.  Results indicate that centralising
services  to  within  WY in  this  geographical  location,  given the context  of  choice will  have the
effect of reducing average travel times for those that have chosen to go out of the WY area for
treatment.
One of the other differences noted in the literature is whether there are any statistically
significant differences in the travel times for individuals living in urban vs. rural areas.  The WY
population is predominantly urban, but around 9% (~900) live in what is classified as a rural (as
opposed to an urban) area.  Table 18 shows the differences in road network and travel times
from the home postcode and LSOA to the hospital attended comparing those living in a rural vs.
urban location.  As expected those living in rural areas had statistically significant longer travel
distances and travel times than those living in urban areas.  There were statistically significant
differences between using the home postcode and LSOA for bus travel times for both urban and
rural residential locations.  For example, using the home postcode for urban locations the
average travel  time by bus  was 43.17 mins  (95% CI  42.71 –  43.61)  using the LSOA for  urban
locations average travel time by bus was 47.73 (95% CI 44.09 – 51.38), so a statistically significant
difference in the means.  Comparing the rural residential locations bus times compared to urban
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using the home postcode average travel times by bus would be 59.16 mins by bus for the rural
residences and 43.17 mins for the urban residences.



















































95% CI 5.15 – 5.30 6.99 – 7.18 14.34 – 14.67 44.09 – 51.38
Travel	times	and	distances	to	the	GP	
This section shows the results of calculating the travel times and distances to the nearest GP.  A
number of studies in Chapter 2 had identified that it might be the location of the GP practice
that is critical, as the gatekeeper to diagnosis and treatment, which is also discussed in articles
such as Croft et al. (2011).  A comparison of the travel times and road distances to the nearest
and registered GP practice are provided in Table 19.   A large proportion of the patients were
not registered at their nearest (by travel distance) GP.   One patient had a home postcode 27
miles from their registered GP.  There was a statistically significant difference in the means
between the distances that patients would be travelling if they attended their nearest GP
compared to the distance from their home location to their registered GP (and the same for
travel  times).   For  example,  using  road  network  distance  to  the  nearest  GP  had  an  average
distance of 0.88 miles (95% CI 0.86 – 0.89), whereas to the registered GP the distance was on
average 1.55 miles (95% CI 1.52 – 1.57).
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(0 – 7.0 miles)
2.51 mins
(0 – 19.75 mins)
















95% CI 1.52 – 1.57 4.21 – 4.33
Differences	between	TKR	and	THR	patients?	
For the analyses it is interesting to see whether there are any differences between the distances
and travel times that THR and TKR patients are travelling.  A summary is provided in Table 20,
where on average THR patients were travelling further, but there was no statistically significant
differences found in the means.   The conclusion for this sample of patients is that there is no
systematic differences in the distances and travel times travelled for this population of THR and
TKR patients to the hospital either using the home postcode or LSOA as the starting point.



















































































The analysis of the individual questions on how easy patients find it to walk and how easy is it
to get into a vehicle, which are two of the 12 questions in  the OHS and OKS are summarized in
Table 21. This provides a summary of the responses at baseline (completed before the operation)
and at follow up (completed six months following the operation) to these two questions.  Whilst
we do not know how patients have travelled (e.g. car / bus) it can be seen from the baseline
data and to some degree the follow up data that the burden of travelling to the hospital or GP
could be quite significant for some patients.  The act of walking to the car/ from a car park to
the hospital or even in getting into a vehicle is problematic and stressful.  For the THR patients
37.1% stated either that they could not walk at all or only around the house before the operation
compared to 30.1% of knee patients.  Prior to the operation very few < 2% reported that it was
impossible to get into a vehicle, but 34.7% of THR patients and 27.1% of TKR patients reported
that it was very difficult.  These two factors (getting into a vehicle and walking) alone show that
a large percentage of patients would have problems travelling to healthcare prior to the
operation and some still having issues with walking and getting into vehicles following the THR
or TKR operation.
Table 21: Problems with walking and using vehicles at baseline and follow up (%)
Hip Replacements Knee Replacements









Not at all 17.7% 2.6% 13.9 % 4.3%
Around the house only 19.4% 5.2% 16.2 % 5.5%
5 – 15 mins 32.9% 10.0% 39.3 % 14.1%
16 – 30 mins 22.2% 18.7% 23.0 % 23.6%



















e Impossible to do 1.5% 0.3% 0.9% 0.4%
Extremely difficult 34.7% 3.4% 27.1% 6.7%
Moderate trouble 49.4% 17.2% 50.7% 27.4%
Very little trouble 11.2% 32.4% 15.4% 33.8%
No trouble at all 3.2% 46.7% 5.9% 31.6%
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Comparing the levels  of  mobility  following the operation between THR and TKR patients  –  a
higher percentage of THR patients (63.6%) had no pain or could walk more than 30 minutes
following the operation compared to the TKR patients (52.4%).  THR patients are also more likely
to report no trouble getting out of/ into a car 6 months following the operation than TKR patients.
The data describes a mixed picture with inequalities in both baseline and follow up being
evidenced in terms of walking and ease of getting into a vehicle.  TKR patients on average find it
easier than THR patients to both walk and get into vehicles prior to the operation, but this trend




A summary of the health outcomes for the HES-PROMS patient population by THR and TKR are
provided next.  These are considered in the order of Table 22 and also consider an assessment
of the level of missing data.
Table 22: Health and Proxy Health Measures
Dataset Measure Use Range/ scale
PROMS EQ-5D-3L Generic - 0.594 – 1.0
EQ-5D VAS Generic 0 – 100
General Health Generic Excellent, Very Good, Good, Fair, Poor
Oxford Hip Score THR 0 – 48
Oxford Knee Score TKR 0 – 48
HES Length of Stay Generic Days
DNA Generic Attended/ DNA
3.3.6.1 EQ-5D-3L
The result  of  the EQ-5D-3L index values  are  summarized  for  the THR patients  at  baseline in
Figure 14  and follow up in Figure 15.  It can be seen that the values at the baseline span from
the lowest -0.549 (worse level of health) up to 1.  It should be expected that given that these
patients are having a THR that they would not be in full health (1) at baseline, but if the operation
has been a success that there would be improvements at follow- up.  Some patients can be seen
to have values < 0 both at baseline and follow up, which are states of health that are considered
worse than death.
141
Figure 14: Baseline EQ-5D-3L (THR)                Figure 15: Follow up EQ-5D-3L (THR)
The index values for the TKR patients are shown at baseline (before the operation) in Figure
16 and follow up in Figure 17.  The distributions again show the full range of index values
from -0.549 (extreme problems on all 5 categories) up to 1 (full health).
Figure 16 Baseline EQ-5D-3L (TKR) Figure 17  Follow up EQ-5D-3L (TKR)
As expected in both subgroups (THR and TKR) there are a range of index values at baseline
ranging from 1 (full  health)  to  -0.549 (worse level  of  health  state  possible).   For  the THR
patients the average index score was 0.325 (95% CI of 0.315 – 0.334) and for the TKR patients
0.385  (95%  CI  0.376  –  0.392)  at  the  baseline.   This  shows  as  a  statistically  significant
difference between the means at the 95% CI, with the THR patients having baseline scores
at a lower level (worse) than the TKR patients.  This rises to 0.76 (95% CI 0.756 – 0.772) for
the THR and 0.71 (95% CI 0.70 – 0.72) for the TKR in the follow up, which is also statistically
significantly different at the 95% CI.  Whilst patients undergoing THR have on average worse
baseline scores compared to the TKR patients they on average have higher scores six months
following the operation.  For this study the key interest is whether the differences within
these subgroups (THR and TKR) are associated in any way with differences in travel times
and distances to healthcare facilities.
Parkin et al. (2016) and Devlin (2016) argue that analysing data changes at the domain level
or assessing whether the index scores improve, do not change, worsen or experience a mixed
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representation of the changes in distributions.  Using this description 90.42% of THR patients
had higher EQ-5D-3L index scores following the operation compared to 84% of TKR patients.
The same domain information as input into the index values (minus the tariff values), is
presented in Table 23 and Figure 18 for the THR patients.  Forty-two percent of THR patients
reported extreme problems in the domain of pain/ discomfort and 19% in the domain of
undertaking usual activities, with only 0.25% of patients stating that they had extreme
problems with mobility in the pre operation data   Following the operation 73% of patients
improved in the pain/ discomfort domain (either from extreme to some or some to no pain).
For the assessment of anxiety and depression 5% of the patients reported a worsening
following the operation.  There is also evidence of variation between patients in terms of
how much improvement there was.






































Figure 18:  THR patients: Scores against domains pre and post operation (%)
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As with the THR patients the majority (98%) of the TKR patients reported that they had some or
extreme problems with pain prior to the operation, 6.3% reported extreme problems with pain
and 59.8% some problems with pain and discomfort six months following the operation (see
Figure 19).  Again a wide range of differing responses within this subgroup can be found.
Interestingly  only  a  very  small  percentage  of  the  TKR  and  THR  patients  reported  extreme
problems in the mobility domain before and after the operation.  This would seem a strange
result given the impact on mobility that leads patients to require a THR or TKR.  The answer may
lie in the description of the mobility domain, which allows patients to answer that they have no
problems in walking about, some problems in walking about or are confined to bed. The majority
as  shown  in  Figure  19  (TKR  patients)  reported  some  problems  in  walking.   There  is  a  big
difference (and degrees of difficulty) between some problems and a very definite answer of
being confined to bed.  The 3 level domains might not pick up some of the subtleties that are
key to patients undergoing THR and TKR.  A newer  5 level question is now available which has
5 levels to each of the domains (Herdman et al.,  2011), so could potentially pick up some of
these changes better).  This newer version was not available for this study.
Figure 19: TKR patients:  Scores against domains pre and post operation (%)
One of the key aspects that the study is interested in is whether differences in travel times and
distances to healthcare facilities are associated with differences in the change in EQ-5D-3L index
values (follow up minus baseline) and whether  patients would notice the difference.  Figure 20






































No Problems Some Problems Extreme Problems
144
shows the distribution of change in scores for the THR patients.  The average change was 0.416
(CI 95% 0.405 – 0.427) (an improvement).  The TKR scores are shown in Figure 21 whereby the
average  change  was  0.305  (95%  CI  0.295  –  0.315)  (an  improvement).    These  average
improvements  are  above the MCID of  0.074 for  EQ-5D-3L,  so  indicating that  the majority  of
patients would notice the difference.
Figure 20: Change in EQ-5D-3L index
(Follow up – Baseline) THR
Figure 21: Change in EQ-5D-3L Index
(Follow up – Baseline) TKR
3.3.6.1.1 EQ-5D-3L Missing data assessment
The level of missing missing data across the complete THR and TKR sample is shown in Figure 22.
This graph splits the data into follow up and baseline data with the black rectangles representing
the missing data.  This figure shows that there is a small number of baseline data that is missing
with also missing follow up data  (black  line at  the right  hand side),  a  larger  proportion with
missing baseline data, but complete follow up data and then a larger proportion with missing
follow up data, but complete baseline data (large black rectangle).






The key issue then is whether there are any systematic differences between those with complete
data and those with missing EQ-5D-3L domain values.   For the THR patients a summary of the
complete data vs. missing data assessment is shown in Table 24 and for the TKR patients the
same assessment is provided in Table 25.  It is assumed that there is a statistically significant
difference where p<0.05.  For the THR patients there was a statistically significant difference by
age, where the younger the patient was the more likely it was that the data was incomplete.
Also, the higher the index of multiple deprivation score (more deprived) the greater the
likelihood that the data was incomplete, as was living alone, increased days in hospital and
having comorbidities.  There was no statistically significant difference based on the travel time
or distance to the hospital.
For the TKR sample, being female, non-white British, living in an area with a higher derivation
score, living alone, spending more days in hospital post operation, attending a hospital that
“requires improvement”, and living closer to the hospital where the operation took place both
in terms of travel time and distance led to being more likely that you would not have complete
data.  Based on this discussion it would seem a valid course of action to undertake the analysis
both with and without missing data imputed.
Table 24: Comparison of THR patients with and without missing data for EQ-5D-3L
Characteristics














Sex (% Male ) 40.69% 40.84% χ 2 p = 0.929
Age (years) 68.02 (10.64) 67.19 (12.43) t-test p = 0.029**
Ethnicity (% White British) 88.75 89.44 χ 2 p = 0.518
Deprivation 21.16 (14.98) 23.97 (15.75) t-test p<0.000***
Living alone (%) 28.23% 31.33% χ 2 p = 0.046**
Days on Waiting List 77.39 (58.83) 78.84 t-test p= 0.473
Days in Hospital 5.20 (4.09) 5.65 (4.25) t-test p = 0.001**
Comorbidities 67.7% 58% χ 2 p <0.001***
Type of Hospital (% NHS provider) 82.99% 84.73% χ 2 p = 0.171
Hospital Quality (%
Good/Outstanding)
43.8% 40.92% χ 2 p = 0.089*
Rural / Urban Location (% Urban) 92.92% 93.02% χ 2 p = 0.910
Travel time to Hospital (mins) 14.85 (9.13) 14.65 (9.49) t-test p = 0.5144
Travel Distance to Hospital (kms) 11.6km (8.95) 11.4km (9.17) t-test p = 0.4836
(Legend *p<0.1, **p<0.05, *** p<0.001)
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Table 25: Comparison of TKR patients with and without missing data for EQ-5D-3L
Characteristics














Sex (% Male ) 47.33% 42.86% χ 2 p = 0.004**
Age (years) 68.96 (9.08) 68.67 (10.18) t-test p = 0.3129
Ethnicity (% White British) 86.57% 82.36% χ 2 p <0.001***
Deprivation 22.90 (15.50) 26.13 (16.56) t-test p<0.001***
Living alone (%) 24.58% 28.28% χ 2 p =0.006**
Days on Waiting List 87.58 (68.60) 89.06 (70.49) t-test p = 0.502
Days in Hospital 5.28 (3.38) 6.20 (6.87) t-test p < 0.000***
Comorbidities (<1 comorbidity) 60.49% 55.97% χ 2 p = 0.003**
Type of Hospital (% NHS provider) 85.70% 85.93% χ 2 p = 0.833
Hospital Quality (%
Good/Outstanding)
40.11% 36.22% χ 2 p = 0.011**
Rural / Urban Location (% Urban) 93.4% 94.24% χ 2 p = 0.280
Travel time to Hospital (mins) 14.7km (8.06) 13.87km (7.65) t-test P< 0.001***
Travel Distance to Hospital (kms) 11.5km (7.7) 10.8km (7.3) t-test P< 0.001***
(Legend *p<0.1, **p<0.05, *** p<0.001)
3.3.6.2 EQ-5D VAS
The distribution of the EQ-5D VAS score for the THR patients are provided in Figure 23(baseline)
and 24 (follow up).   The average score was 62.54 prior to the operation (range 0 – 100) and 95%
CI 61.89 – 63.18.      At 6 months post operation the average score had increased to 74.28 (range
0 – 100) and 95% CI 73.69 – 74.86, so an overall improvement following the operation.
Figure 23: Baseline EQ-5D VAS (THR) Figure 24: Follow up EQ-5D VAS (THR)
The distribution of the EQ-5D VAS scores for the TKR patients are provided in Figures 25 (baseline)
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0  –  100)  and  95%  CI  of  64.94  –  66.05.   At  6  months  post  operation  the  average  score  had
increased to 70.87 (range 0 – 100) and 95% CI 70.31 – 71.43 for the TKR patients.
Figure 25: Baseline EQ-5D VAS (TKR) Figure 26: Follow up EQ-5D VAS (TKR)
There was a statistically significant difference in the mean scores at baseline and follow up
between the THR and TKR patients.  In total 72.79% of the THR patients had an improvement in
their score (8% stayed the same and 19% had a worsening of score).  For the TKR patients, 66%
had an improvement in score, with 24% reporting a worsening and 9% the same score pre and
post operation.    A larger number of TKR patients than THR patients reported that their health
state at 6 months was worse than at baseline (pre–operation).   The distribution of change in
EQ-5D  VAS  scores  are  shown  in  Figure  27  (THR)  with  a  mean  of  10.58.   The  equivalent
distribution for the TKR patients is shown in Figure 28.  The average change was 4.06 (CI 95%
3.43 – 4.70).
Figure 27: Change in EQ-5D VAS score for
THR








































3.3.6.2.1 EQ-5D VAS : Missing Data  Assessment
The results showing missing data for the EQ-5D VAS, are shown in Figures 29 (THR) and 30 (TKR).
They show a similar pattern to the EQ-5D-3L results, where there is less missing data for the TKR
patients than THR patients.  In both cases there are a smaller proportion of the patients with
missing baseline and missing follow up data.   The missing data graphs in Figure 29 and 30 show
that there are a number of variables that could be predictors for missing data for the EQ-5D VAS.
The THR patients  (Table  24)  answering the EQ-5D VAS question were if  they lived in  a  more
deprived area, had more comorbities, lived alone, and spent more days in hospital.  For the TKR
patients (some of the variables differed.  Predictors of having missing data were being non-white
British, living in a more deprived area living alone, having a greater number of longer days in
hospital, and living closer (shorter travel times / distance) to hospital.










Table 26: Comparison of THR patients with and without missing data for EQ-5D VAS
Characteristics













Total 3331 (73.2%) 1219
Sex (% Male ) 41.01% 39.95% χ 2 p = 0.520
Age (years) 67.92 (10.65) 67.51 (12.33) t-test p = 0.2683
Ethnicity (% White British) 88.83% 89.12% χ 2 p = 0.520
Deprivation 20.90 (14.78) 24.51 (16.08) t-test p < 0.001 ***
Living alone (%) 27.71% 32.57% χ 2 p = 0.001 **
Days in hospital 5.17 (3.87) 5.68 (4.77) t-test p < 0.001 ***
Days on the waiting list 77.19 (58.11) 79.29 (54.13) t-test p = 0.2860
Comorbidities (<1 comorbidity) 67.37% 59.39% χ 2 p < 0.001 ***
Type of Hospital (% NHS provider) 83.46% 83.34% χ 2 p = 0.929
Hospital Quality (%
Good/Outstanding)
43.02% 43.23% χ 2 p = 0.898
Rural / Urban Location (% Urban) 92.70% 93.60% χ 2 p = 0.296
Travel time to Hospital (mins) 14.88 (9.13) 14.57 (8.53) t-test p = 0.2941
Travel Distance to Hospital (kms) 11.7km (8.98) 11.4km (8.1) t-test p = 0.3208
(Legend *p<0.1, **p<0.05, *** p<0.001)
Table 27: Comparison of TKR patients with and without missing data for EQ-5D VAS
Characteristics














Sex (% Male ) 47% 44.02% χ 2 p = 0.045 **
Age in years 68.15 (9.17) 69.15 (9.87) t-test p = 0.2130
Ethnicity (% White British) 87.00% 81.56% χ 2 p < 0.000***
Deprivation 22.81 (15.30) 26.11 (16.95) t-test p <0.000 ***
Living alone (%) 24.4% 28.32% χ 2 p = 0.003 **
Days on Waiting List 88.09 (68.65) 87.55 (70.24) t-test p = 0.8031
Days in Hospital 5.31 (3.43) 6.03 (6.59) t-test p <0.001 ***
Comorbidities (<1 comorbidity) 60.2% 57.04% χ 2 p = 0.032 **
Type of Hospital (% NHS provider) 85.67% 86.04 χ 2 p = 0.719
Hospital Quality (%
Good/Outstanding)
39.56% 38.09% χ 2 p = 0.294
Rural / Urban Location (% Urban) 93.56% 93.79% χ 2 p = 0.763
Travel time to Hospital mins 14.69 (8.0) 13.98 (7.85) t-test p = 0.0032  **
Travel Distance to Hospital (kms) 11.5km (7.6) 10.9km (7.6) t-test p=0.0069 **
(Legend *p<0.1, **p<0.05, *** p<0.001)
3.3.6.3 Self- Reported General Health
The summary of responses for the THR and TKR (baseline and follow up) for general health are
shown in Figure 31.   A larger number of patients are putting themselves into the category of
Excellent and Very Good in the post operation phase.  There are differences between the THR
and TKR classification with THR patients more likely to put themselves in a better category after
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the operation than TKR patients.  Key for the statistical models is that there is variation in health
classification.
Figure 31:  Self-Reported General Health pre and post operation (THR and TKR)
It is interesting to note that there is little difference in the patients’ assessment pre and post
operation for  the General  Health  measure,  overall.    This  is  also  shown when looking at  the
change in General Health (did it get worse, stay the same or improve).  For the THR patients
48.9% reported no change, 18.1% a worse classification and 33.0% reported an improvement.
For the TKR patients 53.1% reported no change, 26.7% an improvement and 20.2% worse self-
reported General Health.  As we have seen for the other health measures TKR patients are
reporting less improvement pre-operation to post operation than the THR patients.  There is
therefore a range of responses, as shown in the previously discussed health measures not all
patients reporting an improvement in General Health following the operation.
3.3.6.4 Oxford Hip Score (OHS) and Oxford Knee Score (OKS)
The three previous measures discussed (EQ-5D-3L, EQ-5D VAS and Self-Reported General Health)
were all generic measures (could be applied to a range of disease groups).  The results of the
disease specific OHS (applied to the THR) and OKS (applied to the TKR) are presented next.
 Using the results from these questions the distributions of the OHS at baseline and follow up
are shown in Figures 32 and 33.  At baseline the THR patient’s average score was 17.27 (95% CI
17.04  –  17.50)  and  no  patients  had  a  maximum  score  of  48.   Following  the  operation  this
increased to 37.96 (95% CI 37.67 – 38.26).  It should be noted however that there is still variation
in the change in scores; not everyone saw an improvement, and for those who did, the
magnitude of change varied.









Excellent Very Good Good Fair Poor
151
Figure 32: Baseline OHS Figure 33: Follow up OHS
The distributions of the OKS for the TKR patients are provided in Figures 34 (baseline) and 35
(follow up).  They show a similar pattern to the OHS.  On average as with the EQ-5D-3L and EQ-
5D VAS scores the pre operation OKS were higher than the THR equivalent 18.10 (95% CI 17.90-
18.29), but the post operation scores were on average lower than the OHS at 33.98 (C95% CI
33.69 – 34.27) , but are not comparable due to being based on differing questions and
populations.
Figure 34: Baseline OKS Figure 35: Follow up OKS
The study is interested in these distributions, but also in the change in score following the
operation.  The distribution of the change in score for OHS is reproduced in Figure 36 and for
OKS in Figure 37.   For those patients who underwent a THR the average change in OHS was
20.166 (95% CI 19.854 – 20.4678).  Indicating that whilst the majority of patients showed an
improvement higher than the MCID of 5) there was a large range (-19 to + 45) of outcomes.  For
those patients who underwent a TKR the average change in the OKS was 15.36 (95% CI 15.079
– 15.645).  This is a lower gain that the THR, but showed a similar range of values (-21 to + 46).
As can be seen in Figures 36 and 37 the distribution of change in score broadly follows a normal
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Figure 36: Change in OHS following the THR
(operation)
Figure 37: Change in OKS following the TKR
operation
3.3.6.4.1 OHS/ OKS: Missing Data
Compared  to  the  generic  measures  of  EQ-5D-5L  and  EQ-5D  VAS  the  OHS  and  OKS  had  less
missing data.  This could be due to the relevance of the questions that were being asked, which
were very specific to either THR or TKR.  For the OHS and OKS the results of the missing baseline
and follow up data are shown in Tables 28 and 29.  The predictors of missing OHS results were
being younger, living in a higher deprivation area, living alone, more days in hospital following
the operation, more comorbidities, attending a NHS hospital, attending a hospital of lower
quality, living in an urban location.
Table 28: Comparison of patients with and without missing data for OHS
Characteristics














Sex  (% Male) 39.85 43.33 χ 2 P = 0.065*
Age (years) 68.20 (10.65) 65.86 (13.07) t-test p < 0.001 ***
Ethnicity (% White British) 88.89% 89.14% χ 2 p = 0.837
Deprivation 21.12 (14.87) 25.61 (16.36) t-test p < 0.001 ***
Living alone (%) 28.39% 32.06 χ 2 p = 0.041 **
Days on Waiting List 77.12 (57.7) 80.97 (53.72) t-test p = 0.1018
Days in Hospital 5.21 (3.96) 5.82 (4.88) t-test p < 0.001 ***
Comorbidities (<1 comorbidity) 66.85% 57.20% χ 2 p < 0.001 ***
Type of Hospital (% NHS provider) 82.83% 86.39% χ 2 p = 0.016 **
Hospital Quality (%
Good/Outstanding)
43.79% 39.53% χ 2 p = 0.030 **
Rural / Urban Location (% Urban) 92.74% 93.98% χ 2 p = 0.030 **
Travel time to Hospital (mins) 14.85 (9.01) 14.55 (8.81) t-test p = 0.4144
Travel Distance to Hospital (kms) 11.6km (8.8) 11.4km (8.4) t-test p = 0.4520
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For the OKS 27% of the data was missing (Table 29).  The key predictors of having missing data
were, being younger, being non-white British, living in a more deprived area, living alone, more
days in hospital, more comorbidities, attending a lower quality rated hospital, living closer to
the hospital attended.
Table 29: Comparison of patients with and without missing data for OKS
Characteristics














Sex (% Male ) 46.28% 45.92% χ 2 p = 0.837
Age (years) 69.16 (9.12) 67.65 (10.36) t-test p < 0.001 ***
Ethnicity (% White British) 86.55% 80.70% χ 2 p < 0.001 ***
Deprivation 23.07 (15.61) 26.65 (16.51) t-test p  <0.001 ***
Living alone (%) 25.04% 27.66% χ 2 p = 0.090 *
Days on Waiting List 87.38 (68.37) 90.58 (72.28) t-test p= 0.2053
Days in Hospital 5.36 (3.50) 6.22 (7.63) t-test p <0.001 ***
Comorbidities (<1 comorbidity) 60.39% 54.59% χ 2 p = 0.001 **
Type of Hospital (% NHS provider) 85.70% 86.07% χ 2 p = 0.763
Hospital Quality (%
Good/Outstanding)
39.87% 35.71% χ 2 p = 0.016 **
Rural / Urban Location (% Urban) 93.48% 94.32% χ 2 p = 0.327
Travel time to Hospital (mins) 14.61 (7.68) 13.98 (9.19) t-test p = 0.0245 **
Travel Distance to Hospital (kms) 11.45km (7.3) 10.91km (8.9) t-test p = 0.0476 **
(Legend *p<0.1, **p<0.05, *** p<0.001)
3.3.6.5 Length of Stay (LoS)
The thesis wanted to assess how long patients were staying in hospital following their THR
or TKR.  Focusing on the THR patients the average LoS in hospital was 5.31 days (95% CI 5.194
– 5.427) and TKR patients 5.49 (CI 95% 5.376 – 5.602).  At the 95% CI level there were no
statistically significant differences in the LoS in days between the THR and TKR patients.
There was a large range in the number of days stayed in hospital.  This study is interested in
whether travel time or distance to the hospital is associated with differences in LoS for the
patients.
3.3.6.6 Missing Appointments
Over  the  time  frame  of  the  study  2009/10  to  2011/12  there  were  231,769  outpatient
appointments for patients with a recorded OA diagnosis and 23,636 outpatient
appointments for patients with an RA diagnosis.  A summary is provided in Table 30, with the
different categories of attendance.   The majority of outpatient appointments were attended.
For OA patients 84.53% of the outpatient appointments were attended by the patients and
for RA patients 79.90% were attended.  Reasons for not attending included that the hospital
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had cancelled the appointment or rearranged it, the patient had cancelled the appointment,
the patient had just not attended, or that they attended late and were not seen.  Out of the
170,886  outpatient  appointments  for  patients  with  a  diagnosis  code  of  OA  over  14,000
(5.13%) were missed by patients who did not attend and did not cancel.  Out of the 29,582
outpatient appointments for the RA patients 2,326 (7.85%) were not attended and not
cancelled by the patients.   This is the measure to be included in the logit models 0 = attended
and 1 = not attended.
Table 30:  Missed Inpatient Appointments
Attendance recorded Appointments for patients
with an OA diagnosis
Appointments for patients
with an  RA diagnosis
Attended 231,769 (84.53%) 23,636 (79.90%)
Cancelled by the provider 15,458 (5.64%) 2,279 (7.70%)
Appointment cancelled by
the patient
11,614 (4.24%) 1,280 (4.33%)
Did not Attend (and not
cancelled)
14,053 (5.13%) 2,326 (7.86%)
Attended late and seen 1,159 (0.42%) 56 (0.19%)
Attended late and not seen 122 (0.04%) 5 (0.02%)
Total 170,886 29,582
	
The study is interested whether not attending the appointment is associated with living
further away from the hospital.  With the idea that not attending an outpatient appointment




The first set of models focus on the association between travel times and distances to the
patient’s registered GP and baseline health measures (EQ-5D-3L index, EQ-5D VAS, Self-
Reported General Health, OHS and OKS). This is considered from the perspective of whether
unequal access to the GP is associated with a poorer baseline (pre-operation) health.  A
number of studies included in Chapter 2 concluded that patients were more likely to have
worse health outcomes if they lived further from the GP practice such as Jones et al. (2008b).
The models in this section also assess whether this is also true for OA patients who have
undergone a THR or TKR.
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The first set of models for access to the GP are shown in Table 31.  They include a range of
different ways of including travel time and distance (both continuous, log transformed and
categorical) and are not adjusted for ‘other’ explanatory variables.  The RMSE , R2  and where
applicable pseudo R2 are provided in the tables.
The results for the unadjusted THR models shows that including travel time as a continuous
variable that patients living further from their GP have a higher baseline EQ-5D-index score
(p<0.1), are more likely to report a higher baseline EQ-5D VAS, report being more likely to be
in a better general health category and a higher OHS baseline score.  Including travel time as
a categorical variable compared to those living < 1 minute from their GP living further from
the GP is associated with a higher baseline EQ-5D-3L, EQ-5D VAS score, better General Health
Category and higher OHS score.  The R2 values indicate that the models with travel times as
a category are a slightly better fit for the data and the RMSE are also lower again indicating
a better fit.  The results are of the same magnitude for the distance calculations.
The results show that the further a THR patient lives from their registered GP the more likely
they will have a higher baseline EQ-5D-3L index, higher EQ-5D VAS score, be more likely in a
better general health category and have a higher baseline OKS/ OHS (although not all results
are statistically significant).  This is not the result that was expected, but shows that there is
evidence of an association between the THR living closer to their registered GP and having
poorer baseline health prior to undergoing the THR.  It should be noted that the results were
not all statistically significant.
There is a similar picture for the unadjusted TKR models which show that as travels times to
the GP increase patients are more likely to report that their baseline self-reported health
measures are better.
The next models adjust for the other potential explanatory variables discussed in Table 15.
Identified in the literature. The adjusted models focusing on travel time to the GP (as a
categorical variable) are shown in Table 32.  This include the explanatory variables of gender,
deprivation quintiles, comorbidities, age, living arrangements, ethnic group, days on the
waiting list and month completed the questions (winter vs. all other).
Focusing on EQ-5D-3L first – the adjusted model shown in Table 32  indicates that travel time
(as a categorical variable ) is positively associated with EQ-5D-3L index score for THR patients
(but not statistically significant), but shows mixed results for TKR with those travelling in the
categories  1  min  to  5  mins  having  an  increase  in  baseline  EQ-5D  index  compared  to  the
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baseline and those travelling > 5 mins a worse baseline EQ-5D-index value (none of these
associations are statistically significant).  The model also shows that living in a more deprived
quintile, having comorbidities (compared to none), living alone and having mobility problems
were all associated with a worse (lower) baseline EQ-5D-3L index values.  Living alone was
associated with a statistically significant lower EQ-5D-3L for those THR patients.  Being
between  60  and  80  years  old  (compared  to  being  <  60  years  old)  was  associated  with  a
statistically significant higher baseline EQ-5D-3L index for those with THR and TKR.  Indicating
that those under the age of 60 had poorer self-assessed baseline EQ-5D-3L than those older
than 60 years old for both TKR and THR and poorer self-assessed baseline EQ-5D-3L  than for
those > 80 years old, but only for TKR operations.
Focusing  on  the  EQ-5D  VAS,  there  were  mixed  results.   There  was  a  positive  association
(higher baseline EQ-5D VAS) with increasing travel time to the GP for THR and TKR patients,
(but neither were statistically significant).  Being female, living in the worst deprivation
quintile, having comorbidities and living alone were all associated with a lower baseline EQ-
5D VAS score for THR and TKR.  Non-white British patients had statistically significant lower
baseline EQ-5D VAS compared to White British (p<0.001) for TKR operations.
The results for Self-Reported General Health showed that living further away from the GP
was associated with an increased likelihood of reporting being in a worse general health
category for TKR patients (but not THR patients).   Having comorbidities, living alone, being
white British and increasing days on the waiting list at baseline were associated with a
statistically significant increase in the likelihood of being in a worse general health category
for both THR and TKR.  Non-white British patients were more likely to report being in a better
general health category, as was being over the age of 60 compared to being under the age
of 60 years old.
For  the  OHS  increasing  travel  time  to  the  GP  was  associated  with  higher  baseline  OHS
compared to the base of < 1 minute, but those travelling > 10 minutes had a negative sign
indicating that it was lower (but not statistically significant).  For example patients living 10
minutes further away from the GP would have an expected reduction in OHS score of 0.794
compared to the < 1 minutes travel time.  Living in a more deprived deprivation quintile,
being female, having comorbidities, number of days on the waiting list were all statistically
significantly negatively associated with lower OHS baseline score.
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For OKS measures patients travelling  1 -3 mins, 3 – 5 mins and 5 – 10 mins were associated
with having a higher baseline OKS than those travelling < 1minutes and those travelling > 10
minutes  to  the GP.   For  example,  for  those that  lived 10 minutes  from the GP would be
expected to have a reduction in the OKS score of 0.323.  Living in a more deprived area has
a statistically significant negative association with the score.  For example, a TKR patient
living  in  the  worst  deprivation  quintile  would  have  a  lower  score  by  -  4.22  compared  to
someone in the least deprived quintile (which is above the MCID threshold of 4 for the OKS).
Being female was associated with a worse baseline health score.  Older patients in the 60 –
80 category had higher baseline scores than those in the < 60 years category and this was
statistically significant at p<0.05).
One of the key missing pieces of information is how patients have got to the GP given a large
number prior to the operation have poor mobility. Only 2% of the sample lived within 250
metres walk of the GP and 17% within half a mile of the GP.  The reality of this means that it
could be assumed that those living further away would need a vehicle to get to the GP.
Possible links with poor accessibility is the worsening of scores, as patients live in more
deprived locations.   Here there is a link to being less likely to own a vehicle, as car ownership
declines as deprivation increases (Norman, 2010).  Equally living alone for example, might
present problems with getting to the GP if mobility is an issue.
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Table 31: Measuring the association between travel time/ distance to the GP and health measures in the unadjusted models




+ ve value is better
OLS
 + ve value is better
Ordered Logit
-ve value is an improvement
OLS
 + ve value is better
Sub group THR TKR THR TKR THR TKR THR TKR










Continuous Travel Time, (mins) 0.003* 0.001 0.161 0.177** -0.017 - 0.017* - 0.0004 0.058*




(0.0003) (0.0003) 0.0000/8.214 0.0006/7.70
6
Categorical Base = < 1 mins -- -- -- -- -- -- -- --
1 – 3 mins 0.032 0.025 2.21 1.554 - 0.135 - 0.099 0.692 0.660
3 – 5 0.038 0.026 3.106* 1.089 - 0.058 - 0.009 0.708 0.922**
5 – 10 0.049** 0.022 2.819* 1.835 - 0.261* - 0.141 0.813 1.022**



















Continuous Travel Distance (miles) 0.006* 0.003 0.248 0.317* - 0.033 - 0.030 0.047 0.091
R2/ RMSE 0.0007/0.324 0.002/
0.3158
0.0002/21.914 0.0005/20.67 (0.0002) (0.0002) 0.0000/8.214 0.0003/7.70
7
Categorical Base = < 0.5 miles -- -- -- -- -- -- --
0.5 - 1 miles 0.010 0.023* 0.887 0.455 - 0.016 0.020 0.478 0.872**
1 – 3 miles 0.039** 0.011 1.334 0.695 0.043 0.063 0.786* 0.807**
> 3    miles 0.002 0.017 1.880 1.506 - 0.141 - 0.059 0.121 0.673
> 5   miles 0.060** 0.055* 2.679 2.89 -0.194 - 0.389** 0.978 0.941




(0.0004) 0.0005) 0.0014/8.211 0.0018/7.70
31
(Legend:   *P<0.1, **P<0.05, ***P<0.001)
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Table 32: Is categorical travel time to the GP associated with poorer health status (adjusted model)








-  ve is better
OLS
+ is better
Sub group THR TKR THR TKR THR TKR THR TKR




1 – 3 mins 0.022 0.018 2.349 0.722 - 0.094 0.037 0.362 0.401
3 – 5 mins 0.029 0.020 2.829* 0.342 - 0.018 0.167 0.362 0.602
5 – 10 mins 0.024 - 0.0004 1.850 0.191 - 0.115 0.068 0.176 0.304
> 10 mins 0.031 - 0.0005 1.896 - 0.035 0.045 0.173 - 0.794 - 0.323





2 - 0.026 - 0.031** - 1.629 - 0.313 0.036 0.107 - 0.819** - 1.105**
3 - 0.024 - 0.058** - 0.013 -2.379*** 0.306** 0.269** - 0.638** - 1.970***
4 - 0.078*** - 0.094*** -2.541** -4.122*** 0.469*** 0.529*** - 2.354*** - 3.042***
5 - 0.112*** - 0.138*** - 4.016** - 6.551*** 0.798*** 0.869*** - 3.331*** - 4.219***
Comorbidities
(base = none)
1– 2 - 0.080*** - 0.050*** - 6.235*** - 6.137*** 0.878*** 0.872*** -2.191*** - 1.608***
>2 - 0.090*** - 0.097*** - 5.477*** - 8.554*** 0.929*** 1.197*** -2.252*** - 3.421***
Age groups
(base = < 60)
60 -80 0.064*** 0.107*** 6.341*** 7.076*** -0.289** -0.554*** 1.462*** 2.573***
>80 - 0.007 0.094*** 5.021*** 6.460*** -0.132 -0.534*** - 0.399 1.231**
Living Alone (base = not alone) Alone - 0.021* 0.011 - 1.811** - 1.912** 0.275*** 0.185** 0.058 0.259
Ethnic Group (base = White British) non WB 0.020 - 0.019 0.458 - 3.643*** -0.146 0.391*** -0.019 - 0.677**
Days on the waiting list 0.0001 0.0001** - 0.006 - 0.004 0.001** - 0.001** 0.003 0.004**
Season completed the questions (base =
winter)
0.019 0.020** 0.890 - 0.561 - 0.233** - 0.0093 0.531** 0.458**
Constant 0.4211*** 0.465*** 64.763*** 73.835*** N/A N/A 22.791*** 22.79***
R2 / (Pseudo R2)/ RMSE 0.059/0.315 0.07/ 0.305 0.045/21.44 0.08/ 19.79 (0.0361) (0.0454) 0.086/7.883 0.12/7.263




The previous section focused on access to the GP and looked at whether living further from the
GP was associated with inequalities in baseline health.  It showed that there were mixed results
with the OHS and OKS identifying a negative association (but not statistically significant) with
travelling >10 minutes further to the GP and baseline (<1 minutes) score.  This section now looks
at whether living further from the THR or TKR hospital that the patient attended is associated
with inequalities in change in health measures following the operation (follow up minus
baseline).  The following outcomes are considered:
· Change in EQ-5D-3L
· Change in EQ-5D VAS
· Change in Self- Reported General Health
· Change in OHS
· Change in OKS
3.3.8.1 Unadjusted Model: modelling the association between travel time to hospital and
health outcomes
The models are presented in each case firstly not accounting for missing data and then secondly,
with imputed values.  The THR unadjusted models focusing on travel times to the hospital are
presented in Table 34 and Table 35 (with imputed missing data) and for TKR in Table 35 and
Table 36 (with imputed missing data).   The numbers of patients in each of the categories for
travel time for each of each of the models in the unadjusted and adjusted analysis are provided
in Table 33 for reference.
Table 33: Number (%) of the sample in each of the travel time categories for each of the models
Model < 10 mins 10 – 20 mins 20 – 30 mins > 30 mins Total
THR EQ-5D-3L 1,125 (31%) 1,700 (47%) 636 (17%) 175 (5%) 3,636
EQ-5D VAS 1,079 (30%) 1,699 (48%) 620 (17%) 169 (5%) 3,567
General
Health
1,131(30%) 1,793 (48%) 660 (17%) 178 (5%) 3,762
OHS 1,475 (30%) 2,331 (48%) 821 (17%) 228 (5%) 4,855
TKR EQ-5D-3L 1,346 (30%) 2,073 (47% ) 803 (18%) 225 (5%) 4,447
EQ-5D VAS 1,292 (30%) 2,034 (47%) 774 (17%) 211 (5%) 4,311
General
Health
1,335 (31%) 2,047 (47%) 742 (17%) 231 (5%) 4,355
OKS 1,851(31%) 2,764(47%) 1,020(17%) 291(5%) 5,926
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Focusing on the THR patients first.  As shown in Table 34 increasing travel time to the hospital
(as a continuous measure) had a positive association with improvements in changes in health
for  the  THR  patients.    The  results  for  the  EQ-5D  VAS  and  OHS  showed  that  as  travel  times
increased the EQ-5D VAS and OHS were higher (better).    This result became mixed where travel
time was included as a  categorical variable   Compared to travelling < 10 mins to the hospital,
travelling 10 – 20 and 20 – 30  mins had a positive association (improvement), but travelling
greater than 30 minutes a negative association, which was  statistically significant for the change
in OHS and change in EQ-5D-3L score.   This implies that those living closer and those living the
further away from the hospital have the worst health outcomes following the operation.
Focusing on the MCID thresholds the change in OHS in the unadjusted model shows a difference
of  -1.423  and  whist  statistically  significant  at  p<0.1  is  not  large  enough  to  pass  the  MCID
thresholds discussed in section 3.2.4.2.  The results do however show a  similar picture to the U
shaped results presented in Kim et al. (2000).  Including the imputed missing data gives the same
results (Table 35).  Therefore indicating that the results hold for the total patient population.
For the TKR population Table 36 shows a statistically significant positive association with
changes in health measures when travel time is included as a continuous variable (indicating
that as patients travel further to the hospital that they have an improvement in their health
outcomes.  When travel time is included as  a categorical variable travelling 10 – 20 mins and 20
– 30 mins (compared to < 10 minutes) to the hospital is associated with a statistically significant
positive association for EQ-5D-3L, EQ-5D VAS and OKS, but travelling > 30 mins is associated with
a statistically significant negative association with OKS.   None of the results for the unadjusted
models were statistically significant for self-reported general health.   Imputing the missing data
does not change the overall message.  It shows that using the continuous variable hides some
of the changes that occur for patients living > 30 mins compared to those living < 10 mins from
the hospital.
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Table 34: Are changes in self-reported health following a THR associated with travel time to hospital? (unadjusted)








+ ve is better
OLS
+ is better
Sub group THR THR THR THR THR THR THR THR
Baseline Health Measure -0.744*** -0.746*** - 0.730*** - 0.731*** -1.574 -1.577*** - 0.581*** - 0.585***
Travel time (mins) 0.001 0.087** -0.007* 0.025
Travel time
(base = < 10
mins)
10 - 20 0.012 1.953** - 0.171** 0.886**
20 - 30 0.031** 2.564** -0.257** 0.995**
>30 - 0.047* 1.361 0.156 - 1.423*















(Legend *P<0.1, **P<0.05, ***P<0.001)
Table 35: Are changes in self-reported health following a THR associated with travel time to hospital? (unadjusted including imputed data)








+ ve is better
OLS
+ is better
Sub group THR THR THR THR THR THR THR THR
Baseline Health Measure -0.724*** - 0.726*** -0.730*** -0.732*** -1.543*** -1.546*** -0.574*** -0.574***
Travel time (mins) 0.001 0.087** - 0.007* 0.031**
Travel time
(base = < 10
mins)
10 - 20 0.015* 2.129** -0.172** 0.8075**
20 - 30 0.076*** 2.799** -0.247** 1.081**
> 30 - 0.077* 1.125 0.092 -0.752*
Constant 0.649*** 0.653*** 55.872*** 55.43*** 29.73*** 29.584***
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Table 36: Are changes in self-reported health following a TKR associated with travel time to hospital? (unadjusted model)








+ ve is better
OLS
+ is better
Sub group TKR TKR TKR TKR TKR TKR TKR TKR
Sample 4,447 4,311 5,926 4,879
Baseline Health Measure - 0.708*** - 0.708*** -0.592*** - 0.591*** -1.681*** -1.681*** - 0.481*** - 0.483***
Travel time (mins) 0.001** 0.126*** – 0.006* 0.062***
Travel time
(base = < 10mins)
10 - 20 0.033** 1.750** -0.113* 1.26***
20 - 30 0.035** 2.978*** -0.097 1.69***
>30 0.016 4.371 -0.258 - 1.74*















(Legend - *P<0.1, **P<0.05, ***P<0.001)
Table 37: Are changes in self-reported health  following a TKR associated with travel time to hospital? (unadjusted model) including imputed data








+ ve is better
OLS
+ is better
Sub group TKR TKR TKR TKR TKR TKR TKR TKR
Baseline Health Measure - 0.686*** -0.687*** - 0.590*** -0.590*** -1.407*** -1.408*** - 0.456*** - 0.459***




10 - 20 0.033*** 1.690** -0.185** 1.233***
20 – 30 0.038*** 2.953*** -0.282*** 1.693**
>30 0.024 4.148 - 0.414 - 1.111*
Constant 0.552*** 0.565*** 41.389*** 41.819*** 23.149*** 23.227
(Legend - *P<0.1, **P<0.05, ***P<0.001)
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3.3.8.2 Adjusted Models: modelling the association between travel time to hospital and
health outcomes
The THR adjusted models focusing on travel times to the hospital are presented in Table 38
(without imputed data) and Table 39 (with imputed missing data) and for TKR in Table 39
(without imputed data)  and Table 40 (with imputed data).  The models implement travel time
as a continuous variable and categorical variable split into the categories of < 10 mins, 10 –
20 and 20 – 30 minutes and > 30minutes.  The adjusted models controlled for gender,
deprivation quintiles, comorbidities, age groups (< 60 years old, 60 – 80  and > 80 years old),
living arrangements, ethnic group, days in hospital following the operation, hospital provider
(NHS vs private provider) and hospital quality (base = needs improving vs Excellent/ good).
Starting with the data for the THR patients including travel time to the hospital attended, as
a continuous variable is associated with positive (but non-statistically significant) change in
the EQ-5D-3L index score.  However when included as a categorical variable there are mixed
results compared to travelling < 10 minutes (road network car travel time) there is a positive
association  for those travelling between 20 and 30 minutes, but a negative association for
those travelling > 30 minutes to the hospital compared to 10 minutes.  Controlling for the
‘other’ explanatory variables has not changed the overall signs and significance levels of the
results.  Those living closest and furthest away are associated with poorer self-reported health
outcomes.   Being female, living in a more deprived quintile, having comorbidities, and
spending more days in hospital following the operation were all associated with a statistically
significant negative association with change in EQ-5D-3L index score.  Being over the age of
60 (compared to under 60) was associated with the positive association.    Including the
missing data resulted in the same pattern of results, but only the values for those travelling
20 - 30 minutes (compared to < 10 minutes) were statistically significant, as shown in Table
39.  Days in hospital, having comorbidities and living in the most deprived residential quintiles
were still statistically significantly negatively associated with change in EQ-5D-3L score.
For the EQ-5D VAS increasing travel time to the hospital was associated with a positive (but
non-statistically significant) association with change in EQ-5D VAS score.   Again when
included as the categorical variable those living 10 – 20 minutes & 20 - 30 minutes (compared
to those living < 10 minutes away) had a statistically significant (p<0.1) positive association
with improvements in the change in EQ-5D VAS and again those living > 30 minutes away had
a negative association, but in this case this was not statistically significant.  Living in a more
deprived area, having comorbidities, being over the age of 80 (compared to < 60 years old)
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and greater days in hospital following the operation were all associated with a negative
association with change in EQ-5D VAS score.   Including the missing data did not change the
overall message.
For the self-reported general health measure there were no statistically significant
associations with travel time to the hospital.  Travelling 20 – 30 minutes compared to < 10
minutes  to  the  hospital  was  associated  with  being  more  likely  in  a  worse  general  health
category after the operation. Having comorbidities, being over the age of 80, and longer days
in hospital were all statistically significant negatively associated with being in a worse general
health category following the operation.  Including the missing data did not change the overall
message.
Travel times as a continuous variable shows a negative (but not statistically significant)
association with OHS, but as a categorical variable the results were again mixed.  Those
travelling 20 - 30 minutes away from the hospital showed a positive association (improvement)
in  change  of  OHS  score  compared  to  those  living  closer  and  those  living  >  30  minutes  a
negative association (worse) change of OHS score compared to those living < 10 minutes away.
The imputed data presented similar pattern to the results, with the coefficient for travelling >
30 minutes to hospital was still negative and statistically significant.  The OHS model was the
only THR model that showed a statistically significant and positive association with having the
operation at a privately operated hospital.  This was also statistically significant after
imputation (p<0.05).
Focusing on the TKR patients.  The results of the models are presented in Table 40, after
adjusting for gender, age, deprivation, comorbidities, living arrangements, ethnic group, and
days in hospital, hospital provider and hospital quality and Table 41 imputing the missing data.
For the EQ-5D-3L change in index score there was a positive statistically significant (p<0.1)
association with increasing travel times, where travel time was included as a continuous
variable, so as travel times to the hospital increased the change was higher.  This was a small
change as a 30 minutes increase in travel time would be associated with a 0.03 increase in
EQ-5D-3L.   Not  large enough to  achieve the MCID threshold.    The results  were mixed for
travel time as a categorical variable showed as travel time increased from the base the change
in EQ-5D-3L increased.  Those who were travelling > 30 minutes (compared to < 10 minutes)
showed a positive (but non-statistically significant association).  Living alone was shown as a
negative (but non-statistically significant) association with change in EQ-5D-3L index.  Unlike
the THR results hospital quality (attending a hospital that is classed as Excellent/ good
compared to need improving) was associated with an improved change in EQ-5D-3L score.
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For the EQ-5D VAS results there was a statistically significant (p<0.05) positive association
between travelling further and change in score for the TKR patients.  As can be seen from the
categorical travel time this is being driven from those patients who are travelling between 20
– 30 minutes.   With those travelling > 30 minutes showing a positive (but non-statistically
significant) association.  For the TKR, being female, living in a more deprived residential
location, having comorbidities and greater number of days in hospital were all negatively
associated with change in EQ-5D VAS score.  Both attending a private hospital (compared to
NHS) and hospital that was classed as Excellent/ good compared to needs improving were
both associated with a positive association with change in EQ-5D VAS score, as was being
older than 60 years old.  Including the data using did not change the overall message.
For the TKR self-reported general health results increasing travel time to the hospital
increased the likelihood of being in a worse self-reported general health category, but none
of the results were statistically significant.    The same results were evident when the missing
data was imputed.
For the disease specific OKS measure the results show a positive and statistically significant
association at p<0.1 with travel time as a continuous variable.  This indicates that on average
as travel time to the hospital increases by 10 minutes the OKS score will increase by 0.34.  This
is  below the MCID threshold for noting a difference by the patient.  When included as a
categorical variable the results show that there is a positive statistically significant association
between travelling 10 – 20 and 20 – 30 minutes compared to < 10 mins and a higher OKS
score, whilst those travelling > 30 minutes have a statistically significant negative association
and lower OKS score.  A difference in OKS score of -1.692 compared to those travelling < 10
minutes is below the reported MCID thresholds previously discussed (lowest < 3) , but does
indicate a potential change in the results for those travelling the furthest.  As with the EQ-5D-
3L and EQ-5D VAS results hospital quality was a statistically significant predictor of change in
OKS score and as for EQ-5D VAS attending a private vs a NHS hospital was positively associated
with a positive change in OKS score.    The model that imputed data showed the same overall
message for travel time for the TKR patients using OKS.
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Table 38: Are changes in self-reported health state following an THR associated with travel time to hospital? (Legend: *P<0.1, **P<0.05, ***P<0.001)








-+ ve is better
OLS
+ is better
Sample size 3,636 3,567 3,762 3,822
Baseline Health Measure - 0.780*** -0.781*** -0.762*** - 0.763*** -1.771*** -1.770*** - 0.622*** - 0.629***
Travel time (mins) 0.0001 0.049 -0.003 - 0.005
Travel time
(base = < 10
mins)
10 - 20 0.003 1.315* - 0.118 0.428
20 - 30 0.015 1.567* - 0.158* 0.301
>30 - 0.047 - 0.304 0.239 - 1.593*




2 0.014 0.015 - 0.360 -0.306 - 0.083 -0.094 0.322 0.355
3 - 0.004 - 0.002 - 0.302 - 0.232 - 0.012 -0.029 - 0.653* - 0.623*
4 - 0.041** - 0.038** -2.394*** -2.384** 0.283** 0.262** - 1.729** -1.680***
5 - 0.060*** -0.058*** -3.778*** - 3.602*** 0.252** 0.221** - 3.071*** -2.998***
Comorbidities
(base = none)
1– 2 - 0.062*** - 0.061*** - 6.062*** - 6.047*** 0.781*** 0.781*** - 1.657*** -1.659***
>2 - 0.088*** - 0.088*** - 8.966*** - 8.974*** 1.147*** 1.151*** - 2.581*** -2.589***
Age groups (base
= < 60)
60 - 80 0.040*** 0.040*** 0.297 0.242 -0.009 -0.002 0.805* 0.769**
>80 0.037** 0.036** - 2.26* - 2.317* 0.093 0.099 - 0.817 -0.866
Living Alone (base = not alone) 0.007 0.007 0.563 0.549 0.091 0.092 - 0.201 - 0.213
Ethnic Group (base = White British) - 0.002 -0.001 0.289 0.432 0.067 0.052 0.006 0.385
Days in hospital following operation -0.007*** -0.007*** - 0.478*** -0.477*** 0.034*** 0.034*** - 0.328*** - 0.324***
Hospital provider (base = NHS) Private - 0.001 0.0001 -0.466 - 0.554 0.038 0.044 0.971** 0.906**
Hospital Quality (base = Needs Improving)
Excellent/ good
0.008 0.009 0.467 0.597 -0.010 -0.022 - 0.059 0.017
Constant 0.749*** 0.746*** 65.149*** 64.887*** 33.877*** 33.679***
R2 / RMSE (0.1621) 0.508/0.240 0.509/ 0.240 0.478/ 17.05 0.479/17.048 (0.1617) (0.1621) 0.267/ 8.683 0.267/8.681
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Table 39: Are changes in self-reported health following a THR associated with travel time to hospital (imputing for missing data)?








+ ve is better
OLS
+ is better
Sub group THR THR THR THR THR THR THR THR
Baseline Health Measure - 0.763*** -0.764*** - 0.762*** - 0.763*** -1.739*** -1.740*** - 0.649*** - 0.650***
Travel time (mins) 0.0002 0.043 -0.002 0.010
Travel time
(base = < 10mins)
10-20 – 30 0.002 1.399** -0.104 0.392
20 - 30 0.058** 1.658*** -0.135 0.321*
>30 - 0.063 - 0.413 0.191 - 0.852*




2 0.015 0.015 -0.498 - 0.447 -0.084 -0.094 0.336 0.361
3 -0.009 -0.008 -0.588 - 0.523 -0.003 -0.018 - 0.635 - 0.607
4 -0.037** -0.035** -2.360** - 2.34** 0.277** 0.259** - 1.638** - 1.604***
5 -0.061*** -0.060*** - 3.704*** - 3.539** 0.267** 0.241** - 3.008*** - 2.956**
Comorbidities
(base = none)
1– 2 - 0.063*** -0.063*** - 6.047*** - 5.846*** 0.781*** 0.780*** -1.795*** -1.787***
>2 - 0.086*** - 0.086*** - 9.201*** -9.333*** 1.140*** 1.141*** -2.413*** - 2.404***
Age groups (base
= < 60)
60 - 80 0.044*** 0.0438*** 0.286 0.145 -0.006 -0.003 0.774*** 0.756**
>80 0.040** 0.040** - 2.125* - 2.486* 0.084 0.088 - 0.714 - 0.741
Living Alone (base = not alone) 0.004 0.004 0.580 0.505 0.090 0.092 - 0.199 - 0.214
Ethnic Group (base = White British) -0.007 - 0.006 0.447 0.402 0.064 0.053 0.034 0.075
Days in hospital following operation -0.007*** - 0.006*** -0.499*** - 0.488*** 0.033*** 0.033*** - 0.313*** -
0.3010***
Hospital provider (base = NHS) Private 0.002 0.004 - 0.527 - 0.477 0.029 0.0344 0.986** 1.001**
Hospital Quality (base = Needs Improving)
Excellent/ good
0.006 0.005 0.507 0.584 -0.016 -0.027 0.021 0.090
Constant 0.721*** 0.719*** 65.327*** 64.873*** 33.641*** 33.510***
(Legend:  *P<0.1, **P<0.05, ***P<0.001)
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Table 40: Are changes in self-reported health following a TKR associated with travel time to hospital? - (Legend *P<0.1, **P<0.05, ***P<0.001)








+ ve  is better
OLS
+ is better
Sample (n) 3,636 3,567 3,449 4,045
Baseline Health Measure - 0.752*** -0.752*** -0.645*** - 0.644*** -1.79*** -1.79*** - 0.559*** - 0.561***
Travel time (mins) 0.001* 0.073** - 0.003 0.034*
Travel time
(base = < 10mins)
10 – 20 0.018** 0.81 - 0.076 0.677**
20 - 30 0.014 1.65** - 0.037 0.960**
>30 0.022 3.260 - 0.162 -1.692*




2 - 0.009 - 0.010 -0.625 - 0.613 0.048 0.054 - 0.453 - 0.446
3 -0.009 -0.010 -1.374 -1.328 - 0.019 -0.011 - 0.981** -0.962**
4 - 0.046*** - 0.047*** -3.119*** -3.084*** 0.151* 0.161* -1.953*** -1.921***
5 - 0.057*** - 0.057*** -3.242*** -3.171*** 0.171** 0.177** -2.538*** -2.486***
Comorbidities
(base = none)
1-2 - 0.035*** - 0.035*** -3.852*** -3.836*** 0.543*** 0.543*** -1.100*** - 1.104***
>2 - 0.023 - 0.023 -7.386*** - 7.386*** 0.0.459*** 0.458 -2.110*** - 2.126***
Age groups (base
= < 60)
60 – 80 0.088*** 0.088*** 4.054*** 4.042*** 0.186 0.088 2.855*** 2.805***
>80 0.103*** 0.103*** 3.292** 3.268** - 0.347* 0.190* 2.942** 2.942**
Living Alone (base = not alone) - 0.006 - 0.006 - 0.342 - 0.337 0.069 0.069 - 0.325 0.316
Ethnic Group (base = White British) - 0.016 - 0.015 -1.240 - 1.290 -0.169 -0.171** -1.196** -1.169**
Days in hospital following operation - 0.011*** - 0.011*** -0.451*** - 0.449*** 0.011 0.011 - 0.399*** - 0.388***
Hospital provider (base = NHS) Private 0.012 0.010 2.371** 2.35** -0.108 -0.095 1.251** 1.211**
Hospital Quality (base = Needs Improving)
Excellent/ good
0.028** 0.030*** 1.536** 1.558** -0.073 -0.083 0.455 0.566*
Constant














Table 41: Are changes in self- reported health a TKR associated with travel time to hospital (imputing for missing data)? (*P<0.1, **P<0.05, ***P<0.001)








+ ve is better
OLS
+ is better
Baseline Health Measure - 0.734*** - 0.734*** -0.643*** - 0.646*** - 1.620*** - 1.62*** -0.544*** - 0.544***




10 - 20 0.017** 0.693 -0.0698 0.613**
20 - 30 0.015 1.616** - 0.100 0.878***
>30 0.012 2.938 -0.293 - 1.294*




2 - 0.009 - 0.010 -0.673 - 0.629 0.124 0.129 - 0.416 - 0.431
3 -0.011 - 0.011 -1.531* - 1.3560* 0.029 0.034 - 0.859* - 0.853*
4 -0.042** - 0.042*** -3.149** - 3.070** 0.279** 0.286** - 2.032*** - 2.024***
5 - 0.061*** - 0.061*** -3.513*** - 3.294*** 0.479*** 0.486*** - 2.630*** - 2.601***
Comorbidities
(base = none)
1– 2 - 0.035*** - 0.035*** - 3.821*** - 3.728*** 0.637*** 0.637*** -1.130** - 1.121***
>2 -0.045** - 0.045** -7.254*** -7.392*** 0.849*** 0.849*** -2.172** - 2.178**
Age groups (base
= < 60)
60 - 80 0.090*** 0.090*** 4.158*** 4.101*** - 0.175** - 0.174** 2.801*** 2.758***
>80 0.098*** 0.097*** 3.403** 3.292** -0.072 - 0.068 2.804*** 2.722***
Living Alone (base = not alone) -0.011 - 0.011 -0.293 - 0.493 0.084 0.083 0.261 0.252
Ethnic Group (base = White British) -0.029** - 0.027** -1.213 - 1.195 0.122 0.120 - 1.340*** -1.322***
Days in hospital following operation -0.009*** - 0.008*** -0.433*** -0.439*** 0.045*** 0.045*** - 0.383*** - 0.383***
Hospital provider (base = NHS) Private 0.019 0.017 2.383** 2.424** -0.021 - 0.012 1.272** 1.204**
Hospital Quality (base = Needs Improving)
Excellent/ good
0.032*** 0.032*** 1.530** 1.534** -0.115* - 0.123* 0.467 0.572*
Constant 0.570*** 0.566*** 47.148*** 47.484*** 24.720*** 24.831***
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3.3.8.3 Access to the Hospital: Length of Stay
What the study wanted to know is whether living further from the hospital in which the patients
were treated was associated with spending a longer time in the hospital (in days) from admission
to discharge, as a proxy measure for health outcomes.
The results of the statistical models are shown in Table 42.   In the unadjusted model including
travel times as a continuous variable, travel time in minutes is associated with a positive (but  a
statistically insignificant) association with LoS in hospital for the THR patients and a negative
(but a statistically insignificant) association with LoS in hospital for the TKR patients.  Including
travel time as a categorical variable shows mixed results.  For the THR model travelling 10-20
and 20 – 30 minutes in the unadjusted model is associated with a shorter stay than those
travelling  <  10 minutes  ,  for  those travelling  >  30 minutes  is  associated with a  longer  stay  in
hospital (p<0.05).  For the TKR model travelling 10 – 20 minutes compared to < 10 minutes is
associated with a reduction in average LoS of 0.416 (p< 0.05), but those travelling > 30 minutes
an increase in length of stay  of over 1 day (p<0.05).  In both cases (THR and TKR) travelling > 30
minutes to the hospital compared to < 10 minutes is associated with a stay in longer stay in
hospital.
The adjusted models controlling for gender, age, deprivation, comorbidities, living arrangements,
ethnic groups, days on the waiting list season of the operation, type of hospital attended and
hospital quality are also presented in Table 42.    For THR patients the adjusted model with travel
time as a continuous variable shows a statistically significant positive association with LoS for
THR patients for every extra minute travelled the LoS increases by 0.0172 days.  For the adjusted
model with travel time as a categorical variable those travelling > 30 minutes compared to < 10
minutes to the hospital is associated with an increased stay in hospital of 1.897 days (p<0.05).
Other explanatory variables that had a statistically significant association with LoS for THR
patients were being female, living in a more deprived residential quintile, having comorbidities,
being older and living alone.  Variables associated with reducing the length of stay were
attending a hospital that was classed as Excellent or Good (compared to need improving)
attending a privately provided hospital, having an appointment in winter, number of days on the
waiting list, and being from a Non-White British ethnic group.
The results show that those THR patients travelling >  30 minutes are spending on average 1.897
days longer in hospital than those who travelled < 10 minutes.  Those TKR patients who travelled
greater than 30 minutes spent on average 1.884 days longer in hospital than those who travelled
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< 10 minutes.    The other predicting variables associated with staying longer in hospital include
having comorbidities, living alone, being older than 60 and being in a higher residential
deprivation quintile.
3.3.8.4 Access to the Hospital: Missing Appointments
As discussed earlier there are some implications both for the NHS and the patient of missed
appointments in terms of patients delayed attendance at hospital.  The statistical models that
were run to assess whether living further from the hospital is associated with a higher likelihood
of missing an appointment are shown in Table 43.  In the logit model if the patient attended the
appointment or the appointment was cancelled by the provider (hospital) this is a 0 and if the
appointment was cancelled by the patient, or the patient did not attend and did not cancel or
attended late and was not seen this is represented by 1.   A negative coefficient is interpreted
as being more likely to attend.
The results are split into the OA model and RA model.
For the OA model the results indicate that those patients living 20 – 30 and > 30 mins away from
the hospital compared to < 10 minutes are more likely to attend the outpatient hospital
appointment.  They are less likely to miss an appointment if they are 60 – 80 years old (compared
to under 60) or are White British or male.  This is perhaps counter intuitive to the literature,
which suggests that having to travel further to get to the hospital would be associated with being
more likely to miss an appointment.  The results show that living in a more deprived residential
location is associated with being more likely to miss an appointment.  Living in a rural as opposed
to urban area was associated with a higher likelihood of missing an appointment.   Critically this
analysis shows that rather than those patients living further away from their outpatient
appointment not attending it is those that live closest (using road network travel times) that
have a higher likelihood of not attending the appointment   For the RA model again those who
live the furthest away > 30 minutes compared to < 10 minutes are more likely to not miss their
appointment, with similar associations for the other explanatory variables included in the
models.
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+ ve = Longer stay
Sub group unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Travel time (mins) 4,855 0.003 0.0172** 5.929 -0.003 0.008
Travel time
categories
Base  < 10mins 1,475 1,851
10 – 20 2,331 - 0.094 0.025 2,764 -0.416** -0.303**
20 – 30 821 - 0.119 0.139 1,020 - 0.227 -0.123
> 30 228 0.934** 1.897*** 291 1.121** 1.884**





2 893 0.202 0.174 1021 0.458** 0.444**
3 1005 0.821*** 0.787*** 1164 0.090 0.068
4 1045 0.312* 0.264 1340 0.101 0.065
5 (most deprived 986 0.444** 0.383** 1470 0.278 0.216
Comorbidities
(base = none)
1– 2 1,388 0.709*** 0.703*** 2016 0.887*** 0.874***
>2 285 1.598*** 1.600*** 387 1.887*** 1.871***
Age groups
(base = < 60)
60 - 80 3,316 1.043*** 1.064*** 4,377 0.429** 0.452**
>80 501 3.030*** 3.049*** 591 2.675*** 2.711***
Living Alone (base = not alone)
Alone
1,402 1.042*** 1.050*** 1,515 1.013*** 1.018***
Ethnic Group (base = White British)
non White British
543 -0.501** - 0.517** 844 -0.303 * - 0.332**
Days on the waiting list 4,855 - 0.001 -0.001 5,929 -0.002** -0.002**
Season had operation (base =not
winter) Winter
4,855 - 0.306** - 0.301*** 5,929 - 0.298** - 0.292**
Hospital Provider Type (Base =
NHS) Private Hospital
827 - 0.9829*** - 0.820*** 860 - 1.333*** - 1.313***
Hospital Quality (Base =Needs
Improving ) Excellent/ Good
2,120 - 0.929*** - 0.958*** 2334 -0.778*** -0.815***

























-ve means more likely to
attend
No. Attended No. Missed -ve means more likely to
attend
Model OA Patient Logit Model RA Patient Logit Model
Travel time (mins) 163,543 14,813 - 0.007 19,490 2,458 - 0.006*
Travel time categories < 10 minutes 72,738 6,796 -- 10,676 1,345 --
10 - 20 69,239 6,329 0.023 7,011 889 - 0.003
20 - 30 16,475 1,344 - 0.161*** 1,571 211 0.045
>30 5,054 343 - 0.417*** 232 13 - 0.859**
Gender (base = male) Female 98,226 9,154 0.034* 0.035* 14,684 1,908 0.179** 0.179**
Deprivation Quintiles
1 = least deprived
1 16,324 865 -- -- 1,361 140 -- ----
2 30,316 2,258 0.293*** 0.293*** 3,620 438 0.476*** 0.477***
3 29,792 2,435 0.385*** 0.384*** 3,662 472 0.536*** 0.544***
4 38,415 3,861 0.591*** 0.596*** 5,497 707 0.544*** 0.555***
5 (most deprived 48,696 5,394 0.669*** 0.680*** 5350 737 0.619*** 0.631***
Comorbidities 0 81,277 5,549 --- -- -- -- -- ---
1– 2 57,322 5,633 0.315*** 0.315*** 14,582 1,644 -- ---
>2 24,944 3,631 0.632*** 0.634*** 4,908 814 0.392*** 0.395***
Age groups (base = <
60)
60 - 80 91,037 6,408 - 0.354*** - 0.357*** 11,054 1,472 0.139** 0.139**
>80 30,071 4,473 0.269*** 0.267*** 2,541 349 0.089 0.090
Ethnic Group (base = Other ) White British 123,156 10,702 - 0.236*** - 0.233*** 15,799 1,833 - 0.416*** - 0.407***
Rural Urban (Base = urban) Rural 6,325 788 0.529*** 0.518*** 890 108 - 0.013 - 0.028
Month (Base = non winter) Winter 38,819 3,812 0.109*** 0.109*** 4,315 602 0.0603 0.061
Constant -2.963*** -3.047 -2.796 -2.878***
Pseudo R2 0.028 0.0281 0.0125 0.0130
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3.4 Discussion	
This chapter has sought to use THR and TKR patient data collected by the HES-PROMS linked
dataset to gain a greater understanding of the potential link between travel time to hospital and
the GP and health.  It has focused on the HES-PROMS dataset, as the basis for this analysis, as
this linked dataset included variables that could be used to calculate the travel times and
distances to the healthcare facilities and includes data collected about the patients’ health.
Some key observations that have emerged from the results are discussed next.
Using	PROMS	health	measures	
The study used a variety of measures of heath and proxy measures available within the HES-
PROMS dataset including self-reported; EQ-5D-3L domains, EQ-5D VAS, OHS, OKS and General
Health and those derived from hospital records,  LoS and Missed outpatient appointments.  This
chapter sought to determine whether it was possible to use the health and wellbeing measures
(EQ-5D-3L, EQ-5D VAS, Self-Assessed General Health OHS and OKS, LoS and missed
appointments) as an health outcome measure to explore the associations with travel time and
distance to hospital and the GP.  Assessing whether using travel time is associated with changes
in self-reported health following a TKR or THR has not previously been published.  The systematic
review  discussed  in  Chapter  2  found  that  it  was  more  common  to  focus  on  the  association
between travel time to healthcare and survival or mortality (Zorzi et al., 2012; Tonelli et al.,
2007a),  or  loss  to  follow  up  (Giuliani  et  al.,  2016;  Kerschbaumer  et  al.,  2012)  as  the  health
outcome (or proxy measure).  These measures would be less relevant for operations such as a
THR, as the majority of patients survive and there is minimal follow up for those patients that
do not suffer complications, which can include infections and revisions.    The results show that
it is possible to explore the association between travel time and distance to health and health
outcomes using the five health outcomes measures from the PROMS dataset.
Only the OKS and General Health models showed statistically significant results for the
association with travel times to the GP.  The disease specific measures were more sensitive to
changes in travel times and distances.  In terms of measuring the change in health as a result of
the TKR operation a pattern emerged of improvements in health for those travelling between
10 and 30 minutes from the hospital and negative association with those travelling > 30 minutes
from the hospital.  The OKS was most sensitive again to these results with all categories being
statistically significant.  Only the EQ-5D VAS showed a statistically significant result for the 20 –
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30 minutes category.  In comparison to the THR operation the same pattern emerged with an
improvement in the 20- 30  minutes category and all measures showing a negative association
for those travelling > 30 minutes  Statistically significant results were gained for the EQ-5D-3L,
EQ-5D VAS (at the 20 – 30 minute category) and OHS.  Again the most sensitive was the disease
specific measures, but interesting that the EQ-5D-3L and EQ-5D VAS were able to identify the
same association (though not always at a significance level above 90%).  The study found,  as
was noted by Benson et al. (2016), that the OHS and OKS measures for assessing the changes in
score for the THR and TKR operations were the most sensitive, followed by the EQ-5D-3L Index.
The results found. as shown in previous studies that patients who have had a TKR had lower
gains in health than those who have a THR  (Beard et al., 2015).
The missed appointment model revealed that it was those patients that lived the closest (had
the shortest travel times) that were more likely miss their outpatient appointments.  This result
goes against the distance decay concept in the literature, whereby there is a reduction in
attendance as patients live further away(Hunter and Shannon, 1985).   More work is needed to
explore whether this could still be due to a transport and travelling issue.    Those that travelled
the furthest were statistically significantly more likely to spend more days in hospital, as were
patients who lived alone, those who were older and those with greater comorbidities.  Those
spending longer on the waiting list for their THR or TKR were more likely to spend less time in
hospital following the operation, this could be due to those with more urgent cases (with
complications) being seen quicker.  This may change in the future, as the UK Government had
an 18 week waiting target for patients to be referred and have their THR or TKR, limiting the
number of patients waiting beyond this timeframe.  Due to constraints in the healthcare system
this has just recently been relaxed and there is now a three month minimum waiting time and
no maximum target reducing the need to keep waiting times below 18 weeks (Donnelly, 2018).
Continuous,	Categorical	or	both		
It was anticipated at the start of the study that those patients living further away from the
healthcare facilities (GP or hospital) would have worse health outcomes.  Findings from the
systematic review in Chapter 2 showed the importance of considering travel times and distances
as both categorical variables and continuous variables, as the results might differ.  This was
certainly found to be the case for this patient population.  The results showed that using a
continuous measure of travel time hid a more mixed result that using the categorical travel time.
These models identified a positive (but non-statistically significant) association with change in
EQ-5D-3L when travel time was included as a continuous variable, but when included as 4
categories (< 10 minutes, 10 – 20 minutes ,  20 – 30 minutes  and > 30 minutes) there was a
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positive association at 10 – 20 minutes and 20 – 30 minutes (compared to < 10 minutes and a
negative association at > 30 minutes (compared to < 10 minutes) indicating a worsening effect.
These mixed results would have been missed if the continuous variable alone had been used.
As  shown  in  Table  38  including  travel  time  as  a  continuous  variable  was  associated  with  a
negative (non-statistically significant) association with the OHS score, but when included as a
categorical variable there was a positive association (increase in score) for those patients living
20 – 30 minutes away from the hospital attended, but statistically significant negative
association for those living > 30 minutes away.  Whilst the results were found to be statistically
significant the change in scores from travelling further to the hospital > 30 minutes compared
to < 10 minutes were not large enough to meet the MCID thresholds currently published in the
literature (Beard et al., 2015)of 5 points for OHS and 4 points for OKS.
As noted by Benson et al. (2016) the OKS and OHS are seen as the gold standard measure for
identifying differences in the TKR and THR patients and were found to be more sensitive to
changes in health outcomes in this study for the models that focused on travel times to hospital.
Note that the results did not show any statistically significant associations between travelling
further to the GP and health outcomes.
The strongest association is observed with the models focusing on LoS at hospital.  With patients
on average staying around 2 days longer at hospital if they travelled further than 30 minutes to
the hospital to have their operation than travelling < 10 minutes.  The same U shaped association
is identified with again those patients living in the middle ground 10 – 20 minutes away and 20
– 30 minutes away having a reduction in their LoS compared to those closer and further away.
An unexpected result was found with those travelling further being more likely to attend their
outpatient appointments than those living closer to the hospital.  Again a potential impact from
those patients living closest to the hospital in terms of travel times, but maybe not in terms of
ease of access as discussed in Chapter 1.  The other factors that influence ease of access are
considered in more detail in the next Chapter.
The picture is of a U shaped curve, whereby those living closest and furthest away have the
worst self-assessed health following the THR or TKR operation and those in the middle having
higher self-assessed health. This distribution was also found in the study by Kim et al. (2000),
(although in the disease area of cancer) who found that those who travelled greater than 30km
or less than 20km had worse survival than those in the 20 – 30km band.
In this study possible reasons for these differences include that patients are split between
travelling further for their THR or TKR or having to attend the hospitals closest to their homes
when they are identified as being likely to have potential complications from having the
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operation.  Feedback from one of the local GPs – suggested that they would always suggest to
patients that they should attend the ‘local’ / ‘nearest’ hospital if they thought that the patient
would have any issues whether those of getting there or potential complications following the
operation due to their health.  This could be one potential explanation of why those living the
closest have worse outcomes and stay in hospital longer than those just 10 minutes further
away.   In this study we controlled for baseline differences in health and the number of
comorbidities a patient has (the study included the categories of 0, 1-2,> 2 comorbidities).  The
Charlson Index, used to calculate the number of comorbidities from the patient’s hospital
records goes up to 12, so it could be that some patients with the worst levels of health and a
large number of comorbidities are hidden by being included in the > 2 comorbidities category
resulting in potentially residual confounding.   As discussed in the thesis a recent policy change
is that CCGs are restricting patients with a BMI > 35 and smokers from having easy access to a
THR or TKR.  Not controlling for this in the model (as these two variables were  not available in
the HES-PROMS dataset) may have impacted on the results, as BMI and or smoking might be
unmeasured confounders, as they  may also have an impact on the patients transport
accessibility.
Another potential explanations for the differences in results by travel time to the hospital is
incomplete control in the models for patient deprivation, as the deprivations scores are both
based on the area that the patient lives in (not patient specific deprivation) and the scores have
been banded into quintiles, so reducing the granularity of the data, which  could have led to
residual confounding and biased the results (Becher, 1992).  Another possibility is that as the
results of the models are a combination of patients travelling to 31 different hospitals rather
than one hospital this may have affected the results.  Multi-level modelling early in the model
development showed that the hospitals were not all homogeneous in the association between
travel time and health outcomes and the results may be due to a high degree of heterogeneity
going beyond the type of hospital and hospital quality that was included in the models to control
for type of hospital attended.
These differences in results for those living further away from the healthcare facilities has
implications for the policy of reconfiguring healthcare facilities, as this policy it has the potential
to increase the travel times that some patients have to travel to get to the healthcare facilities.
This research indicates that patients that have to travel > 30 minutes to get to the healthcare
facilities for their operation, would be associated with worse health outcomes.  However, it does
also indicate that focusing on travel time alone is not enough, as those living < 10 minutes from
the healthcare facility had worse outcomes than those travelling between 10 and 30 minutes.
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Would	the	patients	notice	the	difference	in	health?						
The methodology section discussed that one method that can be used to go beyond assessing
whether there is a statistically significant association in the results would be to focus on the
MCID.    The  results  for  the  OKS  models  indicate  that  the  average  difference  for  patients
travelling > 30 minutes to the hospital for a TKR compared to < 10 minutes would be a reduction
in OKS of -1.692 and for OHS it is – 1.593   This would not be classed as meeting the threshold
by which it would be a noticeable clinical difference for patients, with 4 points for OKS and 5
points difference for the OHS  (Beard et al. (2015).  What should be noted though is that in using
the anchor method that patients in the study by Beard et al, (2015) who rated themselves as “ a
little worse” on the anchor scale still had on average a 2 point improvement in OHS/ OKS score
and those that rated themselves  as “much worse” on the anchor scale only showed a small
deterioration on the OHS/OKS score of -3.58 compared to the positive side of the scale.  Thus
implying that the threshold for having a worse health outcome was not symmetrical (and smaller)
to an improvement and therefore that actually the threshold by which a patient might notice
the difference when it is worse to be smaller.  The decline of -1.692/ -1.593 for those travelling
over 30 minutes compared to < 10 minutes could therefore be within an acceptable threshold
whereby patients would potentially notice a clinical difference due to the decline.    This also fits
with the loss aversion theory within the behavioural economics literature, which is that people
feel their loses much more than their gains derived from Kahneman and Tversky (1979)“Losses
loom larger than gains” (p279).  A clinically meaningful loss might therefore need an alternative
approach for research presented in this study that is showing a reduction rather than an
improvement.  Further research is needed to explore this area further.
Measuring	a	patient’s	transport	accessibility	to	healthcare	
	
One of the key limitations of the HES-PROMS dataset for undertaking these type of analyses
focusing on travel times and distances to the healthcare facilities (as a proxy measure for
transport accessibility to healthcare) is that data is not currently collected on how patients
travelled  (e.g.  car,  bus,  PTS,  walk)  to  their  appointments.   For  example  is  the  transport
accessibility  the  same  for  the  following  patients  who  live  20  minutes  by  car  away  from  the
hospital:
· Patient A who has someone to drive them to the hospital and drop them off at the
hospital entrance for their appointment.
· Patient B who has had to walk to the bus stop travel by bus and then walk from the bus
stop nearest the hospital to the hospital for their appointment.
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The answer is no, but it is not possible to gauge this information from the data available in the
HES-PROMS dataset.  What is known, is that a significant proportion of patients, 37% of THR and
30% of TKR patients stated that they either could not walk or were limited to walking around
the house prior to having the operation thus significantly limiting their transport accessibility.
The study calculated the travel times by car and by bus to assess whether there were any
statistically significant differences in travel times.  For this WY patient population travel times
by bus and walk (if everyone had travelled by bus) would have taken on average 44.13 minutes,
with 91 patients not able to make a 10 am appointment had they left their house at 7am and
one patient having to travel 2 hours 50 mins on the bus to get there.  Compared to an average
of 14.85 minutes for travel by car this shows inequalities based on how patients can travel.
Further work is needed in the future to be able to identify who those patients might be whose
journeys could potentially negatively impact on their health outcomes and create inequalities
between different groups based on transport accessibility.
When showing the results of the models to the studies PPI group a discussion was had regarding
the fact that whilst living further away made it more difficult, but what really bothered them
was the level of comfort whilst travelling, issues included getting into the vehicle, cramped
conditions when using the PTS and not knowing how long it would take for the PTS to take them
home.   All of the members of the group had used the PTS for at least some of their hospital
appointments.
Reconfiguring	THR	and	TKR	operations		
Following  on  from  the  2009  Health  Care  Act  (Department  of  Health,  2009)  patients  in  the
timeframe of this patient population 2009/10 to 2011/12 had, in theory, free choice over where
they had their THR or TKR operation.  Patients did not all  select the closest hospital for their
operation with only 36.33% attending the nearest hospital (based on fastest travel time).  This
is  a  similar  level  to  that  found by Tracey et  al.,  (2005a).   Average travel  time to  the nearest
hospital was 9.75 minutes (9.66 – 9.83 CI 95%) compared to 14.85 minutes (14.69 – 15.02 CI
95%) for the actual hospital attended.  Reducing choice through reconfiguring where operations
take place will have more of an impact on those that might move into the > 30 minute category
based on the results of this study.   Additionally those who attended their nearest hospital were
more likely to be in the most deprived deprivation quintiles (P<0.001), where 44% attended their
nearest hospital compared to 32% of those in the least deprived quintiles, and have
comorbidities whereby 69.7% of those patients with >  2 comorbidities attended their nearest
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hospital compared to 35.8% of those with no comorbidities.   The policy may have more of a
negative association with health outcomes if these individuals have to travel further.
Using	patient	confidential	data		
A significant amount of time was allocated in the study to apply for and get ethical approval for
accessing the patient level data used in this chapter.  One of the key drivers for requesting the
patient data was to ensure that the travel times and distances calculated were the most accurate
for the study.  The alternative was the LSOA, which was also used in this study, as a comparator-
requesting this data would have still required ethical approval, but not Section 251 approval.
The study compared using the LSOA (which is representative of an average of 672 household)
and a full home postcode which has up to 80 households.  When using straight-line distance as
the calculation method there was no statistically significant difference between using the LSOA
and the home postcode.  When using the travel distance and the travel time calculations there
was a small difference between using the LSOA and the home postcode calculations.  It should
be noted that for shorter distances (to the nearest hospital) there was a statistically significant
difference of 0.25 of a mile, but this difference was reduced as the distances increased.   On this
basis the results would not have been statistically significantly different if the LSOA calculations
had been used instead of the home postcode calculations.
The aspect of the patient data that did have an impact was not knowing the hospital that the
patient attended compared to using the nearest and assuming that all patients attended the
nearest hospital or GP.  This suggests that when accessing data it is this aspect that would be
worth investing resources in to access.  A comparison between when it is suitable to use the
nearest vs using the actual hospital attended is included in the discussions in Chapter 4.
Strengths	and	Limitations		
The key strengths of the research presented in this chapter is that it used a large WY patient
secondary dataset (> 10,000 patients) that was linked with patient reported outcomes to explore
the association between travel times to hospital and the GP and health (proxy health) outcomes.
One of the key weaknesses was that whilst it was possible to calculate the travel times to the
healthcare facilities, the study did not have any access to how the patients had travelled.  In
using the HES-PROMS dataset (due to its completeness in terms of patients’ data) it did allow
for some of the other potential explanatory factors that affect health outcomes identified in
Chapter 1 to be included (e.g. comorbidities. deprivation quintiles, gender , age, ethnic group),
However,  other  characteristics  or  variables  found  in  the  literature  to  be  important  are  not
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collected by the HES-PROMS dataset.  For example, previous evidence has shown an association
between higher BMI and poorer self-reported health following a THR or TKR (see for example,
Buirs et al. (2016)).    It was not possible to control for this association, as the HES-PROMS dataset
does not collect data on BMI or the components of it.  Equally there are other factors that were
identified in Chapter 1 that have been shown to be associated with differences in health
outcomes such as other lifestyle factors, levels of air pollution or, where individuals lived could
not be controlled for in the models in this Chapter.
 One of the disadvantages of using self-reported data is that it is reliant on patients completing
the questions accurately and fully (i.e. completing all the questions).  As can be seen from the
levels  of  missing  data  patients  were  more  likely  to  complete  the  OKS  and  OHS  sets  of  12
questions in the PROMS dataset than the EQ-5D-3L and EQ-5D VAS.  This may be due to the OKS
and OHS having been developed specifically for this group of patients, so are potentially more
relevant to them.  Whereas the EQ-5D-3L, EQ-5D VAS and general health are generic measures
of HRQoL.  As noted the EQ-5D-3L did not pick up the most extreme mobility issues that this
group of patients is likely to have.   A key strength of this work is that the study employed up-
to-date missing data methodology to assess whether the results were any different with the
missing data imputed using a chained method, so taking account of a larger sample of the
population than having to exclude those who did not complete  all the questions.  The results
showed a similar message with the imputted data, so providing more confidence over the
results.
This case study was based on the population of WY.  One of questions and potential limitations
of focusing on a WY case study is how generalizable the results are to the rest of the UK and to
countries outside of the UK.  WY is one of six metropolitan counties in the UK, the others are
Greater Manchester, Merseyside, South Yorkshire, Tyne and Wear and the West Midlands.
These metropolitan counties predominantly cover urban areas.  It can be seen from the results
in Table 16 that 93% of the patients reside in what is classed an urban area and only 7% in rural
areas.  It is likely that the results will be more comparable to these five other large metropolitan
areas than shire counties that are predominantly rural.   One of the aims of using the ELSA data
set in the next Chapter is to allow the study to make an assessment of how comparable the
travel times are for individuals across different regions of the UK.
One of the strengths of this research, compared to other research included in the systematic
review, was inclusion of both the home postcode of the patients and the hospital attended (from
the HES data) and of health outcomes (from the PROMS dataset).  One of the weaknesses of
using this dataset was that it did not include any information on how patients have travelled to
the healthcare facilities and the study relied on the large secondary dataset and didn’t collect
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any primary data on a sample of patients travel times, but a strength is that it did allow a greater
exploration of some of the key components of a patients travel to hospital or the GP (e.g. their
ability to walk or access vehicles).
3.5 Conclusions		
This chapter has used the HES-PROMS dataset to analyse the association between travel times
and distances to the GP and healthcare facilities for patients undergoing THR and TKR operations
and health outcomes.  It has identified that those patients living closest to the hospital and those
furthest away (travelling > 30 minutes) had the worse health outcomes following the operation.
The key findings that will be taken forward in the remaining chapters of this thesis are:
· Using the LSOA that the patient resides in vs. patient home postcode did not
dramatically change the results, but knowing which hospital the patient attended did.
This should be borne in mind for Chapter 4 given the analysis uses the nearest
healthcare facility as a proxy for the healthcare facility attended.
· One of the key limitations of this analysis is the dataset did not collect information on
how the patient travelled to the healthcare facility.   As shown in this Chapter travelling
by bus has a statistically significantly different travel burden associated with it compared
to travelling by car.  It  is critical therefore to know more about how the patients are
travelling.
· Chapter 3 has used a WY OA patient population that has undergone a THR or TKR.  To
understand more how generalizable these results are to the rest of the country it will be
important in Chapter 4 to assess how similar the travel times and distances to healthcare
facilities across the different regions are to this WY patient population.
· Chapter 3 has used travel time and distance as a proxy measure for transport
accessibility to healthcare.  It is important that the wider aspects of transport
accessibility (ability to walk and access vehicles plus others) as part of GC are
investigated further.
· Due to the small sample size of RA patients it was not possible to include the RA patients
in all the analysis.  The focus of Chapter 4 will be to include individuals with OA and RA
in the analysis.
Chapter 4 will now present the results of the ELSA dataset focusing on OA and RA patients in
England to explore further the health and wellbeing of this population and the associations






The previous chapter used the HES-PROMS dataset to explore the association between travel
times to healthcare facilities and health outcomes for OA patients in WY who had undergone a
THR or TKR operation.   This chapter uses the English Longitudinal Survey on Ageing (ELSA)
dataset to explore the health and wellbeing of individuals with OA and RA in England.  It goes
further than Chapter 3 by drawing on the detailed information collected on the transport
preferences and mobility abilities of people with OA and RA (e.g. Do they have access to a car
when needed?, Do they use public transport?, How easy is it for them to access the GP?).   This
chapter then uses this data to explore the associations between transport accessibility including
the concept of ‘ease of access’ (discussed in Chapter 1) to healthcare using the nearest
healthcare facility and health / wellbeing measures.  This allows the thesis to explore in a greater
depth the potential associations, whilst having a better understanding of how individuals travel
to access healthcare facilities.
This chapter will describe the health and transport data available from the ELSA dataset (year
2012/13) for individuals with OA and RA.  It will then discuss the methodology used to analyse
the  data.   The  results  section  will  present  the  characteristics  of  those  with  OA  and  RA,  a
description of their health and wellbeing and what can be determined about their mobility levels.
The health/ wellbeing and transport accessibility data is then used to explore the associations
between transport accessibility and health for these two MSK groups.  Results will be compared
across the regions in England to assess how comparable they are.  The chapter will then discuss
the findings and draw out conclusions relevant for Chapter 5 and future work.  This chapter
contributes directly towards study objectives 2 and 3, which are:
· Objective 2: To explore and document the healthcare and transport accessibility of
patients with Osteoarthritis and Rheumatoid Arthritis.
· Objective 3: Develop statistical models to examine the associations between transport
accessibility to healthcare and inequalities in health for individuals diagnosed with RA and
OA.




The ELSA is a longitudinal dataset from a representative sample of ~10,000 survey participants
in England living in the community who are > 50 years old.  The survey began in 2002 (Wave 0)
with the sample being drawn from respondents to the Health Survey for England (HSE) (NHS
Digital, 2018c).   Participants once included are followed through until end of life.  The HSE was
designed to monitor trends in the national health overtime starting in 1991 onwards.
Participants in the HSE are selected at random by address in England.  In order to maintain the
sample size overtime additional participants have been included from the HSE in ELSA.   This
longitudinal dataset is now on wave 9 for which the interviews started in 2018.  Waves of data
are  collected  every  two  years.   The  findings  presented  in  this  thesis  are  based  on  the  cross
sectional analysis of wave 6 of the ELSA.
The dataset is freely downloadable from the UK Data Service website (UK Data Archive, 2018),
which stores a range of available datasets including ELSA and HSE.  This survey contains
information about the participants including information about pensions, education,
demographic characteristics, and access to a car, whether they use public transport, how fast
they can walk (carried out every 2 years) and a nurse led interview (which take place every 4
years).   A summary of the key health and wellbeing measures are shown in Table 44.
Table 44: Health and wellbeing measures included in the ELSA survey
Health Measure Description
Assessed by a nurse Body Mass Index (height and weight) , Blood pressure, Lung function,
Walking Speed
Physical Health Mobility, Physician Diagnosed Conditions (e.g. Osteoarthritis) , Falls/
Balance, Pain
Behavioral Health Levels of Physical Activity, Smoking
Well-being Self-Rated Health, Quality of Life (CASP-19), Satisfaction with life,
Centre for Epidemiological Studies Depression scale (CES_D)
In order to preserve anonymity key geographical identifiers in ELSA are kept separate from the
main dataset.  The study required approval from the NatCen Social Research Institute to have
access to the geographical variables of deprivation quintiles (measured using the index of
multiple deprivation) and the easting northing coordinates of the study participants’ homes
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address.  Access to these geographical variables required attending the NatCen data enclave in
London to calculate the travel times and distances to the nearest healthcare facilities and access
the deprivation quintiles.  The resulting calculations (minus the identifying variables) were
transferred electronically to the University and linked to the ELSA dataset.  Approval was granted
in December 2016, but due to issues accessing the data (issues with installing correct software
to analyse the data at the enclave) the enclave was only accessed in December 2017 and the
data transferred and linked in February 2018.  This data was then linked to the main dataset
using the unique individual identifiers, resulting in a dataset with distances and travel times to
the nearest facilities for each ELSA participants (minus the geographical variable) and ELSA
variables.
One advantage of the ELSA dataset is that, as a representative sample of the population living
in the community in England over the age of 50, it includes data that can be considered at both
a national level and within each of the regions of England (shown in Map 3).   One of the potential
limitations of the results from Chapter 3 was an understanding of how generalizable the data
was from the WY locality to the other regions in England in terms of the distances and travel
times patients would have to travel to access healthcare facilities.  Using the ELSA dataset allows
the thesis to review whether there are differences between regions.  One of the key queries is
how generalizable to other contexts is a policy of centralisation of services (e.g. centralising
stroke care in London (Morris et al., 2014) compared to applying this same policy in WY).  If the
nearest hospital was shut in London would the alternative be of a similar distance away to
someone in the same situation living in Yorkshire and Humberside? One of the more pressing
concerns of the move to centralisation of services is that not all regions will be affected equally
– exacerbating the potential impact on health inequalities.
Reasons	for	using	the	ELSA	dataset		
Initially the idea for the thesis had been to use the longitudinal qualities of this dataset linked to
HES.  When ELSA participants complete the two yearly cycle of questions they are asked whether
they give their permission for their data to be linked to other datasets including HES.  Prior to
this study starting it was expected that the ELSA participants data linked to the hospital data
(HES data discussed in Chapter 3) was going to be available.  This would have provided
longitudinal data on the participants linked to hospital attendance and treatment.   When it
became evident during the study that this data was not going to be released in the timeframe
of the study (and is now expected to be released in the summer of 2019), the study was adapted
to look separately at HES data with health data from the PROMS (the focus of Chapter 3) and
ELSA.  One of the limitations of using the HES-PROMS dataset for this study was that whilst it
was possible to calculate the travel times and distances from the patient’s home to the
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healthcare facilities attended no information was available on how these patients travelled and
it was limited to patients with OA that had either had a TKR or THR.  The addition of the ELSA
dataset, whilst a sample of the total population in England provided data on people with RA and
OA (not just those that had had a THR or TKR) linked to health.  The study selected to use Wave
6 of this  dataset, as a cross sectional analysis, as it was granted permission to calculate the
transport accessibility variables for wave 6, which included both the health data collected by the
nurse (collected every four years) and corresponded to the same survey years (2012/13), as the
WY case study in Chapter 3.
This is a new application for this dataset, as firstly, no previous study has used the gridlink
reference of the home address to calculate how far people live from the nearest available
healthcare facilities.  Secondly, no studies have used this data to explore the association
between distance / travel time to healthcare and health outcomes for people with OA/RA.
Determining	the	prevalence	of	OA	and	RA		
Whilst no studies have used this data to explore the association between distance/ travel time
for health outcomes for people with OA/RA work has been undertaken using ELSA  by Imperial
College London for Arthritis UK to produce an MSK prevalence calculator (Arthritis UK, 2017).
Whilst calculating the prevalence of OA/ RA is not the main aim of this thesis, having a better
concept of the numbers with MSK allows the thesis to consider the volumes of patients that
might be affected in Chapter 5, which is focusing on changing where patients might access
healthcare facilities.
There are a number of methods in the literature that have been developed to provide estimates
of the prevalence of OA and RA in the population.  Timmins and Edwards (2016) explored using
spatial microsimulation techniques to develop small area estimates at the ward and local
authority level for OA prevalence.  Marshall et al. (2015) calculated new incidences of OA and
the prevalence rates of OA for the residents of Alberta using the diagnosis codes for OA (ICD10
codes) in the medical records and insurance claims.  They found that for the whole population
(all ages) the prevalence rates were 86.6 for every 1,000 population (8.66%), which  increased
to around 60% for  women who were over  the age of  90 (Marshall  et  al.,  2015).     The MSK
calculator developed by University College London (UCL) is summarized  below with full
technical report available from Adomaviciute et al. (2018).  The team identified a number of risk
factors for OA from the literature, which were matched to the data available within the ELSA
dataset and data available on populations at the Middle Super Output Area (MSOA).  The
following variables were included: age, sex, ethnicity, education, socio economic status, BMI,
physical activity, smoking and member at sports clubs/gyms.  Some risk factors were excluded
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as there was too much missing data within ELSA (e.g. housework/ gardening activity level).   The
tool has two levels of data.  The first includes all cases of hip and knee OA and secondly, cases
of severe hip and knee OA.   Severe OA was separated from all OA by the answer to questions in
the ELSA dataset of “Severity of pain most of the time” and “Difficulty walking ¼ mile unaided”.
If participants stated that they had pain most of the time, or had had previously a THR or TKR or
they were unable to walk ¼ mile unaided then they would be classed as having severe OA.
Separate logistic regression models were run to identify the log odds of having or not having the
different severity and type (hip/ knee) of OA for each of the risk factors using the ELSA data.
Using these results the log odds were calculated for each possible permutation of risk factors
(e.g. female, over the age of 60, who smoke, have a BMI > 30) by adding each of the individual
log odds together.  The log odds were converted to odds ratios (OR) and the prevalence for each
combination of risk factors calculated by the formula (OR/ 1 + 0R).  The same matrix with all the
possible permutations and number of the population were created for each local area (at the
MSOA) using the local data (e.g. number of females, over the age of 60, who smoke) taken from
the census data, Office for National Statistics, household surveys and Sport England Active
People Survey.  The prevalence rates and number of people in each of the cells of the matrix
were then multiple to give the prevalence rates.  The estimates differ by locality based on the
makeup of the local population.  As discussed in Chapter 1 the majority of cases of OA are
diagnosed after the age of 45, so the ELSA dataset and Arthritis UK Calculator provides a good
match  to  the  majority  of  the  OA  population.     It  does  mean  that  they  are  less  relevant  for
populations under the age of 50 with the disease.  Another criticism is that some of the risk data
was not available at the MSOA level and used Local Authority level data (e.g. the physical activity
level and gym membership which was available at a local authority level), so was less local level
specific.  The calculator provides an initial starting point for exploring regional differences in OA.
The results from applying this calculator for England and the WY districts are provided in Table
45. The results from using the Arthritis calculator have shown that the estimated prevalence of
these two MSK diseases does vary across England.
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Map 3:  West Yorkshire and England Regions (source: boundary data ONS (2012))
The OA MSK calculator estimates that 10.9% of the population in England had signs of OA in the
hip, WY at 11.1% is higher than the England average.  Focusing on the districts of WY (considered
in Chapter 3) Leeds has the lowest estimated prevalence of all categories of OA in WY (including
a lower rate than England as a whole).  Bradford has the highest estimated prevalence rates of
OA with 11.7% of the population showing signs of hip OA and 3.7% having severe hip OA.   The
MSK  calculator  for  RA  draws  on  a  number  of  datasets  including  ELSA  and  uses  the  Clinical
Practice Research Datalink (CPRD) (Gardiner et al., 2017).    There is a similar pattern to the OA
results with the Leeds district having the lowest estimated population prevalence of RA in WY.
It is worth noting that due to the larger population in Leeds the MSK calculator estimated that
there are 5,331 cases compared to Calderdale which has the highest population prevalence, but
only 1,551 cases of RA.  West Yorkshire as a whole has lower population prevalence than England,
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As can be seen from Table 45, there is variability depending on area and therefore variability in
demand for services.
Table 45: Estimated prevalence of hip and knee OA and RA (% population)
Hip OA Severe hip
OA
Knee OA Severe knee
OA
RA
England 10.9 % 3.2 % 18.2 % 6.1 % 0.84 %
West Yorkshire (WY) 11.1 % 3.3 % 18.6 % 6.3 % 0.81 %
Bradford 11.7 % 3.7 % 19.7 % 7.1 % 0.82 %
Calderdale 11.6 % 3.4 % 19.2 % 6.6 % 0.87 %
Kirklees 11 % 3.3 % 18.3 % 6.3 % 0.86 %
Leeds 10.6 % 3 % 17.5 % 5.6 % 0.76 %
Wakefield 11 % 3.2 % 19.1 % 6.3 % 0.83 %
Source:  Calculated from Arthritis UK (2017).
4.3 Data	and	Methods	
This chapter uses a range of methods to explore the data.  Firstly, descriptive statistics are used
to describe who the individuals with OA and RA are, their health and wellbeing and transport
options available to them.  Statistical models are then used to explore further the associations
between transport accessibility (measured using travel time / distance and the results of the
questions from the ELSA survey of – ‘How easy is it to access the GP/ Hospital?’) and health/
wellbeing.  Finally, descriptive statistics are used to compare between the results for the
different regions in England. Once the study had access to the transport and deprivation data
and had linked it to the Elsa dataset and had stored it securely in the University’s encrypted drive
there were a number of stages to the process for analysing the data.  These are split into four
section:
Section 4.3.1: Health Outcomes
Section 4.3.2:  Transport and travel times/ distances/ ease of access to the healthcare facilities
Section 4.3.3: Other explanatory / predictor variables
Section 4.3.4: Developing the statistical models
Health	Outcomes		
The overriding aim of this chapter is to identify those ELSA participants that have OA or RA and
then explore in greater detail whether there is an association between transport accessibility
and health / wellbeing.  The ELSA dataset includes a wide range of health and wellbeing
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measures (including Self-Reported General Health, CASP-19 and CES-D), which are described
below.
4.3.1.1 OA / RA diagnosis
To determine which participants had OA and which had RA (or both) the study used the
following self-completed questions in the ELSA survey:
· Have you been told by a doctor that you have arthritis?
· Which types of arthritis do you have?
From these questions in wave 6 it was determined that 2,624 individuals (24.8%) reported that
they had OA and 674 individuals (6.4%) reported that they had RA (92 had both).  These
participants were selected for inclusion in the study.  It should be noted that this was a self-
reported diagnosis and is therefore reliant on the survey respondent correctly answering the
question and knowing whether or not they had arthritis.   As described in Chapter 1 there is
some level of disparity between those patients that have radiograph evidence of OA, clinical
diagnosis, but do not self-report it when asked (Parsons et al., 2015).
The study also compared in some cases the complete ELSA population with the subgroup
identified as having OA or RA to see whether any key differences could be identified.  As shown
above the ELSA dataset asks participants to self-report firstly, whether they have arthritis and
then secondly, if they report that they have arthritis to state whether they have RA or OA.    As
noted in Chapter 1 OA does not simply refer to a homogeneous group of patients who all have
the same issues.  For example, some patients have OA in all of their joints (e.g. hip, spine, knee,
and shoulder) and others are diagnosed with OA in one joint and others with radiographic
evidence of OA, but no symptomatic diagnosis.  For RA, whilst most patients have RA in their
wrists, it can affect different joints.  One disadvantage of the ELSA dataset is that it does not ask
patients to specify where they have arthritis.  For example, someone with arthritis in the hip is
likely to have differing mobility issues to another individual having arthritis in the hands and the
treatments will differ.
4.3.1.2 Self-Reported General Health
One of the key measures of health collected in the ELSA survey is self-reported general health.
This is a commonly used subjective measure of health status.  In ELSA it is measured on the 5
point Likert scale of Excellent, Very Good, Good, Fair and Poor using the question
“Would you say that your health is…”
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It is the one question that is common to the PROMS dataset discussed in Chapter 3.   It was
included to allow a comparison with the results in Chapter 3 and can be compared with the
results from the UK census.
4.3.1.3 CASP-19 Quality of Life
CASP-19 is a quality of life measure developed by Hyde et al. (2003) based on 19 questions in
the domains of control (C) , autonomy (A) , self-realisation (S)  and pleasure (P) and is reproduced
in Table  46.  This  measure was included in  this  study due to  the wider  range of  facets  of  an
individual’s life that it considers to create a measure of quality of life (compared to the single
question used for the self-reported general health measure).  Each question is scored on a 4
point scale (from ‘Often’ to ‘Never’) and there are a mixture of positively and negatively phrased
questions.  To create the overall score questions 1, 2, 4, 6, 8, and 9 (negatively phrased questions)
are reverse coded and then all questions are coded, as follows 4 =0, 3=1, 2 =2, 1 =3 and summed
to give the range 0 – 57,   where 57 represents the highest level of quality of life and 0 complete
absence of quality of life.  This quality of life measure has been previously used in a number of
studies including French et al. (2015), where it was used to focus on how quality of life changed
with age for individuals with and without OA in an Irish national sample, which reported that
the CASP-19 score was found to  decline with  age and was lower  at  each age band for  those
individuals that were identified as having OA compared to those who did not have OA.
Table 46:   CASP-19 questions
Q Questions Often Sometimes Not Often   Never
  1                2                  3                4
C 1 My age prevents me from doing the things I would like
to
2 I feel that what happens to me is out of my control
3 I feel free to plan for the future
4 I feel left out of things
A 5 I can do the thing I want to do
6 Family responsibilities prevent me from doing what I
want to do
7 I feel that I can please myself what I do
8 My health stops me from doing things I want to do
9 Shortage of money stops me from doing things I want to
do
S 10 I look forward to each day
11 I feel that my life has meaning
12 I enjoy the things that I do
13 I enjoy being in the company of others
14 On balance, I look back on my life with a sense of
happiness
P 15 I feel full of energy these days
16 I choose to do things that I have never done before
17 I feel satisfied with the way my life has turned out
18 I feel that life is full of opportunities
19 I feel that the future looks good for me
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Source: (Hyde et al., 2003)
4.3.1.4 Centre for Epidemiologic Studies Depression Scale (CES_D)
The CES-D was developed by Radloff (1977) to measure depressive symptoms in the general
public.    This measure of wellbeing was included in the study, following evidence from studies
including, Handley et al. (2014) and Skarsvag and Wynn (2004) that there is a distance decay
effect in attending psychiatric services (fewer individuals attend) the further they live from the
practices), which may have an effect on health outcomes including depressive symptoms.
McManus et al. (2016 ) described the results of the UK based Adult Psychiatric Morbidity Survey
completed in 2014, which identified that 17% of adults over the age of 16 met the criteria for
one of the common mental disorders.  The CES_D started as 20 questions measured on a 4 point
scale.  A shorter version using yes/ no answers to 8 questions is included in ELSA and is recreated
in Table 47.  The questions that the ELSA participants answered are a mixture of positively and
negatively phrased questions.   If the participant answers yes to the negatively phrased
questions or no to the positively phrased questions (4 & 6) a score of 1 is given and these are
then summed to generate a score between 0 (no depressive symptoms) and 8 (maximum
depressive symptoms).  Studies such as White et al. (2016) have used a cut off of ≥3,  as the
diagnostic criteria for ‘caseness’ in depression using the 8 question CES_D.  The models will be
used to explore whether differences in transport accessibility are associated with this
dichotomised score of < 3 depression symptoms vs ≥3 depression symptoms.
Table 47: CES-D Questions in ELSA
Now think about the past week and the feelings you have experienced. Please tell me if
each of the following was true for you much of the time during the past week
Y N
1 You felt depressed
2 You felt that everything you did was an effort
3 Your sleep was restless
4 You were happy
5 You felt lonely
6 You enjoyed life
7 You felt sad
8 You could not get going
Source: Adapted from NatCen (2014)
The three health and wellbeing variables described above are the key measures that will be






The ELSA dataset contains a wide range of data on how people travel and whether they have
any mobility issues (e.g. difficulties walking).   Questions include whether participants have
access to a car or van when needed (either as the passenger or the driver), whether they use
public transport (and if not why not) and whether they have used the PTS.  For example, the
following key questions about ability to walk and how far are asked:
· How difficult it is for them to walk ¼ mile unaided (using the responses of no difficulty, some
difficulty, much difficulty or unable to)?
· Do they have difficulty walking 100yrds? (using the responses of yes or no)
· How quickly can they walk (with a nurse measuring how long it takes them to walk 2.44
metres)?
One of the consequences of these two MSK diseases is that pain in the joints can make
movement  more  painful  and  therefore  have  a  major  impact  on  mobility  levels  and  how  far
individuals can walk.  Studies such as Vaughan et al. (2017) have reported on one particular
consequence of this, which is that  barriers to mobility for people with or at risk of OA have
higher risks for reduced community participation.  Reduced community participation then
affects other areas of an individual’s lives particularly when referencing back to the measures
such as CASP-19, where one of the questions is “I enjoy being in the company of others”.
This thesis included studies in Chapter 2 that had measured the travel times and distances to
healthcare facilities.  One of the main limitations of this methodology is that it is potentially too
simplistic a measure to capture the true difficulties involved in getting from A to B especially in
a cohort of patients that can have significant mobility issues, as described using the GC function
in Chapter 1.  To provide an example, we could have individual A who lives close to the hospital
(less than 1 mile), lives alone, does not have a car and has a poor level of mobility, so could not
walk there compared to individual B who lives 20 miles away, but has a car and someone who
could drop them at the door of the hospital so they would not have to walk.  The level of difficulty
of getting to the hospital for individual A and B are not the same and there may be a worse
impact on the health outcomes from the difficulty of travelling for individual A - who lives closer.
Individual A is likely to have a higher GC value and be more elastic in their response to changes
in transport accessibility to get to the healthcare facilities.
There are two questions in ELSA that perhaps better capture this broader issue.  Participants are
asked:
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· How easy is it for you to access the GP?
· How easy is it for you to access the Hospital?
The possible responses are; Very Easy, Quite Easy, Quite Difficult, Very Difficult, and Unable to
Go.  Including the responses to these two questions should be a better representation of these
unobserved factors that cannot be captured using a road network or travel time measure.
4.3.2.1 Calculating the travel times and distances to the nearest healthcare facilities
In addition to these transport variables the study calculated the distances and travel times  (road
network and straight-line) to the nearest GP, hospital with rheumatology department, A & E and
bus stop using the  gridlink coordinates of the participants home).The study calculated the travel
time  and  distances  at  the  NatCEN  data  enclave.   This  involved  installing  ArcGIS  14.2  on  the
computer in the enclave and forwarding the ITN network files (discussed in section 3.2.3.2).   The
files  with  a  complete  set  of  geocoded  GP  locations,  rheumatology  departments,  A  &  E
departments and bus stop locations across England, were transferred to the enclave.  The GP
locations were accessed through the EPRACCUR file downloaded from (NHS Digital, 2016a), the
A& E locations and rheumatology departments across England were downloaded from (NHS
Digital, 2017 )and the bus stop data was downloaded from the Public Transport stop data for
England from the Traveline National dataset (TNDS, 2016).
The network analyst tool in ArcGIS was used to calculate the travel times and distances for each
of the ELSA participants for wave 5 and wave 6.  It was not possible to install the Visography
Tracc software at the NatCEN data enclave and so the decision was made to not calculate the
bus travel times for this dataset.   This data was linked back to the archived ELSA dataset using
the unique study participant identifiers.  Unlike the previous analysis outlined in chapter 3 the
geographical data included where the participant lived, but not hospital attended or registered
GP, similar to a large number of the studies described in Chapter 2 (e.g.  Anderson et al., 2013;
Schroen and Lohr, 2009).
Other	Explanatory/	Predictor	Variables	
ELSA includes a large number of variables including a number of which were identified in Chapter
1 as being associated with health inequalities.  The study wanted to include the key variables  in
the models described in Chapter 3 for comparisons plus additional variables collected in the
ELSA dataset that had been identified in the literature, as being associated with health outcomes
for individuals with OA and RA.   The explanatory/ predictor variables considered are
summarized in Table 48.   For OA Age has been shown to be a potential explanatory factor, with
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studies identifying that incidence of OA increases with age especially after age 50 years
(Blagojevic et al., 2010).   Blagojevic et al (2010) also showed evidence that whilst for OA in the
hip there was no evidence of differences by gender, females were more likely to suffer from OA
in the knee and OA in the hand.    Studies in the UK have reported that patients with OA who
need a THR or TKR in the most deprived groups are less likely than those in the least deprived
groups to have a joint replacement (Judge et al., 2010), so potentially leading to difference in
self-reported health outcomes if joint replacements are delayed.  It is documented in the UK
that individuals from non-white groups have poorer health than people from white groups, with
individuals living in the UK originally from Bangladeshi having the poorest health (Nazroo, 2014;
Evandrou et al., 2016).  Smith et al. (2017)  found that ethnic minorities were less likely to receive
a THR or TKR than their white counterparts.  There is the potential for health outcomes to also
vary by education levels, as shown by the study by Davies et al. (2018) who found that staying
longer in education reduced the risk of diabetes and mortality rates.  Whilst smoking status was
considered as a variable in the model, studies have shown conflicting evidence about whether
smoking represents no effect or has a protective factor in development of arthritis (Blagojevic
et al (2010).  Smoking was not included due to the level of missing data.
Whilst a number of the variables have been shown to be associated with differences in health
there is less evidence of whether they also affect the independent variable of transport
accessibility (potential confounders).  It should be expected that access to a car and difficulty
walking would be potential confounder variables, as they could affect both the health outcome
and transport accessibility to healthcare facilities.
Table 48:  Potential Explanatory / Predictor Variables
Variables Categories Included in Chapter
3?
Gender Female, Male YES
Age < 60, 60 – 80 and > 80 YES
Ethnicity White, Other YES
Deprivation Quintiles (%)
(1 = least deprived)
1 – 5 YES
Comorbidities (%) 0, 1-2 and >2 YES
Living Arrangements (%) Living alone vs Married/ Cohabiting YES
Education (obtained) Degree or equivalent, below a degree, Foreign/
other and no qualification
NO
Smoking status (%) Current vs Ex Smoker vs Never NO
Access to a car Access when needed / no access when needed NO
Difficulty Walking 400m No difficulty, some, much/unable NO
One of the variables that was not directly available from the dataset was a comorbidities index.
Documenting the diseases and health is an important part of the ELSA survey, but it does not
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produce its own composite measure.   This was an important variable to control for, as the more
comorbidities a person has the increased likelihood they will attend healthcare facilities more
frequently and have poorer health / quality of life   (Hutchinson et al., 2015).  The results of the
models in Chapter 3 showed that the more comorbidities that an individual has the worse their
health outcomes.
For this study a proxy measure was created using the categories included in the Charlson
comorbidity index and data available in ELSA.  Not all categories were covered in ELSA, as shown
in Table 49 (e.g. ELSA does not collect information on renal disease).  A score of 1 was allocated
for  each  comorbity  that  was  recorded  (either  as  a  confirmed  previous  diagnosis  or  a  new
diagnosis).   These scores  were summed and grouped into 3  categories:   0  comorbidities,  1-2
comorbidities and >2 comorbidities, whilst not a perfect match for the Charlson index it does
allow the thesis to control for some of the main comorbidities (e.g. Dementia and Diabetes).
Table 49: Charlson Index Categories and data available in ELSA




Myocardial infarction Yes Heart Attack 1
Congestive heart failure Yes Congestive Heart Failure 1
Cerebrovascular Disease Yes Stroke 1
Dementia Yes Dementia 1
Chronic Pulmonary Disease Yes Chronic Lung Disease 1
Connective Tissue / Rheumatic Disease Yes Rheumatoid Arthritis 1
Diabetes without complications Yes Diabetes 1
Diabetes without complications Yes
Cancer Yes Cancer 1
Metastatic carcinoma No
Peptic Ulcer Disease No - -
Mild Liver Disease No - -
Moderate or severe liver disease No - -
Paraplegia and Hemiplegia No - -
Renal Disease No - -
Peripheral Vascular Disease No - -
AIDS/HIV No - -
Source: Adapted from (Charlson et al., 1987)
In order to determine which of the available variables to include the study looked at the
correlations between variables (strength of association).  Including two highly correlated
variables, as independent variables in the regression analysis will cause problems with
collinearity.  This has a disabling effect on the coefficient estimates for the independent variable,
as it causes an increase in the standard errors of the coefficients, which can make some variables
incorrectly statistically insignificant.  Pearson’s correlation coefficient and Phi Coefficient were
employed to assess the strength of association between the variables (test for collinearity)
(Hinkle et al., 2003).  The results are shown in Table 50, with Table 13 (see Chapter 3) providing
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a guide on how to interpret the results.  As can be seen from the table the highest correlation
was between walking ability and comorbidities with a positive correlation of 0.33, as shown in
Table 13 this fits it into the category of low correlation.  One area that was potentially expected
to have a high correlation was between deprivation and education level, but whilst positive was
in the negligible category at 0.22.  No variables were excluded on the basis of the correlations.















































Travel Time to GP 1
Access to a car -0.1945* 1
Difficultly walking -0.0617* 0.2590* 1
Gender -0.0206* 0.0972* 0.0487* 1
Age -0.0228* 0.1901* 0.2853* -0.0250* 1
Deprivation -0.1945* 0.2224* 0.1643* 0.0093 -
0.0191*
1
Living Arrangements -0.1040* 0.3663* 0.2204* 0.1573* 0.2242* 0.1382* 1
Comorbidities -0.0278* 0.1463* 0.3314* -0.0481* 0.1970* 0.1015* 0.1152*
Ethnic Group -0.0738* 0.0192 0.0189 -0.0042 -
0.1011*
0.0994* -0.0199
Education -0.0735* 0.2110* 0.2318* 0.1226* -0.0184 0.2242* 0.1427*


























Ethnic Group 0.0031 1
Education 0.1266* -0.0184 1
Ease of Access to GP 0.1496* 0.0744* 0.1240* 1
(Legend * p <0.0.5)
The study used the entry approach (including all explanatory variables at once) or a priori
knowledge to determine variables to include in the regression models, as was used for the
models in Chapter 3.  All included variables had been identified in the literature as potential
predictors of differences in health outcomes for this group in the population and had been
assessed for collinearity.  All variables that were included either had evidence of being
associated with the dependent variable (health outcome) or were being tested by this research
(e.g. travel times and access to a car).  An alternative approach that could have been used to
determine which variables to include is the stepwise approach whereby variables are included
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or removed from the model based on whether they improve or reduce the predictive ability of
the model using a computer algorithm.  However, there has been criticisms of stepwise
approaches, as it has the potential to over fit the model and include variables that have no
associations to the outcome measure (Derksen and Keselman, 1992; Babyak, 2004) and so was
not used here.
Modelling	the	data		
The data from the ELSA dataset has a variety of different health measures and transport
outcomes all of which require different statistical models.  A summary of the data and the
different types of statistical models are provided in Table 51.  Three main types of models are
employed – ordinary least squared or linear regression (OLS), Binary logit regression and ordered
logit regression.  In addition, where the ordered logit regression model is not suitable (described
below) the generalized ordered logit model is used.  This section will briefly describe each of
these models
Table 51:  Health/ wellbeing Outcomes and statistical methods
Outcome Variable Type Categories Model
Access to a car when
needed
Binary 0  = access
1 =  no access
Binary logistic
regression




1 = very easy
2 = quite easy
3 = quite difficult






CASP-19 Continuous 0 - 57 Linear regression
(OLS)















The multiple linear regression (ordinary least squares – OLS), was used for modelling the




= 	 + 	 + +⋯+	 + 	 											 ℎ 	 ~ (0, 		)	
Where:
y = Health/ wellbeing dependent variable
= 	 ℎ 		  (constant) →	 			 = 	 	 	 =
		
In order to apply an OLS model to the data the study is making the parametric assumption that
the data comes from a population with a normal distribution.   This assumes that the values from
the population (from which the sample was taken) are normally distributed.  The central limit
theorem states that “given random and independent samples of N observations each, the
distribution of sample means approaches normality as the size of N increases, regardless of the
shape of the population distribution” (Anderson (2010 ),p 1).   It is widely reported that 30 is the
minimum sample size required to satisfy this ‘large’ N (ibid).  In addition to the study having a
large sample size and a linear relationship the following tests where run to see whether it was
suitable to apply an OLS to the data.  These were:
· Are the residuals (error terms) normally distributed?  This was tested by plotting the
residuals as a histogram and including a normal curve for comparison.
· Are the residuals homoscedastic?  This was tested by plotting the residuals against the
predicted values.  For the residuals to be homoscedastic there should be no pattern to the
data. Where the residuals were found to be heteroscedastic (patterns identified) this was
controlled for using robust errors in the models to correct for this
· Is there any multicollinearity? Are the predictor variables highly correlated with each other?
This was tested by calculating the VIF.
The tests were applied to all the models and the OLS was decided as the approach to be used
for the CASP19 data.  An example of the tests for the CASP19 model focusing on ease of access
to the hospital, as the transport accessibility are shown in Figures 38 to assess whether the
residuals are normally distributed, and Figure 39 to allow an assessment of whether the
residuals are homoscedastic and in Table 52 the results of the VIF to test to see the levels of
multicollinearity between the variables in the model, which averaged at 1.4, so low amounts of
multicollinearity.
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Figure 38 Kdensity plot of the residuals
(CASP19 ease of access to hospital for OA
Figure 39: Scatter plot of residuals vs fitted
values (CASP19 ease of access  to hospital
for OA)
Measures of fit can be used to assess how well the models fit the data.  In terms of evaluating
the fit of the results of the OLS, the study has used the R2, which is a measure of how close the
real data points are to the fitted regression line.  An R2 of 1 indicates that the OLS model explains
all  the  variability.     It  is  often  used  in  the  health  economics  literature  due  to  its  intuitive
interpretation on a scale between 0 and 1.  For example an R2 = 0.18 can be interpreted as 18%
of the variation in the dependent health variable can be explained by the independent variables
in the model. The study also included the Root Mean Square Error (RMSE) in the results tables
to assess the fit of the model, which is the square root of the variance of the residuals.  It can be
interpreted as the standard deviation of the unexplained variance and is a good measure of
how accurately the model predicts the outcome.  Lower values of RMSE indicate a better fit.
Other measures that could also have been used to assess the fit of the model are the adjusted
R2, which adjusts the R2 based on the number of predictors in the model, so that the R2 does not
simply get larger because more variable have been added.
-30 -20 -10 0 10 20
Residuals
25 30 35 40 45
Fitted values
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Table 52: Testing for Multi collinearity (CASP19 ease of access to hospital model for OA )
Variable VIF
Access to a car 1.29




Very Difficult/ Unable to go 1.24
Living arrangements (base =
cohabiting)
Alone 1.20
Age Groups (base = < 60) 60 – 80 1.43
> 80 1.50







Comorbidities (base = none) 1-2 1.08
>2 1.08
Education (Base = A degree) Below a degree 2.14
Foreign / Other 1.60
No Qualifications 2.18




In terms of the coefficients the study is assessing whether the p-values are <0.1, < 0.05 and <
0.001.  This means that the null hypothesis (H0 : β1 = 0)  can be rejected (H1 : β1 ≠ 0) if the p
values are less than the thresholds.  For example, if the p value for the coefficient for an
independent variable was 0.04 then the null hypothesis could be rejected at the 10% and 5%
significance level, but not at the 0.1% significance level.  Having a result that is statistically
significant at the 5% versus 10% level the less likely the model will conclude an association
between the dependent variable and the independent variable, when there is no association.
The literature has focused predominantly on statistically significance levels of below 0.05
(p<0.05), which indicates a 5% risk of making this type of error widely attributed to Fisher (1950).
A number of authors have commented that the p<0.05 is somewhat an arbitrary threshold, that
services a general purpose (Stigler, 2008).  One of the criticism of this threshold is that using just
p<0.05 means that those results with a p value p<0.049 are deemed statistically significant whilst
those at p<0.051 are not.  It is common practice in the field of health economics to present a
range of p values (e.g. p<0.1, 0.05 and 0.01) to show the range at which different variables are
statistically significant.
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OLS models are not suitable for data that is binary (e.g. having / not having access to a car), as it
would violate the assumption that there is a linear association, a better fit are binary logistic
regression models.   In logistic regression the outcome Y (dependent variable), which is a binary
0 or 1 outcome is transformed using a logit transformation (see equation 7) so becomes ln
rather than Y, as used in the OLS equation shown in equation 5.
= 	 + 	 + 	 + ⋯+ 	 + 																	Equation 7
Where:
· ln = the natural log of the odds that Y equals one of the binary categories (0 /1)
·   = the odds ratio (whereby p = the probability of an event occurring e.g.  person
having access to a car when needed or probability  Y = 1))
· = the constant
· 		 	→ 		  = the independent variable coefficients for the n independent variable
x 	to	x
The results are interpreted in a similar way to the OLS model.  It is not possible to use the R2 to
assess  model fit, but a pseudo R2 can be determined, which allows comparisons between the
model with and without covariates (unadjusted and adjusted).  The interpretation of the p values
is the same.   A p value of  ≤ 0.1, 0.05, 0.001 allows you to reject the null hypothesis that the
independent variable coefficient equals zero (H1 : β1 ≠0 ) at the 10%, 5 % and 0.1% levels and
conclude that there is a statistically significant association between the independent variable
and the dependent variable at that level.
Binary logit regression models are a good fit for data with binary outcomes, but other measures
that are included in this study have ordinal data with >2 categories.  For example the measures
of self-reported general health and ease of access to a GP or Hospital (Very Easy, Quite Easy,
Quite Difficult and combined Very Difficult /Unable to Go).  The method commonly used to
model  these  types  of  data  is  the  ordered  logistic  regression  model.   It  caters  for  ordinal
dependent variables (such as the 5 point Likert scales used to measure ease of access and self-
reported general health), where the data is ordered.   The formula is shown in Equation 8, where
the unobserved (latent) variable y* is a function of the constant and independent variables, as
for the OLS, but that the error term is assumed to have a logistic distribution.
∗ = 	 + 	 + +⋯+ 	 + 	 ,																			 ~ (0, )              Equation 8
The continuous unobserved (latent) variable y* is divided into observed, ordinal categories (in
this study 4 categories) using the thresholds of 0 to	 .
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= 				 	 ≪ ∗ < 		 	j = 1 to 4
Where 0 = -∞ and  =	∞ .  For the ease of access to the GP/ hospital the observed categories




1 = 	 																					 	 = −	∞	 ≤ ∗ < 	
2 = 	 																																			 	 ≤ ∗ < 	
3 = 	 																											 		 ≤ ∗ <
4 = 	 . . 																 	 ≤ ∗ < = 	∞
One of the assumptions of the ordered logit regression model is that there is no difference in
the coefficients produced when comparing between the different outcome categories i.e. the
proportional odds are the same of going from Very Easy to Quite Easy and Quite Difficult to Very
Difficult for example.  The Brant Test (Brant, 1990) is used to assess whether this assumption
holds , i.e. whether any deviations from the model (differences when comparing between
categories) are bigger than would be expected by chance.   If the assumptions do not hold then
the option available that is a better fit for the data would be to use a generalized ordered logit
model, which updates the model to allow for different coefficients (betas) between differing
categories (Williams (2006)).   As for the binary logistic regression a pseudo R2 can be calculated
to assess the fit of the model with and without the covariates included and p values to test the
hypothesis.
For each of the methods the statistical model was run first unadjusted (the dependent health /
wellbeing variable and independent transport variable) and then adjusted for the identified
included other explanatory variables.  Descriptive techniques are used to summarize the key




In total there were 10,566 individuals from wave 6 of ELSA included in the case study.  Of these
2,624 (24.8%) reported that they had OA and 674 (6%) had RA.  A summary of the individuals is
provided in Table 53 showing the complete ELSA population and then those that self-reported
that they had OA or RA separately.  On average individuals with OA were more likely to be female,
older,  white  British,  living  in  more  deprived  residential  areas,  were  less  likely  to  have  never
smoked and more likely to have no educational qualifications and be living alone compared to
the complete ELSA sample.   These trends were the same for the population diagnosed with RA
compared to the complete ELSA sample.  Ninety-two (0.9%) individuals self- reported that they
had both RA and OA.
The OA sub group had a higher proportion living in the top two most deprived quintiles
compared to the ELSA population and had a higher proportion of individuals who had
categorized themselves as being White British.  The OA group had a lower proportion of the
population who were current smokers compared to the total ELSA population.  There was a
lower proportion of the OA sub group with a degree or equivalent qualifications and higher
proportion with no qualifications than the ELSA population.
In terms of comorbidities we can see that 31.2% of the ELSA population with RA have more than
two comorbidities compared to only 5.2% in the total ELSA population, showing that the
comorbidity index developed by the study is able to pick up some key differences.  Individuals
with RA are also more likely to have no qualifications, with 38% of the RA sub group not having
any qualification compared to the total population at 25.4% and are also less likely to hold a
degree or equivalent qualifications.  In terms of smoking individuals with RA are more likely to
either be a current smoker or ex-smoker compared to both the OA subgroup and total ELSA
population.  They are also more likely than the OA population and total population to be living
in  areas  that  are  classed as  being in  the top two most  deprived quintiles.   Compared to  the
percentage of women in the ELSA population there are a higher number of females in the RA
population that have self-reported that they have RA.    A number of differences have therefore
already been observed from the descriptive data.
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Table 53: Who	are	the	individuals	with	OA/RA?
Categories All OA RA
Total Sample 10,566 2,624 674
Sex (%) Female 55.2 % 65.7 % 62.8 %
Age (%) < 60 31.6 % 18.1 % 21.8%
60 – 80 57.8 % 67.7 % 61.7 %
> 80 10.5 % 14.2 % 16.5 %





1 25.0 % 23.1 % 17.3 %
2 25.0 % 23.8 % 23.4 %
3 20.9 % 21.4 % 21.0 %
4 16.7 % 17.5 % 20.8 %
5 12.4% 14.1 % 17.6 %
Comorbidities
(%)
0 74.6 % 73.3 % -
1 -2 20.2 % 20.4 % 68.8 %
>2 5.2 % 6.4 % 31.2 %
Smoking
status (%)
Current 12.5 % 10.2 % 14.2 %
Ex 51.9 % 55.5 % 55.6 %






17.7 % 14.6 % 11.2 %
Higher ED below
degree
13.6% 14.2 % 12.0 %
NVQ3/GCE/A level
equivalent
8.6 % 7.3 % 7.0 %
NVQ2/GCE Olevel
equivalent
19.0 % 18.3 % 16.6 %
NVQ1/CSE other
grade equivalent
4.1 % 4.3 % 4.2 %
Foreign/ other 11.5 % 11.6 % 10.6 %






72.0 % 65.8 % 58.6 %
	
Does	the	health	and	wellbeing	of	individuals	with	OA/	RA	differ?	
4.4.1.1 Self-Reported General Health
The first self-reported health outcome measure that is considered is the self-reported general
health question.  The results for the total ELSA population and OA and RA subgroups are
summarized in table 54.    The table shows that whilst 12.1% of the total ELSA population would
rate their health as Excellent only 5.5% of those with OA and 3.1% with RA would give the same
rating indicating some levels of health inequalities between the different groups.  At the other
end of the scale 41.1% of those with OA and 51.1% of those with RA would rate their general
health as Fair or Poor compared to 27% of the total ELSA population.   In the RA group 45.8%
reported that their health was ‘Very Good’ or ‘Good’ compared to 53.1% in the OA group and
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compared to the census data collected in 2011 for the total UK population, where  81.4% of
people in England reported their general health as either ‘Very Good’ or ‘Good’ (ONS, 2016a)
Table 54: Self-Reported General Health (percentage of total)
Total ELSA population OA RA
Sample 9,945 2,542 646
Excellent 1,206 (12.1%) 140 (5.5%) 20 (3.1%)
Very Good 2,883 (30.0%) 509 (20.0%) 102(15.8%)
Good 3,144 (31.6%) 842 (33.1%) 194 (30.0%)
Fair 1,913 (19.2%) 710 (27.9%) 216 (33.4%)
Poor 799 (8.03%) 341 (13.4%) 114 (17.7%)
The data shows that there are some key differences in self-reported health between the general
population over the age of 50 and those with OA or RA within ELSA.   For the analysis focusing
on the associations with health outcomes the data in the Excellent category, which had 20
individuals with RA and 140 individuals with OA was collapsed with the category of Very Good
to create one category due to the small sample sizes, therefore reducing the number of
categories from 5 to 4.   This was justified on the grounds that the study wanted to compare
those with better self-reported general health (Excellent & Very Good) to those with worse self-
reported general health.
4.4.1.2 CASP-19
The second self-reported health measure was the CASP-19 in which 19 individual questions, are
combined to produce a score of between 1 and 57.  The distribution of scores for individuals
with OA and RA are shown in Figure 40 and Figure 41.  They show a high degree of variability of
quality of life across the two subgroups, broadly representing a normal distribution.   The
average  CASP-19  score  for  the  OA  sub  group  was  38.27  (CI  95%  37.89  –  38.65)  and  the  RA
subgroup 37.5 (CI 95% 36.71 – 38.30).  There was some cross-over in the 95% CI between the
two groups indicating that whilst the RA subgroup had lower average scores than the OA
subgroup these were not statistically significantly different.   Both groups had lower average
quality of life scores than the complete ELSA group, whose average was 40.76 (CI 95% 40.57 –
40.95).  With non-overlapping 95% confidence intervals indicating that the lower quality of life
score represents a statistically significant difference between the complete sample and those
identified as having OA or RA.    On average the OA and RA subgroups reported lower quality of
life using the CASP-19 measure than the full ELSA population
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Figure 40: CASP-19 distribution for
individuals with RA
Figure 41: CASP-19 distribution for
individuals with OA
4.4.1.3 CES_D
The third and final self-reported health measure was the CES_D measures of depressive
symptoms in the population.  For the CES_D the average score (out of 8) for the complete ELSA
population was 1.35 (CI95% 1.32 – 1.39)).    The OA subgroup had a higher average score of 1.77
(CI95% 1.69 – 1.86) and RA subgroup higher still at 1.97 (CI95% 1.80 – 2.14).  The 95% CI indicate
that there is some overlap between the OA and RA subgroups , so we could not be confident
that the means differed, but no overlap when compared to the whole ELSA population.  Using
the cut off of ≥3, 30.9 % of individuals with OA and 35.2% of individuals with RA compared to
25.9% of the total ELSA sample fitted the criteria of ‘caseness’.  The CES_D dichotomised score
(<3 and ≥3) is included as the dependent variable in the statistical models using CED_D
4.4.1.4 Summary of the three health outcome measures
A summary of the health and wellbeing measures is provided in Table 55 by subgroup and the
total ELSA population.   In terms of self-reported general health the full spectrum from Excellent
to Poor Health is recorded.   Compared with the total ELSA population the subgroup with OA
were less likely to class their health as Excellent or good are more likely to have a lower CASP-
19 score, and score on average lower on each of the CASP-19 domains.   They were also more
likely to be classed as having a higher number of symptoms of depression.   For those with RA,
they were on average in poorer self-reported general health than both those with OA and the
complete ELSA population.   Those with RA had on average the worst health and wellbeing,
although there were overlaps between the mean values for the OA and RA subgroups indicating
that the means were not statistically significantly different at the 95% confidence level.  In terms
























Table 55: A summary of the health and wellbeing measures (numbers in brackets 95% CI)





Excellent 12.1% 5.5% 3.1%
Very Good 28.99% 20.0% 15.8%
Good 31.6% 33.3% 30.0%
Fair 19.2% 27.9% 33.4%
Poor 8.0% 13.4% 17.7%
CASP-19 Mean 40.8 (40.6 – 41.0) 38.3 (37.9 – 38.7) 37.5 (36.7 – 38.3)
Control (0 – 12) 7.7 (7.6 – 7.7) 6.8 (6.7 – 6.9) 6.5 (6.3 – 6.8)
Autonomy (0 –
15)
10.2 (10.1 – 10.2) 9.4 (9.3 – 9.5) 9.4 (9.2 – 9.6)
Pleasure (0 – 15) 13.1 (13.0 – 13.1) 12.9 (12.8 – 13.0) 12.8 (12.6 – 13.0)
Self-Realisation
(0-15)
9.9 (9.8 – 9.9) 9.1 (9.0 – 9.3) 8.7 ( 8.4 – 9.0)
CES-D Mean 1.35 (1.32 – 1.39) 1.8 (1.69 – 1.86) 1.97 (1.80 -2.14)




4.4.2.1 Distances and travel times to the nearest facilities by car
The study derived the distances and travel times to the nearest healthcare facilities for the ELSA
participants.  The results for the road network distance and travel times using the home location
are summarized in  Table  56.    In  terms of  accessing the nearest  GP the average travel  times
across the whole ELSA sample was 3.53 mins, with a minimum of 0 mins and maximum of 26
mins.  The OA subgroup had similar average travel times to the nearest GP, but the RA subgroup
lived on average closer  to  their  nearest  GP.   The 95% CI  show that  there are  no statistically
significant differences between the three groups in terms of travel times to the nearest GP.  The
same trends were true for the travel distances.
The travel times for accessing the nearest hospital with a rheumatology department were very
similar for the three groups and the 95% CI overlapped suggesting that there were not any
statistically significant differences in the means.  The average travel times for the whole ELSA
sample were 14.52 mins with a minimum of 0 mins and maximum of 86.18 mins.  The results for
accessing the nearest A&E showed a similar picture with average travel times of 16 mins for all
three groups.
The subgroup of individuals who had self-reported that they had OA lived on average 1.2 miles
from their nearest GP, 6.8 miles from the nearest hospital with a rheumatology department and
7.7 miles from the nearest A & E.  The subgroup with RA lived on average 1.11 miles from the
nearest GP, 6.85 miles from the nearest hospital with a rheumatology department and 7.62
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miles from the nearest A & E.    This compares with the WY case study in Chapter 3 of 0.88 miles
from the nearest GP 4.44 miles from their nearest hospital Straight-line distance was included
in the methods to compare with the results from the WY case study (but not included in Table
55).  The calculations show that using a straight-line calculation instead of the road network
distance underestimated the travel distance to the nearest GP by 35%,  the nearest hospital by
27% and the nearest A & E by 25% (for all ELSA participants).  With similar results for the OA and
RA subgroups.
Table 56: Travel times and Distances to the nearest facilities (wave 6)































CI 95% 1.17 – 1.22 3.47 – 3.59 1.13 –
1.23
3.38 – 3.63 1.02 – 1.21 3.11 – 3.58
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0 – 49.3 0 – 86.2 0.53 – 48.13 1.74 – 84.64
The study calculated how far patients would need to travel to reach the second nearest facility
if the nearest facility was not available.  Where restructuring of healthcare services is being
undertaken the implications of shutting the nearest facility or reconfiguring services so patients
have to attend a different hospital for their treatment become more critical, where subsequent
travel to healthcare maybe affected.  The results showed that this would increase average travel
distance to the GP for the OA subgroup by 0.96 miles and the RA subgroup by 0.86 miles.  Access
to the nearest A & E would increase from 7.70 miles to 29.42 miles for the sub group with OA
(with one individual having to travel 126 miles to get to the second nearest A & E).   If the nearest
hospital with a Rheumatology department was shut or patients transferred to the second
nearest this would increase the average travel distances from 6.8 miles to 13.36miles for those
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in the OA sub group and from 6.85 miles to 12.89miles for the RA sub group (as shown in Table
56 and Table 57). For emergency travel to the A & E department the average travel time would
go up by 13 minutes (assuming no congestion on the roads).











GP Mean (SD) 2.14 (1.94) 5.52 (4.32) 1.97 (1.92) 5.19 (4.27 )
CI 95% 2.06 – 2.21 5.35 – 5.68 1.68 – 2.67 4.43 – 6.41
Range 0 – 0.13 0.42 – 29.47 0.03 – 12.21 0.15 – 28.16
A&E Mean (SD) 15.63 (9.53 ) 29.42 ( 16.80) 14.86 ( 9.51) 28.17
(16.80 )
CI 95% 15.27 – 15.99 28.77 – 30.06 13.39 – 17.67 25.51 – 32.96
Range 1.38 - 67.58 3.17 – 126.12 1.67 – 57.99 4.75 – 101.26
NHS
Hospital
Mean (SD) 13.36 (8.16) 25.70 ( 14.57) 12.89 (8.89) 24.86 (15.72)
CI 95% 13.04 – 13.67 25.14 – 26.26 11.48 – 15.55 22.26 – 29.24
Range 0.23 – 56.35 0.96 – 98.74 0.97 – 49.45 2.13 – 85.27
T tests were run to assess whether there were any statistically significant differences in travel
times and distances between wave 5 (2010/11) and 6 (2012/13) of ELSA to determine how stable
they were.  No statistically significant differences were identified between the two waves of the
data.
	
4.4.2.2 Does ability to walk differ by OA / RA?
One of the alternative ways of travelling would be to walk to the GP/ hospital and the majority
of journeys whether walking or in the car require an element of walking (e.g. walking from the
car park to the hospital).  This can cause issues for instance where individuals have problems
walking either from the car park to the healthcare facility, or if using public transport to or from
the bus stop or interchange.   As Figure 42 shows 50% of the people with OA and 44% with RA
have no difficulty walking ¼ mile unaided, which means that 50% in the case of OA and 56% of
those with RA do and of these 19% with OA and 25% with RA would not be able to walk ¼ mile
(402 metres).  ELSA asks a further question - whether participants would have difficulty walking
100 yards (91.44metres), 25% of those with OA and 29% of those with RA stated that they would
have difficulty with this distance.  This shows that the journey to the healthcare facilities is not
just potentially challenging for those living further away, but also as a result of being able to
physically access the transport system (e.g. walking to a bus stop or walking from a car park or
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walking to the GP).   An individual might live very close to the healthcare facilities they need to
attend, but find getting to and from it very difficult.
Figure 42:  Comparison of ability to walk ¼ of a mile (percentages)
Using this data and distances calculated to the nearest bus stop only 1.2% of ELSA participants
had bus stops within 100 metres of their homes and only 12% within 400 metres of their homes
for those with RA, with similar results for the OA subgroup (1.4% and 11.4% respectively).  Thus
making a bus journey impossible for those who found these distances difficult.  It should be
noted that this was the nearest physical bus stop and did not account for whether the buses
passing through this bus stop would go to where the individual might find useful or were at
suitable times.
In the nurses interview in wave 6 a further indicator of mobility is provided in the form of a walk
speed test.  Those who are able to walk and were ≥60 years old were asked to take the test.  The
test  measures  how long it  takes  the individual  to  walk  2.44 metres  (8  feet)  in  seconds.   The
average time it took individuals who had OA was 3.62 seconds, with a range of 1.1 – 46.47 (95%
CI 3.50 – 3.74)   compared to the RA subgroup of 3.95 seconds with a range of range 1.51 – 24.37
(95% CI 3.72 – 4.18) compared to the whole ELSA sample of 3.22 seconds, with a range of 1 –
46.47 (95% CI of 3.17 – 3.27). This translates to an average walk speed of 2.4km per hour for
individuals with OA and 2.2km per hour for individuals with RA.  This is a considerably slower
walking speed than that used for the National Travel Survey (NTS) travel times to the GP and
Hospital, which was 4.8km per hour, as discussed in Chapter 1.  Using these slower walking times








Access times to the GP and hospital will be increased if the walk speed is more than halved, or
if it is assumed that individuals can’t walk the 800m allowed in the NTS calculations to get to the
bus stop to catch the bus.  The results have shown that this is unlikely to be feasible for a large
section of the ELSA population and particularly those in the RA and OA subgroups, indicating
potentially less accessibility for these groups of individuals compared to the general population.
	
Using	public	transport		
An alternative method of travel if individuals cannot travel by car is to use the public transport
network.  ELSA participants were asked whether they travelled by public transport and if they
didn’t why not.  Of those who were eligible for a free bus pass (over the age of retirement) 65 %
of individuals with RA and 68% of individuals with OA had got the free bus pass, which entitled
them to travel for free between 09:30 and 23:00 weekdays and all day at the weekends.    In
total 60% of the ELSA participants with OA and 55% with RA stated that they didn’t use public
transport because they didn’t need to.  Of those people who stated that they didn’t use public
transport because they didn’t need to 98% with RA and 97% with OA had access to a car when
they needed it.  The average distance to the nearest bus stop for those who said that no bus was
available to them was 1 mile range (0 – 2.8miles).
In terms of health and mobility 17.4% of OA participants and 23.8% of RA participants stated
that their health prevents them from using public transport.  As noted above a large proportion
stated that they would have difficulties walking 400 metres (1/4 mile) this is also reflected by
the 16% of OA and 19% of RA ELSA participants would not use public transport due to difficulties
with mobility. These two points were raised by the studies PPI group.  With one member stating
that these were real problems for patients with RA, whereby they didn’t feel they could use a
bus, as firstly, they worried about not being able to pay quick enough due to arthritis in their
hands making it difficult to handle money, and then when on the bus not being able to get up
quick enough when it came to their stop due to the way the disease had affect their agility and
mobility.
One of the key reasons for providing those over the age of retirement with bus passes in England
was to reduce the cost of travel and improve mobility.  Those that stated that public transport
was too expensive were not entitled to a free bus pass, which is only available over the age of
retirement.  There have been issues where in the past free bus passes could not be used before
09:30 on a week day  (a time by which some patients have to be at the hospital by),  but this was
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subsequently changed to allow travel for hospital appointments for free before this time (NEXUS,
2018).
The other main options open to patients for accessing hospital healthcare (not GP) is the Patient
Transport Service (PTS) run by the regional NHS Ambulance Service, which is available to book
in advance.  Some patients may also have access to community transport to get to healthcare
appointments.    The PTS takes non-emergency patients to their inpatient and outpatient
hospital appointments.  For example the Yorkshire Ambulance Trust undertook ~1 million non-
emergency patient journeys in 2016 (NHS, 2018).  Given the ability of patients to choose where
they attend hospital facilities for the majority of appointment those journeys could in theory
take patients living in Yorkshire to any other region in England.  The ELSA survey asks whether
participants  have  used  either  of  these  two  services.   Ninety-Five  ELSA  participants  with  OA
stated that they used the PTS ranging from spontaneously to 2 people stating that they used it
every day or nearly every day.  For those with RA 4% of participants had used the PTS.  Across
all ELSA participants of those that used hospital transport 50% had use of a car when needed.
Thus showing that there is not a clear divide between having a car and not using PTS for hospital
trips.
If we assume that those who do not have access to a car or those who would be the main driver
of the car have to travel for an operation such as an THR (where they would not be able to drive
for 6 weeks after the operation) , they would have to use alternative methods for travelling to
the hospital (e.g. either pay for a taxi, catch the bus, use the patient transport service etc…).   By
assuming in the models in the absence of perfect information (exactly how patients have made
the journey) that everyone is travelling by car from home to hospital is likely to underestimate
the travel times and in the conceptualisation of accessibility overestimate patient’s accessibility
to healthcare.
4.4.3.1 How easy is it to travel to the GP/ hospital?
In terms of assessing transport accessibility to healthcare, two of the key questions in the ELSA
dataset are “How easy is it to access the GP?” and “How easy is it to access the hospital.    How
easy it is will potentially depend on a number of facets including travel time / travel distance,
but also includes how easy it is for the patient to walk and the transport options available to
them.  The results of these questions by total ELSA population and subgroups are shown in
Figure 43 for access to the GP and Figure 44 for access to the hospital.   As can be seen from
these histograms it is easier to get to the GP - with over 60% of the ELSA population answering
that it was very easy to  access  the GP,  compared to  42% stating the same for  accessing the
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hospital.  The RA subgroup were more likely to answer that it was quite difficult, very difficult or
they are unable to go compared to both the OA subgroup and full ELSA sample for both access
to the GP and hospital.
Figure 43:  How easy is it to get to the GP? (Percentage of participants)
Figure 44: How easy is it to get to the Hospital? (Percentage of participants)
The study used the answers to these two questions as the dependent variable to assess whether
there were any predictors of who would be more likely to a) find it difficult to get to the GP or
b) find it difficult to get to the Hospital. The five categories were collapsed into 4 groups (1 =
Very Easy, 2 = Quite Easy, 3 = Quite Difficult, 4 = Very Difficult or Unable to go).  The categories
of  Very Difficult or Unable to Go were combined due to the small sample sizes.   An ordered
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logit model was run and the Brant test used to assess whether the parallel regression
assumption was violated (different coefficients between the different categories).  All of the
models violated the test and so the generalized ordered logit model was used to determine the
coefficients for moving between each of the 4 categories.  The results of these two models are
provided in  Table  58 for  access  to  the GP and Table  59 for  access  to  the hospital.  Using the
generalised ordered logit model allowed those variables that had violated the Brant test (e.g.
drive  time,  access  to  a  car,  the  category  of  much/  unable  to  walk,  age  group  60  –  80  and
comorbidities) to have differing coefficients when moving between the categories, but not all
variables violated the Brant test so are represented with one coefficient that applies across all
categories in the table (e.g. Ethnic group).
Starting with ease of access to the GP (Table 58) travel time in minutes violated the Brant test
and so has three different coefficients.  This table shows that for the full ELSA sample, as drive
time (measured in minutes) increases individuals are more likely to report that they find
accessing the GP less easy than would be expected (be in a higher category), so rather than Very
Easy they would report quite easy and instead of Quite Easy -  Quite Difficult.  These results were
statistically  significant  at  the p<0.001 level.    For  the OA sub group all  the coefficients  were
positive, but only the move between Very Easy and Quite Easy was statistically significant.  This
was also true for the RA sub group, with the exception of the move between Quite Difficult and
Very Difficult/ Unable to Go, which was negative indicating that as travel time increased
individuals  were  more  likely  to  report  that  it  was Quite Difficult compared  to Very Difficult/
Unable to Go.
Not having access to a car was associated with participants being more likely to report finding
accessing the GP less easy.  This result was statistically significant for both the full sample and
the OA subgroup.  The strongest effect for the OA subgroup of not having a car was to make it
more likely that individuals would report that it was Quite Difficult (as opposed to Quite Easy).
This was also true for the RA subgroup.  Individuals were more likely to report finding it less easy
to access the GP if they had some problems walking.
Females were more likely to report that it was easier to access the GP than men.  For the RA
subgroup the model showed a statistically significant effect of females (compared to men) being
more likely to report that it is Quite Difficult rather than Very Difficult / Unable to Go, so again
females being more likely to report that it is easier than males.   Being in the 60 – 80 age group
(compared to < 60 years) was associated with being more likely to report that it was  easier to
access the GP, but those over the age of 80 were more likely to answer that it was less easy to
access the GP.   Living alone was associated with being more likely to report that it less easy to
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access the GP (this was statistically significant at p<0.05 for the complete sample and OA sub
group).
Compared to living in the least deprived quintile (1) all other quintiles were more likely to report
that it was harder to access the GP, although this was only statistically significant for some of
the quintiles).   In terms of ethnic groups, being in the non-white British group was statistically
significantly associated with being more likely to report that it was less easy to access the GP.
Similarly for those with comorbidities compared with having no comorbidities.  Focusing on
education status and compared to having a degree or equivalent having no qualifications was
associated with being more likely to find it more difficult (less easy to access the GP).
Overall a number of predictors were identified that might influence how easy it is to access the
GP.   The knock on effect of these are that patients might be less likely to go to the GP the more
difficult they have assessed it is for them to access it, e.g.  People over the age of 80, men, those
without access to a car, living alone and living further away.
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Table 58: Modelling ease of access to the GP.   Generalized ordered logit model.    (*p<0.1,** p<0.05, ***p<0.001).
Type (sample size) ALL ELSA (9,335) OA (2,166) RA (631)
























Drive Time (mins) 0.07*** 0.73*** 0.004 0.07*** 0.02 0.03 0.06** 0.04 - 0.08*
Access to a car (base = YES) No 0.07*** 0.02** 0.55*** 0.75*** 0.78*** 0.49*** 0.25 0.73** 0.33
Difficulty walking 400m (base = no
difficulty
Some 0.49*** 0.21** -0.02 0.36** 0.40*
Much/ unable 1.32*** 1.35*** 1.06*** 1.20*** 1.44*** 1.22*** 1.35***
Gender (base = male) Female -0.17*** - 0.11 0.05 0.03 -0.73**
Age groups (base <60) 60 – 80 -0.02 -0.46*** -0.48*** 0.17 - 0.18 - 0.29 -0.23
> 80 0.78*** 0.41*** 0.40*** 0.98*** 0.58* 0.74** 0.16
Deprivation
Quintiles  (1 = least deprived)
2 0.15** 0.21* 0.37
3 0.16** 0.19 0.33 0.52* -0.09
4 0.24** 0.30** 0.40
5 0.23** 0.19 0.08
Living (base = married / cohabiting Alone 0.13** 0.23** 0.20
Ethnic Group (base =  white British) Other 0.71*** 0.75** 1.03**
Comorbidities (base = none) 1 -2 0.12** 0.15 0.495*** 0.46** -
>2 0.41*** 0.37* 0.50** 0.82*** 0.35* 0.43* 0.82**
Education
(base = degree or equivalent)
Below a degree -0.16** -0.07 -0.45*
Foreign/ other -0.12 0.02 -0.45
No Qualification 0.10 0.32*** 0.35*** 0.30** -0.20 0.22 0.38
Pseudo R2 0.098 0.131 0.1433
219
The results of the models focused on ease of access to the hospital are presented in Table 59.
The results show that the further a person lived from the nearest hospital they were more
likely to report that it was harder to access the hospital.  This was statistically significant for
all categories.  The model for the complete ELSA sample and OA subgroup violated the Brant
test and has separate coefficients for moving between each of the 4 categories.    As for access
to a GP, not having access to a car or van when needed was statistically significantly associated
with being more likely to report that it was harder to get to the hospital.   Unlike for access to
the GP, there did not appear to be any differences between men and women.  Differing levels
of deprivation did not show any statistically significant effects on the results.
Those in the age group 60 – 80 were associated with being more likely to report finding it
harder to access the hospital compared to those < 60 between the categories of very easy to
quite easy, but the coefficients were not statistically significant for the other categories.
Those in the over 80 age group compared to the <  60 age group had a positive association
with  being  more  likely  to  report  that  it  was  harder  to  access  the  hospital  and  this  was
statistically significant for the complete ELSA population and OA and RA subgroups.  Living
alone  compared  to  cohabiting  was  associated  with  being  more  likely  to  report  being  in  a
harder to access to hospital category.    The same was the case for having no qualifications
compared to having a degree or equivalent for the subgroup with OA.  This was not
statistically significant for the RA sub group.  Being non-white British was associated with
being more likely to report finding it harder to access the hospital and was statistically
significant.
Overall using the generalized ordered logit model to account for the violations in the parallel
assumptions resulted in the models having a higher pseudo R2 values than for those models
that assumed the coefficients were the same between all the categories indicating a better
fit.  When comparing between ease of access to the hospital and ease of access to the GP the
key similarities were the positive associations showing individuals more likely to report that
it was harder to access the hospital for increasing drive time, not having access to a car and
difficulty walking, being in the over 80 age groups and not being in the white British group.
Key differences included gender, where access to hospital showed no statistically significant
differences between males and females, but access to the GP showed a statistically significant
effect of men being more likely to report finding it harder.   Deprivation showed no statistically
significant association for the access to hospital models, and comorbidities had a statistically
significant positive association between being more likely to report a less easy to access
category to the GP categories, but a statistically insignificant association for access to the
hospital.
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Table 59: Modelling ease of access to the Hospital.    Generalized ordered logit model.  ( Legend *p<0.1,** p<0.05, ***p<0.001)

























Drive Time (mins) 0.03*** 0.04*** 0.03*** 0.03*** 0.02*** 0.02*** 0.02**
Access to a car (base = YES No 0.83*** 0.93*** 0.74**
Difficulty walking 400m (base = no
difficulty
Some 0.37*** 0.38** - 0.16
Much/ unable 0.79*** 1.46*** 1.93*** 0.70*** 1.36*** 1.95*** 0.81** 1.41*** 2.14***
Gender (base = male) Female -0.07 0.11 0.04
Age groups (base <60) 60 – 80 0.28*** - 0.07 - 0.20 0.29** - 0.003 - 0.30 0.23
> 80 0.71*** 0.32** 0.11 0.49** 0.89**
Deprivation
Quintiles  (1 = least deprived)
2 0.04 0.12 -0.03
3 - 0.01 0.04 0.29
4 0.04 -0.003 0.17
5 - 0.01 - 0.01 - 0.31
Living (base = married / cohabiting) Alone 0.16** 0.43*** 0.63*** 0.12 - 0.04 - 0.05 - 0.05
Ethnic Group (base =  white British) Other 0.45** 0.63** 0.72
Comorbidities (base = none) 1 -2 0.05 0.17 --
>2 - 0.01 0.001 0.23
Education
(base = degree or equivalent)
Below a degree - 0.21** -0.24** - 0.21** -0.25** -0.06
Foreign/ other - 0.15 -0.24* -0.15* - 0.08 0.04
No Qualification -0.22*** - 0.07 - 0.103
Pseudo R2 0.057 0.074 0.101
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Predicting	having	access	to	a	vehicle	when	needed.	
It was assumed in the majority of studies included in Chapter 2 that patients will have travelled
to hospital or the GP by car and therefore travel time or distance using the road network would
be a good marker. A UK study by  Campbell et al. (2000) backed this up by undertaking a survey
finding that 80% had travelled by car (a majority, but by no means all).   In the ELSA dataset 82.1%
of people with OA and 77.6% of people with RA stated that they had access to a car/ van when
they needed it either as a driver or as a passenger, of these 63% had a car at home and could
drive it.  This means that there is a large proportion of individuals who do not have access to a
car and this could be an underestimate of those who would have access to a car if they needed
to go into hospital and did not have the option of driving home at the end their hospital episode
(e.g. after having an operation).  The models shown in tables 58 and 59 showed that having
access to a car when needed meant that individuals were more likely to report that it was easier
to access both the GP and the hospital.   It would therefore be useful to be able to characterise
those individuals who do not have access to a car / van when needed in order to target help in
the right direction.
To identify which individual characteristics were likely predictors of not having a car / van when
needed the study ran a binary Logit model (0 = no access to a car/van when needed and 1 =
access to a car/van when needed), with results presented in Table 60. Individuals in the total
sample were less likely to have access to a car if they are older, female, living alone or living in a
more deprived residential area.  Ethnic group (white vs non-white) was not found to be a
predictor, but this may be due to the lack of variability (97% of the sample were White British)
in the data.  The OA subgroup showed the same with females, older people, living alone and the
higher levels of residential deprivation, all predictors of not having access to a car.  The RA sub
group has the same sign on each of the coefficients, but the results were not all statistically
significant (one potential explanation is the smaller sample sizes).
The results could help identify which patients might need more information on how to get to
the hospital and support getting there.  Equally this data could be used to assess which areas of
a locality would be more likely to have individuals who do not have access to a car and is picked
up again in Chapter 5 in the scenarios.  Without a better understanding of how people are
travelling to healthcare facilities, studies may be underestimating the true travel times and
distances, as shown by the differences in travel times by public transport vs road network in
Chapter 3.
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Table 60: What are the predictors of not having access to a car/ van when needed?








Access to a car/ van
when needed?
No Access 1,547 455 142
Access 9,017 2,049 491
Gender Male 4,729 -- 856 -- 237 --
Female 5,837 - 0.37*** 1,648 - 0.44** 396 - 0.31
Age groups (base <60) < 60 3,347 -- 372 -- 112 --
60 – 80 6,105 - 0.39*** 1,760 - 0.84*** 412 - 0.10
>80 1,114 - 1.75*** 372 - 2.11** 109 - 1.10**
Comorbidities None 7,881 -- 1,922 -- 0 --
1 2,132 - 0.496*** 534 - 0.256* 441 --
>1 553 - 0.777*** 168 - 0.571** 192 - 0.497**
Living  arrangements Married/
Cohabiting
8,135 -- 1,762 213 --




1 2,634 -- 581 -- 111 --
2 2,643 - 0.40*** 601 -0.18 147 -0.89**
3 2,206 - 0.65*** 538 - 0.36* 132 - 0.46
4 1,764 - 1.21*** 434 -1.13*** 131 -1.06**
5 1,310 - 1.95*** 347 - 1.85*** 110 -1.50***
Ethnic Group White British 8,988 -- 2,441 -- 602 --
Other 358 - 0.24 63 - 0.25 31 - 0.28
Pseudo R2 -- 0.2276 -- 0.2170 -- 0.188





The previous sections of this chapter have focused on the health, wellbeing and travel abilities
of the ELSA participants separately.  This section now explores whether transport accessibility
(measured using travel times/ distance and ease of access) is associated with differences (or
inequalities) in the health and wellbeing measures (Self-Reported General Health, CASP-19, and
CES_D).
4.4.5.1 Association between transport accessibility to the GP and health & wellbeing
measures
As noted in Chapter 1 the GP in the first instance acts as a gatekeeper for referral for diagnosis
and treatment in the case of patients with OA or RA, which may mean a referral to the hospital
or in the case of RA management of treatment solely at the hospital.   If transport accessibility
is a barrier to preventing patients from making / attending doctors’ appointments, this has the
potential to have a knock on effect on individuals’ health.  This section of the thesis uses ELSA
data to model the association between transport accessibility to the GP and health/ wellbeing
outcomes.   The models have expanded on the transport accessibility variables included in
Chapter 3 (travel times and distances) to also include “ease of access” to the GP.   Ease of access
to healthcare allows a broader consideration of the factors that affect transport accessibility, as
discussed in Chapter 1.
The models are firstly presented in Table 61, as an unadjusted analysis with travel times,
distance and ease of access to the GP (as the independent variables) and each of the three health
and wellbeing measures, as the dependent variables, by OA and RA subgroups.  The tables
describe the statistical model used to undertake the analysis and a description of how to
interpret the coefficients.  For example, a positive coefficient on the CASP-19 measure of quality
of life for the continuous travel time model indicates that as travel time to the GP increases the
CASP-19 score increases – quality of life increases.   A negative coefficient on the Self-Reported
General Health model means that an increase in travel time leads to individuals being more likely
to report a better level of general health (on the scale of Excellent\Very Good, Good, Fair and
Poor).     The models that classify travel time/ distance into categories shows that as individuals
live further away from the base line category they are more likely to have a higher score on the
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CASP-19 , be less likely to have depressive symptoms (as indicated by a score ≤3) on the CES-D
be more likely to self-report being in a better health category.
In summary the models with a continuous travel time as the independent variable report that
as travel time increase to the nearest GP individuals are more likely to report a better level of
general health, a higher CASP-19 score, and be less likely to have a score above 3 on the CES_D
This is also witnessed in the categorical models, whereby ELSA participants living further from
the nearest GP are more likely to have better self-reported health than those living closer.
The adjusted models are then presented separately for each health measures, which are:
· Self-Reported General Health - Table 62
· CASP-19 - Table 63
· CES_D  - Table 64
The key observation from Table 61 is that it is the categorical variable – ease of access to the GP
– which shows as a negative impact on self-reported health.  Moving from reporting that it is
Very Easy to access the GP to it being Quite Easy leads to an increased likelihood of reporting
that self-Reported General Health is in a worse category, that the CASP-19 quality of life score
is reduced (implying worse quality of life) and the likelihood of having a CES_D score of over 3 is
increased (all statistically significant at the p<0.001 or p< 0.05 levels). The associations are
stronger as you move towards harder to access categories.  For example, for the OA model -
finding it Very Difficult or Unable To Go to the GP compared to Very Easy is associated with a
reduction in CASP-19 score of 13.67 (statistically significant at p<0.001).
This initial analysis implies that it is not as simple as reducing the travel distance / time to have
a positive association with self-reported health.   The results indicate that individuals living
farther away are more likely to have better health than those who are closer to the GP.  Ease of
access might be a better measure of capturing the difficulties that people face accessing
healthcare beyond the distance or travel time from A to B.
The  next  section  focuses  on  each  of  the  health  and  wellbeing  variables  separately  with  the
adjusted analysis.
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Table 61: Access to the GP - unadjusted models
Health wellbeing
measure




-ve value is an improvement
OLS
-ve value is worse
Binary Logistic
-ve value is an improvement










Travel Time, mins) 2,139 - 0.05*** 513 - 0.06** 2,127 0.13** 507 0.11 2,139 - 0.03** 513 - 0.05*
R2 (Pseudo R2) (0.003) (0.002) 0.002 0.002 0.003 (0.001)
Base = < 1 mins 238 -- 52 -- 235 -- 52 -- 238 -- 52 --
1 – 3 mins 1023 - 0.275* 259 - 0.16 1016 1.55** 259 0.35 1023 - 0.327** 259 - 0.59**
3 – 10 750 - 0.384** 172 - 0.41 749 1.67** 172 0.97 750 - 0.341** 173 - 0.88**
> 10 128 - 0.760*** 30 - 0.91** 127 3.03** 30 1.09 128 - 0.554** 29 - 0.65











Travel Distance (miles) 2,139 - 0.12*** 513 - 0.14** 2127 0.28* 513 0.26 2139 - 0.07* 513 - 0.04
R2 (Pseudo R2) (0.002) (0.002) 0.002 0.002 -- 0.001 (0.001)
Base = <1/2mile 625 -- 209 -- 619 -- 160 -- 625 -- 160 --
1/2 - 1miles 717 - 0.156 213 - 0.20 712 0.72 167 2.00** 717 - 0.20* 167 - 0.531**
1 – 3 miles 598 - 0.252** 180 - 0.36** 598 0.95** 146 2.57** 598 - 0.20 156 - 0.719**
> 3 miles 199 - 0.462** 44 - 0.96** 198 1.33** 40 2.74* 199 - 0.21 40 - 0.378











Base = Very Easy 1225 -- 276 -- 1218 -- 276 -- 1,225 -- 276 --
Quite Easy 714 0.73*** 171 0.44* 710 -4.08*** 171 -3.39*** 714 0.63*** 171 0.44**
Quite difficult 106 1.90*** 36 1.43*** 106 - 9.50*** 36 -8.21*** 106 1.64*** 36 1.11**
Very difficult/ unable to
go
94 2.61*** 30 2.39*** 93 -13.67*** 24 -10.97*** 94 1.79 *** 24 1.36**
R2 (Pseudo R2) (0.04) (0.03) 0.123 0.113 -- 0.05 (0.034)
(Legend *P<0.1, **P<0.05, ***P<0.001)
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4.4.5.2 Transport Accessibility to the nearest GP: Self-Reported General health
The results of the unadjusted general health model (Table 61) showed that living further away
from the GP surgery (measured as both a continuous travel time and distance) was associated
with it being more likely that the individuals would report being in a better general health
category (1 = Excellent/ Very Good, 2 = Good, 3 = Fair, 4 = Poor) than those living closer, which
is shown by the statistically significant negative coefficients.   When split into categories of < 1,
1 – 3, 3 -10m, >10 mins of travel time it is those living the furthest away (> 10 mins) from the GP
that show the strongest likelihood of reporting a better general health category.  Indicating that
those that live closer to the GP are more likely to report poorer self-reported general health.
Using the Ease of Access to  the  GP  variable  there  is  a  positive  association  between  finding
accessing the GP more difficult and a likelihood of being in a worse general health category.
These results using ease of access are all positive (and statistically significant), as it becomes
harder to access the GP (compared to Very Easy) the participant is more likely to report being in
a worse Self-Reported General Health category.
The adjusted models for Self-Reported General Health are presented in Table 62. This adjusted
the model for age, gender, ethnicity, education level, comorbidities, deprivation level, living
arrangement, access to a car and walking ability. For the OA subgroup there is an association
between travelling further to the GP and a decrease in the chance of reporting being in a poorer
general health category (but this was not statistically significant).  Indicating that those who live
further away from the GP are more likely to assess themselves as being in a better general health
category.   As travel time to the GP increased (as a continuous variable) both the OA and RA
participants were more likely to report being in a better self-reported general health category
(this was only statistically significant for the RA subgroup).
Measuring  travel  time  to  the  nearest  GP  using  a  dichotomous  variable  >  5  minutes  and  <  5
minutes showed that those living >5 minutes away compared to those living closer had a positive
(but not statistically significant) association with having a higher likelihood of reporting being in
a poorer general health category for the OA subgroup, but the opposite was true for the RA
subgroup.   As for the unadjusted model there was a positive and statistically significant
association between increasing difficulty in ease of accessing the GP and increased likelihood of
reporting being in a poorer general health category (statistically significant for both subgroups).
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Table 62: Access to the GP: the association with Self-Reported General Health using an Ordered logit model.  Interpretation - negative coefficients = better general
health category (Legend: *p<0.1. **p<0.05, ***p<0.001)
Travel time (mins) Travel Distance (miles) Ease of Access
No. Continuous Categorical Continuous Categorical






minutes 2,428 484 - 0.010 - 0.06**
Base = < 1 min) 296 52 -- --
1 – 3 1226 259 -0.003 - 0.149
3 – 10 875 172 0.057 - 0.324
> 10 mins 145 30 -0.267 - 0.708
Base = < 5 mins 2,477 497 -- --








miles 2,428 484 - 0.018 -0.116
Base  = < 0.5 miles 763 160 -- --
0.5 – 1 miles 851 167 -0.059 -0.157
1 – 3 miles 706 146 0.025 -0.219




Base = Very Easy 1,294 276 -- --
Quite Easy 767 171 0.66*** 0.35**
Quite Difficult 124 26 1.74*** 1.39***
Very difficult/unable 357 30 2.35 *** 1.92***
Pseudo R2 0.181 0.219 0.181 0.218 0.181 0.215 0.181 0.218 0.181 0.219 0.188 0.188
Adjusted for: Age, Gender  Ethnicity, educational level, deprivation, living arrangements, comorbidities, access to a car (N/A ease of access), difficulty walking (N/A ease of access), constant
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4.4.5.3 Transport Accessibility to the GP: CASP-19
The results of the unadjusted models for the CASP-19 measure indicated that as travel distance
and time increased the CASP-19 score increased indicating a better quality of life.  This was only
statistically significant for the OA subgroup.  Focusing on the ease of access variable as ease of
access to the GP worsened (moved away from the base of Very Easy) the CASP-19 score declined
indicating a worse quality of life.  This was statistically significant (p<0.001) for both sub groups.
For example, the CASP-19 score for an individual with OA would be 9.50 lower if they reported
finding accessing the GP Quite Difficult and 13.67 lower compared if they reported that it was
Very Difficult or were Unable to Go compared to those who would report that it was Very Easy.
This is a large decline given the scale of the measures ranges from 0 to 57.
For the adjusted models (shown in table 63)  including travel time as a continuous variable was
associated with a non-statistically significant improvement in the CASP-19 score.  When included
as a categorical variable for the OA subgroup there was a statistically significant positive
association for those travelling 1- 3 minutes by car compared to those travelling less than 1
minute and those travelling greater than 10 minutes compared to less than 1 minute, but a
smaller coefficient and non-statistically significant result for the category 3 – 10 minutes.   For
the RA group there was a negative (but not statistically significant) association between
travelling 1 -3 minutes compared to 1 minute and 3 – 10 minutes compared to < 1 minute
indicating a decline in score, but positive association for those travelling greater than 10 minutes
compared to less than 1 minute.
For the adjusted models including distance as a continuous variable there is a positive (but non-
statistically significant) association, as for the travel time with increasing distance and increasing
(better) CASP-19 score.  The results show that those in the OA subgroup travelling 1- 3 miles to
access the GP are statistically significantly more likely to have a higher CASP-19 score than those
who are travelling < 1 mile (p<0.1).
Using the ‘ease of access’ measure the results were statistically significant and showed that as
the participant reported that it was more difficult to access the nearest GP the CASP-19 score
declined (all statistically significant at p<0.001) for both the OA and RA subgroups.  For example
the CASP-19 score for individuals who find it Quite Difficult to access the GP would be 8.20 less
than an individual who answered that it was Very Easy to access the GP.
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Table 63: Access to the GP: the association with CASP-19 using an OLS model.  Interpretation – positive coefficients = better quality of life
Travel time (mins) Travel Distance (miles) Ease of Access
No. Continuous Categorical Continuous Categorical






minutes 2,034 484 0.005 0.108
Base = < 1 min) 235 52 -- --
1 – 3 1016 259 1.197** -0.291
3 – 10 749 173 0.559 -0.401
> 10 mins 127 29 1.553* 1.00
Base = < 5 mins 1,715 425 -- --








miles 2,034 484 -0.068 0.356
Base  = < 0.5 miles 619 160 -- --
0.5 – 1 miles 712 167 0.351 0.513
1 – 3 miles 598 146 -0.015 0.892




Base = Very Easy 1,218 276 -- --
Quite Easy 710 171 -3.90*** -2.59**
Quite Difficult 106 36 -8.20*** -7.16***
Very difficult/unable 93 24 -11.89*** -7.14***
R2 0.239 0.288 0.239 0.288 0.239 0.287 0.239 0.289 0.239 0.291 0.273 0.299
Adjusted for: Age, Gender  Ethnicity, educational level, deprivation, living arrangements, comorbidities, access to a car (N/A ease of access), difficulty walking (N/A ease of access), constant
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4.4.5.4 Transport Accessibility to the nearest GP:  CES_D
The unadjusted model for the final health measure the CES-D focusing on depressive symptoms
(using the < 3 and  ≥3 cut offs) is  presented in Table 61.  The unadjusted analysis showed that
an increase in travel time or distance was associated with a decline in the likelihood of a score
of  ≥3,  so  the  further  a  patient  lived  from  the  nearest   GP  the  less  likely  they  were  to  have
‘caseworthy’ symptoms (score of ≥3), as defined by the cut off.  Focusing on ease of access to
the GP showed that those that reported that it was harder to access the GP were more likely to
have ‘caseworthy’ symptoms.
For the adjusted model presented in Table 64 the OA subgroup recorded a small positive (but
not statistically significant) association between increasing distance to the GP and increase in
the chance of having ‘case worthy’ symptoms.  When split into categories there was a mixed
results over the different distances with those travelling over 1 mile having a positive (but not
statistically significant) association with increased likelihood of ‘caseworthy’ symptoms.   For the
RA subgroup there was a negative and statistically significant association between travelling
between 1- 3 minutes and 3 – 10 minutes compared to < 1minute and having a score of ≥3 (less
likely to have ‘caseworthy’ symptoms).  As with the unadjusted analysis finding it harder to
access the GP was associated with a higher chance of being in the ‘caseworthy’ category.
For the OA adjusted model not having access to a car was statistically significantly associated
with  a  higher  likelihood  of  having  “case  worthy”  symptoms.   For  the  RA  model  there  was  a
positive coefficient between not having access to a car and a higher likelihood of ‘caseworthy’
symptoms, but the association was not statistically significant.  Having difficulty walking, being
female, having an education below a degree, living in a more deprived location, living alone and
having comorbidities were all statistically significantly associated with an increased likelihood of
‘caseworthy’ symptoms.  Only increased age was associated with a decrease in the likelihood of
‘caseworthy’ symptoms.
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Table 64: Access to the GP: the association with CES_D using binary logistic regression.  Interpretation – positive coefficients = higher likelihood of being
‘caseworthy’ for depression
Travel time (mins) Travel Distance (miles) Ease of Access
No. Continuous Categorical Continuous Categorical






minutes 2,501 631 0.006 - 0.022
Base = < 1 min) 305 78 -- --
1 – 3 1266 342 - 0.133 - 0.52*
3 – 10 900 219 0.029 - 0.66**
> 10 mins 153 35 - 0.058 - 0.52
Base = < 5 mins 2138 567 -- --








miles 2,501 631 0.029 - 0.044
Base  = < 0.5 miles 792 216 -- --
0.5 – 1 miles 876 222 - 0.115 -0.125
1 – 3 miles 727 188 0.117 -0.172




Base = Very Easy 1294 298 -- --
Quite Easy 767 187 0.588*** 0.260
Quite Difficult 124 38 1.356*** 0.221
Very difficult/unable 439 151 1.323*** 0.998***
Pseudo R2 0.139 0.145 0.141 0.149 0140 0.144 0.140 0.144 0.141 0.145 0.106 0.160





This section of the thesis is using the ELSA data to model the association between transport
accessibility to the nearest hospital with a Rheumatology Department and health and welling
variables.   It considers the models for the OA and RA subgroups separately.   The models are
firstly presented as an unadjusted analysis with travel times, distance and ease of access to the
hospital (as the independent variables) and each of the three health and wellbeing measures, as
the dependent variables.  The results of the access to hospital unadjusted models are presented
in Table 65.  The adjusted models are then presented separately under separate sections for
each of the included health and wellbeing outcomes.  Self-Reported general health (Table 66),
CASP-19 (Table 67) and CES-D (Table 68).
The results show a negative association with self-reported general health, as travel time
increases to the nearest hospital, with an increased likelihood that individuals report themselves
as being in a better general health category.  Reporting that it is more difficult to access the
hospital is associated with a statistically significant likelihood of being in a worse general health
category for both the OA and RA subgroups.
For the CASP-19 quality of life measure, as travel times to the hospital increase the CASP-19
increases (gets better) for the OA and RA subgroups.  This is statistically significant for the OA
subgroup but not the RA subgroup.    The same association is evident for the travel distance
association with individuals having a 2.43 increase in the CASP-19 score if they are living greater
than 20 miles away compared to those living the closest (< 5 miles) for the OA subgroup (p<0.001)
and 2.27 increase for those living 10 – 20 miles away for the RA subgroup (p<0.001).  As ease of
access to the hospital gets more difficult there is a larger and statistically significant association
with a reduction in the CASP-19 score for both the OA and RA subgroups.
For  the  CES_D  measure  living  further  away  from  the  hospital  is  associated  with  a  reduced
likelihood of having ‘caseworthy’ symptoms, but finding it harder to access the hospital is
associated with a positive and statistically significant association with an increased likelihood of
‘caseworthy’ symptoms.
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-ve value is an improvement
OLS
-ve value is worse
Binary Logistic
-ve value is an improvement










Travel Time, mins) 2,139 -0.013*** 513 -0.015** 2,127 0.067*** 513 0.033 2,139 -0.016** 513 -0.003
R2 (Pseudo R2) 0.0023 0.004 0.006 0.002 (0.004) (0.0001)
Base = <20 mines 1.667 -- 397 -- 1657 -- 397 -- 1,667 -- 397 --
>20 mins 472 -0.307** 116 - 0.428** 470 1.427** 116 2.088** 472 -0.333** 116 -0.332
R2 (Pseudo R2) (0.002) 0.004 0.004 0.009 (0.003) (0.003)
Base = < 10 mins 860 -- 216 -- 855 -- 216 -- 860 -- 216 --
10 - 20  mins 807 =0.122 181 0.177 802 0.999** 181 -0.385 807 -0.158 181 0.249
20- 30 255 -0.308** 53 -0.053 253 2.008** 53 3.376** 255 -0.436** 53 -0.098
> 30 217 -0.435** 63 - 0.603** 217 1.797** 63 0.681 217 -0.378** 63 -0.321











Travel Distance (miles) 2,139 -0.160*** 513 -0.147 2,127 0.873*** 513 0.702 2,139 -0.172** 513 -0.120
R2 (Pseudo R2) 0.002 0.002 0.007 0.005 (0.004) (0.002)
Base = <5 miles 1014 -- 261 -- 1009 -- 261 -- 1014 -- 261 --
5 – 10 miles 657 -0.197** 136 0.135 652 1.310** 136 0.376 657 - 0.269** 136 0.140
10 – 20 miles 385 -0.378*** 93 -0.193 383 1.685** 93 2.270** 385 - 0.315** 93 -0.349
> 20 miles 83 -0.316 23 - 0.863** 83 2.435** 23 0.371 83 - 0.485* 23 -0.335











Base = Very Easy 778 -- 180 -- 773 -- 180 -- 778 -- 180 --
Quite Easy 946 0.523*** 214 0.012 943 -2.996*** 214 -3.025** 946 0.312** 214 0.383
Quite difficult 263 1.202*** 71 0.819** 262 -6.496*** 71 -7.872*** 263 0.870*** 71 1.296***
Very difficult/ unable to
go
122 1.931*** 41 1.793*** 122 -
11.345***
41 -9.933*** 122 1.671*** 41 1.347***
R2 (Pseudo R2) (0.029) (0.029) 0.11 0.125 (0.034) (0.04)
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4.4.6.1 Transport Accessibility to the Hospital: Self-Reported General Health
The adjusted model for Self-Reported General Health is presented in Table 66.    Travel time
included in the model as a continuous variable was associated with a reduced likelihood of an
individual reporting that they were in a worse health category, as travel time increased.  This
was statistically significant for the RA subgroup.  When split into categories living greater than
30 minutes away from the hospital (compared to < 10 mins) was associated with a statistically
significant reduction in the likelihood of being in a worse general health category.  Indicating
that living further away was not associated with poorer self-Reported General Health.   Living >
20 minutes away from the nearest hospital was associated with a reduced likelihood of reporting
that you were in a poorer general health category for the RA subgroup and this was statistically
significant at  p<0.05.
The RA subgroup showed a statistically significant association between increasing travel
distance and being less likely to report that an individual was in a poorer health category.  The
OA results were not statistically significant.
The models focusing on ease of access to the hospital for both the OA and RA subgroups models
showed results that as it becomes more difficult to access the hospital there is an increased
likelihood of individuals reporting that they were in a worse general health category.
For the variables controlled for in the OA models not having access to a car, having difficulty
walking, being male, being < 60 years old, having a qualification below that of a degree, having
comorbidities and living in the most deprived 2 quintiles were associated with a an increased
(and statistically significant) likelihood of reporting that they were in a worse general health
category.   Being female and older than 60 years old was associated with a higher likelihood of
being in a better general health category.
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Table 66: Access to the Hospital: the association with General Health using an ordered logit model.  Interpretation - negative coefficients = better general health
Travel time (mins) Travel Distance (miles) Ease of Access
No. Continuous Categorical Continuous Categorical






minutes 2,046 606 - 0.005 - 0.018**
Base = < 10 mins 860 280 -- --
10 – 20 807 228 0.095 -0.100
20 – 30 225 67 0.041 -0.023
> 30 mins 217 71 - 0.254* -0.884**
Base = < 20 mins 1,667 508 -- --








miles 2,046 606 - 0.006 - 0.031**
Base  = < 10 miles 1,014 340 -- --
10 – 20 miles 657 169 0.019 -0.082
20 – 30 miles 385 110 - 0.076 -0.320




Base = Very Easy 778 194 -- --
Quite Easy 946 234 0.51*** - 0.09
Quite Difficult 263 76 1.10*** 0.69**
Very
difficult/unable
122 47 1.62*** 1.31**
Pseudo R2 0.182 0.222 0.182 0.222 0.182 0.221 0.181 0.222 0.181 0.222 0.186 0.209
Adjusted for: Age, Gender  Ethnicity, educational level, deprivation, living arrangements, comorbidities, access to a car (N/A ease of access), difficulty walking (N/A ease of access), constant
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4.4.6.2 Transport Accessibility to the Hospital: CASP-19
The results of the unadjusted CASP-19 models were provided in table 62.  Living  further away
from the nearest hospital with a rheumatology department was associated with a higher CASP-
19 score (higher quality of life) for both the RA and OA groups.   Whereas the ease of access to
the hospital was associated with a decline in the score, as the ease of access was recorded as
being more difficult.
The results of the adjusted models for the CASP-19 measure of quality of life are presented in
Table 67.  They show that there is a positive (but non-statistically significant) association with
increasing travel time to the nearest hospital and very small increases in the CASP19 score.  For
example, an individual from the OA subgroup travelling greater than 30 minutes to the hospital
would have an increase in the CASP-19 score of 0.76 compared to a similar individual taking less
than 10 minutes.    There were no statistically significant results for the associations between
increasing  travel  distance  to  the  hospital  and  CASP-19  score.   For  the  variables  that  were
controlled for – not having access to a car, having difficulty walking, having an education below
a degree, having comorbidities and living in the most deprived quintiles were associated with a
reduction in the CASP-19 score that was also statistically significant for the OA subgroup.   Being
older than 60 years old compared to < 60 years old was associated with an increase in the CASP-
19 score that was also statistically significant.
Like  the  other  health  and  wellbeing  measures,  whilst  travel  time  or  distance  did  not  have  a
negative impact on this health and well-being measure the ease of access to the hospital variable
did.  The more difficult the participants reported that it was to access the hospital the larger to
the reduction in CASP-19 score (p<0.001).  For example, reporting that it was very difficult/ they
were unable to access the hospital was associated with a reduction in CASP-19 score of 9.54
compared to reporting that it was Very Easy to access the hospital.
237
Table 67: Access to the Hospital: the association with CASP-19 using an OLS.  Interpretation – positive coefficients = better quality of life
Travel time (mins) Travel Distance (miles) Ease of Access
No. Continuous Categorical Continuous Categorical






minutes 2,034 484 0.022 0.001
Base = < 10 mins 855 216 -- --
10 – 20 802 181 0.148 0.053
20 – 30 253 53 0.431 2.610**
> 30 mins 217 63 0.762 0.148
Base = < 20 mins 1,657 337 -- --








miles 2,034 484 0.245 0.409
Base  = < 10 miles 1009 261 -- --
10 – 20 miles 652 136 0.465 0.615
20 – 30 miles 383 93 0.418 1.809*




Base = Very Easy 773 180 -- --
Quite Easy 943 214 - 3.07*** -2.47***
Quite Difficult 262 71 - 5.95*** -7.02***
Very difficult/unable 122 41 - 9.54*** -5.45***
Pseudo R2 0.240 0.286 0.240 0.293 0.239 0.289 0.239 0.288 0.240 0.292 0.277 0.319
Adjusted for: Age, Gender  Ethnicity, educational level, deprivation, living arrangements, comorbidities, access to a car (N/A ease of access), difficulty walking (N/A ease of access), constant
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4.4.6.3 Transport Accessibility to the hospital: CES_D
The final models focus on the CES_D measure of depressive symptoms.  The unadjusted models
focusing of access to the hospital and CES_D were presented in Table 62.  For the unadjusted
models living further away (in terms of travel time and distance) was associated with a reduction
in the odds of being in the ‘caseworthy’ category.  Finding it more difficult to access the hospital
had the opposite association.
The adjusted CES_D models are presented in Table 68.  Including travel time as a continuous
variable shows a negative association with odds of having “caseworthy” symptoms, which is
statistically significant for the RA subgroup (but not for the OA subgroup).  As the travel time to
the hospital increases the odds of having ‘caseworthy’ symptoms decline.  When split into travel
time categories those travelling > 30 mins had a statistically significant negative association with
CES_D (lower odds of having case worthy symptoms).  None of the travel distance models have
statistically significant coefficients for the travel distance variables, but they are all negative.
Indicating that those closest to the hospital have an increased likelihood of symptoms compared
to those living further away.
Whilst travel distance was not found to be statistically significant, not having access to a car,
having difficulty walking, being female, being younger than 60 years old, having no educational
qualifications, living alone , having comorbidities and living in a  more deprived residential area
were associated with an increased odds of having ‘caseworthy’ symptoms for the OA subgroup
(at a statistically significant level).  For the RA sub group only being < 60 years old was associated
with increased odds (at a statistically significant level) of having ‘caseworthy’ symptoms.
Worsening ease of access to the hospital was associated with increased odds of having
‘caseworthy’ symptoms.
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Table 68: Access to the Hospital: the association with CESD using binary logistic regression.  Interpretation – positive coefficients = higher likelihood of being
‘caseworthy’ for depression (* p<0.1, **p<0.05, ***p<0.001)
Travel time (mins) Travel Distance (miles) Ease of Access
No. Continuous Categorical Continuous Categorical






minutes 2,501 484 - 0.007 0.004
Base = < 10 mins 1086 216 -- --
10 – 20 979 181 - 0.042 0.194
20 – 30 304 53 - 0.107 0.077
> 30 mins 255 63 -0.249 -0.261
Base = < 20 mins 2,065 397 -- --








miles 2,501 484 -0.067 -0.107
Base  = < 10 miles 1287 261 -- --
10 – 20 miles 790 136 -0.099 0.057
20 – 30 miles 454 93 -0.117 -0.309




Base = Very Easy 814 180 -- --
Quite Easy 1013 214 0.296** 0.37*
Quite Difficult 299 71 0.561** 1.22**
Very difficult/unable 139 41 0.883*** 0.85*
Pseudo R2 0.140 0.135 0.140 0.137 0.140 0.135 0.140 0.135 0.140 0.136 0.136 0.139
Adjusted for: Age, Gender  Ethnicity, educational level, deprivation, living arrangements, comorbidities, access to a car (N/A ease of access), difficulty walking (N/A ease of access), constant
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Does	access	to	the	GP	and	hospital	vary	by	region?	
It is often noted in the literature that there is a London / outside of London divide in terms of
transport availability, with London having a more comprehensive transport system allowing
individuals to travel more quickly and to where they need to get to in an easier fashion than
travel in other parts of the country (Institite for Public Policy Research, 2018).  It  is therefore
important to consider the implications of comparing a centralisation policy that could be applied
in London (e.g. stroke care described in Morris et al.  (2014)), with a similar policy outside of
London, where the distances and access to alternative transport may differ.     In addition it is of
interest to this thesis to make an assessment of how representative the WY case study included
in Chapter 3 is of the rest of England.
Comparing across regions did show some statistically significant differences in the travel times
and distances that individuals would have to travel to get to either the nearest GP or hospital.
Table 69 provides a summary of the descriptive statistics for the travel times and distances and
ease of access to the hospital split by the ELSA individuals in Yorkshire and Humberside
(including the WY) in London and ‘all others’.   It can be seen that there is a statistically significant
difference in the travel times and distances between these three groups, with Yorkshire and
Humberside more closely aligned to the rest of the country (excluding London).
The average road network distance to a GP is 0.49 miles in London compared to Yorkshire and
Humberside of 1.2 miles and all  others of 1.26 miles. Table 70 shows how far away the next
nearest GP would be if the nearest was closed.  In terms of distance to the GP there is a 1.26
miles difference between the distance that an individual in London would have to travel to the
next nearest GP and the same individual in Yorkshire and Humberside.
It is interesting to note that whilst the distances and travel times are shorter in London, a higher
percentage of individuals in that region in ELSA say it is either Quite Difficult or they are Unable
to get to access the GP.  In terms of how easy it is to access the GP the London region individuals
were more likely to state that it was harder/ unable to access the GP that the other regions.  One
of the consequences of having better transport infrastructure in London is a lower levels of car
ownership and given access to a car is a predictor of ease of access, this might contribute to this
difference that regardless of having on average closer GP surgeries it is still harder to get to a GP
without a car.




London The rest of England





0.81  (SD 1.03)
CI 95% 0.75 – 0.87
Range (0 – 6.51)
0.31 (SD 0.19)
CI 95% 0.30 – 0.32
Range (0 – 1.32)
0.84 (SD 0.92)
CI 95% 0.82 – 0.86
Range (0 – 8.49)
Network
Distance
1.20 (SD 1.39 )
CI 95% 1.1 – 1.3
Range (0 – 8.11)
0.49 (SD 0.32 )
CI 95% 0.47 – 0.51
Range (0 – 2.49)
1.26  (1.32)
CI 95% 1.2 – 1.3
Range (0 – 11.86)
Travel time 3.50 (SD 3.54)
CI 95% 3.3 – 3.7
Range (0 – 25.78)
1.58 (SD 0.9)
CI 95% 1.5 – 1.6
Range (0 – 9.81)
3.75 (SD 3.34)
CI 95% 3.7 – 3.8
















3.70 (SD 3.04 )
CI 95% 3.52 – 3.88
Range (0.08 – 17.80)
1.87 (SD 0.94)
CI 95% 1.81 – 1.93
Range (0.10 – 5.12)
5.55 (SD 4.54)
CI 95% 5.45 – 5.64




CI 95% 4.92 – 5.37
Range ( 0.17 – 28.44)
2.69 (SD 1.26 )
CI 95% 2.61 – 2.77
Range (0.23 – 6.89)
7.51 (SD 5.85)
CI 95% 7.38 – 7.63
Range (0 – 49.28)
Travel time 11.48  (SD 7.22)
CI 95% 11.1 – 11.9
Range (0.86 – 58.69)
6.28 (SD 2.57 )
CI 95% 6.1 – 6.5
Range (0.92 – 17.03)
15.64 (SD 10.64 )
CI 95% 15.6 – 16.1







CI 95% 4.28 – 4.75
Range (0.09 – 19.49)
2.04 (SD 1.01)
CI 95% 1.98 – 2.11
Range (0.10 – 5.12)
6.19 (SD 4.93)
 CI 95% 6.08 – 6.29
Range (0.10 – 43.53)
Network
Distance
6.10 (SD  4.88 )
CI 95% 5.8 – 6.4
Range (0.17 – 28.44)
2.97 (SD 1.36  )
CI 95% 2.9 – 3.1
Range (0.28 – 6.89)
8.28 (SD 6.30)
CI 95% 8.1 – 8.4
Range (0.20 – 49.28)
Travel time 13.08 (SD 14.36 )
CI 95% 12.6 – 13.6
Range (0.86 – 58.69)
6.86 (SD 3.39 )
CI 95% 6.7 – 7.0
Range(0.92 – 17.03)
17.18 (SD 11.40 )
CI 95% 16.9 – 17.4













Very Easy 67.09% 63.2% 65.32%


















Very Easy 44.99% 44.2% 42.93%




For accessing the nearest A& E and nearest hospital with a rheumatology department the same
pattern emerges, with statistically significantly different average travel distances and time in
London compared to both Yorkshire and Humberside and the rest of England.
In comparison for the WY hip and knee patients the average travel time to the nearest GP was
4.26 mins and road network travel distance 1.55 miles and distance to the nearest hospital of
7.01 miles and 9.75 mins.  In London using the ELSA population the nearest GP was 1.58 mins
and road network travel 0.49 miles.
242
Table 70: If the nearest facility is closed how far away is the next nearest facility?
Yorkshire &
Humberside
London The rest of England
GP Network
Distance
2.01 (SD 1.89 )
CI 95% 1.90 – 2.12
Range (0.17 – 10.81)
0.75 (SD 0.38 )
CI 95% 0.73 – 0.78
Range  (0.10 – 2.78)
2.28 (SD 1.99)
CI 95% 2.24 – 2.32
Range (0.03 – 13.79)
Travel time 5.24 (SD 4.32)
CI 95% 4.92 – 5.49
Range (0.57 – 27.63)
2.22 (SD 1.07 )




CI 95% 5.81 – 6.00





11.05 (SD 5.99  )
CI 95% 10.69 – 11.40
Range (1.74 – 29.55)
4.17 (SD 1.39 )
CI 95% 4.08 – 4.26
Range  (0.23 – 8.26)
14.73 (SD 8.40)
CI 95% 14.56 – 14.91
Range (0.40 – 56.42)
Travel time 21.70 (SD 10.38  )
CI 95% 21.09 – 22.31
Range (4.46 – 66.59)
8.92 (SD 2.91 )




CI 95% 27.91 – 28.55
Range (1.94 – 100.92)
A & E Network
Distance
14.47 (SD 14.47 )
CI 95% 13.99 – 14.95
Range (1.38 – 42.13)
4.83(SD 1.75 )
CI 95% 4.72 – 4.94
Range ( 1.17 –
11.83)
17.08 (SD 9.58)
CI 95% 16.87 – 17.28
Range (1.96 – 69.15)
Travel time 27.67 (SD 14.36 )
CI 95% 26.82 – 28.52
Range (4.77 – 75.45)
10.01 (SD 3.39 )
CI 95% 9.80 – 10.23
Range  (2.43 –
25.33)
32.04 (SD 16.89)
CI 95% 31.68 – 32.39
Range (5.73 – 126.12)
4.5 Discussion	
This chapter has sought to use the ELSA dataset to gain a greater understanding of the potential
association that having to travel to healthcare facilities has on individuals with OA and RA on
health and wellbeing.   Key observations that have emerged from the results are discussed next.
Do	individuals	with	OA	or	RA	differ?			
The results of the analysis of the ELSA population show key differences in the sub groups that
have OA and RA.  The data shows that individuals with OA are more likely to be older, female,
have lower levels of education, be current or ex-smokers and more likely to live alone and live
in more deprived residential areas than the general ELSA population.     In terms of health and
wellbeing participants with OA were more likely to state that their general health was poor/ fair,
have a lower level of quality of life (using the CASP-19 measure) and more likely to have a CES_D
score =>3 compared to the overall ELSA population.   The findings from the Arthritis calculator
indicate that around 10.9% of the English population have OA in the hip of which 3.2% is classed
243
as severe. With a higher proportion of people with OA in the knee (at 18.2% of the population
in England), of these 6.1% having severe OA in the knee.
Individuals with RA were more likely to be female, older, and live in more deprived residential
areas, have a larger number of comorbidities, be current smokers than the overall ELSA
population.  They were also more likely to have no educational qualifications or be living alone
than the general population, be more likely to live in area in the worst deprivation quintiles,  be
a current or ex-smokers, have no educational qualifications and be living alone than the overall
ELSA population.  In terms of health the results from the study show that individuals with RA
have on average lower  CASP-19 quality  of  life  scores,  are  more likely  to  have a  score on the
CES_D above 3 and be in a poorer self-reported general health category than those with OA and
the overall ELSA population.  This ties in with the findings of Dominick et al. (2004)who reported
that compared to individuals without arthritis “older adults with OA and RA reported poorer
general health, physical health, mental health, and sleep as well as more activity limitations and
pain”   (p  5)  and that  individuals  with  RA reported lower  HRQoL scores  than those with  OA.
There are less individuals with RA, as shown by the number self-reporting in the ELSA dataset
and the estimation from the Arthritis Calculator of 0.84% of the English population with RA.
Individuals with RA have differing needs, on average more comorbidities and as discussed in this
thesis in Chapter 1 require access to hospital when in need of treatment.
The results presented in this chapter has shown that there are key differences between
individuals who have self-reported that they have OA or, RA, which will affect their demand and
use of healthcare services.  For example individuals with RA had on average more comorbidities.
This was also evident in Chapter 3 whereby there were only 50 patients with RA who had had a
THR or TKR in the WY dataset out of over 10,000 over the period 2009/10 and 2011/12, so a
much smaller population affected.  Data is not currently collected on PROMS from before and




One of the key reasons for using the ELSA dataset was that it collected a wealth of information
including about how individuals travelled (e.g.  Do they have access to a car?).  The results
showed  that  individuals  with  RA  were  more  likely  to  state  that  it  was  Quite  Difficult,  Very
Difficult or they are Unable to Go to the GP or hospital than those with OA.  This was also higher
for those with OA than the overall ELSA population.
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The study results revealed that not having a car, living alone and living in a more deprived
residential location were all  associated with reporting that it was harder to access the GP or
hospital.  Chapter 3 used travel time or distance to the actual healthcare facility as the measure
of transport accessibility.  This chapter showed (particularly in Table 58 and Table 59) that travel
time was an important variable in the multidimensional measure that is ease of access to the GP
or hospital.  These models showed that as travel time increased to the GP or hospital individuals
were more likely to report being in a worse access to healthcare category. Critically these models
also showed the importance of variables such as not having access to a car, or living in a more
deprived residential location.  These variables were independent of living further from the
healthcare facilities.  Two individuals living 10 minutes away from the GP, one with a car and the
other not having access to a car, would have differing transport accessibility levels.
In terms of the GC model discussed in Chapter 1, we can now populate in a more complete way
Figure 5, as shown below in Figure 45.  We have point 0 where the individual has zero transport
accessibility and is unable to travel and 1 where there are no burdens of transport accessibility.
In-between there are the four categories.  For the model focusing on ease of access to the GP
we can see that not having access to a car, having some or much difficulty walking and living
further from the GP and living on their own and having no qualifications compared to a degree
moves individuals towards the left in Figure 45.  This means moving from a position of it being
very easy to access the GP/ hospital to being more likely to say that it is less easy to access the
GP and the worst case scenario that they are unable to go.
By understanding better the weights that individuals place on burdens that restrict transport
accessibility and increase GC alternative solutions can be sought.  Whilst drive time has been
shown to contribute to GC  other aspects of GC (e.g. cost of travel, level of comfort) may play a
larger part in determining an individual’s transport accessibility to healthcare.  For example,
limited travel horizons may mean that a particular group of patients don’t travel to the
healthcare facilities that they need to attend.  Results from Chapter 2 found that coming from a
non-white British ethnic group made  it more likely that that the individual would report that it
is harder to access the GP and hospital (tables 52 and table 53).  Previous results have identified
ethnicity as an important factor, but this may be linked to language barriers for patients for
whom English is a second language and/ or prior experience or knowledge of the healthcare
system.   Lake  et  al.  (2011)  in  their  study  of  TB  treatment  reported  that  the  distance  to  the
healthcare centre was not significant for native British patients, but was for patients who were
not born in Britain.
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Figure 45: GC model of ease of access to healthcare
As discussed in Chapter 2 individuals may have a maximum travel time that they are willing to
travel to healthcare.  McGrail et al. (2015) found that communities where the population was
sparsely located were found to be willing to travel a maximum of 22.2 minutes more to visit the
primary care practice than those in closely settled communities. The review found evidence that
patients were more willing to travel attend healthcare for critical care (e.g. Joseph and Boeckh
(1981), but more likely to miss follow up appointments (e.g. Lara et al. (2005)), so different travel
horizons based on the type of healthcare that was being accessed.
In a world where we do not currently have perfect information on how individuals travel and
more specifically how they travel to healthcare (with the exception of those attending A & E by
Ambulance) the ELSA analysis has expanded this knowledgebase.   The studies reviewed in
Chapter 2 and case study in Chapter 3 focused purely on a measure of travel time or distance to
the  healthcare  facility.   Using  the  ELSA  dataset  allowed  a  more  rounded  definition  of  the
difficulties that patients face when travelling to healthcare using the definition of “how easy is
it to access…” the GP or the hospital.    17.9% of those with OA and 28.9% of those with RA do
not have use of a car.  Of those participants with a car/ van available at home 28% of those with
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RA and 20.7% with OA don’t drive it.  The statistically significant predictors of not having access
to  a  car  or  van  when  needed  were  being  female,  older,  living  alone  and  living  in  a  more
residentially deprived area.  The evidence showed that having access to a car when needed did
not perfectly correlate with not using the NHS PTS to get to hospital, as shown by the fact that
50% of the individuals who stated that they used PTS fitted into this category.  But it provides a
proxy measure of a minimum of 18% of those with OA and 29% of those with RA would have to
arrange an alternative method (than to use a car/ van available to them) to get to hospital.  This
is likely to be an underestimate of the issue, as some individuals attending hospital, particularly
those having surgical procedures, will not be able to drive themselves home depending on
treatment received.  The SEU (2003) reported  that having access to a car is only one part of the
pictures with “31 per cent of people without a car have difficulties travelling to their local hospital,
compared to 17 per cent of people with a car” (p7).  Each of the statistical models found that not
having access to a car was associated poorer health.  This could be one of the reasons for
individuals in London (with lower car ownership at around), reporting that it was more difficult
to access the GP.  The percentage of households without a car in 2016/17 in London was 45%
compared to 24% in Yorkshire and the Humberside (DfT, 2018).  The option of PTS is not available
for GP appointments.
The	GP	as	the	gatekeeper	
The research shows that the GP is the main gatekeeper in getting patients referred speedily to
the hospital in the case of RA and as the main port of starting treatment and diagnosis for
patients with OA.  A number of the studies in the review chapter identified late stage diagnosis
of cancer associated with living further from the GP (e.g.  Jones et al. (2008b)).  A number of
potential explanatory variable were considered as factors that might be associated with
individuals finding it harder to access the GP and one of these was being male.  Females were
more  likely  to  record  that  it  was  easier  to  access  the  GP.   The  study  found  no  statistically
significant  difference  for  how  hard  it  was  to  access  the  hospital  by  gender.   One  of  the
implications of not promptly going to the GP is the potential for later stage diagnosis and further
complications.  For example in the case of RA not getting prompt treatment can lead to greater
level of deformity, as “structural damage occurs early in active RA” (Emery et al. (2002) p290).
This issue of men finding it harder to go to the GP has been considered in the literature.  Banks
and Baker (2013)  argues that men experience barriers from two angles, firstly, getting help is
seen as being “incompatible with the masculine “norms” of strength, stoicism and self-reliance”
on one side and “this reluctance makes them unwilling to overcome the many practical
barriers …including lack of extended opening hours, inconveniently located services…”(p40).  This
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may contribute to the findings in this study that men are more likely to report that it is more
difficult to access the GP than women.  Although ultimately when looking at the results for the




This chapter explored using the ELSA health and wellbeing measures (CASP-19, CES-D and
General Health) the association with travel times and distances and ease of access to the nearest
healthcare facilities.  The results showed that across all models using the measure of ease of
access consistently resulted in statistically significant results.  As responders stated that they
found it harder to access either the GP or hospital they were statistically significantly more likely
to have ‘caseworthy’ symptoms for depression, a lower CASP-19 score and more likely to be in
a worse general health category.  The results using travel time or distance were mixed.  With
the majority showing that as travel times increased away from the healthcare facilities the
health and wellbeing of the individual improved.  There are potentially differences in individuals
who live closer to the healthcare facilities having worse health and wellbeing than those living
further away that may not have been adequately captured by the explanatory variables included
in the model (e.g. BMI and smoking were not included).  This will need to be explored further in
future work.  As discussed in Chapter 3 this could also be due to not adequately controlling for
area deprivation for those living in urban areas and closer to the GP facilities.  The measure of
IMD is area based not individual based, so not specific to the individuals ELSA participants, but
specific to the area in which they live.
Another factor could be that as in the Chapter 3 case study individuals did not all attend the
nearest facility (this was not possible to ascertain from the ELSA dataset).  If their actual travel
times to the healthcare facilities were known and they differed because they did not attended
their nearest facility, this could mean that travelling further being associated with better health
outcomes is not representative , as discussed next in section 4.5.5.   None of the studies in the
review in Chapter 2 had applied the health and wellbeing measures, as used in this chapter.
Previous studies focusing on mental health services had identified that those living further away
were less likely to attend healthcare facilities (e.g. Skarvag and Wynn(2004) and MaCarthy et al
(2007)).
Nearest	vs	hospital	attended	
This case study calculated the travel times and distances to the nearest healthcare facilities, as
the actual places that the patients would attend were unknown.  This mirrors a large number of
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studies in the systematic review (Chapter 2), where 48% of the studies used the nearest
healthcare facility as the destination point.  Which measure to use nearest or actual and whether
they are valid deserves some discussion, as in some cases they maybe measuring exactly the
same thing and in others something very different.  In order to approach this discussion I
produced Figures 46 and 47, which show five patients (1- 5) and three hospitals (A, B, C).  Figure
46 assumes that patients 1 -5 attend their nearest facility and Figure 47 the actual facility that
they attended.
Figure 46: Nearest hospital (2 hospitals with 5 patients)
Figure 47: Hospital attended (3 hospitals 5 patients)
In this example the order of the patients is 1, 4,2,3,5 for distance from the healthcare facility for
patients attending the ‘nearest’ facility, but 1, 4, 3, 5, 2 if considering the hospital attended.
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If it could be reasonably assumed that the ‘nearest’ is the only option , the actual healthcare
attended data is not available, there are few providers or that there are similar travel times to
alternative options then using the ‘nearest’ would be a good approximation for the actual
hospital attended.  Whilst in the context of THR and TKR and access to healthcare for patients
with OA and RA there are currently multiple providers and choice over where to attend.  There
are  other  examples  in  healthcare  where  the  nearest  is  more  likely  to  be  the  actual  hospital
attended.  Since 2009 patients have had the right due to changes in the NHS constitution to
choose where they want to attend for their first outpatient appointment for elective surgery
(e.g. for THR or TKR) and their GP surgery,   There are however other diseases and treatments
where there is  no choice for  patients  over  where they can be sent,  for  example:  emergency
services, rapid access pain clinics, some cancer services maternal health and mental health
services (NHS, 2019a), under these scenarios the actual  centre that treats patients for these
diseases is more likely to be the same as the ‘nearest facility’.  Although not always, as there are
examples where due to a lack of beds patients are sent out of their local area, with examples in
maternity(Merrick, 2018) and mental health treatment(Campbell, 2018).
One of the issues with using the nearest facility that can be deduced from Figure 46 and 47 is
that some patients that are closer to the nearest facility may have actually travelled the furthest
to the hospital attended, as shown by patient 2 in Figure 46 and 47.  As noted in Chapter  one of
the patients in the HES-PROMS dataset who travelled the furthest from their home postcode to
the hospital attended when assuming that they attended their nearest hospital had one of the
fastest travel times (so was closest).  Using the nearest in the case of patient 2 and the patient
in Chapter 3 will reduce the travel time associated with the health outcome that is included in
the model, so would not be measuring the association that travelling further to the facilities had
on their health outcomes.  It will also change the ordering of patients in terms of travel time/
distance to the hospital included in the model.  One of the key reasons why patients have
attended a wide range of hospitals (31) for TKR and THR is that they have choice over where to
attend and there are many hospitals within a short additional travel time, so there is more scope
for the nearest not to be the actual hospital attended.  This is shown by the WY case study where
only 36% of the patients attended their nearest hospital for their THR or TKR.  This is similar to
the results found by  Tracey et al. (2014)  where 38% of women attended the nearest facility for
treatment for ovarian cancer.   In both of these cases applying the nearest facility approach
means that over 60% of the patients in each case would have been allocated to a hospital in the
travel time calculations that they did not attend, so could be a very different travel time than
the one they experienced.
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Another argument for using the nearest facility is for scenarios where it could be assumed that
if patients did bypass their local hospital then this is in itself an indicator that they have better
levels of transport accessibility in terms of being willing and able to travel further.  This is also
one of the arguments put forward for the studies that showed a bias towards living further away
and having an improvement in health outcomes, where patients living further away were argued
to be healthier and more motivated to travel to the specialised centres (Lipe et al.,  2012), so
maybe less affected by the increase in travel time that this decision have resulted in, so less
affected by ease of access issues.  However, choice of healthcare facility is likely to rely on a
number of different factors other than ease of access e.g.  GP recommendation or GP preferred
provider, reputation, ease of access for visitors and the ‘nearest facility by travel time’ might not
have featured in this choice.   For example, one of the members of the PPI group stated that -
they had chosen a hospital based on how easy it was for their family to travel to the hospital by
bus rather than selecting the nearest hospital (by car) that they would have attended.  This could
be shown in the Figures 46 and 47 by patient 5 attending hospital A, which was in fact easier for
their family to get to by public transport than the ‘nearest’ hospital B.  Another example was
given where, one of the PPI group described that they were advised by their doctor to attend a
specific hospital and be seen by a specific consultant for treatment for RA, which bypassed their
local hospital.  This resulted in an extra 12 miles to get to the appointments and extra 30 minutes
of travel time compared to the nearest appointment.  This was not on the basis of finding it easy
to travel to (as the individual had to use the PTS to get to the hospital), but that the choice of
hospital was made and the travel arrangement had to follow on after.    This can be shown in
Figures 46 and 47 by an assumption that person 2 has travelled to hospital A, as their nearest,
but has in fact been sent by their GP to Hospital C.   By assuming this person is attending the
nearest facility rather than the one that was attended could, it might be argued misrepresent
their transport accessibility and association of this (especially as they were making multiple trips)
with their health.    Using the travel time categories in Chapter 3 and 4 and assuming that they
had attended their nearest this would put them in the base group in the models (< 10 mins),
where a  more representative  travel  time that  they experienced would be the  >  30 minutes
group.  Assuming that patients have attended the ‘nearest’ facility may have the undesirable
impact of reordering the patients in terms of who have actually travelled the furthest (if we want
to know the impact of travel time (as a proxy for transport accessibility) on health outcomes and
distorting the data.
There are likely to be patients for which a longer distance or travel time (and subsequent impact
on GC) would not have a large effect on their levels of transport accessibility (due to being fairly
inelastic in demand).    This could be one of the possible explanations for the distance bias results
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in Chapter 2, whereby patients travelling further for their treatment were shown to have
improvements in health compared to those who travelled a shorter distance – the impact of
increasing the distance/ travel time does not impact on their transport accessibility.  Equally
assuming that those living nearest the ‘actual’ or ‘nearest’ hospital have better transport
accessibility (in the context of the broader range of factors discussed in Chapter 1 and GC
formula) maybe a gross simplification and may go some way to providing one potential
explanation for why in the some of the studies those living closest to the healthcare facility
maybe associated with worse health outcomes (i.e. it is not just the pure distance or travel time
from A to B by car).  So patient 1 travelling to hospital A whilst having a shorter distance, may
find it harder to get to the healthcare facility than patient 5.
Do	travel	times	to	the	GP	or	hospital	differ	by	region?	
The study wanted to know how different the travel times and distances to healthcare facilities
were across the different regions in England.  This was in order to, firstly, make an assessment
of how different the travel times used in Chapter 3 (WY case study) were compared to the rest
of the country and secondly, how different the scenarios would be centralising healthcare in
London compared to the rest of the country.  The results showed a statistically significant
difference in the travel times to the GP and hospital in Yorkshire and Humberside compared to
London, with London having on average quicker travel times to the nearest GP, hospital and A
&  E.  The travel times in Yorkshire were more similar (but lower) to the ‘rest of the country’.
Interestingly, whilst the average travel times to a GP in London were statistically significantly
shorter than the rest of England a higher percentage of individuals in London (7.4%) reported
that it was quite difficult or they were unable to go compared to the rest of the country.  This
also plays into the above discussion whereby transport accessibility to healthcare is not simply
the travel time to the facility - it is more complex than that.  The results indicate that London
has very differing results to the rest of England, but that Yorkshire and Humberside has
comparable travel time / distance (if slightly faster) than the rest of England (excluding London).
This was also true for the results that focused on where the individual would have to travel to
attend the next nearest facility if the closest were shut.   This could partly be explained by the
less densely populated areas outside of London, but also through research that has shown that
some areas of the UK have in the past had less access to healthcare facilities than others.    This
issue was first identified by Tudor Hart (1971) who wrote about the inverse care law where he
concluded that “in areas with the most sickness and death, general practitioners have more work,
larger lists, less hospital support and inherently more clinically ineffective traditions of
consultations, than in the healthiest areas and hospital doctors shoulder heavier caseloads with
252
less staff” (p412), so exacerbating health inequalities across the country.  This inverse care law
highlighted that good quality healthcare was inversely associated with the need for it in the local
population.   This  trend  of  some  areas  across  the  UK  having  fewer  GPs  for  the  need  of  the
population they are serving still holds.  Data has shown that there is a Forty percent variation in
GPs per patient across the Regions in England, with South London and the  South West NHS
regions having the highest number of GPs per patient and the East midlands the lowest number
of GPs per patient (NHS Digital, 2018b),so a variation.
Limitations		
The ELSA case study has allowed the thesis to explore a wide range of factors that can affect an
individual’s transport accessibility to healthcare and has been able to focus on three self-
reported  measures  of  quality  of  life  (CASP-  19),  general  health  and  levels  of  depressive
symptoms in the ELSA population.  However it does have a number of limitations.   Firstly, there
was no data available on the healthcare facilities that patients had attended or if they had even
attended a healthcare facility (GP or Hospital) in the timeframe of the survey.  As noted before,
this part of the study was designed to use the linked HES –ELSA dataset, which would have not
only given more information on whether they attended healthcare facilities in the time period,
but where they attended and how frequently.  This limited the analysis to assuming that any
healthcare facilities that they had attended were the nearest facilities to their home address.
Critically having the linked HES-ELSA dataset would also have allowed an assessment of self-
reported diagnosis vs. clinical diagnosis of OA and RA by comparing the diagnosis codes in HES
with the self-reported diagnosis in the ELSA survey.  As discussed in Chapter 3 there is a wide
variation in the case of patients with radiographic evidence of OA not having a symptomatic
diagnosis of OA and vice versa and some patients with a diagnosis not realising that they have a
diagnosis (Parsons et al., 2015).  For example, were there some individuals in the ELSA dataset
that had not correctly answered whether they had either OA or RA?   As discussed in Chapter 1
and 3 there are different ways that OA and RA can affect an individual (e.g. different joints
affected), this was not possible to pick this up using this secondary dataset.
The study has highlighted the association between ‘ease of access’ and worse health outcomes.
It would then have benefited from some qualitative research to explore in more depth how
individuals interpret this measure aside from the interpretation of the data in this chapter.  This
was highlighted by the PPI group, who in the discussions were able to provide some suggestions
in terms of factors that helped their ease of access.
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One of the limitation of the application of this dataset in this thesis is that it is used as cross
sectional data (rather than making use of the panel data).  It was only possible to get the grid
link references for waves 5 and 6 at the time of the study and only wave 6 included the nurse
collected health data.  Future work could improve the analysis by making use of the panel data,
which has the potential to see whether changes in health (e.g. depressive symptoms) over a
time period were associated with being closer or further away from the healthcare facilities and
whether they fluctuated.  It would be possible to update this work with future waves of the data
to explore whether the associations change over time.
4.6 Conclusions	
This Chapter has applied the ELSA dataset health and wellbeing measures to analyse the
association between travel times, distances and ease of access to the nearest GP and hospital
for individuals with OA and RA.  One of the main findings has been that including travel times ad
distances as the proxy measure of transport accessibility may underrepresent how easy or hard
it is for individuals to travel to the hospital or GP.  Whilst ease of access to the GP and hospital
was found to be statistically significantly associated with poorer health and wellbeing in terms
of Self-Reported General Health, CASP-19 quality of life measure, CES_D measure of depressive
symptoms,  living  further  away  (by  distance  or  travel  time)  from  the  hospital  or  GP  was
associated with better health and wellbeing, but was statistically significantly associated with
poorer ease of access.  There is a large degree of variability in access to the GP and hospitals
across England. Interestingly, although having the shortest drive time and distance to the GP,
those ELSA participants living in London had a higher percentage of individuals who stated that
it was very difficult or were unable to go, implying that the issue is not as simple as focusing on
travel time and distance.  The travel burden for different individuals (e.g. with and without a car)
will be different.
The key findings that will be taken forward to Chapter 5 are:
1. Given that the results show that not having access to a car when needed is associated
with poorer health and wellbeing outcomes, not knowing how individuals are travelling
in the national datasets seems a missed opportunity to tackle some of the potential
health inequalities.  Using the predictors of not having a car presented in this chapter
(gender, age group, living arrangements, comorbidities, residential deprivation and
ethnic group), which are also present in the WY dataset it would be possible to estimate,
which of the WY patients is likely to have access to a car and use these in the scenarios
in Chapter 5.
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2. There  is  more  confidence  in  the  generalisability  of  the  WY  case  study  given  the
comparison of distances/ travel times across the regions in England (excluding London).
3. Increasing travel time as part of the ease of access measure is associated with poorer
health and wellbeing.  The requirement for particular groups of individuals to travel
further to the GP or hospital could lead to a worse association with health and wellbeing.
Chapter 5 will use the WY case study described in Chapter 3 and undertake a number of
scenarios changing where the THR and TKR patients would access the hospital.  For each of the
scenarios an assessment is made on which individuals would be negatively or positively affected
by the change and assesses what is the impact on health outcomes. It then estimates using the
predictors of not having a car, which of the WY patients could be expected to not have a car.






Chapter 2 reviewed the evidence on travelling further to healthcare facilities and associations
with health outcomes.  Chapters 3 and 4 undertook detailed case studies at a local level (WY)
and national level (England) to focus on differences in health and wellbeing associated with
differences in distance or travel time to healthcare facilities.  Up to this point there had been no
consideration of what a policy of reconfiguring of where patients access the healthcare system
might look like and the impact this might have on patients travel times to healthcare facilities.
Chapter 5 is designed to develop and test a number of potential changes (scenarios)  to where
patients access healthcare facilities. The analysis to date, and other published work, have
documented the inequalities in the geographical distribution of both GP practices and hospitals
in England, (e.g. Gravelle and Sutton (2001)). Changing this further through a process of
reconfiguration has the potential to widen these geographical differences, and potentially
increase health inequalities.
Since April 2008 patients in England have been able to choose any hospital across England (that
takes NHS patients) for the majority of NHS treatments (exceptions include emergency services,
cancer services, maternity services and mental health services).  As shown in Chapter 3 only 36%
of patients attended their nearest hospital for their THR or TKR with 64% travelling further.   A
policy such as centralisation of services that in effect restricts choice could have the impact of
reducing rather than increasing the average travel times that some patients would have chosen
to travel, but still increase travel for others.  It is worth noting as shown by the results in Chapter
4 that ease of access to the hospital or GP is not just about travel time or distance alone.  It could
be possible to reduce travel times by car, but at the same time make the healthcare facilities
less easy to access by other forms of transport.
The	policy	of	reconfiguring	and	centralising	healthcare	services	
Reconfiguration of healthcare services is “a deliberately induced change of some significance in
the distribution of medical, surgical, diagnostic and ancillary specialties that are available in each
hospital or other secondary or tertiary acute care unit in locality, region or health care
administrative area” Fulop et al. (2012) (p128).   Centralisation is one possible reconfiguration,
whereby patients are treated in a smaller number of specialising hospitals.  The drivers for
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promoting changes to how the healthcare services are provided tend to be due to one or more
of the following reasons; cost, quality of care, access to healthcare facilities and workforce issues.
The majority of studies in the literature have focused on the first two of these.
Costs have been a key driver for changing how services are provided.  The King's Fund (2018)
summarized the current state of the NHS in England by highlighting that in 2017/18 that 44% of
Trusts were in deficit and that total deficit for 2017/18 was £960million. Reconfigurations that
aim to save money are in part therefore to try to meet demand whilst coping with increasing
costs.  Palmer (2011) argues that where there are limits to efficiencies that can be implemented
in hospitals “more significant productivity improvements requires redesigning the way patients
flow into, through and out of hospitals, in order to allow reductions in hospital capacity and to
make savings” (p7). There is the potential to change how one hospital caters for the patient care
pathway or change which treatments are provided across a number of available hospitals.  There
is mixed evidence as to whether reconfiguring healthcare services can achieve cost effective
savings.  For example, Hollingworth and Ness (2012) reviewed 20 studies that had evaluated
whether centralisation of cancer care was cost effective (the health gains represented value
for money), finding that 68% of the included studies showed evidence of cost reductions, but
only one study was able to provide evidence that it had been cost effective.
In terms of quality of care a growing body of literature explores whether there have been any
improvements in health outcomes as a result of reconfiguration of where patients attend / are
sent.   For  example,  (Morris  et  al.,  2014;  Woo  et  al.,  2012;  Forshaw  et  al.,  2006)  all  found
evidence of improved health outcomes where patients were treated at specialised centres.
Morris et al., (2014) and the updated Morris et al. (2019) focused on evaluating the impacts of
centralising stroke care in London and Manchester.  Prior to centralisation patients with a
suspected stroke in the Greater Manchester area were sent to one of 12 hospital; after
centralisation patients were sent to one of three hospitals that were hyperacute stroke care
centres  (one open 24/7 and two open between 7am and 11pm).  In London prior to
centralisation there were 30 hospitals for stroke admission , after centralisation patients would
be sent to one of 8 hyperacute stroke care specialised centres.  Results published from this
study have found that this has been associated with reduced mortality rates and LoS in acute
hospitals.  However, there was no evaluation of the impact on travel times – patients would be
sent to the nearest hospital at the time.
Reconfiguration has also been argued as one solution to cope with increasing demands for
healthcare services whilst restrictions have been placed on the number of hours the workforce
can work and the availability in the NHS for senior staff to be based across multiple sites all
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covering the same specialisims.  The introduction of the European working time directive
(applied to doctors from 1s April 2004) restricted the number of hours of work to no more than
48 hours a week (EU, 2004), which put a strain on maintaining appropriate staffing levels, which
were reliant on junior doctors completing more than 48 hours per week.   This combined with
shotages of healthcare staff has meant that  trusts often struggle to maintain adequate staffing
levels across the NHS.  A thinktank piece by The Kings Fund has forecast that unless change
happens “NHS staff shortages could reach 250,000 by 2030”(Iacobucci, 2018) (p9). Workforce
pressures are likely to be one of the most significant drivers of reconfiguration, as moving care
for specific treatment to smaller numbers of sites requires for example less volume of specialist
staff to oversee the running of the services resulting in potential economies of scale.
The final driver, and the focus of this thesis, is access to healthcare facilities.   Indeed good access
is not just about getting an appointment when patients need it.  It is also about access to the
right person, providing the right care, in the right place at the right time.  There is a need to
provide services in the right place to meet patients’ needs.  Research by Basemap (2015) used
GIS methods to calculate travel times for patients to stroke care if one of two hospitals were
shut in Somerset, UK.  The conclusion was to keep both hospitals open, as the additional travel
time for some patients could adversely impact on the speed by which they are treated (and
knock on impacts on health outcomes).  Stroke care is interesting because treatment and
outcomes are very time dependent – the quicker you are treated the better the outcome is likely
to be.  Whilst elective surgery such as THR and TKR is not as time dependent.   Changes to where
services  are  located  as  a  results  of  policies  such  as  centralisation  or  reconfiguring  where
operations take place may still have a big impact – especially for those individuals who do not
have access to a car to make the journey and instead rely on public transport or other services
including the PTS to get to appointments  (Lovett et al. (2002)).
Service reconfiguration changing where patients attend hospital is not a new policy in the UK.
There is a process in place where health authorities want to make changes.  Following the NHS
(2006)  National  Services  Health  Act  2006  health  authorities  are  required  to  put  out  any
significant service change to a public consultation and any proposed changes must be assessed
against four tests, which are known as the Lansley (after the then secretary of state).  These
four tests are described in Barratt and Raine (2012) and summarized below :
· Does the proposal have support from GP commissioners?
· Has there been strengthened public and patient engagement?
· Is there clarity on the clinical evidence base?
· Do the proposals provide consistency with current and prospective patient choice? (p20)
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Whilst these tests have been set up by the NHS, it is expected that health authorities will apply
them in their local situation.  In England there is an Independent configuration Panel (ICP) that
is set up to review proposals for changes to NHS services, but also significant reconfiguration
changes.   On their website they list that in the last year they have provided “advice on referrals
from West Yorkshire, Northumberland and  South Tyneside and Sunderland” for reconfiguration
of services (Independent Reconfiguration Panel, 2019).
Current policy requires that local areas in England (e.g. WY and Harrogate) produce Sustainable
Transformation Plan (STPS) to document how they will  provide care in their local area now and
in the future.  The WY and Harrogate Plan has a key aim of reducing health inequalities in the
area (NHS England, 2018b).  Other areas in England have proposed changes to service provision
in their STPs including, merging hospitals (e.g. Royal Bournemouth and Poole Hospital in
Dorset), proposing shutting some A & E departments and downgrading the types of patients
that they can treat  (e.g. Dewsbury), closing maternity units (e.g.Alston, Maryport and Wigston
in Cumbria) and shutting or downgrading acute hospitals (e.g. keeping one out of three acute
hospitals in Leicestershire open) (BBC, 2017).
In WY, whilst there is no current plans for reconfiguring the hospitals providing THR and TKR
there is a precedence for reconfiguring stroke care.  Before 2007  healthcare providers in each
of the NHS trusts within West Yorkshire and Harrogate moved to select one hospital (where
there were previous multiple sites providing stroke care) to centralise care resulting in five
hospitals that would provide Hyper Acute Stroke Units (HASU).  The hospitals were Leeds
General Infirmary (LGI), Harrogate District Hospital, Calderdale General Hospital, Pinderfields
Hospital and Bradford Royal Infirmary.  Sites were selected based on workforce issues,
efficiency arguments and evidence from the London case study that sites that see less than 600
cases  in  a  year  have worse health  outcomes (mortality  and LoS).   A  subsequent  review had
identified that two of the sites do not currently achieve 600 cases a year (Harrogate District
Hospital and Pinderfields Hospital) and the hospital that takes the largest number of stroke
patients (LGI) does not exceed what had been determined as the upper limit before a provider
gets too big to achieve health benefits of 1,500 patients per year (NHS England, 2015).  A new
consultation reviewing the current situation and considering the future is focusing on limiting
these hospitals to 3 or 4 rather than 5 in the future in part based on meeting the quantity
targets (Networks, 2016).
In terms of orthopaedics there are examples across hospitals of plans to reconfiguring elective
surgery on one site.  For example, Heart of England Foundation Trust (2014 ) included proposals
to  locate  elective  surgery  for  orthopaedics  at  one  hospital  rather  than  carrying  out  the
procedure at three hospitals to improve efficiency and tackle workforce issues.
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Rather than reconfiguring services across existing hospital providers an alternative option
would be to build a new hospital to meet demands.  There are signs that this is one of the
focuses of the current UK Government.  For example, in 2018 it was reported in the press that
the Government  would aim to build one new hospital a year (Smyth C, 2018)   There are a
number of new hospitals currently being built in the NHS.  For example, there are two new
hospital buildings planned in Leeds (within the WY case study) (Trust, 2019).  The NHS has
produced guidelines for building new hospitals (DH, 2014), where it is clear that the plan needs
to provide “access and easy circulation for patients, staff and visitors (both non-disabled and
disabled) on foot, on bicycles, in cars or on public transport (sustainable transport
considerations should be encapsulated in a transport plan);dedicated blue light routes and a
discrete segregated access for goods vehicles to receiving and delivery areas” (p16).  They also
highlight the need to consider parking areas and locating hospitals within good public transport
routes.
One of the ex-panel members on the ICP in his review of the reconfiguration process within the
NHS challenged the NHS “to build greater consideration of accessibility issues into its
reconfiguration proposals” (p8), as he argues that whilst access is considered as one of the
drivers of reconfiguration it is usually seen as “just something that has to be accommodated
within proposal”(Barret, 2012)(p5).  More work therefore needs to consider the impact on
patients.  Implementing policies including centralisation or reconfiguring where services are
located within an area requires a big step change in current practice, as shown by the four
Lansley criteria.  Drawing from the results of Chapters 2 – 4 it is evident that travel to healthcare
could play a role in patient health and wellbeing and therefore any changes to where patients
attend healthcare should be evaluated accordingly in terms of access, alongside the other key
drivers of quality, cost and workforce pressures.
With a growing body of literature showing an association between higher volume providers of
THR  /TKR  having  better  health  outcomes(Hervey  et  al.,  2003;  Katz  et  al.,  2001)  and  higher
volume  surgeons  having  better  health  outcomes  (Ravi  et  al.,  2014;  Basques  et  al.,  2016)  in
terms of shorter LoS, less post-operative complications and lower mortality rates.  Considering
to reconfigure where patients access healthcare services is a valid approach for this patient
group.   This chapter considers a number of different options or scenarios based on similar
changes proposed or made as a result of reconfiguration to services in the NHS.
Operationalising	the	reconfiguration/	centralisation		
Operationalising the process of investigating changing where healthcare services should/ could
be located can be tackled in a number of different ways.  A scenario requiring patients to attend
260
their nearest hospital, could be completed in a similar way to the case studies in Chapter 3 and
4, whereby the distance/ travel times to the nearest facilities are calculated (essentially not
giving patients a choice and minimising their travel).  Following this policies such as finding the
one central location that minimises the travel times/ distance (likely to be a central major city
hospital) become more complex requiring GIS software.  After this the options become more
complex, requiring models that optimise the number of hospitals attended (e.g. location-
allocation  models  -  see  section  5.2.2)  and  making  changes  to  minimise  the  impact  on
accessibility levels through assessing the impact of closing specified  hospitals on travel time
thresholds.    A number of potential scenarios are presented in this chapter ranging from
attending the nearest facility to minimising the number of hospitals that could be attended to
allow an assessment of potential associations with health outcomes
Access	to	a	car		
One of the major limitations of the HES-PROMS WY dataset used in Chapter 3 was that data
had not been collected on how patients travelled to hospital for their appointments.  Results
from Chapter 4 identified that among other characteristics not having access to a car was
associated with poorer health and wellbeing.   Chapter 3 also identified mirroring those results
of Kim et al. (2000), that there was a negative association with those living the closest and those
living the furthest away (a U shaped distribution).  This ties in with the concept that it is not
necessarily the distance or travel time that is the issue, but the ease of access associated with
travelling to the hospital or GP (of which distance however long or short contributes).    The
journey for a patient living 30 minutes away from a GP, who can travel by car directly from
home to the GP, and park close by minimising walking distance, is likely to have less of an issues
travelling to healthcare compared to a patient living 800m from the GP, without access to a car
and with a reduced ability to walk.  If the process of restructuring could be weighted to reduce
the impact of travel to healthcare on the group of individuals who find it harder to access
healthcare (noting that for some the increased distance does not impact on their health) then
this could contribute to reducing health inequalities.  To focus on this issue section 5.4
estimates using the missing data methodology applied in Chapter 3, which of the WY patients
are more likely to not have access to a car.
The next section of Chapter 5 starts by describing the data and methods that are being used to
develop and test the different policy scenarios.  It then tests a number of different scenarios and
summarises their differences.  Missing data methodology is used to estimate which of the WY
patient population is more likely to not have access to a car (Section 5.4).  The scenarios are then
run again to see whether there are any differences in the results if the policy is focused on those
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who are less likely to have a car.  Section 5.6 focuses on whether it matters how patients travel,
which is then followed by discussions and conclusions.
This chapter targets objective 4, of the study, which is:
· To test the results of the systematic review and statistical models to explore policy
implications of restructuring healthcare services for individuals
5.2 Data	and	methodology	
Data	Description	(patient	vs	population	data)	
The analysis uses two populations to develop and test a number of reconfiguration scenarios,
which are the WY HES-PROMS THR and TKR patient data included in Chapter 3 and the WY
population data, which is represented by the LSOA zones in WY.   There were 10,875 patients
(see Map 4) in the patient population and 1388 LSOA zones in the WY population (see Map 5).
Within each LSOA in England there are on average 1,614 people (ONS, 2017 ). This provides a
WY THR/TKR patients vs WY population approach.  The LSOA were created by ONS to improve
the reporting of small area statistics.  They included large enough numbers of people so that it
was less likely to be able to identify individual people from the data.  The study has used the
population weighted centroid of the LSOA to compare with the patient data as the starting
location.  This is the median centre point of all people living in the LSOA.  For an LSOA covering
a wider geographical area there is the potential for people to be living some distance from the
LSOA population weighted centroid.  For others in densely populated urban areas it is likely to
be a more accurate representation of where they actually live.  As shown already in Chapter 3
there was no statistically significant difference in the travel times when comparing the LSOA and
the home postcode as the starting points for patients travelling to hospital.  The key different
here is that there may be some LSOAs that have no patients included in the patient dataset and
those that do might not be uniformly distributed (some zones may have more).
These two groups have been selected to allow an assessment of whether the results are any
different using a patient population, based on the home postcodes of where the patients live
(which have been shown to not be uniformly distributed across WY), compared to the WY
population that is represented by the LSOA zones (starting points population weighted LSOA
centroids).  As can be seen when comparing Maps 4 and 5 there are some locations in WY where
there are higher concentrations of THR and TKR patients than others.  If the results of the
comparison are not statistically significantly different (patient data vs population data) then this
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may reduce the need to access the patient data and future analysis could be based on the LSOA
zones.
Map 4: Patient data: WY THR and TKR
patents (represented on the map as LSOA
locations not home postcode to maintain
anonymity)
Map 5: Population data: LSOA zones and
population weighted centroids in West
Yorkshire
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The aim was to develop a number of scenarios based on evidence in the literature that could be
tested to assess whether they impact negatively or positively on patient travel times and then
to assess whether different groups (e.g. across deprivation quintiles) were more or less affected
by the changes and in doing so how this might be associated with changes in health outcomes.
In doing this it would propose a method that could be applied to assess the impact of policies
such as centralisation or reconfigurations of hospital services.
5.2.2.1 Comparing the patient data and West Yorkshire LSOA
The study used two approaches to assess whether there are any differences in using patient’s
data vs assuming that patients are uniformly distributed across the LSOA zones in the WY region
to calculate distances and travel times to a subset of the healthcare facilities.  If planning where
specific patients attend healthcare facilities is the main aim then using the patient dataset would
be  the  ‘correct’  approach.   As  this  thesis  has  shown  patients  with  OA  or  RA  have  different
characteristics to the general population and are not uniformly distributed across a region, as
shown by the arthritis calculator and maps in this chapter.
There were twenty  LSOA zones that  had no records  of  a  patients  having a  THR or  TKR.   The
average patients who had undergone a TKR or THR per zone was 7.51 with a range of 0 – 27
patients and standard deviation of 4.26.  It can be seen that there are some significant
differences with the two datasets when testing for statistically significant hotspots in the West
Yorkshire Data using the number of patients per LSOA.  Map 7 shows the hot spot analysis results
for the patient data by LSOA in WY.  The map shows statistically significant spatial clusters of
high values (hot spots) and low values (cold spots).  As can be seen there are some definite
differences across the LSOA in WY.  With a number of areas with statistically significant high
number of patients (in the red colour) mostly on the boundaries of the WY region and large
areas with low numbers of patients in each LSOA (the blue area) in the centre.
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Map 7:  Hot spot analysis of number of patients having a THR and TKR in West Yorkshire by LSOA
5.2.2.2 Calculating the travel times for the scenarios
The travel times to hospitals were calculated based on the scenarios developed in this chapter
and methods described in Chapter 3.  The scenarios were operationalized using a combination
of software packages.  ARCGIS 10.4 was used to implement Location- Allocation models and
calculate the changes in travel time by car and Visography Tracc to calculate changes in travel
time by bus.   Calculating the travel times for the different scenarios used the same methodology
as in Chapter 3, road network travel times as a proxy for journey times by car and bus travel
times using bus schedules and bus stops.
To be able to optimise the hospitals that the patients or population would attend required a
different set of tools.  This study used the Location-Allocation models, which are described
below in more detail.  An extensive body of literature has focused on using Location-Allocation
models  to  identify  optimal  locations  for  schools,  fire  stations  and hospitals,  with  the aim of
finding optimal locations that minimises the overall distance travelled by individuals.   Rahman
and Smith (2000) reviewed the use of Location-Allocation models for healthcare facilities in
developing countries and found that the studies had been used to identify optimal locations
for new facilities (ex- ante) ,  evaluate whether previous location decisions had proved to be
.
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effective (ex-post) and to provide alternative options that would potentially have been better.
Other literature including Daskin and Dean (2004) and Afshari and Peng (2014) have reviewed
the Location- Allocation literature for healthcare facilities.
The Location-Allocation method uses algorithms to optimise the location for a given set of
facilities.  This works with candidate facilities (e.g. hospitals) and demand points (e.g. patients
home locations) and from this chooses a subset of the hospitals (i.e. the user can specify the
number of hospitals to be operational) that minimises the distance (using the road network).
It  is  possible  to  restrict  the  maximum  distances/  travel  times  that  patients  can  travel  (so
identifying locations that patients would not be able to get to).  There are options to allow one
or multiple hospitals to be selected to minimise the distances or travel times.  The process
works by producing an origin-destination matrix using the shortest distance between each of
the hospitals and patient’s home locations.  This matrix is then adjusted using Hillsman editing
(using a p-median structure), (Hillsman, 1984), which enables the solver heuristic (location –
allocation solver) to create a number of solutions refined using the Teitz and Bart (1968) vertex
substitution heuristic.  These solutions are then combined using a meta-analysis to create
better solutions and when the program cannot find any improvements it presents the ‘best’
solution identified.    The outputs from this method are the hospitals that have been selected
(as the optimal locations), whereby patients have been ‘optimally’ allocated to each hospital
and the travel times using the road network that each individual would have to travel under
this scenario.    This method can be used to operationalise a number of the potential scenarios,
where a restricted set of hospitals is being tested.
5.2.2.3 Assessing how accessibility has changed
Once the optimisation process has been completed a second critical phase is needed to
determine whether accessibility for individuals has changed and whether this differs by
different groups in society (in order to focus on inequalities).  The study has focused on
measuring travel time thresholds.  The thresholds relate to the models in Chapter 3 and 4 for
car of < 10 minutes and > 30 minutes, as they are the two extremes categories  for the models
applied in Chapter 3 and Chapter 4 (categories of <10 mins, 10 – 20 , 20 -30 and > 30 minutes).
The cut offs used for car travel would not have been suitable for the travel times by bus (due to
the longer travel times) and so the cuts off for the thresholds used in UK policy for measuring
how ‘accessible’ hospitals are by bus of 60 mins and 120mins have been used.  This was
previously discussed in Chapter 1.
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 In addition an assessment for each scenario of how many of the patients (using the data in
Chapter 3) would have to travel < 10 minutes and > 30 minutes, as a comparator and more
specifically how many under each scenario and patient characteristics (e.g. deprivation
quintiles) would have to travel < 10 minutes and > 30 minutes to assess for inequalities.
5.2.2.4 Predicting the health outcomes
The final stage of the methodology is to use the models developed in Chapter 3 to predict the
impact on health outcomes from changing where the patients access the healthcare facilities
from the differing scenarios.  The study is using four of the models described from Chapter 3 to
predict what would happen to the health outcomes if the patients in the WY case study (HES-
PROMS and OA population) attended a range of different healthcare facilities.  These models
are:
· LoS for THR  (see results  Table 42)
· LoS for TKR (see results Table 42)
· OHS  (see results Table 40)
· OKS (see results Table 38)
The models with travel times as a categorical variable (0 – 10, 10 – 20, 20 – 30 > 30 mins), were
selected as they were found to have a higher R2 and lower RMSE than the models with travel
time as a continuous variable.  The prediction model uses the results of the models (LoS and
OHS/OKS) and applies them to the new data, which include the following potentially altered
explanatory variables: altered travel times (as patients may now be attending a new hospital
than previously), altered quality of hospital (as the quality of hospital that the patient is now
attending might be different) and finally altered hospital provider (as they may previously have
attended a private hospital).  The predicted health outcomes were calculated in STATA 15 and
involved running the models, dropping the old variables and predicting the expected health
outcomes for each of the patients using the new variables determined by the different scenarios
(including altered travel times, quality of hospital and hospital provider) using the PREDICT ()
function.   The results are presented by comparing the average health outcomes by scenario,
range and 95% CI.
Estimating	those	with	and	without	a	car	
The analysis in Chapter 4 identified that there are groups of people that are more likely to find
it harder to access a hospital and thus be most affected by changes in where hospitals are
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located.  This is the group without access to a car and who answered that is was not ‘Very Easy’
to access the hospital.  In England 25.8% of households do not own a car and this rises to 29.4%
in WY and ranges from 32% in Leeds to 26% in Kirklees  (ONS, 2016a).  Finding it harder to access
the GP or hospital was uniformly associated with poorer health and well-being outcomes (worse
general health category, lower CASP-19 score and a push towards having ‘caseworthy’
symptoms of depression (see chapter 4).  It is therefore critical to try and identify who these
individuals are if a targeted approach to restructuring healthcare services is going to minimise
inequalities.
Chapter 4 identified that whilst travel distance/ time to healthcare was associated with whether
individuals perceived it harder to access the GP and hospital, there were other transport related
factors that were key to the rhetoric of understanding what it was that made it harder to access
healthcare facilities.   One of these has been not having access to a car. For example, the  Social
Exclusion Unit (2003) estimated that  “31% of people without a car have difficulties travelling to
their local hospital, compared to 17% of people with a car (p2).   Not having data on how patients
travelled was one of the main limitations of the HES – PROMS data used in Chapter 3.   The
results of Chapter 4 showed that individuals without access to a car when needed had lower
CASP-19 score, higher odds of being in a worse general health category and higher odds of
having ‘caseworthy’ symptoms of depression.    Similarly those who stated that it was harder to
access  the  hospital  where  more  likely  to  have  poorer  health  outcomes.   In  order  to  try  and
incorporate this critical element into the analysis it is useful to estimate which individuals were
more  likely  to  not  own  a  car  and  therefore  be  more  likely  to  find  it  harder  to  access  the
healthcare facilities.
In order to estimate which patients  are more likely to not have access to a car in the WY patient
population the study made use of the predictors of not having access to a car/ van when needed
from the ELSA population in Chapter 4 that were also common to the HES-PROMS WY dataset.
The variables included gender, age groups (< 60, 60 – 80 and > 80), living alone, residential
deprivation quintiles, comorbidities and ethnic group.    This estimation was completed using
the  missing  data  methodology  described  in  Chapter  3.     The  subset  of  ELSA  data,  with  the
following variables - gender, age groups, living arrangements, comorbidities, deprivation
quintiles, ethnic group and car availability was appended to the HES-PROMS WY dataset.   The
only variable that wasn’t common was car availability that was being estimated and was treated
as missing in the HES-PROMS dataset.    Essentially not having access to a car when needed is
treated as missing in the HES-PROMS dataset and estimated using the variables in the ELSA
dataset and STATA code in Box 2.    This process was completed using all the ELSA data and then
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separately the ELSA data for those individuals that have OA, as Chapter 4 found that groups had
slightly different characteristics to the complete ELSA population.
Missing data code for imputing having access to a car
mi set mlong
set seed 2018
mi register imputed SPCar
mi register regular sex Agegroups living ethnicity Deprivation_Quintiles Comorbidities
mi impute chained(logit) SPCar = sex i.Agegroups i.Deprivation_Quintiles living_arrangement
ethnicity i.comorbities, add (30) dots
Box 2: Missing data code to estimate who doesn’t have a car
For the patient population 30 iterations were completed each with 10,785 imputations.  The
percentage of the population that was estimated to not have a car ranged from 15.54% to 18.48%
with an average of  17.22 % across the iterations when measured using the complete ELSA data
and 15.54% to 20.02% with an average of  17.53% when the sub group of OA ELSA participants
was used.
Developing	the	Scenarios		
The scenarios were developed using the literature for reconfiguring where THR and TKR patients
could attend hospital.  As noted by Barret (2012) there needs to be an increased focus on access
to healthcare as one of the drivers of service reconfiguration.  These scenarios focus on
reconfiguration from this perspective.  The scenarios are summarized in Table 71 and described
below.
The Current Scenario is based on the results of the case study in Chapter 3.  It  assumes that
there is no change in where patients in WY access their healthcare facilities, across 31 hospitals.
Scenario 1 is focusing on building a new hospital, as has been proposed in a number of case
studies around the UK and recently in Leeds in WY.  It focuses purely on a location that would
minimise travel times, with accessibility as the driver for the reconfiguration.  The results from
Chapter 3 showed that travelling > 30 minutes to the hospital was associated with poorer health
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outcomes, so by limiting the number of hospital to one centralised location it would result in the
is one location that would minimise this across the WY region.
Scenario 2 is focusing on reconfiguring all the services to one existing location.  Examples of this
in the literature include Heart of England Foundation Trust (2014 ) , where the health authority
configured to just one hospital in the region undertaking  elective orthopaedic surgery.   The
difference here is that the accessibility analysis Is one of the driving factors is being undertaken
first.
Scenario 3 requires  patients  to  attend  their  nearest  hospital  for  their  THR  or  TKR.   This  is
removing the choice of hospital.  The aim of this scenario is to assess what would happen if travel
times were minimised for all patients (as they would all be travelling to their nearest hospital).
Scenario 4(a-g) + Scenario 5 is drawing from the literature that shows that improved health
outcomes are associated with the reconfiguration of health services that increase the volume of
patients treated at a hospital.  This was the justification for the reconfiguration of stroke care at
5 sites in WY.  The literature has also shown that increased volume of patients has better health
outcomes  for  patients  undergoing  a  THR  or  TKR.   Each  of  these  scenario  test  which  from  a
transport accessibility driving force perspective would minimise the travel times for the patient’s
population if centralisation at one hospital was the focus of the reconfiguration.  As in the case
of the WY stroke care reconfiguration example, the providers currently undertaking the largest
number of THR or TKR have been selected for the scenario. Scenario 5 discusses in more detail
which of the 7 hospitals would be the one that minimises travel times.
Scenario 6 Focuses on the impact on travel times from reconfiguring at two of the largest current
providers of THR and TKR.  This is similar in nature to the Manchester stroke care which changed
from providing care at  12 hospitals  in  the region to  1  24/7 hospital  and 2  part  time opening
hospitals.  The focus of the analysis in Morris et al (2014) was the association with health
outcomes (mortality and LoS), in this case the aim is to assess whether dropping to two hospitals
from 31 affects the travel times that patients would travel for their THR or TKR and be associated
with changes in OHS, OKS and LoS in hospital.
Scenario 7 closely resembles the stroke reconfiguration in WY, as the location allocation model
is used to select which four hospitals (currently with the largest THR and TKR patients) in the
region would minimise travel times, as the driving force between hospital reconfiguration.  This
is likely to be the most realistic scenario as with a patient load of over 10,000 patients in WY
over three years each hospital would need to treat on average 833 patients per year.
270
 The developed scenarios can then be compared with this baseline Scenario.  These scenarios
were  shown  to  the  studies  PPI  group  to  get  feedback.   They  were  interested  in  how  these
different scenarios would affect their access to healthcare facilities.  They felt the most realistic
was scenario 7 - that reduced the number of hospitals down to four of the main centres that
currently provide healthcare and include hospitals that they attended.
For each of the scenarios a comparison is made between the different travel times by car and
public transport and using the patient data vs the WY population data.  With the patient data an
additional assessment is made on the impact on accessibility, the travel times and critically in
terms of inequalities,  which groups in society (age, gender, ethnicity, living arrangements and
residential  deprivation levels),  would be more or  less  affected by each of  the scenarios.   An
Assessment is made of the predicted changed in health outcomes from these scenarios and then
what would be the impact if the scenarios were based on minimising the travel times for those
patients who have been estimated to not have a car.
Table 71:  Reconfiguration Scenarios
Scenario Title Description
Baseline Current situation No changes made to where patients attend healthcare
Scenario 1 A new hospital If  you  could  start  from  scratch  the  one  location  that
would minimise travel times across WY
Scenario 2 One current
hospital
This scenario takes the 31 currently attended  hospitals
and identifies, which one hospital would minimise
travel times
Scenario 3 Nearest Hospital Individuals would be required to attend their nearest
hospital
Scenario 4a - g 7 Largest Hospital
providers
A comparison between centralising services at each of
the 7 largest public providers of hip and knee providers
Scenario 5 One out of 7 Centralising services at one of the 7 largest providers
Scenario 6 2 Hospitals Centralising services at 2 of the 7 largest providers






For each scenario the travel times by bus and car for each group (WY patient population vs WY
population) have been calculated and are summarized in Table 72.  This includes the average
travel times by car and bus for each scenario by the patient population and WY population LSOA
zones.  It also summarizes the percentage of patients in the case of the patient population and
percentage of zones in the case of the WY population LSOA zones that would not be able to get
to a 10 am appointment if leaving by 7 am and travelling by bus.
For the patient population additional analysis focusing on comparisons by the different patient
characteristics are summarized in Table 73.  In terms of gender, age, deprivation, living alone,
being from a non-white British background and what percentage of the population would be
travelling < 10 minutes to the hospital and   > 30 minutes for each scenario.  These results are
discussed in more detail in the next sections by scenario.
Table 72:  Average travel times by car and bus by scenario and % who could not get there by bus
buy 10am if leaving at 7am and walking <800m to the bus stop.
(SD) Patient population WY Population (LSOA zones)
Car Bus % of
patients
















73.14 (33.74) 1.38% 19.61 (9.69) 67.41 (33.99) 0.3%
Scenario 3 9.74 (4.45) 26.9 (12.28) 0.8% 7.15 (3.10) 26.5(11.99 0.07%
Scenario 4a 39.72 (13.7) 116.5 (39.6) 27.7% 39.62 (12.58) 119.33
(36.16)
24.8%
Scenario 4b 24.6 (10.7) 85.1 (34.9) 3.2% 23.6 (10.5) 82.3 (34.8) 2.0%
Scenario 4c 24.99 (10.4) 84.26 (37.9) 2% 27.8 (10.99) 79.01 (38.1) 1.1%
Scenario 4d 28.6 (11.8) 98.3 (42.2) 8% 23.34 (10.6) 98.2 (39.9) 5.1%
Scenario 4e 22.6 (8.5) 87.2 (31.3) 1.6% 21.0 (7.9) 82.8 (30.3) 0.2%
Scenario 4f 41.9 (11.1) 113.2 (32.8) 27.6% 41.33 (10.7) 113.1 (31.1) 23.3%
Scenario 4g 33.7 (13.24) 105.4 (44.2) 16.6% 32.7 (11.97) 104.1 (40.8) 12.5%
Scenario 5 22.6 (8.5) 87.2 (31.3) 1.6% 21.0 (7.9) 82.8 (30.3) 0.2%
Scenario 6 18.35  (8.14) 60.1 (27.3) 0.7% 19.01 (7.7) 65.6 (28.9) 0.07%
Scenario 7 13.7 (6.1) 44.95 (21.0) 0.9% 12.9 (5.94) 42.5 (20.4) 0.07%
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Table 73: Patient population travelling < 10 mins and >30 mins by car under each the scenario2
mins Gender Age
(yrs)





Male  Female 68.3 1 2 3 4 5
Current status
All 4,707 6,076 68.3 1,860 1,914 2,169 2,385 2,457 2,917 1,387
Patients  <10 29% 32% 68.6 15.9% 24.1% 29.9% 33.9% 45.1% 33.1% 43.5%
>30 4.9% 4.8% 66.4 7.0% 7.2% 4.6% 3.2% 3.2% 3.9% 3.39%
Scenario 1 : One new hospital that minimises travel time by car
< 10  8.1% 8.0% 67.9 1.3% 5.9% 9.2% 10.0% 12.0% 8.4% 8.1%
>30 15.6% 14.6% 68.1 25.2% 17.9% 13.0% 11.2% 10.6% 13.4% 13.2%
Scenario 2: One existing hospital that minimises travel times across WY
Patients <10  12.8% 14.2% 68.7 5.6% 9.7% 13.9% 13.6% 22.43% 15.8% 16.7%
>30 20.2% 18.0% 67.8 22.8% 25.7% 20.2% 15.0% 13.6% 17.6% 14.8%
Scenario 3: Attending the nearest hospital
Patients <10 57.3% 58.7% 68.3 33.3% 46.7% 59.8% 67.3% 75.3% 66.6% 61.2%
>303 - - - - - - - - - -
Scenario 4: Centralizing at one of the 7 largest hospitals providing hip and knee replacements
Airedale  <10 1.3% 1.8% 69.3 2.7% 2.3% 3.1% 0.04% 0.3% 0.02% 0.6%
>30  76.5% 74.0% 68.34 70.6% 74.7% 74.1% 80.8% 74.2% 74.6% 72.5%
Bradford <10 8.2% 9.9% 68.1 1% 2.82% 7.8% 11.7% 17.3% 9.5% 17.2%
>30 31.6% 28.7% 68.0 36.9% 33.0% 27.5% 29.5% 24.9% 26.8% 29.9%
Chapel
Allerton
<10 7.7% 10.1% 68.8 5% 21.6% 8.6% 6.0% 16.2% 10.8% 11.6%
>30 33.7% 31.8% 68.0 36.2% 37.4% 32.4% 32.2% 26.7% 26.5% 27.6%
Calderdale
Royal
<10 5.2% 4.9% 68.1 3.5% 5.9% 5.7% 5.6% 4.4% 5.2% 2.2%
>30 43.4% 44.7% 68.5 58.3% 47.2% 39.2% 35.7% 43.8% 43.0% 43.9%
Dewsbury
& District
<10 7.0% 6.6% 67.1 2.4% 7.2% 8.3% 7.6% 7.7% 6.7% 5.6%
>30 17.2% 18.4% 68.2 31.4% 21.5% 15.9% 12.1% 12.3% 17.3% 13.3%
Harrogate
District
<10 -- -- -- -- -- -- -- -- -- --
>30 87.9% 85.0% 68.1 68.8% 82.4% 88.5% 94.1% 91.2% 85.0% 87.0%
Pontefract <10 6.3% 5.3% 67.4 2.3% 3.3% 3.3% 9.6% 8.8% 4.6% 6.6%
>30  62.7% 63.5% 68.7 80.0% 66.7% 63.4% 58.4% 51.7% 64.6% 58.0%
Scenario 6: Centralising at 2 hospitals
<10 16% 16.9% 68.7 15.6 15.2 15.4% 18.4% 17.7% 17.9% 19.5
>30 7.8% 8.3% 68.1 7.5% 9.2% 8.4% 9.3% 6.2% 8.9% 7.6%
2 Scenario 5 is identical to Scenario 4 Dewsbury and District Hospital.
3 3 individuals
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Scenario 7: Centralising at 4 hospitals
<10 32.0% 30.7% 68.1 31.2 32.5 30.2% 32.3% 29.8% 31.2 29.8
>30 0.02% 0.5% 70.9 0.5% 0.5% 0.4% 0.4 0.3 0.7 0
Scenario	1:	A	new	hospital	
The first scenario involves finding the optimal location that minimises travel distance to one new
hospital across the WY region.  Using the WY population (1387 LSOA zones in WY, as the starting
location) the optimal hospital location is shown in Map 8.  For this location the average travel
times by car using the road network are 16.86 mins  and range 3.86 – 34.64 mins.   If travelling
by bus the average bus travel times would be 75.5 mins and range 6.95 – 173.1 mins.  Individuals
living in 6 out of the 1387 LSOA zones would not be able to access this new  hospital for a 10am
appointment using the current bus network and schedule, potentially leading to inequalities
(there are on average 1614 individuals in each LSOA).    As can be seen in Map 9 the optimal
location is in the middle of a residential area, so would be less likely to be selected as the location
for other practical reasons.
The location identified using the patient population is shown in  Map 10 and the aerial photo in
Map 11.  As can be seen whilst still fairly central it does not give the same location as using the
WY population data.  Using the patient data the average travel time by car to this location would
be 20.62 mins (SD 5.91) and range 6.2 – 40.19 mins.  One hundred and fifty six individuals in the
patient  population  could  not  get  to  this  location  by  bus  (if  they  left  by  7am)  for  a  10am
appointment and the average travel times for those that could would be 81.78 mins (SD 29.07)
with a range of 8.73 – 166.41mins (~2.5 hours).   Using a comparison between the patient vs
population data does give differing results for where the new hospital should be built to
minimise travel distances.  The average travel time using the WY population data is 16.86 mins
compared to 20.62 mins using the patient population, showing a difference for this scenario.
This scenario also highlights the differences (or inequalities) between making the journey by car
and using public transport.    The travel time to make the same journey by bus for the patient
population is on average 61.2 mins longer than making the same journey by car.  A number of
patients would have to leave the house at 7am in the morning to get to the hospital in time for
a 10am appointment, with travel times by bus at their highest at 2 hours 46 mins to make the
journey using the existing bus schedule and network.
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Map 8 & Map 9 : Scenario 1: New hospital location (WY population - LSOA centroids) and
Aerial View
 Map 10 & Map 11 :  Scenario 1: New hospital location (patient population) and Ariel view
Eighty–five percent of patients could get to the scenario 1 location in 30 minutes or less by car.
Following  an  assessment  of  the  bus  travel  times  only  2.8%  of  the  patients  could  get  to  this
location by bus/ walk in <30 minutes, 24.9% in <60 minutes  and 87.8% in < 2 hours.  The travel
times by bus to scenario 1 are displayed in Map 12 below.  Thus highlighting again the very
different accessibility travel times by bus and car.  The highest travel time band is 120 – 167 for
bus travel times and 40 – 60 minutes for car travel times .  When compared against the patient
being able to choose where to attend the hospital (current state) Scenario 1 would on average
increase travel times by car by an average 5.8 minutes and almost double the travel times by
bus to get to the new hospital.  Under scenario 1 there would be more patients travelling > 30
mins to the hospital for each of the categories in Table 73.  For example, 14.6% of females would
be travelling > 30 mins compared to 4.8% in the current state.    For those in the most deprived
quintile 10.6%, would be travelling > 30 minutes compared to 3.2% under the current status.
Thereby highlighting some inequalities due to changing location.
®v
.
0 5 102.5 Miles
Author: C Kelly, Date 19_01_2019
Source: ONS 2011 Census Digitised Boundary Data
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Source: ONS, 2011 Census: Digitised Boundary Data
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It is unlikely that one new  hospital that could cover all the operations needed for THR and TKR
in WY, due to the climate of needing to save money, but creating a scenario that is so ‘extreme’
does show the levels of details that could be employed when thinking about where to locate a
facility.
Map 12: Scenario 1: Travel times by bus (mins) (Patient population)




Scenario 2 focuses on which one hospital out of the 31 hospitals that were attended by patients
in the WY case study in Chapter 3 would minimise travel times for the patient and WY population.
Testing Scenario 2 using the WY population data results in the Nuffield Health Leeds Hospital
(one of the private hospitals in WY), shown in Map 6 (p 262) as the optimal location.  The average
travel time to this hospital would be 19.61 mins (SD 9.69) and range 1.6 – 49.8 mins.
The same hospital is selected for scenario 2 when using the patient data, as shown by Map 15.
Average travel times to the hospital for the patients would be 21.37 mins,  range 0.9 – 56.8.  The
results show that the same hospital would have been selected using either the WY population
and  patient data, but that using the WY population data underestimated the travel times for
the patient population.
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Map 14:  Scenario 2: Centralising to one hospital (WY population)
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Using the WY population data the average travel time by bus to reach this hospital in Scenario 2
would be 67.41 mins (SD 33.99) range 6.13 – 165.5 mins with individuals in five zones not be
able to access the hospital in time for a 10 am appointment.  Using the patient data the average
travel times by bus would be 73.14mins (SD 33.74) range 6.13 – 165.3mins and 138 patients
could not make a 10am appointment across 47 zones.   Compared to Scenario 1 the travel times
by car are longer, but the travel times by bus have shortened by 10 minutes, indicating that
changing where patients access healthcare and improving bus travel times, does not necessarily
mean that car travel times will also reduce or vice versa.
Map 16: Scenario 2 - Bus travel times (using the patient population)
In total 81.6% of the patients could access the Nuffield Health Leeds Hospital in <30 minutes.
In terms of accessibility 9.3% of individuals could get to the Scenario 2 hospital by bus in under
30 minutes, 53.9% within 60 mins and 89.0% in 120 minutes.
Scenario 2 as shown in Table 73 increases the percentage of patients travelling  >30 mins in all
groups compared to Scenario 1 with the exception of those in  least deprived quintile who have
a 3.6% reduction in patients travelling >30 mins.  There is also an increase in the percentage of
patients in the most deprived quintile travelling <10 minutes to the hospital (so less) compared
to the current scenario.  On average patients in Scenario 2 would be travelling 6 mins further by
car and 29 mins further by bus compared to the current state.
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When looking to centralise it is unlikely that a private hospital would be chosen as the candidate
hospital.  In particular it is likely to not have the equipment, facilities and expertise for
operations that are straightforward.  This hospital treated 330 patients over the 2009/10 and
2011/12 timeframe (as shown in Table 74)  and replaced 260 hips and 477 knees in 2017 (737 in
total) ((National Joint Registry, 2017).   This makes it less likely that on its own would be able to
meet current and future demand alone and an alternative scenario would be preferred.   This is
a hypothetical scenario, however, given the current hospitals attended by THR and TKR patients
in  WY  it  would  be  the  optimal  location  to  minimise  travel  times  if  treatment  were  to  be
centralised at one current hospital.
Scenario	3:		Attending	the	nearest	hospital	
The analysis in Chapter 3 indicated that 36% of patients attended their nearest hospital.
Scenario 3 minimises travel times by requiring patients to attend their nearest hospital out of
the 31 possibilities.   It is the one scenario that guarantees that no patients will travel any further
than they used to by car (not necessarily by bus).  Using the WY population and restricting
attendance to travelling to the nearest hospital would reduce the number of hospitals attended
down from 31 to 21.  A significant drop of over 10 hospitals (approaching 1/3).   Applying this
Scenario to the patient data results in the same 21 hospitals being selected, as shown in Table
74.  Interestingly one of the main hospitals that is selected both from access by car and by bus
as the nearest is the Leeds General Infirmary.  This hospital only treated 10 of the WY patients
in the case study, this is in part due to Chapel Allerton being the main provider for RA and OA
patients in Leeds.  This scenario may mean that some hospitals that weren’t previously THR or
TKR specialists, might provide a more optimal location (reduce travel times) for patients to
access.  Hospitals such as Airedale General Hospital would under this scenario  only treat 60% of
the WY THR and TKR patients that they actually did treat and others such as Huddersfield who
only had one operation in the WY case study would now be allocated 363 patients.
One of the results is that the optimal hospital in Scenario 2 (Nuffield health Leeds Hospital)
would not have been selected as the nearest hospital by car using either the patient or WY
population data (see table 74), but was identified for some WY zones and patients, as being the
nearest in terms of bus travel times.
In Scenario 3 the average travel time by car for the WY population would be 7.15 mins  and
range 0.94 – 19.88 and average travel time by bus would be 26.5 mins, range 2.67 – 87.61 mins.
Only one LSOA zone (coordinates 410480 eastings and 436381 northings) would not able to
reach the nearest hospital by bus for a 10 am appointment.
280
Using the patient data for Scenario 3 would reduce the average travel time by car to 9.74 mins
(SD 4.45) and range 0 – 34 mins.  It would maximise the ability of patients to attend the hospital
by bus.   Under this scenario only 0.8% would not be able to access the hospital by bus or walking
for a 10 am appointment (if they left their house by 7am).  The average travel time for those
who could make the journey by bus would be 26.9 mins (SD 12.28) range 0 – 102 mins.








No. % No. % No. %
Airedale General Hospital 942 8.10 573 5.70 54 3.89
BMI The Duchy Hospital 76 0.65 34 0.34 1 0.07
BMI The Huddersfield 135 1.16 923 9.18 105 7.57
Bradford Royal Infirmary 1179 10.14 1139 11.33 190 13.70
Burnley General Hospital 11 0.09 17 0.17 3 0.22
Calderdale Royal Hospital 2132 18.34 724 7.20 88 6.34
Chapel Allerton Hospital 1486 12.78 499 4.97 88 6.34
City Hospital Campus 2 0.02 0 0.00 0 0.00
Claremont Hospital 1 0.01 0 0.00 0 0.00
Dewsbury and District Hospital 583 5.01 16 0.16 2 0.14
Doncaster Royal Infirmary 19 0.16 0 0.00 0 0.00
Freeman Hospital 1 0.01 0 0.00 0 0.00
Harrogate District Hospital 1908 16.41 169 1.68 14 1.01
Huddersfield Royal Infirmary 1 0.01 363 3.61 39 2.81
James Cook University Hospital 1 0.01 0 0.00 0 0.00
Leeds General Infirmary 10 0.09 1357 13.50 247 17.81
Northern General Hospital 21 0.18 0 0.00 0 0.00
Nuffield Health Leeds Hospital 331 2.85 0 0.00 0 0.00
Nuffield Health York Hospital 3 0.03 0 0.00 0 0.00
Pinderfields General Hospital 412 3.54 591 5.88 88 6.34
Pontefract General Infirmary 929 7.99 786 7.82 93 6.71
The Yorkshire Clinic 888 7.64 1013 10.08 95 6.85
Rochdale Infirmary 2 0.02 48 0.48 8 0.58
Royal Hallamshire Hospital 2 0.02 0 0.00 0 0.00
Royal Orthopaedic Hospital 3 0.03 0 0.00 0 0.00
Spire Leeds 152 1.31 107 1.06 19 1.37
Spire Longlands 58 0.50 907 9.02 157 11.32
Spire Methley Park Hospital 289 2.49 536 5.33 65 4.69
Spire Elland Hospital 37 0.32 248 2.47 31 2.24
Wrightington Hospital 5 0.04 0 0.00 0 0.00
York Hospital 9 0.08 0 0.00 0 0.00
A number of the patients living at the extreme edges of WY would still find that travelling just
outside of the region would get them to their nearest hospital.  For example, Harrogate hospital
is still the fastest hospital to get to for 169 of the patients and Burnley for 17 of the patients by
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car.  This goes down to 14 patients to Harrogate hospital and 3 to Burnley when looking at which
is the nearest by bus travel time.
If individuals attended their nearest hospital 99.9% would get there < 30 minutes by car and
100 % < 40 minutes by car.  For the bus journeys if individuals attended their nearest hospital
60.1% of then would be able to get there < 30 minutes bus/ walk journey, 98.0%  <60 minutes
and 99% <120 minutes.  As shown in Table 72 this scenario would reduce average travel times
by  car  to  9.74mins  and  bus  to  26.9mins.   Table  73  shows  that  this  scenario  maximises  the
percentage of patients living in the most deprived quintile travelling < 10 minutes (compared to
all other scenarios).   For those living alone 66.6% would be able to access the nearest hospital
in less than 10 minutes.
In terms of centralising care and treatment this scenario does reduce the number of hospitals
that patients would be attending (particularly in the WY region) and might be a more realistic
option than Scenarios 1 and 2 (focusing on 31 down to 21).  The key policy issue will be that
currently as discussed in Chapter 1, patients do currently have some choice over where they
attend and this scenario would remove this.    If looking to cut further the number of locations
that patients attend within WY a better scenario might be to focus on centralising at one of the
existing largest providers in WY.
Scenario	4:	Selecting	one	of	the	7	largest	hip	and	knee	replacement	
providers	as	a	centralised	facility	
Scenario 4 focuses on the travel times if just one of the existing larger hospitals that provides
THR  and  TKR  was  selected.   This  being  a  more  likely  scenario  than  Scenario  1,  which  would
require a new hospital to be built.  Or Scenario 2 which identified a private hospital as the
optimal location.  It is more likely that one of the existing hospitals that currently undertakes a
larger number of THR or TKR would become the centralised hospital.   In total there are 7 NHS
hospitals within WY and Harrogate that over the period 2009/10 – 2011/12 completed over 500
THR and TKR operations, as shown in Table 74.   These are:  Airedale General Infirmary, Bradford
Royal Infirmary, Chapel Allerton Hospital, Calderdale Royal Infirmary, Dewsbury and District
Hospital, Harrogate District Hospital and Pontefract General Hospital.  Table 75 reports the
travel times and distances if all of the patient population attended one of these 7 hospitals.
Table 76 shows the same for the WY population data.  The hospitals that are least accessible for
the patient population and WY population are Harrogate General Hospital followed by Airedale
General Hospital.  As can be seen in Map 6 (page 262) Harrogate General Hospital is north of the
WY boundary and Airedale General Hospital is in the top left of WY.  The average travel time to
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get  to  Harrogate hospital  is  42 mins  and Airedale  40 mins  using the patient  data.   Using the
population data (zones) results in lower travel times and distances compared to using the
patient data.
The hospital that would minimise average travel time by car for the patients would be Dewsbury
District Hospital followed by Chapel Allerton Hospital and Bradford Royal Infirmary.   As shown
in Table 76  average travel times by car to Dewsbury and District Hospital, would be 23 mins if
measured using the patient data and 21 mins if measured using the WY population data.  This
in on average 10 minutes more than the current state.  This would still results in some people
travelling  >  30  minutes  by  car.   Using  the  public  transport  travel  times  as  an  indicator  of
accessibility  if  you  didn’t  have  a  car,  on  average  it  is  quicker  to  get  to  Chapel  Allerton  and
Bradford Royal infirmary than Dewsbury District Hospital, but all three were shown to be the
most accessible.  Airedale and Harrogate had the longest travel times, but also both had over
25% of patients who couldn’t get to the hospital by 10am.  Critically using the WY population
data (zone centroids) as the starting locations did not identify such large numbers of patients
who would find it difficult getting to the hospital on time if they didn’t have a car.
The hospital to patient ratios (what proportion of individuals can get to that hospital in 30 mins
by car and 30 and 60 minutes by bus) for scenario 4 and 5, are provided in
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Table 77.     The  results  in  Table  73  show  that  when  comparing  patient  travel  times  that
centralising the hospital treatment at Dewsbury and District hospital would lead to the lowest
percentage of patients living in the most deprived quintile travelling over 30 minutes by car at
12.3%.  Centralising at Harrogate District Hospital would lead to 91.2% of patients in the most
deprived quintile travelling over 30mins, but less (68.8%) of those in the least deprived quintile
travelling over 30 mins.  Centralising at Chapel Allerton hospital would lead to the highest
percentage of women travelling less than 10 mins to the hospital.  Centralising at Bradford Royal
Infirmary would lead to the highest percentage of men travelling less than 10mins to the hospital.
There are definitely differences across the 7 hospitals by the different groups and inequalities in
the times that patients would need to travel.
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Current State Average 7.23 14.85 (8.5) 44.12 (23.5) 150
(1.4%)Range 0.01 -115.50 0.10 – 175.99 0.24 – 170.81
Airedale General
Hospital
Average 21.08 (8.21) 39.72 (13.65) 116.51 (39.6) 2,784
(27.7%)Range 0.29 – 42.21 2.54 – 77.24 4.2 – 171.8
Bradford Royal
Infirmary
Average 12.90 (6.47) 24.63 (10.70) 85.06 (34.9) 323 (3.2%)
Range 0 – 31.36 0 – 57.72 0.24 – 175.83
Chapel Allerton
Hospital
Average 13.81 (6.39) 24.99 (10.37) 84.26 (37.87) 247 (2%)
Range 0.36 – 33.69 1.33 – 62.27 4.72 – 180
Calderdale Royal
Infirmary
Average 15.62 (7.37) 28.56 (11.78) 98.32 (42.16) 810 (8%)
Range 0.18 – 35.59 1.34 – 62.83 2.87 – 176.05
Dewsbury and
District Hospital
Average 12.34 (5.04) 22.62 (8.49) 87.22 (31.26) 163 (1.6%)
Range 0.15 – 28.80 0.77 – 57.74 1.68 – 179.26
Harrogate District
Hospital
Average 23.75 (6.68) 41.89 (11.14) 113.19 (32.8) 2,775
(27.6%)Range 6.34 – 42.53 12.82 – 79.56 18.13 – 176.0
Pontefract
General Hospital
Average 19.91 (8.45) 33.68 (13.24) 105.38 (44.2) 1,665
(16.6%)Range 0.19 – 41.14 0.96 – 77.62 4.25 – 180















Average 21.04 (7.54) 39.62 (12.58) 119.33 (36.16) 344
Range 0.48 – 41.16 2.63 – 76.77 4.12 – 170.1
Bradford Royal
Infirmary
Average 12.33 (6.30) 23.62 (10.50) 82.26 (34.78) 28
Range 0.27  30.31 1.45 – 54.25 2.92 – 175.77
Chapel Allerton
Hospital
Average 15.20 (6.87) 27.78  (10.99) 79.01 (38.07) 16
Range 0.30 – 32.36 1.86 – 57.00 3.17 – 174.58
Calderdale Royal
Infirmary
Average 12.89 (6.56) 23.34 (10.61) 98.17 (39.86) 71
Range 0.40 – 33.59 1.40 – 55.29 4.04 – 170.45
Dewsbury and
District Hospital
Average 11.45 (4.71) 21.03 (7.92) 82.75 (30.26) 3
Range 0.32 – 25.74 1.28 – 44.43 3.58 – 162.85
Harrogate District
Hospital
Average 23.45 (6.45) 41.33 (10.72) 113.09 (31.07) 324




Average 19.41 (7.72) 32.70 (11.97) 104.13 (40.77) 173
Range 0.45 – 40.78 1.72 – 65.39 4.16 – 179.84
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Table 77: Accessibility index ratios.
Patients in time








1 Harrogate 1,524 95 548







5 Dewsbury and District 8,856 423 1988






Scenario 4 focused on access to each of the 7 hospitals, whereas scenario 5 uses the Location -
allocation model to determine which one hospital would be selected if the aim was to minimise
travel times to one of the seven hospitals.  The Location-Allocation model selected Dewsbury
and District Hospital (as expected as the optimal location under Scenario 4 by travel time) to
send all  the patients  to  as  shown in  Map 17 if  only  one hospital  out  of  the seven was to  be
selected.  The same was selected for the WY population data.  For average travel times see Table
75 and 76 for this scenario.
Given the larger numbers of patients expected to require THR and TKR in the future due to an
ageing population it is more likely that multiple hospital sites would be needed to cover the
demand for THR and TKR  and Location- Allocation models can help with this process.
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Map 17: Centralising to one of the 7 largest hospitals (WY patient data)
Scenario	6:	Optimising	across	two	hospitals	
As one of the key issues identified in Chapter 1 is that the demand for THR and TKR are expected
to increase with the increasing population over the age of 50.   It is more likely that one hospital
will not be able to meet this future demand alone.  The next scenario is to optimise the travel
times  to  more  than  one  hospital.   The  Location-Allocation  function  in  ARCGIS  10.4  was
programmed to minimise the travel times (using the road network) to two locations for scenario
6 out of the 7 possible larger NHS hospital.  Using the WY population data the Location-
Allocation method identified that the two hospitals that minimised travel times by car were















Author: C Kelly, Date: 09_01_2019
Source: ONS, 2011 Census: Digitised Boundary Data
Projection: Transverse Mercator
Projection Coordinate System: British National Grid
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Map 18: Minimising travel time to 2 hospitals (using WY population  data)
Map 19: Centralising services over 2 Hospitals (patient data)
Using the patient data the model selected Chapel Allerton Hospital (Location3) and Calderdale
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average travel time using this option is 18.35 mins by car  and distance 9.67miles.  With the
average travel time to Chapel Allerton Hospital at 19.09 mins and Calderdale Royal Hospital
17.43 mins by car.   The results of this model are shown in Map 19.
Under the scenario of centralising services across two hospitals different hospitals are selected
as the optimal hospitals for the patient vs WY population.  This is partly reflective of patients not
being uniformly located across the LSOA zones.  This should be expected given the age and
gender profile of patients who undergo THR and TKR, as described in Chapter 3 differs from the
general population in age, gender etc…   Given the very specific characteristics of this type of
treatment it may increase the argument for using patient data in these type of analysis and
decision making processes.
When calculating the travel times by bus for the patients to these 2 locations (assuming that
individuals attended the nearest out of the two hospitals) 72 patients could not get to either of
the 2 hospitals for a 10am appointment.  Using the patient data the average travel time by bus
for those who could attended was 60.1 mins.  Using the WY population LSOA zones the average
travel times by bus would be 65.6mins.   The distributions of travel times by bus are presented
in Map 20 for the 2 hospitals for the patient data.   Map 21 shows those locations that could not
get to the hospitals < 60 minutes of bus travel, so identifying potential pockets of inaccessibility.
It  is  not  just  those on the periphery  of  the region that  have longer  travel  times by buses.   A
number of pockets where accessibility is limited can be identified from the maps closer to the
centre.
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Map 20: Scenario 6: Travel times by bus to the 2 hospitals (patient data))
Map 21: Scenario 6: Locations in WY that could not get to either of the 2 hospitals within 60 mins
by bus (patient data
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Scenario	7:	Centralising	over	4	hospitals		
To  meet  a  growing  demand  it  may  be  necessary  and  more  realistic  to  select  more  than  2
hospitals for the WY region and Scenario 7 tests this by selecting four hospitals out of the largest
7.  The Location- Allocation model selected Bradford Royal Infirmary (location2), Chapel Allerton
Hospital (location 3) and Calderdale Royal Hospital (location4) and Pontefract Hospital (location
7) to minimise the overall travel times.  Both the WY population and patient data optimisation
selected the same 4 hospitals out of 7, as shown in Map 23 and Map 22.   Under Scenario 7 the
average travel time would be 13.67 mins and average total distance 6.71 miles) using the patient
data.  Compared to the current state this reduces the average travel times by car.  Using the WY
population data the average travel time across the 4 hospitals would be 12.90 mins and range
1.2 – 31.92 mins.
Calculating the travel times by bus for the patient population for Scenario 7, average bus
journeys of 44.95 mins (SD 21.02) and range 1.25 – 128.34.  Ninety-Four patients could not reach
and of the 4 hospitals in the timeframe.  For the calculations using the WY population only 1
LSOA zone could not reach at least one of these 4 hospitals within the given timeframe of an
appointment at 10 am in the morning.  The average travel times would be 42.49 mins and range
2.86 – 114.7 mins.    The distributions shows how long it would take to get to the nearest of the
4 hospitals by bus using the patient data are provided in Map 24.  Map 24 shows those patients
that would have travel times > 60 minutes by bus.  Therefore identify potential geographical
regions where more support to access healthcare would be needed.
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Map 22: Scenario 7: Centralising services over 4 hospitals (Patient Population)
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Map 24: Scenario 7:  Travel times by bus to the 4 hospitals
Map 25: Scenario 7: Areas that could not get to any of the hospitals by bus within 60 minutes
As summarized in Table 72 this scenario reduces the average travel times by car compared to all
other scenarios (with the exception of scenario 3 - nearest hospital) including the current state.
It does the same for bus travel times and has only marginally longer average bus travel times
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than the nearest hospital.  The results show that only 0.3% of patients would have to travel by
car for over 30 minutes to get to one of these hospitals.  A large reduction compared to some of
the alternative scenarios.
Summary	of	the	scenarios		
A number of scenarios have been tested to see whether this type of data could be usefully used
as a mechanism for prioritising future resources.  One of the key findings from Chapter 3 was
that it was actually the individuals living closest and furthest away from the hospital that had
the worst health outcomes.  Using these scenarios we can have a look to assess whether the
characteristics of the individuals fitting into the > 30 mins and < 10 mins brackets change
dependent on the model used, as shown in Table 73.
Focusing on the scenarios by group.  Chapter 3 of this thesis identified that women were more
likely than men to find accessing the hospital more difficult.  With the exception of Scenario 3,
which required attending the nearest hospital (by fastest travel time) Scenario 7 minimises the %
of women and men who would have to travel to the nearest of the 4 hospitals in a travel time
over 30 minutes by car .  With 0.02% of men and 0.5% of women having a travel time of over 30
minutes.  The next best Scenario is the current status and then Scenario 1 the one ‘super’
hospital where 15.6% of men and 14.6% of women would have to travel over 30 minutes.  As
shown in Table 74 Scenario 7 has a similar average bus travel time to the current status (44.12
mins vs 44.95 mins), but much longer travel times compared to the nearest hospital (Scenario
3), which has travel times of 26.9 mins on average.  Compared to the ‘Super’ hospital the bus
travel times are much lower in Scenario 7 at 44.95 mins vs 81.8 mins.
From Chapter 3 and 4 it was identified that living in a more deprived residential location was
associated with poorer health and wellbeing outcomes, so it would be good to see whether any
of the scenarios are worse or better for this group of patients.   As shown in Table 73 45.1% of
patients living in the most deprived quintiles are < 10 minutes away from the hospital in the
current scenario.  Requiring patients to attend their nearest hospital (Scenario 3) increases this
to 75%.  All the other scenarios reduce the % of patients in the most deprived quintiles that are
travelling the least (< 10 minutes).  Under Scenario 4, 91% of those in the most deprived quintile
would have to travel > 30 minutes to get to Harrogate District Hospital compared to 68.8% in
the least deprived quintile.  The hospital in Scenario 4 that maximises the number of patients
travelling < 10 minutes in the most deprived quintile is Bradford.  Here 17.3% of those in the
most deprived quintile are travelling < 10 minutes compared to 1% of those in the least deprived
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quintile.  It is shown in Table 73 that scenarios that are minimising driving time do not have the
same impact across all deprivation groups.
Living alone, was shown in Chapter 3 to have a negative association with ease of access.
Individuals  living  alone  were  more  likely  to  report  that  it  was  harder  to  access  the  hospital.
Under the current baseline scenario 33.1% of those patients that live alone are travelling < 10
minutes and 3.9% over 30 minutes.  Under Scenario 1 (‘super’ hospital) less patients living alone
are  travelling  <  10  minutes  to  the  hospital  and  more  are  travelling  >  30  minutes  (13.4%).
Scenario  2  increases  the number travelling  <  10 minutes  (compared to  Scenario  1),  but  also
increases the number of patients travelling > 30 minutes (compared to Scenario 1).     Scenario
3 (nearest facility) results in 66.6% of those patient that live alone travelling < 10 minutes.  Under
Scenario 4 Chapel Allerton Hospital has the highest percentage of patients living alone with a
travelling time of < 10 minutes (10.8%).  Dewsbury has the lowest percentage of patients who
live alone travelling > 30 minutes.      Harrogate and Airedale have the highest percentage of
patients living alone travelling > 30 minutes under scenario 4.     Scenario 6 has a higher
percentage of patients living alone travelling < 10 minutes and lower percentage of patients
travelling > 30 minutes compared to scenario 1, 2, 4 and 5.      Under Scenario 6, 17.7% of patients
who live alone would be able to get to the hospital in < 10 minutes’ drive time using the road
network.    This increases to 31.2% in Scenario 7.    This is very close to the current state of 33.1%
and reduces the percentage travelling > 30 minutes from 3.9% in the current state to 0.7% in
Scenario 7.
The results in Chapter 3 showed that White British patients travelled further to the healthcare
facilities that those who were classified as non-white British.  How the scenarios impact on those
in the non-white British category are shown in Table 73.  In the current state 43.5% of non-white
British Patients would have travelled < 10 minutes to have their THR or TKR operation and 3.9% >
30 minutes.  Changing this to Scenario 1 results in only 8.4% now travelling < 10 minutes and
13.4% > 30 minutes, so patients would have to travel further.  Under Scenario 2 more non-white
British  patients  (than  Scenario  1)  are  travelling  <  10  minutes,  but  more  are  travelling  >  30
minutes.  Under Scenario 4 centralising at Bradford would have the highest percentage of non-
white British patients travelling < 10 minutes, but centralising at either Chapel Allerton Hospital
or Dewsbury and District hospital would result in a lower percentage of non-white British
patients having to travel > 30 minutes 27.6% (Chapel Allerton Hospital) and 13.3% (Dewsbury
and  District).   Scenario  3  (centralising  at  2  hospitals)  results  in  19.5%  of  non-white  British
patients travelling < 10 minutes and 7.6% over 30 minutes.  Whilst 29.8% of non-white British
patients would have had a journey of < 10 minutes under Scenario 7.
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Testing	the	scenarios	to	predict	the	impacts	on	health	outcomes		
This Chapter has so far focused on the changes in travel time and distance as a result of changing
where patients access healthcare, but in terms of answering the research question the key
question is:
Do these changes make any difference to patient’s health outcomes?
Using the regression models developed in Chapter 3 this section predicts the change in health
outcomes from changing where patients attend healthcare facilities.
Firstly, the results focus on the impact on LoS in hospital for the WY THR and TKR patients.  The
model predicts that under the current scenario the average LoS in hospital for a patient
undergoing a THR is 5.329 days and for a TKR is it higher at 5.511 days, with non-overlapping 95%
CI.  Out of the 10 scenarios tested there is a predicted difference of 1.61 days in hospital between
the lowest and highest THR scenarios and a predicted difference of 1.60 between the lowest and
highest for TKR.  In terms of cost to the NHS 1.60 days as an inpatient is around £400 per day,
so £640 between the highest  and lowest  averages(NHS,  2018 ).   In  terms of  the cost  to  the
patient staying longer in hospital has been shown to have a negative effect on health and
wellbeing.  For example, Ferrando et al. (2008) found that bed rest in hospital for over 10 days
can lead to 10 years of muscle decline in otherwise healthy older adults.  The results show for
the model where everyone is sent to Airedale hospital (scenario 4a) for their TKR this would
result the longest average stays in hospital at 7.103 days compared to the currents state of 5.51
days.  For THR the longest LoS would be to send everyone to Pontefract Hospital, as shown in
Table 81, closely followed by Harrogate (scenario 4f).  Centralising at four of the seven largest
NHS hospitals increases the LoS for the THR by 0.255 and TKR by 0.296 of a day compared to the
current state.
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95% CI Average LoS 95% CI
Sample 4,855 5,590
Current State 5.329 5.286 – 5.372 5.511 5.475 – 5.548
Scenario 3: Nearest 4.878 4.837 – 4.921 5.501 5.470– 5.561
Scenario 4a: Airedale 6.368 6.325 – 6.410 7.103 7.06 – 7.146
Scenario 4b: Bradford 5.899 5.850 – 5.948 6.137 6.092 – 6.181
Scenario 4c: Chapel Allerton 5.485 5.424- 5.545 5.649 5.609 – 5.690
Scenario 4d: Calderdale 6.142 6.095 – 6.189 6.417 6.374 – 6.460
Scenario 4e Dewsbury 5.652 5.606 – 5.698 6,142 6.104 – 6.179
Scenario 4f: Harrogate 6.431 6.374 – 6.488 6.784 6.748 – 6.821
Scenario 4g: Pontefract 6.488 6.437 – 6.538 7.042 6.999 – 7.085
Scenario 5:  7 largest NHS 5.541 5.501 – 5.581 5.850 5.818 – 5.881
Scenario 7: Centralising at 4
hospitals
5.584 5.545 – 5.623 5.807 5.774 – 5.839
The results for predicting changes in OKS for the TKR are shown in Table 79.  Using the predictive
model it can be seen that the scenario whereby everyone is sent to Airedale hospital would have
the  lowest  average  positive  change  in  OKS  (13.667)  as  a  result  of  the  TKR  compared  to  the
current  state  (15.473).   A  difference of  2  points  on average.   Under  the asymmetrical  losses
versus gains arguments made in section 3.4.3  a difference of 2 points as a ‘loss’ could be argued
to be beyond the MCID and represent a significant difference.  Limiting the number of hospitals
within the WY region could have an impact on health outcomes. The scenario that limits the
hospitals attended to four (scenario 7) has changes in OKS for the TKR at a similar level to the
currents state (difference of 0.388).  This could show that minimising the hospitals in this way is
less likely to have a detrimental impact on health outcomes.  Whilst still needing to assess what
the impact on this might be from changing the number of patients at each hospital.
The results for THR patients focusing on the changes in OHS are shown in Table 80.  As shown in
the original results tables in Chapter 3 patients tend to have better health outcomes for THR
than TKR.  This is seen in the higher predicted change in OHS following the THR compared to
Table  79  above  for  TKR.   The  difference  in  predicted  average  health  change  in  OHS  for  the
current state is 20.394 and the lowest change is for scenario 4f Harrogate at 18.861.   Whilst
again not a large difference in the average change score, but a statistically significant difference
as the 95% CI do not cross.  It may be possible to limit the number of hospitals (as was the case
in the Manchester and London stroke centralisation examples) and achieve very similar
predicted health outcomes to the current state.  This of course only considers the perspective
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of assumed gains from increasing the numbers treated at each hospital and minimising travel
time.




Current State 15.473 15.359 – 15.586
Scenario 3: Nearest 15.261 15.147 – 15,374
Scenario 4a: Airedale 13.667 13.551 – 13,783
Scenario 4b: Bradford 14.739 14.623 – 14.854
Scenario 4c: Chapel Allerton 15.278 15.161 – 15.394
Scenario 4d: Calderdale 14.421 14.305 – 14.538
Scenario 4e Dewsbury 15.091 14.976 – 15.206
Scenario 4f: Harrogate 13.971 13.857 – 14.086
Scenario 4g: Pontefract 13.996 13.879 – 14.114
Scenario 5: Nearest of 7 largest by car 15.134 15.021 – 15.247
Scenario 7: Centralising at 4 largest hospitals 15.085 14.972 – 15.198




Current State 20.394 20.206 - 20.503
Scenario 3: Nearest 20.348 20.199 – 29.497
Scenario 4a: Airedale 19.005 18.85 – 19.154
Scenario 4b: Bradford 19.861 19.713 – 20.010
Scenario 4c: Chapel Allerton 19.792 19.585 – 19.998
Scenario 4d: Calderdale 19.591 19.442 – 19.740
Scenario 4e Dewsbury 20.072 19.923 – 20.222
Scenario 4f: Harrogate 18.818 18.669 – 18.967
Scenario 4g: Pontefract 19.164 19.012 – 19,316
Scenario 5: Nearest of  7 largest by car 20.282 20.133 – 20.430




As identified in this thesis there are certain groups of individuals including those who may not
have access to a car that are more likely to find it harder to access the healthcare facilities.  If it
was  possible  to  identify  those who were more likely  to  find it  harder  to  access  the facilities
targeted support could be put in place.  This sub set of the population could also then be used
as the target for where hospitals should be restructured rather than having to base the decisions
on the whole population of patients.  In doing this this would be directly targeting inequity.
Iteration 10 was selected from the 30, to be used in the analysis, as it had identified that lowest
percentage of patients who were more likely to not have access to a car (15.5%).  A summary of
the population with and without a car in iteration 10 is provided in Table 81.     It shows that on
average individuals who were estimated to not have a car lived closer to the hospital that they
attended  for  their  THR  or  TKR,  were  more  likely  to  attend  their  nearest  GP,  had  a  higher
percentage of females than males, were likely to be older and  live in a more highly deprived
residential area.  The model estimated that a much lower percentage of men than women had
no access to a car.  This is likely to be an underestimate, as if the man is the main driver and is
the one having a THR or TKR then they would be unable to drive and so would have to use an
alternative form of transport.
Table 81: summary of estimated population with and without a car
No car/ van availability Car availability
Total 1,547 8,924
Travel time to hospital 13.84 mins 15.06 mins
Attended the nearest Hospital 38.3% 35%
Attended the nearest GP 90% 86%
Travel time to the GP 14.78 mins 16.32 mins
Female 22% 78%
Male 11% 89%
Age (years) 72.29 67.49
Index of Multiple Deprivation 30.16 21.46
Living alone 39.8% 60.2%







If an individual had access to a car or someone to drive them, then not being able to get to the
appointment by bus would be less of an issue, but based on the knowledge that a large number
of households in WY do not own a car this is more of an issue.    Whilst Chapter 3 showed that
travelling further had a negative association with patient’s health outcomes for those travelling
the furthest.  Chapter 4 highlighted that actually it is those who find accessing healthcare the
most difficult that was associated with poorer health and wellbeing outcomes, with travelling
potentially further contributing to this.  When targeting where to locate healthcare services it
could be potentially more beneficial to base the change around minimising the impact on those
who fit into these categories (those finding it harder to access the healthcare facilities).  In
particular individuals with mobility issues (e.g. reduced ability to walk), those without access to
a car and those who would rate being able to access hospital as difficult.  This section uses the
subset of patients identified using the missing data analysis, as estimated as being more likely
to not have access to a car when needed.  It then applied this new population (subgroup no car)
to the original scenarios which now have a label nc (no car) next to them.  A summary of the
results for the set of scenarios based on the non-car owners is provided in Table 82.
Scenario	1nc:	One	new	hospital	
The scenarios are repeated for this new comparison.  The previous analysis looked at where you
would locate a hospital if you wanted to minimise the travel times for all patients.  Under this
scenario it is minimising the travel times for those patients who have been estimated would not
have a household car to get to the appointment.  The average travel time by car would be 21.63
and range 3.63 – 48.03 mins, with journey times by bus at an average 80.56mins.   Applying this
location then to those who were estimated to have a car would result in an average travel time
of 22.29 and range 2.61 – 50.41.   On average using this method those in the car available group
would have higher average travel times than those estimated to not have a car.    Compared to
determining this new hospital based on the complete patient population (as shown in Table 72)
the average travel times by car would increase, but the average travel times  by bus for those
who were estimated to not have a car would decrease.
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Table 82:  Which scenario is best for non-Car owners? (95% CI)
Estimated car
owners
Estimated Non Car Owners




















































































Scenario 5: One of 7 by
car
Dewsbury and District























Using the sub set of patients estimated to not have a car the one existing hospital that minimises
travel time by car for non-car owners is the private hospital Spire Methley Park a different
hospital to Scenario 2.  The average travel time for those to Scenario 2nc is 21.63 mins (SD 9.47)
and range 0.9 – 54.19 mins.  Average distance 11.81 miles (SD 5.73) and range 0.3 – 30.11.  If
the non-car owners travelled by bus the average travel times would be 76.56mins, so faster
travel times by bus than Scenario 1nc.
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Scenario	3nc:	Attending	the	nearest	hospital	
For Scenario 3 as expected attending the nearest hospital reduces overall travel times compared
to the baseline scenario.  In the total patient population presented in Table 72 the average travel
time to the nearest hospital was 9.74.  Splitting this up by those patients estimated to have a car
and those estimated to not have a car (as shown in Table 82) indicate that those non car owners
would have a longer average travel time by bus and car to the nearest facility compared to the
car owners.   The average bus travel time if everyone had travelled by bus using the patient data
was 27.3mins.  Under this scenario 13 patients who did not have a car would also not be able to
get to the hospital by bus for the 10am appointment.
Scenario	4nc	and	Scenario	5nc:	Centralising	at	one	of	the	7	largest	hospitals	
and	Scenario	5nc	
Focusing on the largest of the current hospitals and focusing on scenario 4 (a-g) and Scenario 5,
we can see how many of those who we have estimated to not have a car would not be able to
make an appointment by 10am, as shown in table 80.  It can be seen that Dewsbury Hospital has
the lowest number of non-car owners who could not get to a 10am appointment, with Harrogate
having the largest at 478.  This differs when considering the shortest average bus travel times
whereby, as shown in Table 83 Scenario 4b Braford Royal Infirmary has the shortest average bus
travel times.  This differs from focusing on the fastest travel times for those with a car, which
would select Scenario 4e Dewsbury and District.  It also differs from the results in Table 72 where
the fastest average travel times by bus for the total patient population would have selected
Scenario 4c (Chapel Allerton Hospital) and not Bradford, as having the quickest travel times by
bus.  In terms of WY patients travelling to hospital by bus there are large differences in the ease
of access by bus to these different hospitals (as shown in Table 83).
302
Table 83: Individuals estimated to not have access to a car focusing on bus travel





could not get there
OR  bus travel time
> 1 hours
a) Airedale General Hospital 377 1,290 91.7%
b) Bradford Royal Infirmary 32 1,045 57.7%
c) Chapel Allerton Hospital 36 1,314 69.92%
d) Calderdale Royal Infirmary 77 1,427 81.12%
e) Dewsbury and District
Hospital
25 1,546 81.12%
f) Harrogate District Hospital 478 1373 95.6%
g) Pontefract General Hospital 297 1365 84.3%
Scenario	6nc:	Centralising	at	2	hospitals	
Minimising the travel time for non car owners resulted in Calderdale and Chapel Allerton
Hospitals being selected.  The average travel time by car to these hospitals for those patients
who were estimated to not have access to a car was 17.95 mins and range 0.98 – 43.53, whilst
making  those  same  journeys  by  bus  would  take  on  average  45.11  mins  with  15  patients
estimated not to have a car and also not able to make a 10 am appointment by bus even if they
left at 7am in the morning, as shown in Table 82.  For those patients that were estimated to
have access to a car these two hospitals would result in an 18.04 min average journey (SD 7.97)
and range 1.07 to 50 mins.  Or 9.49 mile on average journey by car range 0.23 miles to 25.49
miles.
Scenario	7nc:	Centralising	at	4	hospitals	
For scenario 7nc: the location allocation method prioritising non car owners selected Pontefract,
Bradford, Chapel Allerton and Calderdale as the 4 hospitals.  These were the same hospitals, as
selected using the total patient population.  The average travel time by car for those estimated
to not have a car was 13.61 minutes and by bus 45.11 mins.  This resulted in a faster travel time
by car than the current state (where they actually attended), but a slower travel time by bus.
For  the  estimated  car  owners  the  travel  times  to  the  closest  of  these  four  hospitals  was  on
average 13.73 mins.
Summary	of	scenarios	for	non-car	owners		
By identifying who we think does not have access to a car (in the absence of perfect information)
we can narrow the resources put into targeting centralisation policies and target those that
would find it hardest to reach the healthcare facilities to minimise the burden.  Using this
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method it would be possible to target the reconfiguration of healthcare services to reduce the
travel  time by bus  or  car  for  those who would find it  harder  to  access  the hospital,  but  also
identify which patients who do not have a car and could not get to the hospital by bus are likely
to live.
5.6 Does	it	matter	how	individuals	travel?	
One of the criticism of the majority of the papers in the systematic review presented in Chapter
2 was that they made the assumption that patients travelled by car to hospital.  This was due to
not having enough data to divide up the patients into different travelling modes and calculate
travel times and distances accordingly.  This is also one of the problems with the HES-PROMS
dataset reported in Chapter 4, which collected no information on how patients travelled to
hospital.  This is a large gap our the knowledge, given that we know there is a large disparity
between the travel times and distances using public transport to get to hospital and travelling
by car and the journey times by the patient transport services, which make up a large proportion
of  travel  to  hospital  for  patient  journeys.   The Yorkshire  Ambulance Service  carried out  over
886,312 patient transport service journeys alone in 2013/14 (NHS, 2018), for purposes of getting
patients to and from outpatient clinics, to admitted patient treatment and treatments including
dialysis and chemotherapy.   Given that patients currently have a choice over where they attend
this means that the Yorkshire Ambulance Services (as an example) could be required to drive
patients to wherever in the country they had chosen to attend, at no cost to the patient.  Whilst
it was not possible to know which patients had travelled to their inpatient appointment for their
THR or TKR by PTS, we know from Chapter 5 that a large number of people with a car are using
the service.
 In order to compare travel times by the different modes (car, bus and PTS) the PTS logs for one
of the hospitals used in the WY dataset (Chapel Allerton), were analysed to see for each journey
made in 2017 what was the travel time by PTS to get to the hospital.  The comparable car and
bus journey times were then calculated using the methods described in Chapter 3 for
comparison.  This dataset included all patient journeys by PTS to Chapel Allerton Hospital and
was not restricted to those travelling with OA or RA (as this data was not available).  The data is
summarized in Table 84.
The results show that on average it is 20 minutes quicker to travel to the hospital by car than
bus (using the bus schedule) and on average a further 6 minutes longer on average using the
PTS.   For the 48 patients who couldn’t get there by bus the average travel time by PTS was 68
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mins and drive time 35.62 mins.  In terms of PTS this doesn’t include the waiting time for the
service to arrive, or the waiting time at the end of the appointment to actually get on the bus,
so maybe an underestimate of the total time.  This analysis using Chapel Allerton PTS data shows
comparable bus and PTS travel times, but do highlight the inequalities when comparing those
who can travel by car and those who travel using the PTS or public transport.
Table 84:  Comparing PTS, bus and car travel times to Chapel Allerton Hospital
Journeys
Sample = 9,567
Bus travel time* Car travel time Time on the PTS (mins)
Inwards Outwards






Range 3 – 174 2.02 – 49.4 1 - 273 1 - 223
* Forty-Eight journeys could not get to the hospital by bus and were excluded
5.7 Discussion	
This chapter has sought to develop and apply different scenarios for reconfiguring where WY
patients would access the hospital for THR and TKR and apply a method to estimate which
patients are more likely to not have access to a car when needed.    Some key observations that
have emerged from the results are discussed next.
Patient	vs.	population	data		
The type of data used is critical.  The analyses revealed differences in the results dependent on
whether patient data or WY population data was used.  One of the major discussions in Chapter
3 was of the time intensive nature of getting access to patient level data, which required high
level ethical approval.  The results using the patient data allowed the results to be more specific
to the geographical distribution of the patients and target where the demand is located.  Plus it
allows the decision makers to identify key locations with limited accessibility (ability to get to
the healthcare facility).   As described in Chapter 3 the profile of patients who undergo THR and
TKR does differ from the general population in WY, which is also shown by the Arthritis calculator
results presented in Chapter 4, whereby the five different districts of WY (Leeds, Bradford,
Calderdale, Wakefield and Kirklees) had differing level of population arthritis.  The differences
were also highlighted by the Hot spot analysis presented in Map 7, which showed that some
LSOAs had higher than expected numbers of patients with THR/ and others lower than expected,
so not uniformly distributed by LSOA.  Also highlighted by the fact that scenarios presented in
this chapter show that Scenario 6 (centralising at 2 hospitals) resulted in different hospitals being
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selected (as the optimal locations that minimised road network travel time) based on the two
different population groups (WY patients and WY population).  However, Scenario 7 which
optimised travel times across 4 hospitals in WY selected the same 4 hospitals for the patient
data and population data.  Does it matter?  The answer depends on which type of
reconfiguration is being applied.  In this case study it did not make any difference in the decision
for some of the scenarios, as shown by Scenario 2 (selecting one of the existing hospital) and
Scenario 7 (selecting 4 hospitals).  However, for Scenario 6 modelling using the patient dataset
and WY population dataset resulted in selecting 2 different hospitals.  In addition the WY
population data underestimated how long it would take patients to get to the hospitals (both in
terms of car and bus travel time).  For example, under Scenario 1 the average travel time by car
for the patient population using home postcodes was 20.62 minutes, but for the WY population
it  was  16.86 mins  (difference of  over  4  minutes).   In  this  case it  underestimated how long it
would take, but under scenario 6 it over estimated.  In reality without having access to the
patient data in the first place it was not possible to know how distributed across WY the patients
were to make a decision on this.  Although the data from the Arthritis UK Calculator which is
available now at the CCG level would have given a guide at the district level.
Is	changing	the	hospital	attended	associated	with	different	health	
outcomes?	
The study tested a number of scenarios in this Chapter to assess whether changing where
patients attended hospital would be associated with differences in travel times, with
accessibility identified as one of the key drivers for reconfiguration.  The ultimate goal was to
assess whether this would ultimately be associated with changes in patients’ health outcomes.
Using the predictive models from Chapter 3 allowed this process to be operationalised.  The
results give an indication that by changing where patient’s access healthcare it is possible to
predict changes in LoS, OKS and OHS following a THR or TKR.
One of the limitations of the scenarios is that they limited changes to within the WY region, so
limited the ultimate travel times that patients would have to travel to get to the reconfigured
healthcare facility.  The furthest any one patient would have to travel would be 42 miles and
79.5 mins.  In the literature more extreme cases of getting patients to specialist hospitals are
witnessed,  for  example  one  patient  in  Kerschbaumer  et  al.  (2012)  travelled  870km  to  the
specialist hospital for brain surgery.  The review in Chapter 2 did show evidence that patients
are willing to travel further depending on the severity and urgency of this healthcare need.  This
may be less pertinent for operations such as THR or TKR where it is an elective surgery.  This
willingness to travel further depending on the risk is also shown by research published by
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Vallejo-Torres et al. (2018) which found using discrete choice experiments that patients were
willing  to  travel  up  to  75mins  to  reduce  the  risk  of  complications  of  1%.   It  is  with  this
understanding that whilst an association between travelling further and lower quality of life has
been presented within this thesis, the other side of the coin is the level of care and specialist
team that the patients receive in the healthcare facility that they attend.  Whilst a number of
the scenarios have targeted increasing the numbers of patients that any one hospital would see,
which has been shown in the literature to improve health outcomes (Katz et al., 2001; Hervey
et al., 2003).  It has not been possible to look at all four sides of the reconfiguration process;
accessibility, workforce, quality and cost, which would have needed to have been targeted using
alternative research approaches than the secondary datasets that were used.
Restructuring	where	patients	attend	hospital	
This chapter tested a number of scenarios to focus on how healthcare services could be
restructured and then evaluated in terms of its impact on different groups in society.  Critically
Chapter 3 and Chapter 4 showed that certain groups in society have worse health and wellbeing
outcomes (e.g. those living in more deprived residential location or living alone).  This study
allowed a comparison not only between the different scenarios in terms of how travel times
varied, but also how the different groups were negatively or positively affected by these
scenarios.  This is a real strength of this applied method.  The policy of getting patients to attend
their nearest hospital reduced the number of hospitals attended and also made travel by bus
and car an easier option in terms of reduced travel times.  This would however, require both a
change to the NHS constitution and to enforce that certain hospitals to change the volume of
patients that they offered THR and TKR operations to.  For example, the LGI in Leeds was the
nearest hospital for a large number of the patients, but only undertook 10 THR or KR operations
in the timeframe 2009 – 2012.  The study showed that centralising the hospitals at 4 of the main
hospitals in WY that currently do HR and KR operations resulted in lower average travel times
by car and almost identical average travel times by bus to the baseline scenario (where patients
currently attend –across 31 hospitals).
Focusing reconfiguration around those patients who would find accessing the healthcare
facilities harder seems intuitively sound.  It is worth noting that this part of the analysis was only
possible using the patient data, as it required additional information about the patients (e.g.
living alone, ethnic group, age, gender etc..) to be able to use the missing data methodology.
The results of comparing using the patient population vs. basing the decisions on the subset
estimated to  not  have a  car  did  result  in  differing solutions.   This  could  be a  method that  is
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developed further.  It worth remembering that these scenarios were hypothetical, but based on
real patients and the hospitals that they could have attended.  The method could be applied to
real decisions that are currently being made.
How	do	patients	travel?	
Does it matter? Clearly if decisions are being made on the basis of travel times using a car as the
fastest  way  of  getting  to  hospital  then  those  patients  who  do  not  travel  by  car  are
underrepresented in the travel times required to get to hospital.  For example, assuming the
patient population all travelled by car would have resulted in an average travel time per patient
to get to their HR or KR for Scenario 1 of 20.62 (as shown in Table 74).  If we assume instead that
those patients estimated to not have a car (1,546) all travelled by bus and those estimated to
have a car travelled by car travelled by car (the remainder)  the average travel time would then
be  29.62 mins.  These are similar proportion of car and non car owners as report in other studies
(Campbell et al., 2001)As the SEU(2003) reported a large percentage of patients have difficulties
accessing healthcare facilities.  Chapter 4 has shown that a large number of patients do not have
access to a car when needed.  As shown by the Chapel Allerton Hospital case study there is also
significant differences in the travel times that different patients have to travel to get to hospital
(whether by car, bus or PTS).  The missing data methodology allowed the study to test a method
that has not previously been applied to estimate those who would find it harder to access the
hospital  due  to  not  having  a  car.   This  tried  to  reduce  the  issue  of  not  having  the  perfect
information.  It should matter, as a critical element of the treatment process – needing to get to
the appointment or in the case of the GP make the appointments as the first step in getting
referred.  Given that the NHS is currently paying to transport patients to their inpatient,
outpatient appointments (with patients having a choice about where they can go) an evaluation
of this impact of this on the costs and health outcomes is needed.  For example - Do those who
travel by PTS have worse outcomes?
What	about	restructuring	other	healthcare	facilities?	
Whilst the focus of this chapter has been on where to locate secondary healthcare facilities and
who might be affected, the thesis has shown that actually for patients with OA or RA it is access
to the GP (as the gatekeeper to the treatment) that might be the critical healthcare facilities to
access.  This is important given Patient Transport Service is available to get to the Hospital, but
no such service exists for getting to the GP (although some GPs do do home visits).  Whilst as
both the Chapter 3 and 4 case studies have shown that on average individuals, as might be
308
imagined living closer to the GP than the distance would be needed to get to the hospital, there
may still be a burden of getting there, as the distance of 1 mile to the GP might be as hard for
an individual without a car as not being able to walk beyond 400m and having to travel 10 miles
to the hospital by car.   As shown by the GC function described in Chapter 1, restructuring that
changes where patients access healthcare facilities, if it has an impact on the cost of travel, the
time is takes, the levels of comfort, changes to an area unknown by the patient etc.… then it is
likely to alter how easy it is to access the  healthcare facility.  As this thesis has shown there is
some evidence that making the ease of access more difficult is associated with worse health
outcomes.   Policies  such  as  longer  opening  hours  for  GPs  (NHS  England,  2018a),  will
disadvantage  certain  groups  if  the  transport  is  not  available  to  match  the  new  times  of  the
appointments (e.g. late at night or Sunday travelling), both of which have been associated with
reduced public transport scheduling and night-time travel associated with increased fear of
travelling (Dobbie et al., 2010)
5.8 Conclusions	
This chapter has applied a number of methods to explore the potential impacts on patients and
the WY population of restructuring where they access healthcare facilities.  In particular it has
used Location-Allocation tools to optimise locations of healthcare facilities to minimise road
network travel times.  Critically it has then focused on whether different groups (e.g. those in
more deprived residential locations) would be negatively affected and whether this differs by
scenarios and predicted whether these changes would be associated with changes in the health
outcomes.  One of the key issues raised in this thesis is that we do not know how these patients
are travelling to the healthcare facilities.  Planning healthcare services based on the quickest
travel times by car is no longer a valid option given the large numbers of the population who do
not have access to a car, not considering the alternative methods will put increasing demands
on a cost to the NHS (the PTS to transport patients to their appointments).  This chapter tested
a method to estimate which patients are more likely not to have access to a car, which in the
absence of perfect information could be used to target restructuring policies towards reducing
the travel burden for this group in society.  Using the methods applied in this chapter would
allow decision makers to look at potential options and also focus in on those patients that may




This final chapter provides a summary of the thesis, its key contributions, strengths and
limitations. This is followed by a discussion of how this work could be taken forward in the future
and policy implications.  Finally, overall conclusions arising from the work are presented.
6.2 Summary	of	the	thesis	
The aim of this thesis as described in Chapter 1 was as follows:
To investigate the association between transport accessibility to healthcare and health
inequalities for individuals with RA and OA.
To meet this aim this thesis was split into six chapters, which are summarised below.
Chapter 1 described the potential determinants of health and health inequalities.  Studies in the
literature have shown that patients living further away from the healthcare facilities that they
need to attend had poorer health outcomes.  Such findings suggest that transport accessibility
to healthcare facilities is inherent in this and therefore a potential determinant of health
inequalities that merits further investigation.  This is particularly true, in the context of policies
such as centralisation of services, whereby changes to where patients receive healthcare have
the potential to result in differences in access to healthcare.   Whilst it is not realistic to expect
equal travel times or distances from each patient’s home address to each hospital (inherently
there will always be some inequalities in terms of travel times or distances) the chapter
established that the impact on health from living further away should be evaluated and, where
policy changes are being made, consideration should be given to reducing inequalities.
Chapter 2 presented the results of the systematic review that was designed to bring together
studies that had directly considered the association between differences in travel times and
distances to healthcare and potential inequalities in health outcomes (or proxy outcomes) in
Global North countries. Significantly, no prior studies were identified that had considered the
OA or RA disease groups, with the majority of studies instead focusing on cancer.
Chapter 3 presented the results of the first case study (WY HES-PROMS) focused on patients
with OA who had had a HR or KR.  It analysed , whether those living further from the GP had
differences in baseline health, and whether the change in health following the operation were
associated with differences in travel times and distances to the hospital.
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Chapter 4 presented the results of the second case study using the participants in the ELSA data
for individuals over the age of 50 years old who had either RA or OA.  Using Wave 5 of the ELSA
the  study  explored  whether  travel  times  to  the  healthcare  facilities  (GP  and  Hospital),  were
associated with inequalities in health and wellbeing.  Going further than Chapter 3, it explored
whether a broader definition of ‘ease of access’ would actually be more applicable,  as living
further away is only one aspect of what can make getting to the GP or hospital more difficult.
This chapter identified some key predictors of individuals who would not have access to a car
and highlighted problems with the extant assumption made in the majority of studies in Chapter
2 that all patients can get to the hospital directly using their own car.
Chapter 5 developed and tested a number of scenarios to assess the impact on patient travel
times (by bus and car) that would result if changes were made to the locations of the THR and
TKR operations.  This compared both the HES-PROMS WY data (patient population) from
Chapter 3 with using the WY LSOA centroid based population (WY population).  An assessment
was made concerning whether the different scenarios affected groups in society (e.g. gender,
age, deprivation) differently, as identified from the key groups identified that are associated in
the literature with health inequalities (discussed in Chapter 1).   The predictors of who were
more likely to not have access to a car when needed (developed in Chapter 4) were applied to
the WY HES – PROMS dataset using missing data methodology to make an assessment (in the
absence of perfect knowledge) about those patients that are more likely to have not travelled
by car.
Chapter 6 summarises and presents together the key findings.  It discusses strengths and
limitations of the research, policy implications, and possible ways of taking forward the work
presented in this thesis.
6.3 Summary	of	Research	findings		
To meet the main aim of this thesis the study was divided into 4 key objectives.  A summary of
the findings established in the individual chapters of the thesis that contribute to each of these
objectives is presented below.
Objective 1: To undertake a systematic review to provide evidence concerning the association
between transport accessibility to healthcare and health outcomes.
Chapter 2 presented the results of the systematic review to meet this objective.  The key findings
from the systematic review revealed that the majority of studies (77%) showed evidence of an
association between inequalities in health outcomes (poorer health outcomes) the further a
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patient lived from the healthcare facilities that they needed to attend.  The majority of studies
focused on cancer patients.  No studies were identified that had considered patients with
arthritis (OA or RA).  Ninety-five percent of the studies assumed that patients would travel by
car. A lack of information regarding how patients have travelled, and the underlying assumption
that they can get to the hospital directly by car, has the potential to challenge the external
validity of their findings and was identified as a limitation in a number of the studies.
The review highlighted some of the problems when using secondary datasets, especially where
there is incomplete data, e.g. not knowing which hospital or GP that the patients attended, and
simply assuming that they attended the nearest. The findings showed that it is not just about
identifying patients who have to travel the furthest, as there was evidence of patients living in
close proximity to the healthcare facilities often fairing the worst.  For example, Kim et al. (2000)
presented a nonlinear association where those living the closest and furthest away had poorer
health  outcomes.   This  was also  identified in  the research presented in  this  thesis.    Using a
continuous travel time measure in some cases hid the more complex association between
distances and travel times and health outcomes.
The review in Chapter 2, surveyed the growing body of studies that have provided evidence of
travelling further to healthcare being a determinant of health inequalities and highlighted the
need to expand this evidence base particularly for disease groups that had not been considered.
It is important to note that the systematic review had mixed results with a number of studies
reporting no evidence of an association, five cancer studies showed as travel times increased
health outcomes improved and some found a U shape association.
Objective 2:  To explore and document the healthcare needs and transport accessibility to
healthcare of patients with OA and RA
As described in Chapter 1 patients with OA and RA are treated in different ways and are
associated with different health outcomes and demands (Figure 4 (page 32) for OA and Figure 6
(page36)  for  RA).   The  key  commonality  is  the  GP  as  the  Gatekeeper  with  patients  being
potentially diagnosed by the GP in the case of OA patients and being referred to a specialist in
the case of RA patients. Chapter 4 provides the most comprehensive comparison between
individuals with RA and OA and the general population over the age of 50 years old, including
information about how the individuals travelled.  It found that there Were no statistically
significant differences in the travel times / distances to the nearest facilities for those with OA
compared to those with RA.  Average travel times to the GP were 1.18 miles for OA vs 1.11 miles
for RA.  Average distance to the hospital was 14.5 miles for OA vs 14.54 for RA.  Regarding
generalising the WY case study to the rest of England, the study found that the Yorkshire and
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Humberside region (including WY) had a longer travel distances to the healthcare facilities  than
London,  but  similar  distances  /  travel  times to  the rest  of  England (outside of  London).   For
example, the average was 1.20 miles to the nearest GP in Yorkshire and Humberside vs. 0.49
miles in London for the ELSA participants.
Interrogating the ELSA datasets showed that 82.1% of individuals with OA and 77.6% with RA
stated that they had access to a car when they needed it.  Whilst not everyone had access to a
car when needed, the results showed that even those who stated that they had access to a car
used the PTS or community transport to get to hospital.  Whilst previous studies had focused on
travel by car there are other stages that are critical to the journey, e.g. walking from the car park
to the hospital. Chapter 4 recorded  that 19% of those individuals with OA and 25% of those
with RA stated that they would not be able to walk 402 metres (1/4 mile) unaided.  The average
walk speed test for individuals who could walk was 2.4km and hour for OA, 2.2km an hour for
RA, compared to 4.8km per hour for the general ELSA population (so slower).  This is particularly
interesting when compared with the assumption used for how long to plan for pedestrians
crossing a road at a pedestrian crossing facility which is 1.2 metres a second or 4.3km per hour
DfT (1995), i.e. quicker than the average walk times for OA or RA patients.  Chapter 3 which
focused on patients with OA identified “access issues” with walking, but also with difficulties
getting into the vehicles.  As noted in Chapter 3, when presented with the results focused on
travel times the study’s PPI group reported that living further away made travel to health care
more difficult, but what really bothered them was the level of comfort whilst travelling, issues
getting into the vehicle, cramped conditions when using the PTS, and not knowing how long it
would take for the PTS to take them home or an accurate time of when they would be picked
up.
The results of Chapter 4 identified that a better measure of transport accessibility to healthcare
might be to focus on ‘ease of access’, subsuming and including travel times to healthcare.    This
fits in better with the GC function introduced in Chapter 1.  The results showed that living further
away from the hospital (travel time), not having access to a car, having difficulty walking, being
over the age of 80 years old, living alone, belonging to a non-white British ethnic group, and
having fewer qualifications were all predictors of poorer ‘ease of access’.   This  echoes  the
observation from Chapter 2 that distance is not the sole determining factor and Chapter 1 that
a more holistic measure is required.   Key observations described in Chapter 4 showed that even
those with a car have difficulties getting to hospital.  Key issues with travelling include individuals
travel horizons, the cost of the journey, their ability to physically undertake the journey (e.g. get
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into  a  vehicle  or  walk  to  a  bus  stop)  and  their  feelings  of  safety  and  security.    This  can  be
expressed in terms of GC.
Objective 3: Develop statistical models to examine the associations between transport accessibility
to healthcare and inequalities in health for individuals diagnosed with RA and OA.  For two case
studies:
o Case Study 1: West Yorkshire –  using the linked HES-PROMS dataset
o Case Study 2: England – Using the ELSA dataset
Chapters 3, 4 and 5 made the most significant contribution to this objective.  In developing the
cases studies one of the key process needed was to obtain ethical approval.  For the HES-PROMS
dataset this involved getting Section 251 approval to allow access to patient home postcode
data.  For the ELSA dataset approval from NatCen was required access to the grid link reference
for where individuals live in order to calculate the travel times and distances to the nearest
facilities.  This involved a significant time commitment, but allowed the study to have access to
data on actual people and more specifically the details needed on where they lived (home
postcodes).The results showed that using the home postcode as the starting location compared
to using the LSOA (that would not have required Section 251 approval) made a small and in most
cases statistically insignificant difference to the results.  A comparison was made between using
the actual hospital attended and the nearest facility for the HES-PROMS data.  This showed that
this made a statistically significant difference to the travel time / distance results.  Knowing the
hospital attended (vs nearest hospital) had more impact than having the home postcode (vs.
simply the LSOA) of the patient when calculating the travel times to the healthcare facilities.
The study focused on a range of health and wellbeing measures. Chapter 3 (using HES-PROMS
data) utilised EQ-5D-3L, EQ-5D VAS, Self-Reported General Health, OHS and OKS. Chapter 4
(using ELSA data) utilised Self-Reported General Health, CASP-19 and CES_D.  These required a
range of statistical models to analyse the data and produced differing results by method.  With
the exception of  Moist  et  al  (2008),  Thomas et  al  (2015)  and Redhage et  al  (2013),  who had
focused on HRQoL none of the studies in the Chapter 2 review had applied the same health
measures listed above.  It was the first time they had been tested to assess the travel time/
distance association.  In  using these health and wellbeing measures there was an attempt to
determine whether it was possible to see any statistically significant changes from measuring
the association with travel time/ distance. Chapter 3 and Chapter 4 showed that it was possible
to consider the association between the large range of health and wellbeing measures (not
considered in the prior literature reviewed in Chapter 2) and travel distance, time and ease of
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access.   It  should be noted that what a patient might consider as an important difference is
likely to be different to a statistically significant difference.  The results showed that associations
between travel time / distance and changes in health and wellbeing measures whilst in some
cases were statistically significant, where not large enough to meet the MCID identified from
the literature for OHS/OKS and EQ-5D-3L, but that critically it identified that MCID’s for loses
rather than gains in health maybe very different.   More work is needed in this area.
Using the ELSA dataset in Chapter 4 allowed the study to focus the models on ‘ease of access’
to the healthcare facilities.  The models calculating  access to the GP showed that as ‘ease of
access’  decreased  individuals  were  more  likely  to  report  being  in  a  worse  general  health
category (having lower CASP-19 scores) and  have a higher likelihood of having ‘caseworthy’
depression symptoms,.   The results were mixed for travel times to the GP.  For Chapter 3 the
models that focused on access to the GP found that as travel times increased individuals who
were going to have a TKR were more likely to report being in a better general health category
and having a higher baseline OKS.  For access to the GP the THR patients living further away >
10 minutes vs 1 minutes from the GP were associated with a lower baseline OHS.
The model results that focused on changes to health/ wellbeing following  a THR/ TKR showed
that whilst including travel times as a continuous were statistically insignificant, when the travel
times were split into time categories mixed results emerged.  Those THR patients travelling for >
30 minutes had a negative association (statistically significantly worse) change in OHS and EQ-
5D-3L than those travelling for < 10minutes.  However, patients travelling between 10 to 20 and
20 to 30 minutes had a positive association (statistically significantly better change in OHS) than
those travelling less than 10 minutes to the hospital.  This shows similar results to some of the
studies identified in Chapter 2, whereby it is those that travel the shortest and longest distances
that have the poorer health outcomes, after controlling for other explanatory factors.    Including
‘Ease of access’ to the hospital as the transport accessibility measure for the ELSA dataset (was
associated with poorer self-reported  health, a higher likelihood of being in a worse general
health category, lower CASP19 score, higher likelihood of being classed as ‘caseworthy’ for
depression), as individuals reported it was harder to access the hospital and GP.
Objective 4: To test the results of the systematic review and statistical models to explore policy
implications of restructuring healthcare services.
The aim of the study was to see whether changes in transport accessibility was associated with
differences in health outcomes and whether then if you changed where patients attend
healthcare facilities (e.g. through a policy of reconfiguration or centralisation ) this would be likely
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to be associated with a change in  patients’ health outcomes.  The results of Chapter 3 show that
those who are furthest away (and to a lesser extent, those closest) from the hospitals that they
attend have the worst change in health outcomes following the THR or TKR.  Any policy that
changes how easy it is for these individuals to access a new hospital will potentially affect this.
A number of scenarios were tested to assess population groups that would be affected.  The
easiest way of minimising travel times to hospital was to get patients to attend their nearest
hospital.  However, this poses a number of issues including the allocation of a large number of
patients to hospitals that previously undertook a small number of operations and goes against
the current NHS policy of choice (NHS, 2017).  The results of the scenarios showed that there
was the potential to impact on differing relevant groups by altering where they attend
healthcare facilities.  The results of the predictive modelling identified that changing where
some patient’s accessed healthcare (increasing travel times for some) had the potential to
change the average LoS in hospital and OKS/OHS health outcomes.
One of the key aspects that was identified as potentially affecting the accessibility of patients to
hospital was ability to access a car to travel.  The missing data methodology provided a new
method for  estimating car  ownership  drawing from the evidence from ELSA on what  factors
were potential predictors of car ownership.  Identifying those that are more likely to require an
alternative method of getting to their hospital appointment.  Further work would be needed to
test this methodology. In terms of evaluating where healthcare services should be reconfigured,
Chapter 5 showed that it is critical to use patient data (as patients were not uniformly distributed
within a geographical area) and to be able to evaluate the groups of individuals that are more
likely to find it harder to access the healthcare facilities and assess changes in health. Chapter
4, for example, established that individuals with these two MSK diseases in a number of ways
from the general population.
6.4 Thesis	Contributions,	Strengths	and	limitations		
Meeting these objectives has led to a number of valuable and novel contributions to the
research and evidence base.  This was the first systematic review that had brought together key
studies in global north countries that focused on travel time / distance to healthcare and health
outcomes.  As of April 2019 36 papers have cited this work.
This study was the first to apply for home postcode data for the HES-PROMS dataset and use
this data to calculate travel times to the hospitals (both attended and nearest) and registered
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GP.  By applying for Section 251 approval this will now set a precedent for other researchers to
have access  to  the same data.     The recommendation would be that  having LSOA is  a  very
accurate proxy for home postcode (which is a proxy measure in itself for where the patient lives
– the patients full address) and that it is not necessary to apply for home postcode.
This study was the first to apply for the home postcode (grid-link reference) for using the ELSA
dataset and calculating the travel times to the healthcare facilities.  It has provided evidence at
a regional level that there are inequalities in access to healthcare facilities, particularly
comparing London and to the rest of England.  The study highlighted that it is not necessarily
distance or travel time per se that is important, as whilst in London the travel times/ distances
were shorter, but that ELSA participants in London were more likely to state that it was harder
to get to both the GP and hospital.
None of the studies surveyed in Chapter 2 had calculated equivalent public transport times for
the patients yet we know that not all patients have access to a car when needed.  The results
showed a statistically significant difference in travel times for patients if they travelled by public
transport and Chapter 5 showed that these travel times are approximately equivalent to the
average  travel  times  using  the  PTS  using  the  hospital  in  Leeds  as  an  example.   The
recommendation that emerges is that we need to know more about how patients are travelling
to accurately determine whether travel times have an association.
This thesis has proposed a novel missing data methodology to estimate the proportion of
patients with no car as a proxy for those who might or might not travel to the hospital or GP by
alternative modes of travel.  The thesis showed an association between not having a car and
worse health / wellbeing using the ELSA dataset.  The recommendation that emerges would be
for  a  more  detailed  collection  of  travel  to  healthcare  data,  so  we  know  how  patients  have
travelled. This would enable questions such as, “Does travelling by PTS lead to worse outcomes?”
to be answered.  Plus who should be targeted with extra help for accessing healthcare facilities.
The study used the models developed in Chapters 3 to predict the association with health
outcomes (LoS and changes in OKS and OHS) following a policy of changing where patients
accessed healthcare facilities.  This has allowed the study to quantify the potential impacts on
health from restructuring where patients access healthcare facilities.  Whilst location allocation
methods have been applied to various policy changes in the literature (e.g. Afshari and Peng
(2014)) and using the results of linear regression for predictive modelling is commonly used in
the statistical literature.  The thesis has not found any examples in the literature where these
two approaches have been used together, as demonstrated in this thesis.
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The key strengths and limitations of the research have been discussed throughout the thesis,
but some key issues are summarized here.
When the study was designed it was planned to use the ELSA-HES linked dataset.  When this
dataset was not available due to delays due to patient confidentiality issues the study focused
on analysing the two datasets separately, as the HES-PROMS data and ELSA.  This provided a key
strength as it allowed a larger cohort of patients and individuals to be included (over 10,000
HES-PROMS THR and TKR patients) plus 3,298 individuals with OA or RA from the ELSA dataset.
One  of  the  limitations  of  using  the  HES-PROMS  dataset  was  that  with  only  50  RA  patients
included who had had a TKR or THR this was too small a sample to provide valid results, so the
focus for this case study reverted to OA patients.
The key strengths of the HES-PROMS dataset was that it collected baseline and follow-up data
using a range of health and wellbeing measures and allowed calculations of the travel times to
hospital for the TKR and THR operations using the most accurate home postcode of the patient
and hospital attended.  A key weakness was that it didn’t include links to primary care data
(other than listing the registered GP practice) and in common with the majority of the studies
reviewed in Chapter 2, did not have any data on how the patients travelled to hospital.  The
calculated travel times did not include any allowance for weather conditions or traffic
congestion, or the time spent finding a parking space and walking to the hospital, which could
all  impact  on the actual  travel  time for  the patients.    Another  limitation in  the HES-PROMS
dataset was that there was a large proportion of data that was missing due to patients not
completing parts of the questions.  This could lead to bias.  A strength of the study was that it
employed  missing  data  methodology  to  try  and  take  account  of  the  potential  bias  from  not
including these patients with missing data in the analysis.  The study showed similar results to
other  studies  such  as  Kim  et  al  (2000)  who  found  a  U  shaped  curve  with  those  closest  and
furthest away having the poorer health outcomes
The key strengths of using the ELSA dataset was that it included a range of health and well-being
measures for individuals that could be identified as having OA or RA.  One of the limitations is
that due to the study using one wave of the data and therefore unlike the HES-PROMS data not
having two data points there was potential issues with using this cross sectional dataset in terms
of seeing whether health changed over time.   For example it is not possible to determine from
one data point whether having a worse level of quality of life using the CASP19 causes individuals
to find accessing the GP more difficult or whether it is the other way around (i.e. that finding the
GP harder to access causes a lower CASP19).   This could be partly solved in the future using
longitudinal analysis methods.  Other limitations are that unlike the HES-PROMS dataset
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information is not available on whether individuals visited the hospital or which hospital they
attended, so nearest had to be used.
To look into this research areas further requires going beyond use of secondary datasets.    The
study has been designed to answer the research question using a range of methods including: a
systematic review analysis of secondary datasets and health accessibility analysis of scenarios
that focused on changing where patients attended healthcare facilities.   The study was designed
to utilise existing secondary dataset rather than collecting primary data (accessing patients with
OA or RA directly), as there were disease specific datasets accessible with both patients data
(e.g. ethnic group, home postcode) and health outcomes data.  In the timeframe available for
the thesis this was preferred as it was the more effective way of ensuring a large sample size
and having the variables to answer the research question posed.  Using the secondary datasets
allowed the whole population to be included in the case of the population in Chapter 3 or a
stratified sample of the population in the case of the population in Chapter 4 for a given time
period and covered a relevant area for this study.   Alternative methods that were considered
as part of the study were to collect primary data through questionnaires completed by patients
and undertake detailed qualitative analysis through patient interviews and focus groups.
Advantages to collecting some primary data would have been the ability to ask patients how
long it actually took them to travel to the appointment (allowing for congestion/ road works /
differences in the weather) and explore details of any difficulties they had in accessing the
healthcare facilities.   Focusing on answering the research question using interviews and focus
groups would have allowed a greater exploration of some of the difficulties patients face in
terms of accessing healthcare facilities, which is important and has been recommended for
further research, but this approach would have been very expensive and time consuming to get
a large enough and representative sample size to explore the associations with health outcomes
that were the focus of this thesis.
Not having information on how patients travel is a key element that is missing from the data
used in this thesis.  A key strength is that this absence has been highlighted by the study and the
study has proposed a potential method to estimate those who might not have access to a car
for  these trips.   More work is  needed in  this  area to  firstly  start  to  record how patients  are
travelling to hospital / the GP and secondary applying methods to estimate this where this is not
available.   Finally, a key strength is that this study had proposed a method that would allow
future restructuring decisions to be evaluated in terms of impacts on health inequalities.
6.5 Policy	Implications		
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There are a number of policy implications that arise out of this thesis that should be considered,
which are discussed next.
It has been highlighted in this thesis that decisions impacting on patient journey to healthcare
facilities sometimes fall between the gap of differing bodies: the NHS in charge of the patients
within the healthcare system, the DfT responsible for the Transport Network, Local Authorities
responsible for the local transport planning, bus companies responsible for running the bus
system, the ambulance service for running the PTS, together with other organisations such as
community transport to get patients to hospital.  It is a complex system with multiple
stakeholders.  Added to this we don’t know (with the exception of emergency ambulance trips)
how the patients in the system are travelling.  An ageing population is likely to put an increased
strain on how patients get to hospital appointments beyond using a private car to get there, so
policy should consider this complex system in more detail.  An ageing population
Centralisation vs locally provided care: The study expected to see health outcomes becoming
worse the further the patient travelled to the hospital or the GP, thereby  implying that making
patients travel further by moving away from locally provided care to centralised care would have
an impact on health inequalities.  What was observed was a U shaped curve with both those
living closest and those living furthest away having poorer health outcomes.   With an ageing
population and increasing demand for healthcare more thought is needed as to where patients
attend healthcare.  This is particularly important for centralised vs local provision.   The results
of this thesis suggest that a policy of reducing the travel times for those travelling the furthest
would be associated with improvements in health outcomes, but consideration also needs to be
given to how those who are travelling the shortest distances (what could be classed as attending
local healthcare) get to healthcare, especially those without access to a car.  There is evidence
of a trade-off between travelling further and health outcomes.  Such analysis could consider, for
example the trade-offs between ‘ease of access’ and the four key forces behind reconfiguration,
workforce  demands,  cost,  quality  and  safety.   As  Barret  (2012)  states  the  NHS  should  be
including accessibility analysis as a core input to reconfiguration proposals rather than it being
an add on that considers the consequences on travel time from other considerations such as
change due to cost or workforce issues.
6.6 Further	Research	
This study was designed to develop a methodology that, whilst being applied to the two MSK
groups of OA and RA, could then could be more generally applied to other disease groups.  In
particular, it would be possible and potentially revealing to apply this methodology to three of
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the main disease groups identified in the systematic review – cancer, kidney dialysis and mental
health.  Currently, patients for operations and treatment for OA and RA can choose where they
access this treatment (i.e. which hospital).  Disease groups that do not currently have a choice
over where they receive treatment in the UK NHS, are cancer, kidney dialysis, and mental health
treatment  (NHS,  2017).   It  would  be  important  to  assess  whether  this  lack  of  choice  and
potentially longer average travel distance and increased number of hospital visits has a greater
impact on health outcomes.  There is some initial evidence of this from the review in Chapter 2.
One of the key findings from this study is that ‘ease of access’ might be a better framework to
explore the travel burden that patients experience in accessing hospital treatment (this would
include the complexities involved in navigating to the healthcare facilities and the experiences
of travelling).  This fits better with the model of GC introduced in Chapter 1, whereby a patients
transport accessibility is a function not only of the travel time to the healthcare facilities, but
also the out-of-pocket costs, and other disutility’s associated with travelling from A to B.  One
way that this could be explored further would be to go beyond the secondary datasets and
undertake qualitative research, i.e. interview the patients and undertake evaluations of their
travel experiences in their own words and then link this back to the secondary datasets.   The
PPI group findings presented in this thesis identified that issues in parking and then walking to
the healthcare facility, long waiting times to access the PTS,  journey times being longer than
the road network time would suggest, and uncomfortable travelling conditions, were all key
aspects that contributed to the ease of access.  These issues could be better assessed using
qualitative methods.
When the research study was first designed it was expected that it would be possible to use the
linked ELSA-HES dataset.  This dataset would have provided detailed information about
individuals (e.g. how they travel and health and wellbeing).  It would have also revealed the
timing, location, and nature of hospital episodes. This would have allowed a more
comprehensive analysis that combines the information used in Chapter 3 and 4.  However, this
dataset is due only to be released in the summer of 2019 (6 years later than it was first proposed).
When released, it would therefore be possible to extend the work in this thesis to include this
linked dataset.
6.7 Final	Conclusions		
In the face of increasing demand for healthcare services and a focus on how to improve health
outcomes and reduce inequalities it is important that a holistic approach is employed, that
considers all parts of the patient journey – the journey through the healthcare system and the
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transport journey to healthcare.  It is the latter part that is considered in this thesis.  The thesis
has provided evidence that the transport element of the journey should be considered when
determining the overall health of the patient.  Any policy that changes where patients access
healthcare should be evaluated in terms of how it impacts on travel to healthcare and health
outcomes and going beyond the implications to those travelling by car.
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Proximity adj3  health*.ti,ab health*adj3 access*.ti,ab Health status.ab,ti
Proximity adj3
hospital*.ti,ab
health* adj3 care.ti,ab Health inequal*.ab,ti
Travel*.ab,ti health* adj3 facilit*.ti,ab “health related quality of
life”.ab,ti
Distance*.ab,ti hospital*.ti,ab Hrqol.ab,ti
Patient adj3 transport.ti,ab inpatient*.ab,ti Mortality.ab,ti
Journey*adj5 (car or bus or
transit or transport* or
public transport or
train).ti,ab
outpatient*.ti.ab Delay* adj3 diagnosis.ab,ti
Time to hospital*.ab,ti health* adj3 appoint*.ab,ti Late* adj3 diagnosis.ab,ti
Transportation of patients/ rural adj3 health*.ab.ti Miss*adj3 appoint*.ab,ti
Travel/ urban adj3 health*.ab,ti Health adj3 outcome.ab,ti
communit* adj3 health*.ti,ab Quality of life.ab,ti
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health* adj3 screen*.ti,ab Did not attend.ab,ti
clinic.ab,ti or clinics.ab,ti Health status/ or health status
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practice/ or hospitals, high-
volume/ or hospitals, low-
volume/ or hospitals,
private/ or hospitals, public/
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Mass screening/ Treatment adj3 follow adj3
up.ab,ti
Urban health/ Patient complian*.ab,ti
Rural health/
Health services/ or primary healthcare/ or general practice/ or
tertiary healthcare/
Emergency service, hospital/














Harris Hip Score HSS ü ü The HHS is a clinician assessed outcome measure focused on the domains of – pain, function,





KSS ü ü ü This measure was designed as an objective tool, but has been adapted over time to include
both clinician and patient input.  It involves an initial assessment of demographic details,
including an expanded Charnley functional classification.  The objective knee score,
completed by the surgeon, includes a VAS score of pain, walking on level ground and on stairs
or inclines, as well as an assessment of alignment, ligament stability, and ROM, along with
deductions for flexion contracture or extensor lag. Patients record their satisfaction,





HOS ü ü The HOS was developed to apply to younger patients (< 60) and the reflect differences in
what they might want to achieve.  It is based on two scales focusing on abilities to undertake
- Activities of daily life and secondly sporting activities. The results from these scales are








WOMAC ü ü ü The WOMAC is a 24 item questionnaire in the three domains of: pain, joint stiffness and
physical functioning.  Score between 0 and 96.  Higher scores represent a worse health








KOOS ü ü Developed from the WOMAC.  It includes 5 subscales: Pain (10 items), Symptoms (5 items),
Activity of Daily Living (17 items), Sport and Recreation Function (4 items) and Hip Related
Quality of Life (4 items). A total score is calculated by using a formula to produce a score that
ranges from 0-100 with higher scores representing better function.





HOOS ü ü Developed from the WOMAC and adapted from the KOOS.  Same description as KOOS but
applied to the hip.
ROOS et al. (1998)
Oxford Hip
Score
OHS ü ü This patient completed questionnaire consists of 12 questions designed to assess function
and pain over the previous 4 weeks for patients undergoing hip replacement surgery.  The





OKS ü ü This is the knee equivalent of the OHS. Discussed in Chapter 3. Dawson et al.
(1998)
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EQ-5D-3L ü ü This patient completed questionnaire measures health across five domains: mobility, self-








ü ü This VAS asks patients how good or bad their health on a scale of 0 – 100.  It was designed to





SF36 ü ü This patient completed questionnaire measures health across eight areas: role limitations due
to physical health, role limitations due to emotional problems, energy/fatigue, emotional






SF12 ü ü This patient completed questionnaire was developed as a shorter sub set of the SF36. Ware et al. (1996)
General Health ü ü This general questionnaire asks the question - In general, would you say that your health is
excellent, very good, good, fair, or poor?. As well as being used on its own it forms one




LEFS ü ü ü This patient completed questionnaire asks twenty questions about level of difficulties with
general activities on a five point scale from extreme/ unable to do to no difficulties.  The









SCT ü ü Measures the time to ascend and descend a flight of stairs. Hughes et al.
(1998)
6 – minute walk
test
6 mWT ü ü Measures how far patients can walk in 6 minutes. (Ko et al., 2013)
Single Limb
Stance Time
SLST ü ü Measures how long a patient can stand one legged with their eyes open. Potvin et al. (1980)
Range of
Motion
ROM ü ü ü Measures the range of movement around a joint. Roach and Miles
(1991)
Complications ü ü There are a number of potential complications from having a TKR or THR.  These include:
blood clots, differing length of legs, joint dislocations, fractures and infections.
Healy et al. (2016)




ü ü Number of days in hospital following the operation. Burn et al. (2018)
Blood loss
during surgery
ü ü Quantity of blood loss during the operation. Browne et al.
(2013)
Mortality ü ü Death during the operation or a certain time points following the operation. Hunt et al. (2017)
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ü ü ü This score has input from the clinician and patient.  The Charnley hip score assesses pain, hip




ü ü The Mayo hip questionnaire completed by patients assesses the domains of pain, function
and mobility.  It generates a total score clinical score ranging 0-80 (Excellent result is 72-80
points, good is 64-71 points, fair is 56-63 points, and poor is less than 55 points)
Singh et al. (2016)
Nottingham
Health Profile
NHP ü ü The NHP was developed to be used in epidemiological studies of health and disease. It
consists of two parts. Part I contains 38 yes/no items in 6 dimensions: pain, physical mobility,
emotional reactions, energy, social isolation and sleep. Part II contains 7 general yes/no
questions concerning daily living problems.
Hunt and McEwan
(1980)
